BRPI0710380A2 - compound, composition, pest control composition, invertebrate, spray, bait, trap device, control methods, protection methods, treated seed and protection composition - Google Patents
compound, composition, pest control composition, invertebrate, spray, bait, trap device, control methods, protection methods, treated seed and protection composition Download PDFInfo
- Publication number
- BRPI0710380A2 BRPI0710380A2 BRPI0710380-8A BRPI0710380A BRPI0710380A2 BR PI0710380 A2 BRPI0710380 A2 BR PI0710380A2 BR PI0710380 A BRPI0710380 A BR PI0710380A BR PI0710380 A2 BRPI0710380 A2 BR PI0710380A2
- Authority
- BR
- Brazil
- Prior art keywords
- alkyl
- compound
- composition
- formula
- optionally substituted
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title claims abstract description 327
- 239000000203 mixture Substances 0.000 title claims abstract description 215
- -1 invertebrate Substances 0.000 title claims abstract description 165
- 241000607479 Yersinia pestis Species 0.000 title claims abstract description 138
- 238000000034 method Methods 0.000 title claims abstract description 72
- 239000007921 spray Substances 0.000 title claims description 26
- 125000001424 substituent group Chemical group 0.000 claims abstract description 84
- 150000003839 salts Chemical class 0.000 claims abstract description 29
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims abstract description 27
- 229910052757 nitrogen Inorganic materials 0.000 claims abstract description 25
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 24
- 125000000623 heterocyclic group Chemical group 0.000 claims abstract description 21
- 125000001316 cycloalkyl alkyl group Chemical group 0.000 claims abstract description 19
- 150000001204 N-oxides Chemical class 0.000 claims abstract description 16
- 125000005119 alkyl cycloalkyl group Chemical group 0.000 claims abstract description 16
- 229920006395 saturated elastomer Polymers 0.000 claims abstract description 14
- 125000000753 cycloalkyl group Chemical group 0.000 claims abstract description 11
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims abstract description 8
- 229910052736 halogen Inorganic materials 0.000 claims description 66
- 150000002367 halogens Chemical class 0.000 claims description 61
- 241001465754 Metazoa Species 0.000 claims description 53
- 239000007787 solid Substances 0.000 claims description 45
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 42
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 39
- 238000009472 formulation Methods 0.000 claims description 38
- 125000004076 pyridyl group Chemical group 0.000 claims description 37
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 33
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 30
- 239000003085 diluting agent Substances 0.000 claims description 27
- 239000007788 liquid Substances 0.000 claims description 26
- 125000003118 aryl group Chemical group 0.000 claims description 23
- 125000004429 atom Chemical group 0.000 claims description 23
- 235000013305 food Nutrition 0.000 claims description 22
- 125000001188 haloalkyl group Chemical group 0.000 claims description 22
- 239000002689 soil Substances 0.000 claims description 22
- 239000004094 surface-active agent Substances 0.000 claims description 22
- 239000013543 active substance Substances 0.000 claims description 21
- 230000000590 parasiticidal effect Effects 0.000 claims description 21
- 125000000171 (C1-C6) haloalkyl group Chemical group 0.000 claims description 20
- 229910052799 carbon Inorganic materials 0.000 claims description 20
- 241000238876 Acari Species 0.000 claims description 19
- 241000255925 Diptera Species 0.000 claims description 19
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 claims description 18
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims description 18
- 239000005660 Abamectin Substances 0.000 claims description 18
- 238000011282 treatment Methods 0.000 claims description 18
- 241000193388 Bacillus thuringiensis Species 0.000 claims description 16
- 229940097012 bacillus thuringiensis Drugs 0.000 claims description 15
- 229910052739 hydrogen Inorganic materials 0.000 claims description 14
- 239000002917 insecticide Substances 0.000 claims description 14
- 241000256856 Vespidae Species 0.000 claims description 12
- 125000004432 carbon atom Chemical group C* 0.000 claims description 12
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 claims description 11
- 241000256602 Isoptera Species 0.000 claims description 11
- 230000015572 biosynthetic process Effects 0.000 claims description 11
- 125000004663 dialkyl amino group Chemical group 0.000 claims description 11
- 238000003786 synthesis reaction Methods 0.000 claims description 11
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims description 10
- IBSREHMXUMOFBB-JFUDTMANSA-N 5u8924t11h Chemical compound O1[C@@H](C)[C@H](O)[C@@H](OC)C[C@@H]1O[C@@H]1[C@@H](OC)C[C@H](O[C@@H]2C(=C/C[C@@H]3C[C@@H](C[C@@]4(O3)C=C[C@H](C)[C@@H](C(C)C)O4)OC(=O)[C@@H]3C=C(C)[C@@H](O)[C@H]4OC\C([C@@]34O)=C/C=C/[C@@H]2C)/C)O[C@H]1C.C1=C[C@H](C)[C@@H]([C@@H](C)CC)O[C@]11O[C@H](C\C=C(C)\[C@@H](O[C@@H]2O[C@@H](C)[C@H](O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](OC)C3)[C@@H](OC)C2)[C@@H](C)\C=C\C=C/2[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\2)O)C[C@H]4C1 IBSREHMXUMOFBB-JFUDTMANSA-N 0.000 claims description 10
- 241000257303 Hymenoptera Species 0.000 claims description 10
- 241000700605 Viruses Species 0.000 claims description 10
- 229950008167 abamectin Drugs 0.000 claims description 10
- 125000004414 alkyl thio group Chemical group 0.000 claims description 10
- 239000000463 material Substances 0.000 claims description 10
- 125000001425 triazolyl group Chemical group 0.000 claims description 10
- 125000004769 (C1-C4) alkylsulfonyl group Chemical group 0.000 claims description 9
- 125000000229 (C1-C4)alkoxy group Chemical group 0.000 claims description 9
- 125000006828 (C2-C7) alkoxycarbonyl group Chemical group 0.000 claims description 9
- 125000003601 C2-C6 alkynyl group Chemical group 0.000 claims description 9
- 230000000967 entomopathogenic effect Effects 0.000 claims description 9
- 239000003112 inhibitor Substances 0.000 claims description 9
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 9
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 claims description 8
- 125000004739 (C1-C6) alkylsulfonyl group Chemical group 0.000 claims description 8
- 125000006700 (C1-C6) alkylthio group Chemical group 0.000 claims description 8
- 125000004737 (C1-C6) haloalkoxy group Chemical group 0.000 claims description 8
- XTFIVUDBNACUBN-UHFFFAOYSA-N 1,3,5-trinitro-1,3,5-triazinane Chemical compound [O-][N+](=O)N1CN([N+]([O-])=O)CN([N+]([O-])=O)C1 XTFIVUDBNACUBN-UHFFFAOYSA-N 0.000 claims description 8
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 claims description 8
- 239000005894 Emamectin Substances 0.000 claims description 8
- 239000005906 Imidacloprid Substances 0.000 claims description 8
- 239000005907 Indoxacarb Substances 0.000 claims description 8
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 8
- 241000257226 Muscidae Species 0.000 claims description 8
- 239000005950 Oxamyl Substances 0.000 claims description 8
- VQXSOUPNOZTNAI-UHFFFAOYSA-N Pyrethrin I Natural products CC(=CC1CC1C(=O)OC2CC(=O)C(=C2C)CC=C/C=C)C VQXSOUPNOZTNAI-UHFFFAOYSA-N 0.000 claims description 8
- 125000004448 alkyl carbonyl group Chemical group 0.000 claims description 8
- RRZXIRBKKLTSOM-XPNPUAGNSA-N avermectin B1a Chemical compound C1=C[C@H](C)[C@@H]([C@@H](C)CC)O[C@]11O[C@H](C\C=C(C)\[C@@H](O[C@@H]2O[C@@H](C)[C@H](O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](OC)C3)[C@@H](OC)C2)[C@@H](C)\C=C\C=C/2[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\2)O)C[C@H]4C1 RRZXIRBKKLTSOM-XPNPUAGNSA-N 0.000 claims description 8
- 239000011230 binding agent Substances 0.000 claims description 8
- PXBRQCKWGAHEHS-UHFFFAOYSA-N dichlorodifluoromethane Chemical compound FC(F)(Cl)Cl PXBRQCKWGAHEHS-UHFFFAOYSA-N 0.000 claims description 8
- CXEGAUYXQAKHKJ-NSBHKLITSA-N emamectin B1a Chemical compound C1=C[C@H](C)[C@@H]([C@@H](C)CC)O[C@]11O[C@H](C\C=C(C)\[C@@H](O[C@@H]2O[C@@H](C)[C@H](O[C@@H]3O[C@@H](C)[C@H](NC)[C@@H](OC)C3)[C@@H](OC)C2)[C@@H](C)\C=C\C=C/2[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\2)O)C[C@H]4C1 CXEGAUYXQAKHKJ-NSBHKLITSA-N 0.000 claims description 8
- 229940056881 imidacloprid Drugs 0.000 claims description 8
- YWTYJOPNNQFBPC-UHFFFAOYSA-N imidacloprid Chemical compound [O-][N+](=O)\N=C1/NCCN1CC1=CC=C(Cl)N=C1 YWTYJOPNNQFBPC-UHFFFAOYSA-N 0.000 claims description 8
- 125000002883 imidazolyl group Chemical group 0.000 claims description 8
- VBCVPMMZEGZULK-NRFANRHFSA-N indoxacarb Chemical compound C([C@@]1(OC2)C(=O)OC)C3=CC(Cl)=CC=C3C1=NN2C(=O)N(C(=O)OC)C1=CC=C(OC(F)(F)F)C=C1 VBCVPMMZEGZULK-NRFANRHFSA-N 0.000 claims description 8
- KZAUOCCYDRDERY-UHFFFAOYSA-N oxamyl Chemical compound CNC(=O)ON=C(SC)C(=O)N(C)C KZAUOCCYDRDERY-UHFFFAOYSA-N 0.000 claims description 8
- HYJYGLGUBUDSLJ-UHFFFAOYSA-N pyrethrin Natural products CCC(=O)OC1CC(=C)C2CC3OC3(C)C2C2OC(=O)C(=C)C12 HYJYGLGUBUDSLJ-UHFFFAOYSA-N 0.000 claims description 8
- VJFUPGQZSXIULQ-XIGJTORUSA-N pyrethrin II Chemical compound CC1(C)[C@H](/C=C(\C)C(=O)OC)[C@H]1C(=O)O[C@@H]1C(C)=C(C\C=C/C=C)C(=O)C1 VJFUPGQZSXIULQ-XIGJTORUSA-N 0.000 claims description 8
- 229910052717 sulfur Inorganic materials 0.000 claims description 8
- 125000004738 (C1-C6) alkyl sulfinyl group Chemical group 0.000 claims description 7
- 125000006656 (C2-C4) alkenyl group Chemical group 0.000 claims description 7
- 125000006650 (C2-C4) alkynyl group Chemical group 0.000 claims description 7
- 125000006773 (C2-C7) alkylcarbonyl group Chemical group 0.000 claims description 7
- WCXDHFDTOYPNIE-RIYZIHGNSA-N (E)-acetamiprid Chemical compound N#C/N=C(\C)N(C)CC1=CC=C(Cl)N=C1 WCXDHFDTOYPNIE-RIYZIHGNSA-N 0.000 claims description 7
- IQVNEKKDSLOHHK-FNCQTZNRSA-N (E,E)-hydramethylnon Chemical compound N1CC(C)(C)CNC1=NN=C(/C=C/C=1C=CC(=CC=1)C(F)(F)F)\C=C\C1=CC=C(C(F)(F)F)C=C1 IQVNEKKDSLOHHK-FNCQTZNRSA-N 0.000 claims description 7
- 239000005875 Acetamiprid Substances 0.000 claims description 7
- 241000239290 Araneae Species 0.000 claims description 7
- 108700003918 Bacillus Thuringiensis insecticidal crystal Proteins 0.000 claims description 7
- 239000005885 Buprofezin Substances 0.000 claims description 7
- 239000005944 Chlorpyrifos Substances 0.000 claims description 7
- 241000255628 Tabanidae Species 0.000 claims description 7
- 229960002587 amitraz Drugs 0.000 claims description 7
- QXAITBQSYVNQDR-ZIOPAAQOSA-N amitraz Chemical compound C=1C=C(C)C=C(C)C=1/N=C/N(C)\C=N\C1=CC=C(C)C=C1C QXAITBQSYVNQDR-ZIOPAAQOSA-N 0.000 claims description 7
- PRLVTUNWOQKEAI-VKAVYKQESA-N buprofezin Chemical compound O=C1N(C(C)C)\C(=N\C(C)(C)C)SCN1C1=CC=CC=C1 PRLVTUNWOQKEAI-VKAVYKQESA-N 0.000 claims description 7
- IRUJZVNXZWPBMU-UHFFFAOYSA-N cartap Chemical compound NC(=O)SCC(N(C)C)CSC(N)=O IRUJZVNXZWPBMU-UHFFFAOYSA-N 0.000 claims description 7
- SBPBAQFWLVIOKP-UHFFFAOYSA-N chlorpyrifos Chemical compound CCOP(=S)(OCC)OC1=NC(Cl)=C(Cl)C=C1Cl SBPBAQFWLVIOKP-UHFFFAOYSA-N 0.000 claims description 7
- 229950006824 dieldrin Drugs 0.000 claims description 7
- DFBKLUNHFCTMDC-PICURKEMSA-N dieldrin Chemical compound C([C@H]1[C@H]2[C@@]3(Cl)C(Cl)=C([C@]([C@H]22)(Cl)C3(Cl)Cl)Cl)[C@H]2[C@@H]2[C@H]1O2 DFBKLUNHFCTMDC-PICURKEMSA-N 0.000 claims description 7
- NGPMUTDCEIKKFM-UHFFFAOYSA-N dieldrin Natural products CC1=C(Cl)C2(Cl)C3C4CC(C5OC45)C3C1(Cl)C2(Cl)Cl NGPMUTDCEIKKFM-UHFFFAOYSA-N 0.000 claims description 7
- YKBZOVFACRVRJN-UHFFFAOYSA-N dinotefuran Chemical compound [O-][N+](=O)\N=C(/NC)NCC1CCOC1 YKBZOVFACRVRJN-UHFFFAOYSA-N 0.000 claims description 7
- RDYMFSUJUZBWLH-SVWSLYAFSA-N endosulfan Chemical compound C([C@@H]12)OS(=O)OC[C@@H]1[C@]1(Cl)C(Cl)=C(Cl)[C@@]2(Cl)C1(Cl)Cl RDYMFSUJUZBWLH-SVWSLYAFSA-N 0.000 claims description 7
- 125000005347 halocycloalkyl group Chemical group 0.000 claims description 7
- NJPPVKZQTLUDBO-UHFFFAOYSA-N novaluron Chemical compound C1=C(Cl)C(OC(F)(F)C(OC(F)(F)F)F)=CC=C1NC(=O)NC(=O)C1=C(F)C=CC=C1F NJPPVKZQTLUDBO-UHFFFAOYSA-N 0.000 claims description 7
- YTYGAJLZOJPJGH-UHFFFAOYSA-N noviflumuron Chemical compound FC1=C(Cl)C(OC(F)(F)C(C(F)(F)F)F)=C(Cl)C=C1NC(=O)NC(=O)C1=C(F)C=CC=C1F YTYGAJLZOJPJGH-UHFFFAOYSA-N 0.000 claims description 7
- 125000003226 pyrazolyl group Chemical group 0.000 claims description 7
- 125000004890 (C1-C6) alkylamino group Chemical group 0.000 claims description 6
- 125000006645 (C3-C4) cycloalkyl group Chemical group 0.000 claims description 6
- 241001674044 Blattodea Species 0.000 claims description 6
- JFLRKDZMHNBDQS-UCQUSYKYSA-N CC[C@H]1CCC[C@@H]([C@H](C(=O)C2=C[C@H]3[C@@H]4C[C@@H](C[C@H]4C(=C[C@H]3[C@@H]2CC(=O)O1)C)O[C@H]5[C@@H]([C@@H]([C@H]([C@@H](O5)C)OC)OC)OC)C)O[C@H]6CC[C@@H]([C@H](O6)C)N(C)C.CC[C@H]1CCC[C@@H]([C@H](C(=O)C2=C[C@H]3[C@@H]4C[C@@H](C[C@H]4C=C[C@H]3C2CC(=O)O1)O[C@H]5[C@@H]([C@@H]([C@H]([C@@H](O5)C)OC)OC)OC)C)O[C@H]6CC[C@@H]([C@H](O6)C)N(C)C Chemical compound CC[C@H]1CCC[C@@H]([C@H](C(=O)C2=C[C@H]3[C@@H]4C[C@@H](C[C@H]4C(=C[C@H]3[C@@H]2CC(=O)O1)C)O[C@H]5[C@@H]([C@@H]([C@H]([C@@H](O5)C)OC)OC)OC)C)O[C@H]6CC[C@@H]([C@H](O6)C)N(C)C.CC[C@H]1CCC[C@@H]([C@H](C(=O)C2=C[C@H]3[C@@H]4C[C@@H](C[C@H]4C=C[C@H]3C2CC(=O)O1)O[C@H]5[C@@H]([C@@H]([C@H]([C@@H](O5)C)OC)OC)OC)C)O[C@H]6CC[C@@H]([C@H](O6)C)N(C)C JFLRKDZMHNBDQS-UCQUSYKYSA-N 0.000 claims description 6
- 239000005891 Cyromazine Substances 0.000 claims description 6
- 239000005892 Deltamethrin Substances 0.000 claims description 6
- 241000233866 Fungi Species 0.000 claims description 6
- 239000005912 Lufenuron Substances 0.000 claims description 6
- 239000005914 Metaflumizone Substances 0.000 claims description 6
- MIFOMMKAVSCNKQ-HWIUFGAZSA-N Metaflumizone Chemical compound C1=CC(OC(F)(F)F)=CC=C1NC(=O)N\N=C(C=1C=C(C=CC=1)C(F)(F)F)\CC1=CC=C(C#N)C=C1 MIFOMMKAVSCNKQ-HWIUFGAZSA-N 0.000 claims description 6
- 239000005916 Methomyl Substances 0.000 claims description 6
- 239000005930 Spinosad Substances 0.000 claims description 6
- 239000005942 Triflumuron Substances 0.000 claims description 6
- 239000000853 adhesive Substances 0.000 claims description 6
- LVQDKIWDGQRHTE-UHFFFAOYSA-N cyromazine Chemical compound NC1=NC(N)=NC(NC2CC2)=N1 LVQDKIWDGQRHTE-UHFFFAOYSA-N 0.000 claims description 6
- 229950000775 cyromazine Drugs 0.000 claims description 6
- 229960002483 decamethrin Drugs 0.000 claims description 6
- OWZREIFADZCYQD-NSHGMRRFSA-N deltamethrin Chemical compound CC1(C)[C@@H](C=C(Br)Br)[C@H]1C(=O)O[C@H](C#N)C1=CC=CC(OC=2C=CC=CC=2)=C1 OWZREIFADZCYQD-NSHGMRRFSA-N 0.000 claims description 6
- 239000003906 humectant Substances 0.000 claims description 6
- 229960000521 lufenuron Drugs 0.000 claims description 6
- PWPJGUXAGUPAHP-UHFFFAOYSA-N lufenuron Chemical compound C1=C(Cl)C(OC(F)(F)C(C(F)(F)F)F)=CC(Cl)=C1NC(=O)NC(=O)C1=C(F)C=CC=C1F PWPJGUXAGUPAHP-UHFFFAOYSA-N 0.000 claims description 6
- UHXUZOCRWCRNSJ-QPJJXVBHSA-N methomyl Chemical compound CNC(=O)O\N=C(/C)SC UHXUZOCRWCRNSJ-QPJJXVBHSA-N 0.000 claims description 6
- 239000003380 propellant Substances 0.000 claims description 6
- NHDHVHZZCFYRSB-UHFFFAOYSA-N pyriproxyfen Chemical compound C=1C=CC=NC=1OC(C)COC(C=C1)=CC=C1OC1=CC=CC=C1 NHDHVHZZCFYRSB-UHFFFAOYSA-N 0.000 claims description 6
- 238000002791 soaking Methods 0.000 claims description 6
- 229940014213 spinosad Drugs 0.000 claims description 6
- 125000000335 thiazolyl group Chemical group 0.000 claims description 6
- CYRMSUTZVYGINF-UHFFFAOYSA-N trichlorofluoromethane Chemical compound FC(Cl)(Cl)Cl CYRMSUTZVYGINF-UHFFFAOYSA-N 0.000 claims description 6
- XAIPTRIXGHTTNT-UHFFFAOYSA-N triflumuron Chemical compound C1=CC(OC(F)(F)F)=CC=C1NC(=O)NC(=O)C1=CC=CC=C1Cl XAIPTRIXGHTTNT-UHFFFAOYSA-N 0.000 claims description 6
- 239000003981 vehicle Substances 0.000 claims description 6
- 125000004749 (C1-C6) haloalkylsulfinyl group Chemical group 0.000 claims description 5
- ZOCSXAVNDGMNBV-UHFFFAOYSA-N 5-amino-1-[2,6-dichloro-4-(trifluoromethyl)phenyl]-4-[(trifluoromethyl)sulfinyl]-1H-pyrazole-3-carbonitrile Chemical compound NC1=C(S(=O)C(F)(F)F)C(C#N)=NN1C1=C(Cl)C=C(C(F)(F)F)C=C1Cl ZOCSXAVNDGMNBV-UHFFFAOYSA-N 0.000 claims description 5
- 241000894006 Bacteria Species 0.000 claims description 5
- 239000005884 Beta-Cyfluthrin Substances 0.000 claims description 5
- 239000005946 Cypermethrin Substances 0.000 claims description 5
- 239000005899 Fipronil Substances 0.000 claims description 5
- 239000005663 Pyridaben Substances 0.000 claims description 5
- 239000005926 Pyridalyl Substances 0.000 claims description 5
- QQODLKZGRKWIFG-RUTXASTPSA-N [(R)-cyano-(4-fluoro-3-phenoxyphenyl)methyl] (1S)-3-(2,2-dichloroethenyl)-2,2-dimethylcyclopropane-1-carboxylate Chemical compound CC1(C)C(C=C(Cl)Cl)[C@@H]1C(=O)O[C@@H](C#N)C1=CC=C(F)C(OC=2C=CC=CC=2)=C1 QQODLKZGRKWIFG-RUTXASTPSA-N 0.000 claims description 5
- 125000003282 alkyl amino group Chemical group 0.000 claims description 5
- OMFRMAHOUUJSGP-IRHGGOMRSA-N bifenthrin Chemical compound C1=CC=C(C=2C=CC=CC=2)C(C)=C1COC(=O)[C@@H]1[C@H](\C=C(/Cl)C(F)(F)F)C1(C)C OMFRMAHOUUJSGP-IRHGGOMRSA-N 0.000 claims description 5
- 239000003124 biologic agent Substances 0.000 claims description 5
- CWFOCCVIPCEQCK-UHFFFAOYSA-N chlorfenapyr Chemical compound BrC1=C(C(F)(F)F)N(COCC)C(C=2C=CC(Cl)=CC=2)=C1C#N CWFOCCVIPCEQCK-UHFFFAOYSA-N 0.000 claims description 5
- 229960001591 cyfluthrin Drugs 0.000 claims description 5
- QQODLKZGRKWIFG-QSFXBCCZSA-N cyfluthrin Chemical compound CC1(C)[C@@H](C=C(Cl)Cl)[C@H]1C(=O)O[C@@H](C#N)C1=CC=C(F)C(OC=2C=CC=CC=2)=C1 QQODLKZGRKWIFG-QSFXBCCZSA-N 0.000 claims description 5
- ZXQYGBMAQZUVMI-UNOMPAQXSA-N cyhalothrin Chemical compound CC1(C)C(\C=C(/Cl)C(F)(F)F)C1C(=O)OC(C#N)C1=CC=CC(OC=2C=CC=CC=2)=C1 ZXQYGBMAQZUVMI-UNOMPAQXSA-N 0.000 claims description 5
- 229960005424 cypermethrin Drugs 0.000 claims description 5
- KAATUXNTWXVJKI-UHFFFAOYSA-N cypermethrin Chemical compound CC1(C)C(C=C(Cl)Cl)C1C(=O)OC(C#N)C1=CC=CC(OC=2C=CC=CC=2)=C1 KAATUXNTWXVJKI-UHFFFAOYSA-N 0.000 claims description 5
- 229940013764 fipronil Drugs 0.000 claims description 5
- RYLHNOVXKPXDIP-UHFFFAOYSA-N flufenoxuron Chemical compound C=1C=C(NC(=O)NC(=O)C=2C(=CC=CC=2F)F)C(F)=CC=1OC1=CC=C(C(F)(F)F)C=C1Cl RYLHNOVXKPXDIP-UHFFFAOYSA-N 0.000 claims description 5
- RGNPBRKPHBKNKX-UHFFFAOYSA-N hexaflumuron Chemical compound C1=C(Cl)C(OC(F)(F)C(F)F)=C(Cl)C=C1NC(=O)NC(=O)C1=C(F)C=CC=C1F RGNPBRKPHBKNKX-UHFFFAOYSA-N 0.000 claims description 5
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 5
- DWFZBUWUXWZWKD-UHFFFAOYSA-N pyridaben Chemical compound C1=CC(C(C)(C)C)=CC=C1CSC1=C(Cl)C(=O)N(C(C)(C)C)N=C1 DWFZBUWUXWZWKD-UHFFFAOYSA-N 0.000 claims description 5
- AEHJMNVBLRLZKK-UHFFFAOYSA-N pyridalyl Chemical group N1=CC(C(F)(F)F)=CC=C1OCCCOC1=C(Cl)C=C(OCC=C(Cl)Cl)C=C1Cl AEHJMNVBLRLZKK-UHFFFAOYSA-N 0.000 claims description 5
- GOLXNESZZPUPJE-UHFFFAOYSA-N spiromesifen Chemical compound CC1=CC(C)=CC(C)=C1C(C(O1)=O)=C(OC(=O)CC(C)(C)C)C11CCCC1 GOLXNESZZPUPJE-UHFFFAOYSA-N 0.000 claims description 5
- NKNFWVNSBIXGLL-UHFFFAOYSA-N triazamate Chemical compound CCOC(=O)CSC1=NC(C(C)(C)C)=NN1C(=O)N(C)C NKNFWVNSBIXGLL-UHFFFAOYSA-N 0.000 claims description 5
- XJFIKRXIJXAJGH-UHFFFAOYSA-N 5-chloro-1,3-dihydroimidazo[4,5-b]pyridin-2-one Chemical group ClC1=CC=C2NC(=O)NC2=N1 XJFIKRXIJXAJGH-UHFFFAOYSA-N 0.000 claims description 4
- 241001147758 Bacillus thuringiensis serovar kurstaki Species 0.000 claims description 4
- 239000005653 Bifenazate Substances 0.000 claims description 4
- RAPBNVDSDCTNRC-UHFFFAOYSA-N Chlorobenzilate Chemical compound C=1C=C(Cl)C=CC=1C(O)(C(=O)OCC)C1=CC=C(Cl)C=C1 RAPBNVDSDCTNRC-UHFFFAOYSA-N 0.000 claims description 4
- 239000005945 Chlorpyrifos-methyl Substances 0.000 claims description 4
- LWLJUMBEZJHXHV-UHFFFAOYSA-N Dienochlor Chemical compound ClC1=C(Cl)C(Cl)=C(Cl)C1(Cl)C1(Cl)C(Cl)=C(Cl)C(Cl)=C1Cl LWLJUMBEZJHXHV-UHFFFAOYSA-N 0.000 claims description 4
- 239000005893 Diflubenzuron Substances 0.000 claims description 4
- 239000005947 Dimethoate Substances 0.000 claims description 4
- 241000256103 Simuliidae Species 0.000 claims description 4
- 239000005665 Spiromesifen Substances 0.000 claims description 4
- 239000005937 Tebufenozide Substances 0.000 claims description 4
- 239000005938 Teflubenzuron Substances 0.000 claims description 4
- QGLZXHRNAYXIBU-WEVVVXLNSA-N aldicarb Chemical compound CNC(=O)O\N=C\C(C)(C)SC QGLZXHRNAYXIBU-WEVVVXLNSA-N 0.000 claims description 4
- 125000003545 alkoxy group Chemical group 0.000 claims description 4
- 125000004390 alkyl sulfonyl group Chemical group 0.000 claims description 4
- VHLKTXFWDRXILV-UHFFFAOYSA-N bifenazate Chemical compound C1=C(NNC(=O)OC(C)C)C(OC)=CC=C1C1=CC=CC=C1 VHLKTXFWDRXILV-UHFFFAOYSA-N 0.000 claims description 4
- DUEPRVBVGDRKAG-UHFFFAOYSA-N carbofuran Chemical compound CNC(=O)OC1=CC=CC2=C1OC(C)(C)C2 DUEPRVBVGDRKAG-UHFFFAOYSA-N 0.000 claims description 4
- WCMMILVIRZAPLE-UHFFFAOYSA-M cyhexatin Chemical compound C1CCCCC1[Sn](C1CCCCC1)(O)C1CCCCC1 WCMMILVIRZAPLE-UHFFFAOYSA-M 0.000 claims description 4
- FHIVAFMUCKRCQO-UHFFFAOYSA-N diazinon Chemical compound CCOP(=S)(OCC)OC1=CC(C)=NC(C(C)C)=N1 FHIVAFMUCKRCQO-UHFFFAOYSA-N 0.000 claims description 4
- UOAMTSKGCBMZTC-UHFFFAOYSA-N dicofol Chemical compound C=1C=C(Cl)C=CC=1C(C(Cl)(Cl)Cl)(O)C1=CC=C(Cl)C=C1 UOAMTSKGCBMZTC-UHFFFAOYSA-N 0.000 claims description 4
- 229940019503 diflubenzuron Drugs 0.000 claims description 4
- MCWXGJITAZMZEV-UHFFFAOYSA-N dimethoate Chemical compound CNC(=O)CSP(=S)(OC)OC MCWXGJITAZMZEV-UHFFFAOYSA-N 0.000 claims description 4
- HJUFTIJOISQSKQ-UHFFFAOYSA-N fenoxycarb Chemical compound C1=CC(OCCNC(=O)OCC)=CC=C1OC1=CC=CC=C1 HJUFTIJOISQSKQ-UHFFFAOYSA-N 0.000 claims description 4
- CNKHSLKYRMDDNQ-UHFFFAOYSA-N halofenozide Chemical compound C=1C=CC=CC=1C(=O)N(C(C)(C)C)NC(=O)C1=CC=C(Cl)C=C1 CNKHSLKYRMDDNQ-UHFFFAOYSA-N 0.000 claims description 4
- 125000005843 halogen group Chemical group 0.000 claims description 4
- 230000000749 insecticidal effect Effects 0.000 claims description 4
- HOQADATXFBOEGG-UHFFFAOYSA-N isofenphos Chemical compound CCOP(=S)(NC(C)C)OC1=CC=CC=C1C(=O)OC(C)C HOQADATXFBOEGG-UHFFFAOYSA-N 0.000 claims description 4
- 125000001786 isothiazolyl group Chemical group 0.000 claims description 4
- 125000000842 isoxazolyl group Chemical group 0.000 claims description 4
- 239000002949 juvenile hormone Substances 0.000 claims description 4
- 229930014550 juvenile hormone Natural products 0.000 claims description 4
- 150000003633 juvenile hormone derivatives Chemical class 0.000 claims description 4
- KBHDSWIXRODKSZ-UHFFFAOYSA-N methyl 5-chloro-2-(trifluoromethylsulfonylamino)benzoate Chemical compound COC(=O)C1=CC(Cl)=CC=C1NS(=O)(=O)C(F)(F)F KBHDSWIXRODKSZ-UHFFFAOYSA-N 0.000 claims description 4
- YNKFZRGTXAPYFD-UHFFFAOYSA-N n-[[2-chloro-3,5-bis(trifluoromethyl)phenyl]carbamoyl]-2,6-difluorobenzamide Chemical compound FC1=CC=CC(F)=C1C(=O)NC(=O)NC1=CC(C(F)(F)F)=CC(C(F)(F)F)=C1Cl YNKFZRGTXAPYFD-UHFFFAOYSA-N 0.000 claims description 4
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims description 4
- 125000002971 oxazolyl group Chemical group 0.000 claims description 4
- QYMMJNLHFKGANY-UHFFFAOYSA-N profenofos Chemical compound CCCSP(=O)(OCC)OC1=CC=C(Br)C=C1Cl QYMMJNLHFKGANY-UHFFFAOYSA-N 0.000 claims description 4
- 125000000714 pyrimidinyl group Chemical group 0.000 claims description 4
- FBQQHUGEACOBDN-UHFFFAOYSA-N quinomethionate Chemical compound N1=C2SC(=O)SC2=NC2=CC(C)=CC=C21 FBQQHUGEACOBDN-UHFFFAOYSA-N 0.000 claims description 4
- 239000011734 sodium Substances 0.000 claims description 4
- 229910052708 sodium Inorganic materials 0.000 claims description 4
- QYPNKSZPJQQLRK-UHFFFAOYSA-N tebufenozide Chemical compound C1=CC(CC)=CC=C1C(=O)NN(C(C)(C)C)C(=O)C1=CC(C)=CC(C)=C1 QYPNKSZPJQQLRK-UHFFFAOYSA-N 0.000 claims description 4
- CJDWRQLODFKPEL-UHFFFAOYSA-N teflubenzuron Chemical compound FC1=CC=CC(F)=C1C(=O)NC(=O)NC1=CC(Cl)=C(F)C(Cl)=C1F CJDWRQLODFKPEL-UHFFFAOYSA-N 0.000 claims description 4
- XLNZEKHULJKQBA-UHFFFAOYSA-N terbufos Chemical compound CCOP(=S)(OCC)SCSC(C)(C)C XLNZEKHULJKQBA-UHFFFAOYSA-N 0.000 claims description 4
- QSOHVSNIQHGFJU-UHFFFAOYSA-L thiosultap disodium Chemical compound [Na+].[Na+].[O-]S(=O)(=O)SCC(N(C)C)CSS([O-])(=O)=O QSOHVSNIQHGFJU-UHFFFAOYSA-L 0.000 claims description 4
- 125000004306 triazinyl group Chemical group 0.000 claims description 4
- ZXQYGBMAQZUVMI-RDDWSQKMSA-N (1S)-cis-(alphaR)-cyhalothrin Chemical compound CC1(C)[C@H](\C=C(/Cl)C(F)(F)F)[C@@H]1C(=O)O[C@@H](C#N)C1=CC=CC(OC=2C=CC=CC=2)=C1 ZXQYGBMAQZUVMI-RDDWSQKMSA-N 0.000 claims description 3
- 125000006771 (C1-C6) haloalkylthio group Chemical group 0.000 claims description 3
- ZDOOQPFIGYHZFV-UHFFFAOYSA-N 2-ethyl-4-[(4-phenoxyphenoxy)methyl]-1,3-dioxolane Chemical compound O1C(CC)OCC1COC(C=C1)=CC=C1OC1=CC=CC=C1 ZDOOQPFIGYHZFV-UHFFFAOYSA-N 0.000 claims description 3
- QDFVXXBCJYNKKC-UHFFFAOYSA-N 4-[4-(4-chlorophenyl)-4-cyclopropylbutyl]-1-fluoro-2-phenoxybenzene Chemical compound C1=C(OC=2C=CC=CC=2)C(F)=CC=C1CCCC(C=1C=CC(Cl)=CC=1)C1CC1 QDFVXXBCJYNKKC-UHFFFAOYSA-N 0.000 claims description 3
- 241000193830 Bacillus <bacterium> Species 0.000 claims description 3
- 239000005874 Bifenthrin Substances 0.000 claims description 3
- 229920002101 Chitin Polymers 0.000 claims description 3
- 108010062745 Chloride Channels Proteins 0.000 claims description 3
- 102000011045 Chloride Channels Human genes 0.000 claims description 3
- 239000005887 Chromafenozide Substances 0.000 claims description 3
- 239000005657 Fenpyroximate Substances 0.000 claims description 3
- 239000005900 Flonicamid Substances 0.000 claims description 3
- 239000005901 Flubendiamide Substances 0.000 claims description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 3
- 229940123669 Mitochondrial electron transport inhibitor Drugs 0.000 claims description 3
- 239000005923 Pirimicarb Substances 0.000 claims description 3
- 239000005931 Spirotetramat Substances 0.000 claims description 3
- YASYVMFAVPKPKE-UHFFFAOYSA-N acephate Chemical compound COP(=O)(SC)NC(C)=O YASYVMFAVPKPKE-UHFFFAOYSA-N 0.000 claims description 3
- 239000000556 agonist Substances 0.000 claims description 3
- UISUNVFOGSJSKD-UHFFFAOYSA-N chlorfluazuron Chemical compound FC1=CC=CC(F)=C1C(=O)NC(=O)NC(C=C1Cl)=CC(Cl)=C1OC1=NC=C(C(F)(F)F)C=C1Cl UISUNVFOGSJSKD-UHFFFAOYSA-N 0.000 claims description 3
- 239000000544 cholinesterase inhibitor Substances 0.000 claims description 3
- HPNSNYBUADCFDR-UHFFFAOYSA-N chromafenozide Chemical compound CC1=CC(C)=CC(C(=O)N(NC(=O)C=2C(=C3CCCOC3=CC=2)C)C(C)(C)C)=C1 HPNSNYBUADCFDR-UHFFFAOYSA-N 0.000 claims description 3
- JXSJBGJIGXNWCI-UHFFFAOYSA-N diethyl 2-[(dimethoxyphosphorothioyl)thio]succinate Chemical compound CCOC(=O)CC(SP(=S)(OC)OC)C(=O)OCC JXSJBGJIGXNWCI-UHFFFAOYSA-N 0.000 claims description 3
- 239000002158 endotoxin Substances 0.000 claims description 3
- YYJNOYZRYGDPNH-MFKUBSTISA-N fenpyroximate Chemical compound C=1C=C(C(=O)OC(C)(C)C)C=CC=1CO/N=C/C=1C(C)=NN(C)C=1OC1=CC=CC=C1 YYJNOYZRYGDPNH-MFKUBSTISA-N 0.000 claims description 3
- RLQJEEJISHYWON-UHFFFAOYSA-N flonicamid Chemical compound FC(F)(F)C1=CC=NC=C1C(=O)NCC#N RLQJEEJISHYWON-UHFFFAOYSA-N 0.000 claims description 3
- ZGNITFSDLCMLGI-UHFFFAOYSA-N flubendiamide Chemical compound CC1=CC(C(F)(C(F)(F)F)C(F)(F)F)=CC=C1NC(=O)C1=CC=CC(I)=C1C(=O)NC(C)(C)CS(C)(=O)=O ZGNITFSDLCMLGI-UHFFFAOYSA-N 0.000 claims description 3
- 125000004440 haloalkylsulfinyl group Chemical group 0.000 claims description 3
- 125000004441 haloalkylsulfonyl group Chemical group 0.000 claims description 3
- 239000005910 lambda-Cyhalothrin Substances 0.000 claims description 3
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims description 3
- 229960000490 permethrin Drugs 0.000 claims description 3
- RLLPVAHGXHCWKJ-UHFFFAOYSA-N permethrin Chemical compound CC1(C)C(C=C(Cl)Cl)C1C(=O)OCC1=CC=CC(OC=2C=CC=CC=2)=C1 RLLPVAHGXHCWKJ-UHFFFAOYSA-N 0.000 claims description 3
- LMNZTLDVJIUSHT-UHFFFAOYSA-N phosmet Chemical compound C1=CC=C2C(=O)N(CSP(=S)(OC)OC)C(=O)C2=C1 LMNZTLDVJIUSHT-UHFFFAOYSA-N 0.000 claims description 3
- RGCLLPNLLBQHPF-HJWRWDBZSA-N phosphamidon Chemical compound CCN(CC)C(=O)C(\Cl)=C(/C)OP(=O)(OC)OC RGCLLPNLLBQHPF-HJWRWDBZSA-N 0.000 claims description 3
- YFGYUFNIOHWBOB-UHFFFAOYSA-N pirimicarb Chemical compound CN(C)C(=O)OC1=NC(N(C)C)=NC(C)=C1C YFGYUFNIOHWBOB-UHFFFAOYSA-N 0.000 claims description 3
- ZYHMJXZULPZUED-UHFFFAOYSA-N propargite Chemical compound C1=CC(C(C)(C)C)=CC=C1OC1C(OS(=O)OCC#C)CCCC1 ZYHMJXZULPZUED-UHFFFAOYSA-N 0.000 claims description 3
- CLSVJBIHYWPGQY-GGYDESQDSA-N spirotetramat Chemical compound CCOC(=O)OC1=C(C=2C(=CC=C(C)C=2)C)C(=O)N[C@@]11CC[C@H](OC)CC1 CLSVJBIHYWPGQY-GGYDESQDSA-N 0.000 claims description 3
- JXHJNEJVUNHLKO-UHFFFAOYSA-N sulprofos Chemical compound CCCSP(=S)(OCC)OC1=CC=C(SC)C=C1 JXHJNEJVUNHLKO-UHFFFAOYSA-N 0.000 claims description 3
- UBCKGWBNUIFUST-YHYXMXQVSA-N tetrachlorvinphos Chemical compound COP(=O)(OC)O\C(=C/Cl)C1=CC(Cl)=C(Cl)C=C1Cl UBCKGWBNUIFUST-YHYXMXQVSA-N 0.000 claims description 3
- 125000004767 (C1-C4) haloalkoxy group Chemical group 0.000 claims description 2
- 125000004765 (C1-C4) haloalkyl group Chemical group 0.000 claims description 2
- UZBGCGWTKJESDV-UHFFFAOYSA-N 2-nitro-5-[2-oxo-5-phenyl-5-(trifluoromethyl)-1,3-oxazolidin-3-yl]benzonitrile Chemical compound C1=C(C#N)C([N+](=O)[O-])=CC=C1N1C(=O)OC(C(F)(F)F)(C=2C=CC=CC=2)C1 UZBGCGWTKJESDV-UHFFFAOYSA-N 0.000 claims description 2
- 125000004189 3,4-dichlorophenyl group Chemical group [H]C1=C([H])C(Cl)=C(Cl)C([H])=C1* 0.000 claims description 2
- 239000005898 Fenoxycarb Substances 0.000 claims description 2
- 108010052164 Sodium Channels Proteins 0.000 claims description 2
- 102000018674 Sodium Channels Human genes 0.000 claims description 2
- 210000000416 exudates and transudate Anatomy 0.000 claims description 2
- GJEREQYJIQASAW-UHFFFAOYSA-N flufenerim Chemical compound CC(F)C1=NC=NC(NCCC=2C=CC(OC(F)(F)F)=CC=2)=C1Cl GJEREQYJIQASAW-UHFFFAOYSA-N 0.000 claims description 2
- 150000002596 lactones Chemical class 0.000 claims description 2
- 108010003516 norsynephrine receptor Proteins 0.000 claims description 2
- 125000004430 oxygen atom Chemical group O* 0.000 claims description 2
- BULVZWIRKLYCBC-UHFFFAOYSA-N phorate Chemical compound CCOP(=S)(OCC)SCSCC BULVZWIRKLYCBC-UHFFFAOYSA-N 0.000 claims description 2
- IOUNQDKNJZEDEP-UHFFFAOYSA-N phosalone Chemical compound C1=C(Cl)C=C2OC(=O)N(CSP(=S)(OCC)OCC)C2=C1 IOUNQDKNJZEDEP-UHFFFAOYSA-N 0.000 claims description 2
- 125000004434 sulfur atom Chemical group 0.000 claims description 2
- 239000005936 tau-Fluvalinate Substances 0.000 claims description 2
- INISTDXBRIBGOC-XMMISQBUSA-N tau-fluvalinate Chemical compound N([C@H](C(C)C)C(=O)OC(C#N)C=1C=C(OC=2C=CC=CC=2)C=CC=1)C1=CC=C(C(F)(F)F)C=C1Cl INISTDXBRIBGOC-XMMISQBUSA-N 0.000 claims description 2
- 125000000026 trimethylsilyl group Chemical group [H]C([H])([H])[Si]([*])(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 2
- BHEYXIGGNVYACW-UHFFFAOYSA-N 4-aminobutanoyl chloride Chemical compound NCCCC(Cl)=O BHEYXIGGNVYACW-UHFFFAOYSA-N 0.000 claims 1
- MUQNGPZZQDCDFT-JNQJZLCISA-N Halcinonide Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H]3OC(C)(C)O[C@@]3(C(=O)CCl)[C@@]1(C)C[C@@H]2O MUQNGPZZQDCDFT-JNQJZLCISA-N 0.000 claims 1
- WTKZEGDFNFYCGP-UHFFFAOYSA-N Pyrazole Chemical compound C=1C=NNC=1 WTKZEGDFNFYCGP-UHFFFAOYSA-N 0.000 claims 1
- 241000219315 Spinacia Species 0.000 claims 1
- 235000009337 Spinacia oleracea Nutrition 0.000 claims 1
- 239000002313 adhesive film Substances 0.000 claims 1
- 125000005037 alkyl phenyl group Chemical group 0.000 claims 1
- QQQYTWIFVNKMRW-UHFFFAOYSA-N diflubenzuron Chemical compound FC1=CC=CC(F)=C1C(=O)NC(=O)NC1=CC=C(Cl)C=C1 QQQYTWIFVNKMRW-UHFFFAOYSA-N 0.000 claims 1
- 229940028332 halog Drugs 0.000 claims 1
- 238000005507 spraying Methods 0.000 abstract description 17
- 230000006378 damage Effects 0.000 abstract description 11
- 125000003342 alkenyl group Chemical group 0.000 abstract description 5
- 125000000304 alkynyl group Chemical group 0.000 abstract description 4
- 125000004457 alkyl amino carbonyl group Chemical group 0.000 abstract description 3
- 238000012360 testing method Methods 0.000 description 57
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 54
- 241000196324 Embryophyta Species 0.000 description 46
- 239000000243 solution Substances 0.000 description 36
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 36
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 32
- 239000000047 product Substances 0.000 description 32
- 241000254173 Coleoptera Species 0.000 description 30
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 30
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 30
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 28
- 230000009418 agronomic effect Effects 0.000 description 26
- 230000002829 reductive effect Effects 0.000 description 26
- 239000004480 active ingredient Substances 0.000 description 25
- 239000011541 reaction mixture Substances 0.000 description 25
- 238000002360 preparation method Methods 0.000 description 23
- 238000005160 1H NMR spectroscopy Methods 0.000 description 21
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 21
- 239000002904 solvent Substances 0.000 description 20
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 18
- 230000000694 effects Effects 0.000 description 17
- 241000254032 Acrididae Species 0.000 description 16
- 241001124076 Aphididae Species 0.000 description 16
- 241000238631 Hexapoda Species 0.000 description 15
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 15
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 15
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 15
- 239000003795 chemical substances by application Substances 0.000 description 15
- 239000008187 granular material Substances 0.000 description 15
- 238000005481 NMR spectroscopy Methods 0.000 description 14
- 230000003071 parasitic effect Effects 0.000 description 14
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 13
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 13
- 235000013339 cereals Nutrition 0.000 description 12
- 229920000742 Cotton Polymers 0.000 description 11
- 241000219146 Gossypium Species 0.000 description 11
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 11
- 238000006243 chemical reaction Methods 0.000 description 11
- 235000013399 edible fruits Nutrition 0.000 description 11
- 239000000543 intermediate Substances 0.000 description 11
- 239000002609 medium Substances 0.000 description 11
- 238000003756 stirring Methods 0.000 description 11
- KXDAEFPNCMNJSK-UHFFFAOYSA-N Benzamide Chemical compound NC(=O)C1=CC=CC=C1 KXDAEFPNCMNJSK-UHFFFAOYSA-N 0.000 description 10
- 235000013601 eggs Nutrition 0.000 description 10
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 9
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 9
- 240000008042 Zea mays Species 0.000 description 9
- 235000014113 dietary fatty acids Nutrition 0.000 description 9
- 150000002148 esters Chemical class 0.000 description 9
- 239000000194 fatty acid Substances 0.000 description 9
- 229930195729 fatty acid Natural products 0.000 description 9
- 230000012010 growth Effects 0.000 description 9
- 239000004615 ingredient Substances 0.000 description 9
- 239000010410 layer Substances 0.000 description 9
- 239000003921 oil Substances 0.000 description 9
- 235000019198 oils Nutrition 0.000 description 9
- 239000000843 powder Substances 0.000 description 9
- 102000004169 proteins and genes Human genes 0.000 description 9
- 108090000623 proteins and genes Proteins 0.000 description 9
- 238000001228 spectrum Methods 0.000 description 9
- 230000009885 systemic effect Effects 0.000 description 9
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 9
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 8
- 235000010469 Glycine max Nutrition 0.000 description 8
- 244000068988 Glycine max Species 0.000 description 8
- 241000244206 Nematoda Species 0.000 description 8
- 235000002595 Solanum tuberosum Nutrition 0.000 description 8
- 244000061456 Solanum tuberosum Species 0.000 description 8
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 8
- 150000001298 alcohols Chemical class 0.000 description 8
- 150000001412 amines Chemical class 0.000 description 8
- PFKFTWBEEFSNDU-UHFFFAOYSA-N carbonyldiimidazole Chemical compound C1=CN=CN1C(=O)N1C=CN=C1 PFKFTWBEEFSNDU-UHFFFAOYSA-N 0.000 description 8
- 239000012044 organic layer Substances 0.000 description 8
- 244000045947 parasite Species 0.000 description 8
- 238000010898 silica gel chromatography Methods 0.000 description 8
- 239000000725 suspension Substances 0.000 description 8
- 241000254171 Curculionidae Species 0.000 description 7
- 241000238814 Orthoptera Species 0.000 description 7
- 240000007594 Oryza sativa Species 0.000 description 7
- 235000007164 Oryza sativa Nutrition 0.000 description 7
- 241001674048 Phthiraptera Species 0.000 description 7
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical group C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 7
- 241000258242 Siphonaptera Species 0.000 description 7
- 239000000654 additive Substances 0.000 description 7
- 235000020971 citrus fruits Nutrition 0.000 description 7
- 239000012141 concentrate Substances 0.000 description 7
- 235000008504 concentrate Nutrition 0.000 description 7
- 239000003480 eluent Substances 0.000 description 7
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 7
- 239000003337 fertilizer Substances 0.000 description 7
- 239000004009 herbicide Substances 0.000 description 7
- 125000004435 hydrogen atom Chemical class [H]* 0.000 description 7
- 150000002576 ketones Chemical class 0.000 description 7
- 230000008569 process Effects 0.000 description 7
- 235000018102 proteins Nutrition 0.000 description 7
- 235000009566 rice Nutrition 0.000 description 7
- 239000012279 sodium borohydride Substances 0.000 description 7
- 229910000033 sodium borohydride Inorganic materials 0.000 description 7
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 6
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 6
- 241000207199 Citrus Species 0.000 description 6
- 241000258924 Ctenocephalides felis Species 0.000 description 6
- 239000005909 Kieselgur Substances 0.000 description 6
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 6
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 6
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 6
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 6
- 230000009471 action Effects 0.000 description 6
- 239000003153 chemical reaction reagent Substances 0.000 description 6
- 239000004495 emulsifiable concentrate Substances 0.000 description 6
- 239000000839 emulsion Substances 0.000 description 6
- 238000011156 evaluation Methods 0.000 description 6
- 230000036541 health Effects 0.000 description 6
- 150000002466 imines Chemical class 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 238000006467 substitution reaction Methods 0.000 description 6
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 6
- 241000238421 Arthropoda Species 0.000 description 5
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 5
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 5
- 241000258937 Hemiptera Species 0.000 description 5
- 206010061217 Infestation Diseases 0.000 description 5
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 5
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 5
- 241000220225 Malus Species 0.000 description 5
- 241000255969 Pieris brassicae Species 0.000 description 5
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 5
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 5
- 240000006365 Vitis vinifera Species 0.000 description 5
- 235000014787 Vitis vinifera Nutrition 0.000 description 5
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 5
- 239000002253 acid Substances 0.000 description 5
- 235000005822 corn Nutrition 0.000 description 5
- 229960004132 diethyl ether Drugs 0.000 description 5
- 150000004665 fatty acids Chemical class 0.000 description 5
- 239000000499 gel Substances 0.000 description 5
- 230000014509 gene expression Effects 0.000 description 5
- 229910052749 magnesium Inorganic materials 0.000 description 5
- 239000011777 magnesium Substances 0.000 description 5
- 238000002156 mixing Methods 0.000 description 5
- 239000002297 parasiticide Substances 0.000 description 5
- 229920000642 polymer Polymers 0.000 description 5
- 239000012312 sodium hydride Substances 0.000 description 5
- 229910000104 sodium hydride Inorganic materials 0.000 description 5
- 239000011593 sulfur Substances 0.000 description 5
- 235000020357 syrup Nutrition 0.000 description 5
- 239000006188 syrup Substances 0.000 description 5
- BAKXBZPQTXCKRR-UHFFFAOYSA-N thiodicarb Chemical compound CSC(C)=NOC(=O)NSNC(=O)ON=C(C)SC BAKXBZPQTXCKRR-UHFFFAOYSA-N 0.000 description 5
- 239000002023 wood Substances 0.000 description 5
- AGMMRUPNXPWLGF-AATRIKPKSA-N (2,3,5,6-tetrafluoro-4-methylphenyl)methyl 2,2-dimethyl-3-[(e)-prop-1-enyl]cyclopropane-1-carboxylate Chemical compound CC1(C)C(/C=C/C)C1C(=O)OCC1=C(F)C(F)=C(C)C(F)=C1F AGMMRUPNXPWLGF-AATRIKPKSA-N 0.000 description 4
- 125000004741 (C1-C6) haloalkylsulfonyl group Chemical group 0.000 description 4
- IZXIZTKNFFYFOF-UHFFFAOYSA-N 2-Oxazolidone Chemical class O=C1NCCO1 IZXIZTKNFFYFOF-UHFFFAOYSA-N 0.000 description 4
- 244000144730 Amygdalus persica Species 0.000 description 4
- 241001600408 Aphis gossypii Species 0.000 description 4
- 241000271566 Aves Species 0.000 description 4
- 240000007124 Brassica oleracea Species 0.000 description 4
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 description 4
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 description 4
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 description 4
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 4
- 241000282472 Canis lupus familiaris Species 0.000 description 4
- 241000490513 Ctenocephalides canis Species 0.000 description 4
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 4
- 241000283086 Equidae Species 0.000 description 4
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 4
- 241000721621 Myzus persicae Species 0.000 description 4
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 4
- 241001510001 Periplaneta brunnea Species 0.000 description 4
- 241001516577 Phylloxera Species 0.000 description 4
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 4
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 4
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical compound CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 description 4
- 235000006040 Prunus persica var persica Nutrition 0.000 description 4
- 229920002472 Starch Polymers 0.000 description 4
- 235000009754 Vitis X bourquina Nutrition 0.000 description 4
- 235000012333 Vitis X labruscana Nutrition 0.000 description 4
- 230000000895 acaricidal effect Effects 0.000 description 4
- 239000000642 acaricide Substances 0.000 description 4
- 125000000738 acetamido group Chemical group [H]C([H])([H])C(=O)N([H])[*] 0.000 description 4
- 230000001070 adhesive effect Effects 0.000 description 4
- 229910052791 calcium Inorganic materials 0.000 description 4
- 239000011575 calcium Substances 0.000 description 4
- 239000000969 carrier Substances 0.000 description 4
- 238000000576 coating method Methods 0.000 description 4
- 125000004122 cyclic group Chemical group 0.000 description 4
- SWXVUIWOUIDPGS-UHFFFAOYSA-N diacetone alcohol Chemical compound CC(=O)CC(C)(C)O SWXVUIWOUIDPGS-UHFFFAOYSA-N 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 239000003995 emulsifying agent Substances 0.000 description 4
- 239000000835 fiber Substances 0.000 description 4
- 239000012530 fluid Substances 0.000 description 4
- 229910052731 fluorine Inorganic materials 0.000 description 4
- 239000000417 fungicide Substances 0.000 description 4
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 4
- 230000002363 herbicidal effect Effects 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 239000002736 nonionic surfactant Substances 0.000 description 4
- 235000015097 nutrients Nutrition 0.000 description 4
- 239000003960 organic solvent Substances 0.000 description 4
- 229910052760 oxygen Inorganic materials 0.000 description 4
- 239000006072 paste Substances 0.000 description 4
- 239000008188 pellet Substances 0.000 description 4
- 239000000575 pesticide Substances 0.000 description 4
- 229920001223 polyethylene glycol Polymers 0.000 description 4
- 229910052700 potassium Inorganic materials 0.000 description 4
- 239000011591 potassium Substances 0.000 description 4
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 4
- 230000009467 reduction Effects 0.000 description 4
- 239000000779 smoke Substances 0.000 description 4
- CDBYLPFSWZWCQE-UHFFFAOYSA-L sodium carbonate Substances [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 4
- 239000000600 sorbitol Substances 0.000 description 4
- 235000010356 sorbitol Nutrition 0.000 description 4
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 4
- 235000000346 sugar Nutrition 0.000 description 4
- 150000003871 sulfonates Chemical class 0.000 description 4
- 239000003826 tablet Substances 0.000 description 4
- URAYPUMNDPQOKB-UHFFFAOYSA-N triacetin Chemical compound CC(=O)OCC(OC(C)=O)COC(C)=O URAYPUMNDPQOKB-UHFFFAOYSA-N 0.000 description 4
- 235000013311 vegetables Nutrition 0.000 description 4
- XUNYDVLIZWUPAW-UHFFFAOYSA-N (4-chlorophenyl) n-(4-methylphenyl)sulfonylcarbamate Chemical compound C1=CC(C)=CC=C1S(=O)(=O)NC(=O)OC1=CC=C(Cl)C=C1 XUNYDVLIZWUPAW-UHFFFAOYSA-N 0.000 description 3
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 3
- 229960000549 4-dimethylaminophenol Drugs 0.000 description 3
- 241001098072 Acanthocephalus Species 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- 241001425390 Aphis fabae Species 0.000 description 3
- 241000273311 Aphis spiraecola Species 0.000 description 3
- 235000000832 Ayote Nutrition 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 3
- 241000907223 Bruchinae Species 0.000 description 3
- 241000258920 Chilopoda Species 0.000 description 3
- 235000009854 Cucurbita moschata Nutrition 0.000 description 3
- 235000009804 Cucurbita pepo subsp pepo Nutrition 0.000 description 3
- 241001635274 Cydia pomonella Species 0.000 description 3
- 241000995027 Empoasca fabae Species 0.000 description 3
- HMIBKHHNXANVHR-UHFFFAOYSA-N Fenothiocarb Chemical compound CN(C)C(=O)SCCCCOC1=CC=CC=C1 HMIBKHHNXANVHR-UHFFFAOYSA-N 0.000 description 3
- 241001660203 Gasterophilus Species 0.000 description 3
- 241000237858 Gastropoda Species 0.000 description 3
- 241000270322 Lepidosauria Species 0.000 description 3
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 3
- 241000124008 Mammalia Species 0.000 description 3
- 241000699666 Mus <mouse, genus> Species 0.000 description 3
- 241000699670 Mus sp. Species 0.000 description 3
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 3
- 241000764801 Nomius pygmaeus Species 0.000 description 3
- 241001147398 Ostrinia nubilalis Species 0.000 description 3
- 229910019142 PO4 Inorganic materials 0.000 description 3
- 241000500437 Plutella xylostella Species 0.000 description 3
- 239000002202 Polyethylene glycol Substances 0.000 description 3
- 239000005927 Pyriproxyfen Substances 0.000 description 3
- 241000254152 Sitophilus oryzae Species 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- 241000256251 Spodoptera frugiperda Species 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 3
- KVIZNNVXXNFLMU-AIIUZBJTSA-N [2,3,5,6-tetrafluoro-4-(methoxymethyl)phenyl]methyl (1r,3r)-2,2-dimethyl-3-[(e)-prop-1-enyl]cyclopropane-1-carboxylate Chemical compound FC1=C(F)C(COC)=C(F)C(F)=C1COC(=O)[C@H]1C(C)(C)[C@@H]1\C=C\C KVIZNNVXXNFLMU-AIIUZBJTSA-N 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 125000004644 alkyl sulfinyl group Chemical group 0.000 description 3
- 125000000129 anionic group Chemical group 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 239000003899 bactericide agent Substances 0.000 description 3
- 239000004202 carbamide Substances 0.000 description 3
- 229920002678 cellulose Polymers 0.000 description 3
- 239000001913 cellulose Substances 0.000 description 3
- 235000010980 cellulose Nutrition 0.000 description 3
- 230000001276 controlling effect Effects 0.000 description 3
- 229920001577 copolymer Polymers 0.000 description 3
- 239000012043 crude product Substances 0.000 description 3
- 239000003599 detergent Substances 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 235000005911 diet Nutrition 0.000 description 3
- 230000000378 dietary effect Effects 0.000 description 3
- 238000007598 dipping method Methods 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 239000002270 dispersing agent Substances 0.000 description 3
- 239000006185 dispersion Substances 0.000 description 3
- 239000000428 dust Substances 0.000 description 3
- 230000007613 environmental effect Effects 0.000 description 3
- 238000001704 evaporation Methods 0.000 description 3
- 230000008020 evaporation Effects 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- 238000007667 floating Methods 0.000 description 3
- 239000011737 fluorine Substances 0.000 description 3
- 239000006260 foam Substances 0.000 description 3
- 230000037406 food intake Effects 0.000 description 3
- 229960003692 gamma aminobutyric acid Drugs 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- XDDAORKBJWWYJS-UHFFFAOYSA-N glyphosate Chemical compound OC(=O)CNCP(O)(O)=O XDDAORKBJWWYJS-UHFFFAOYSA-N 0.000 description 3
- 125000004438 haloalkoxy group Chemical group 0.000 description 3
- 125000004995 haloalkylthio group Chemical group 0.000 description 3
- 244000000013 helminth Species 0.000 description 3
- 239000001257 hydrogen Substances 0.000 description 3
- 239000005457 ice water Substances 0.000 description 3
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 3
- 150000002632 lipids Chemical class 0.000 description 3
- 239000012669 liquid formulation Substances 0.000 description 3
- 229910052744 lithium Inorganic materials 0.000 description 3
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 3
- 235000019341 magnesium sulphate Nutrition 0.000 description 3
- 235000009973 maize Nutrition 0.000 description 3
- QCAWEPFNJXQPAN-UHFFFAOYSA-N methoxyfenozide Chemical compound COC1=CC=CC(C(=O)NN(C(=O)C=2C=C(C)C=C(C)C=2)C(C)(C)C)=C1C QCAWEPFNJXQPAN-UHFFFAOYSA-N 0.000 description 3
- KRTSDMXIXPKRQR-AATRIKPKSA-N monocrotophos Chemical compound CNC(=O)\C=C(/C)OP(=O)(OC)OC KRTSDMXIXPKRQR-AATRIKPKSA-N 0.000 description 3
- OFBQJSOFQDEBGM-UHFFFAOYSA-N n-pentane Natural products CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 3
- 239000005645 nematicide Substances 0.000 description 3
- 230000003647 oxidation Effects 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- 238000007911 parenteral administration Methods 0.000 description 3
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N phenylbenzene Natural products C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 3
- 239000010452 phosphate Substances 0.000 description 3
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 3
- 239000000049 pigment Substances 0.000 description 3
- 229920002451 polyvinyl alcohol Polymers 0.000 description 3
- 235000019422 polyvinyl alcohol Nutrition 0.000 description 3
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 3
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 3
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 3
- 235000015136 pumpkin Nutrition 0.000 description 3
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 3
- 229940080817 rotenone Drugs 0.000 description 3
- JUVIOZPCNVVQFO-UHFFFAOYSA-N rotenone Natural products O1C2=C3CC(C(C)=C)OC3=CC=C2C(=O)C2C1COC1=C2C=C(OC)C(OC)=C1 JUVIOZPCNVVQFO-UHFFFAOYSA-N 0.000 description 3
- 239000004576 sand Substances 0.000 description 3
- 239000000377 silicon dioxide Substances 0.000 description 3
- 210000003491 skin Anatomy 0.000 description 3
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 3
- 235000017557 sodium bicarbonate Nutrition 0.000 description 3
- 241000894007 species Species 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- 239000004546 suspension concentrate Substances 0.000 description 3
- 150000003512 tertiary amines Chemical class 0.000 description 3
- 231100000331 toxic Toxicity 0.000 description 3
- 230000002588 toxic effect Effects 0.000 description 3
- 108700012359 toxins Proteins 0.000 description 3
- WYRSGXAIHNMKOL-UHFFFAOYSA-N $l^{1}-sulfanylethane Chemical compound CC[S] WYRSGXAIHNMKOL-UHFFFAOYSA-N 0.000 description 2
- QSLPNSWXUQHVLP-UHFFFAOYSA-N $l^{1}-sulfanylmethane Chemical compound [S]C QSLPNSWXUQHVLP-UHFFFAOYSA-N 0.000 description 2
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical class OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 2
- IWZSHWBGHQBIML-ZGGLMWTQSA-N (3S,8S,10R,13S,14S,17S)-17-isoquinolin-7-yl-N,N,10,13-tetramethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-amine Chemical compound CN(C)[C@H]1CC[C@]2(C)C3CC[C@@]4(C)[C@@H](CC[C@@H]4c4ccc5ccncc5c4)[C@@H]3CC=C2C1 IWZSHWBGHQBIML-ZGGLMWTQSA-N 0.000 description 2
- CKPCAYZTYMHQEX-NBVRZTHBSA-N (e)-1-(2,4-dichlorophenyl)-n-methoxy-2-pyridin-3-ylethanimine Chemical compound C=1C=C(Cl)C=C(Cl)C=1C(=N/OC)/CC1=CC=CN=C1 CKPCAYZTYMHQEX-NBVRZTHBSA-N 0.000 description 2
- IAKOZHOLGAGEJT-UHFFFAOYSA-N 1,1,1-trichloro-2,2-bis(p-methoxyphenyl)-Ethane Chemical compound C1=CC(OC)=CC=C1C(C(Cl)(Cl)Cl)C1=CC=C(OC)C=C1 IAKOZHOLGAGEJT-UHFFFAOYSA-N 0.000 description 2
- DZDSQRPDUCSOQV-UHFFFAOYSA-N 1-(3,5-dichlorophenyl)-2,2,2-trifluoroethanone Chemical compound FC(F)(F)C(=O)C1=CC(Cl)=CC(Cl)=C1 DZDSQRPDUCSOQV-UHFFFAOYSA-N 0.000 description 2
- LQDARGUHUSPFNL-UHFFFAOYSA-N 1-[2-(2,4-dichlorophenyl)-3-(1,1,2,2-tetrafluoroethoxy)propyl]1,2,4-triazole Chemical compound C=1C=C(Cl)C=C(Cl)C=1C(COC(F)(F)C(F)F)CN1C=NC=N1 LQDARGUHUSPFNL-UHFFFAOYSA-N 0.000 description 2
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical compound CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 description 2
- UPILBRXBUSZRGP-UHFFFAOYSA-N 2-(3,5-dichlorophenyl)-2-(trifluoromethyl)oxirane Chemical compound C=1C(Cl)=CC(Cl)=CC=1C1(C(F)(F)F)CO1 UPILBRXBUSZRGP-UHFFFAOYSA-N 0.000 description 2
- CYEJMVLDXAUOPN-UHFFFAOYSA-N 2-dodecylphenol Chemical compound CCCCCCCCCCCCC1=CC=CC=C1O CYEJMVLDXAUOPN-UHFFFAOYSA-N 0.000 description 2
- YIWUKEYIRIRTPP-UHFFFAOYSA-N 2-ethylhexan-1-ol Chemical compound CCCCC(CC)CO YIWUKEYIRIRTPP-UHFFFAOYSA-N 0.000 description 2
- NHQDETIJWKXCTC-UHFFFAOYSA-N 3-chloroperbenzoic acid Chemical compound OOC(=O)C1=CC=CC(Cl)=C1 NHQDETIJWKXCTC-UHFFFAOYSA-N 0.000 description 2
- YEJRWHAVMIAJKC-UHFFFAOYSA-N 4-Butyrolactone Chemical compound O=C1CCCO1 YEJRWHAVMIAJKC-UHFFFAOYSA-N 0.000 description 2
- AQPDTYYKDYMCTH-UHFFFAOYSA-N 4-acetamido-2-methylbenzoic acid Chemical compound CC(=O)NC1=CC=C(C(O)=O)C(C)=C1 AQPDTYYKDYMCTH-UHFFFAOYSA-N 0.000 description 2
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 2
- 108010000700 Acetolactate synthase Proteins 0.000 description 2
- 241001133760 Acoelorraphe Species 0.000 description 2
- 241000253994 Acyrthosiphon pisum Species 0.000 description 2
- 244000291564 Allium cepa Species 0.000 description 2
- 235000002732 Allium cepa var. cepa Nutrition 0.000 description 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 2
- 241000238679 Amblyomma Species 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 241001259789 Amyelois transitella Species 0.000 description 2
- 241000272517 Anseriformes Species 0.000 description 2
- 241001166626 Aulacorthum solani Species 0.000 description 2
- 206010004194 Bed bug infestation Diseases 0.000 description 2
- 241001302798 Bemisia argentifolii Species 0.000 description 2
- 241000254127 Bemisia tabaci Species 0.000 description 2
- 241001631693 Blattella asahinai Species 0.000 description 2
- 241000929635 Blissus Species 0.000 description 2
- 235000004977 Brassica sinapistrum Nutrition 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 244000025254 Cannabis sativa Species 0.000 description 2
- 108091006146 Channels Proteins 0.000 description 2
- 241000426497 Chilo suppressalis Species 0.000 description 2
- 241001124134 Chrysomelidae Species 0.000 description 2
- 241000931705 Cicada Species 0.000 description 2
- 241000254137 Cicadidae Species 0.000 description 2
- 241001414835 Cimicidae Species 0.000 description 2
- 241001465977 Coccoidea Species 0.000 description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 2
- 241001340508 Crambus Species 0.000 description 2
- 241001506147 Cryptotermes brevis Species 0.000 description 2
- 241000219112 Cucumis Species 0.000 description 2
- 235000015510 Cucumis melo subsp melo Nutrition 0.000 description 2
- 240000004244 Cucurbita moschata Species 0.000 description 2
- XFXPMWWXUTWYJX-UHFFFAOYSA-N Cyanide Chemical compound N#[C-] XFXPMWWXUTWYJX-UHFFFAOYSA-N 0.000 description 2
- 241001480793 Dermacentor variabilis Species 0.000 description 2
- 241001205778 Dialeurodes citri Species 0.000 description 2
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 2
- 241001420794 Formica rufa Species 0.000 description 2
- 241000189565 Frankliniella Species 0.000 description 2
- 241000927584 Frankliniella occidentalis Species 0.000 description 2
- 241000287828 Gallus gallus Species 0.000 description 2
- 239000005562 Glyphosate Substances 0.000 description 2
- 244000020551 Helianthus annuus Species 0.000 description 2
- 235000003222 Helianthus annuus Nutrition 0.000 description 2
- 241000400808 Herpetogramma phaeopteralis Species 0.000 description 2
- 241001387505 Heterotermes tenuis Species 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 241000748095 Hymenopappus filifolius Species 0.000 description 2
- 241000922049 Ixodes holocyclus Species 0.000 description 2
- 241000238703 Ixodes scapularis Species 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- 241001638457 Lasius alienus Species 0.000 description 2
- 241000258916 Leptinotarsa decemlineata Species 0.000 description 2
- 241001015409 Listronotus maculicollis Species 0.000 description 2
- 241000238865 Loxosceles reclusa Species 0.000 description 2
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 2
- 241000922538 Melanoplus sanguinipes Species 0.000 description 2
- 241000952627 Monomorium pharaonis Species 0.000 description 2
- 241000238745 Musca autumnalis Species 0.000 description 2
- 241000257159 Musca domestica Species 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 2
- UFWIBTONFRDIAS-UHFFFAOYSA-N Naphthalene Chemical compound C1=CC=CC2=CC=CC=C21 UFWIBTONFRDIAS-UHFFFAOYSA-N 0.000 description 2
- 241000133263 Nasonovia ribisnigri Species 0.000 description 2
- 241000238834 Nauphoeta cinerea Species 0.000 description 2
- 241000359016 Nephotettix Species 0.000 description 2
- 241001012098 Omiodes indicata Species 0.000 description 2
- 241000790252 Otodectes cynotis Species 0.000 description 2
- 241000488583 Panonychus ulmi Species 0.000 description 2
- 241001494479 Pecora Species 0.000 description 2
- 241000517307 Pediculus humanus Species 0.000 description 2
- 241000238675 Periplaneta americana Species 0.000 description 2
- 241001510004 Periplaneta australasiae Species 0.000 description 2
- 241000286209 Phasianidae Species 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 241000255129 Phlebotominae Species 0.000 description 2
- YGYAWVDWMABLBF-UHFFFAOYSA-N Phosgene Chemical compound ClC(Cl)=O YGYAWVDWMABLBF-UHFFFAOYSA-N 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- 241000227425 Pieris rapae crucivora Species 0.000 description 2
- 239000004372 Polyvinyl alcohol Substances 0.000 description 2
- 241000254101 Popillia japonica Species 0.000 description 2
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
- 241000941017 Psila Species 0.000 description 2
- 241001466030 Psylloidea Species 0.000 description 2
- 241000718000 Pulex irritans Species 0.000 description 2
- MWMQNVGAHVXSPE-UHFFFAOYSA-N Pyriprole Chemical compound ClC=1C=C(C(F)(F)F)C=C(Cl)C=1N1N=C(C#N)C(SC(F)F)=C1NCC1=CC=CC=N1 MWMQNVGAHVXSPE-UHFFFAOYSA-N 0.000 description 2
- 244000088415 Raphanus sativus Species 0.000 description 2
- 241001481703 Rhipicephalus <genus> Species 0.000 description 2
- 241000167882 Rhopalosiphum maidis Species 0.000 description 2
- 241001510236 Rhyparobia maderae Species 0.000 description 2
- 229930001406 Ryanodine Natural products 0.000 description 2
- 102000001424 Ryanodine receptors Human genes 0.000 description 2
- 241000563489 Sesamia inferens Species 0.000 description 2
- 241000256108 Simulium <genus> Species 0.000 description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- 240000003768 Solanum lycopersicum Species 0.000 description 2
- 239000005664 Spirodiclofen Substances 0.000 description 2
- 241000256248 Spodoptera Species 0.000 description 2
- 241000256247 Spodoptera exigua Species 0.000 description 2
- 241001494115 Stomoxys calcitrans Species 0.000 description 2
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 2
- ULUAUXLGCMPNKK-UHFFFAOYSA-N Sulfobutanedioic acid Chemical class OC(=O)CC(C(O)=O)S(O)(=O)=O ULUAUXLGCMPNKK-UHFFFAOYSA-N 0.000 description 2
- 241000255626 Tabanus <genus> Species 0.000 description 2
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 2
- 239000005840 Tetraconazole Substances 0.000 description 2
- 241001374808 Tetramorium caespitum Species 0.000 description 2
- 241001454293 Tetranychus urticae Species 0.000 description 2
- 241000339374 Thrips tabaci Species 0.000 description 2
- 241000271862 Toxoptera Species 0.000 description 2
- 241000018137 Trialeurodes vaporariorum Species 0.000 description 2
- 241000255993 Trichoplusia ni Species 0.000 description 2
- 241000251539 Vertebrata <Metazoa> Species 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 241000209149 Zea Species 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- LNUFLCYMSVYYNW-ZPJMAFJPSA-N [(2r,3r,4s,5r,6r)-2-[(2r,3r,4s,5r,6r)-6-[(2r,3r,4s,5r,6r)-6-[(2r,3r,4s,5r,6r)-6-[[(3s,5s,8r,9s,10s,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-3-yl]oxy]-4,5-disulfo Chemical compound O([C@@H]1[C@@H](COS(O)(=O)=O)O[C@@H]([C@@H]([C@H]1OS(O)(=O)=O)OS(O)(=O)=O)O[C@@H]1[C@@H](COS(O)(=O)=O)O[C@@H]([C@@H]([C@H]1OS(O)(=O)=O)OS(O)(=O)=O)O[C@@H]1[C@@H](COS(O)(=O)=O)O[C@H]([C@@H]([C@H]1OS(O)(=O)=O)OS(O)(=O)=O)O[C@@H]1C[C@@H]2CC[C@H]3[C@@H]4CC[C@@H]([C@]4(CC[C@@H]3[C@@]2(C)CC1)C)[C@H](C)CCCC(C)C)[C@H]1O[C@H](COS(O)(=O)=O)[C@@H](OS(O)(=O)=O)[C@H](OS(O)(=O)=O)[C@H]1OS(O)(=O)=O LNUFLCYMSVYYNW-ZPJMAFJPSA-N 0.000 description 2
- FJJCIZWZNKZHII-UHFFFAOYSA-N [4,6-bis(cyanoamino)-1,3,5-triazin-2-yl]cyanamide Chemical compound N#CNC1=NC(NC#N)=NC(NC#N)=N1 FJJCIZWZNKZHII-UHFFFAOYSA-N 0.000 description 2
- 102000005421 acetyltransferase Human genes 0.000 description 2
- 108020002494 acetyltransferase Proteins 0.000 description 2
- 230000000996 additive effect Effects 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 239000000443 aerosol Substances 0.000 description 2
- 238000005054 agglomeration Methods 0.000 description 2
- 230000002776 aggregation Effects 0.000 description 2
- 239000000783 alginic acid Substances 0.000 description 2
- 235000010443 alginic acid Nutrition 0.000 description 2
- 229920000615 alginic acid Polymers 0.000 description 2
- 229960001126 alginic acid Drugs 0.000 description 2
- 150000004781 alginic acids Chemical class 0.000 description 2
- 125000004183 alkoxy alkyl group Chemical group 0.000 description 2
- 150000004996 alkyl benzenes Chemical class 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- 150000001408 amides Chemical class 0.000 description 2
- 150000001414 amino alcohols Chemical class 0.000 description 2
- 239000003945 anionic surfactant Substances 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 239000002518 antifoaming agent Substances 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 229960000892 attapulgite Drugs 0.000 description 2
- 239000005667 attractant Substances 0.000 description 2
- CJJOSEISRRTUQB-UHFFFAOYSA-N azinphos-methyl Chemical group C1=CC=C2C(=O)N(CSP(=S)(OC)OC)N=NC2=C1 CJJOSEISRRTUQB-UHFFFAOYSA-N 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 239000000440 bentonite Substances 0.000 description 2
- 229910000278 bentonite Inorganic materials 0.000 description 2
- 235000012216 bentonite Nutrition 0.000 description 2
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 2
- PUJDIJCNWFYVJX-UHFFFAOYSA-N benzyl carbamate Chemical compound NC(=O)OCC1=CC=CC=C1 PUJDIJCNWFYVJX-UHFFFAOYSA-N 0.000 description 2
- 239000004305 biphenyl Substances 0.000 description 2
- 235000010290 biphenyl Nutrition 0.000 description 2
- 229920001400 block copolymer Polymers 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- RYAGRZNBULDMBW-UHFFFAOYSA-L calcium;3-(2-hydroxy-3-methoxyphenyl)-2-[2-methoxy-4-(3-sulfonatopropyl)phenoxy]propane-1-sulfonate Chemical compound [Ca+2].COC1=CC=CC(CC(CS([O-])(=O)=O)OC=2C(=CC(CCCS([O-])(=O)=O)=CC=2)OC)=C1O RYAGRZNBULDMBW-UHFFFAOYSA-L 0.000 description 2
- KBPLFHHGFOOTCA-UHFFFAOYSA-N caprylic alcohol Natural products CCCCCCCCO KBPLFHHGFOOTCA-UHFFFAOYSA-N 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 150000001721 carbon Chemical group 0.000 description 2
- 125000002915 carbonyl group Chemical class [*:2]C([*:1])=O 0.000 description 2
- 230000000747 cardiac effect Effects 0.000 description 2
- 239000003093 cationic surfactant Substances 0.000 description 2
- 235000013330 chicken meat Nutrition 0.000 description 2
- 239000000460 chlorine Substances 0.000 description 2
- 235000019504 cigarettes Nutrition 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 229940125782 compound 2 Drugs 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 150000001879 copper Chemical class 0.000 description 2
- 229910052802 copper Inorganic materials 0.000 description 2
- 239000010949 copper Substances 0.000 description 2
- OPQARKPSCNTWTJ-UHFFFAOYSA-L copper(ii) acetate Chemical compound [Cu+2].CC([O-])=O.CC([O-])=O OPQARKPSCNTWTJ-UHFFFAOYSA-L 0.000 description 2
- 235000012343 cottonseed oil Nutrition 0.000 description 2
- RWGFKTVRMDUZSP-UHFFFAOYSA-N cumene Chemical compound CC(C)C1=CC=CC=C1 RWGFKTVRMDUZSP-UHFFFAOYSA-N 0.000 description 2
- JHIVVAPYMSGYDF-UHFFFAOYSA-N cyclohexanone Chemical compound O=C1CCCCC1 JHIVVAPYMSGYDF-UHFFFAOYSA-N 0.000 description 2
- MWKFXSUHUHTGQN-UHFFFAOYSA-N decan-1-ol Chemical compound CCCCCCCCCCO MWKFXSUHUHTGQN-UHFFFAOYSA-N 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- GUJOJGAPFQRJSV-UHFFFAOYSA-N dialuminum;dioxosilane;oxygen(2-);hydrate Chemical compound O.[O-2].[O-2].[O-2].[Al+3].[Al+3].O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O GUJOJGAPFQRJSV-UHFFFAOYSA-N 0.000 description 2
- FBOUIAKEJMZPQG-BLXFFLACSA-N diniconazole-M Chemical compound C1=NC=NN1/C([C@H](O)C(C)(C)C)=C/C1=CC=C(Cl)C=C1Cl FBOUIAKEJMZPQG-BLXFFLACSA-N 0.000 description 2
- HCUYBXPSSCRKRF-UHFFFAOYSA-N diphosgene Chemical compound ClC(=O)OC(Cl)(Cl)Cl HCUYBXPSSCRKRF-UHFFFAOYSA-N 0.000 description 2
- 238000010410 dusting Methods 0.000 description 2
- 239000000975 dye Substances 0.000 description 2
- 244000078703 ectoparasite Species 0.000 description 2
- 210000002615 epidermis Anatomy 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 230000002349 favourable effect Effects 0.000 description 2
- 244000037666 field crops Species 0.000 description 2
- 235000013312 flour Nutrition 0.000 description 2
- 125000001153 fluoro group Chemical group F* 0.000 description 2
- 238000007429 general method Methods 0.000 description 2
- 238000010353 genetic engineering Methods 0.000 description 2
- 150000002314 glycerols Chemical class 0.000 description 2
- 235000013773 glyceryl triacetate Nutrition 0.000 description 2
- 150000002334 glycols Chemical class 0.000 description 2
- 229940097068 glyphosate Drugs 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 150000004820 halides Chemical class 0.000 description 2
- 238000003306 harvesting Methods 0.000 description 2
- CATSNJVOTSVZJV-UHFFFAOYSA-N heptan-2-one Chemical compound CCCCCC(C)=O CATSNJVOTSVZJV-UHFFFAOYSA-N 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- ZSIAUFGUXNUGDI-UHFFFAOYSA-N hexan-1-ol Chemical compound CCCCCCO ZSIAUFGUXNUGDI-UHFFFAOYSA-N 0.000 description 2
- AOGQPLXWSUTHQB-UHFFFAOYSA-N hexyl acetate Chemical compound CCCCCCOC(C)=O AOGQPLXWSUTHQB-UHFFFAOYSA-N 0.000 description 2
- 150000004678 hydrides Chemical class 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- MLFHJEHSLIIPHL-UHFFFAOYSA-N isoamyl acetate Chemical compound CC(C)CCOC(C)=O MLFHJEHSLIIPHL-UHFFFAOYSA-N 0.000 description 2
- NNPPMTNAJDCUHE-UHFFFAOYSA-N isobutane Chemical compound CC(C)C NNPPMTNAJDCUHE-UHFFFAOYSA-N 0.000 description 2
- ZXEKIIBDNHEJCQ-UHFFFAOYSA-N isobutanol Chemical compound CC(C)CO ZXEKIIBDNHEJCQ-UHFFFAOYSA-N 0.000 description 2
- QWTDNUCVQCZILF-UHFFFAOYSA-N isopentane Chemical compound CCC(C)C QWTDNUCVQCZILF-UHFFFAOYSA-N 0.000 description 2
- HJOVHMDZYOCNQW-UHFFFAOYSA-N isophorone Chemical compound CC1=CC(=O)CC(C)(C)C1 HJOVHMDZYOCNQW-UHFFFAOYSA-N 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 2
- 239000007937 lozenge Substances 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 230000035800 maturation Effects 0.000 description 2
- NNKVPIKMPCQWCG-UHFFFAOYSA-N methamidophos Chemical compound COP(N)(=O)SC NNKVPIKMPCQWCG-UHFFFAOYSA-N 0.000 description 2
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 2
- MEBQXILRKZHVCX-UHFFFAOYSA-N methidathion Chemical compound COC1=NN(CSP(=S)(OC)OC)C(=O)S1 MEBQXILRKZHVCX-UHFFFAOYSA-N 0.000 description 2
- 239000004530 micro-emulsion Substances 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 229910052901 montmorillonite Inorganic materials 0.000 description 2
- 238000002703 mutagenesis Methods 0.000 description 2
- 231100000350 mutagenesis Toxicity 0.000 description 2
- CRSOQBOWXPBRES-UHFFFAOYSA-N neopentane Chemical compound CC(C)(C)C CRSOQBOWXPBRES-UHFFFAOYSA-N 0.000 description 2
- GJQIMXVRFNLMTB-UHFFFAOYSA-N nonyl acetate Chemical compound CCCCCCCCCOC(C)=O GJQIMXVRFNLMTB-UHFFFAOYSA-N 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- YLYBTZIQSIBWLI-UHFFFAOYSA-N octyl acetate Chemical compound CCCCCCCCOC(C)=O YLYBTZIQSIBWLI-UHFFFAOYSA-N 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 150000002924 oxiranes Chemical class 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052625 palygorskite Inorganic materials 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 239000008194 pharmaceutical composition Substances 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 239000003016 pheromone Substances 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- 230000008635 plant growth Effects 0.000 description 2
- 229920005862 polyol Polymers 0.000 description 2
- 150000003077 polyols Chemical class 0.000 description 2
- 229920001451 polypropylene glycol Polymers 0.000 description 2
- 229920002689 polyvinyl acetate Polymers 0.000 description 2
- 239000011118 polyvinyl acetate Substances 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 235000012015 potatoes Nutrition 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 125000006239 protecting group Chemical group 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 230000005180 public health Effects 0.000 description 2
- 150000003254 radicals Chemical class 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 125000006413 ring segment Chemical group 0.000 description 2
- JJSYXNQGLHBRRK-SFEDZAPPSA-N ryanodine Chemical compound O([C@@H]1[C@]([C@@]2([C@]3(O)[C@]45O[C@@]2(O)C[C@]([C@]4(CC[C@H](C)[C@H]5O)O)(C)[C@@]31O)C)(O)C(C)C)C(=O)C1=CC=CN1 JJSYXNQGLHBRRK-SFEDZAPPSA-N 0.000 description 2
- 108091052345 ryanodine receptor (TC 1.A.3.1) family Proteins 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 239000002002 slurry Substances 0.000 description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 description 2
- 235000017550 sodium carbonate Nutrition 0.000 description 2
- MFRIHAYPQRLWNB-UHFFFAOYSA-N sodium tert-butoxide Chemical compound [Na+].CC(C)(C)[O-] MFRIHAYPQRLWNB-UHFFFAOYSA-N 0.000 description 2
- DTDSAWVUFPGDMX-UHFFFAOYSA-N spirodiclofen Chemical compound CCC(C)(C)C(=O)OC1=C(C=2C(=CC(Cl)=CC=2)Cl)C(=O)OC11CCCCC1 DTDSAWVUFPGDMX-UHFFFAOYSA-N 0.000 description 2
- 230000000087 stabilizing effect Effects 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 239000000021 stimulant Substances 0.000 description 2
- 229960005322 streptomycin Drugs 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 2
- 239000000375 suspending agent Substances 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- 235000012222 talc Nutrition 0.000 description 2
- 239000003760 tallow Substances 0.000 description 2
- 150000004685 tetrahydrates Chemical class 0.000 description 2
- CZDYPVPMEAXLPK-UHFFFAOYSA-N tetramethylsilane Chemical compound C[Si](C)(C)C CZDYPVPMEAXLPK-UHFFFAOYSA-N 0.000 description 2
- 239000004753 textile Substances 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- YWSCPYYRJXKUDB-KAKFPZCNSA-N tralomethrin Chemical compound CC1(C)[C@@H](C(Br)C(Br)(Br)Br)[C@H]1C(=O)O[C@H](C#N)C1=CC=CC(OC=2C=CC=CC=2)=C1 YWSCPYYRJXKUDB-KAKFPZCNSA-N 0.000 description 2
- 229960002622 triacetin Drugs 0.000 description 2
- QAEDZJGFFMLHHQ-UHFFFAOYSA-N trifluoroacetic anhydride Chemical compound FC(F)(F)C(=O)OC(=O)C(F)(F)F QAEDZJGFFMLHHQ-UHFFFAOYSA-N 0.000 description 2
- UCPYLLCMEDAXFR-UHFFFAOYSA-N triphosgene Chemical compound ClC(Cl)(Cl)OC(=O)OC(Cl)(Cl)Cl UCPYLLCMEDAXFR-UHFFFAOYSA-N 0.000 description 2
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical group C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 1
- OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 description 1
- YNWVFADWVLCOPU-MDWZMJQESA-N (1E)-1-(4-chlorophenyl)-4,4-dimethyl-2-(1H-1,2,4-triazol-1-yl)pent-1-en-3-ol Chemical compound C1=NC=NN1/C(C(O)C(C)(C)C)=C/C1=CC=C(Cl)C=C1 YNWVFADWVLCOPU-MDWZMJQESA-N 0.000 description 1
- MYUPFXPCYUISAG-UHFFFAOYSA-N (2,4-dichlorophenyl)(phenyl)pyrimidin-5-ylmethanol Chemical compound C=1N=CN=CC=1C(C=1C(=CC(Cl)=CC=1)Cl)(O)C1=CC=CC=C1 MYUPFXPCYUISAG-UHFFFAOYSA-N 0.000 description 1
- SAPGTCDSBGMXCD-UHFFFAOYSA-N (2-chlorophenyl)-(4-fluorophenyl)-pyrimidin-5-ylmethanol Chemical compound C=1N=CN=CC=1C(C=1C(=CC=CC=1)Cl)(O)C1=CC=C(F)C=C1 SAPGTCDSBGMXCD-UHFFFAOYSA-N 0.000 description 1
- GHYOCDFICYLMRF-UTIIJYGPSA-N (2S,3R)-N-[(2S)-3-(cyclopenten-1-yl)-1-[(2R)-2-methyloxiran-2-yl]-1-oxopropan-2-yl]-3-hydroxy-3-(4-methoxyphenyl)-2-[[(2S)-2-[(2-morpholin-4-ylacetyl)amino]propanoyl]amino]propanamide Chemical compound C1(=CCCC1)C[C@@H](C(=O)[C@@]1(OC1)C)NC([C@H]([C@@H](C1=CC=C(C=C1)OC)O)NC([C@H](C)NC(CN1CCOCC1)=O)=O)=O GHYOCDFICYLMRF-UTIIJYGPSA-N 0.000 description 1
- CXNPLSGKWMLZPZ-GIFSMMMISA-N (2r,3r,6s)-3-[[(3s)-3-amino-5-[carbamimidoyl(methyl)amino]pentanoyl]amino]-6-(4-amino-2-oxopyrimidin-1-yl)-3,6-dihydro-2h-pyran-2-carboxylic acid Chemical compound O1[C@@H](C(O)=O)[C@H](NC(=O)C[C@@H](N)CCN(C)C(N)=N)C=C[C@H]1N1C(=O)N=C(N)C=C1 CXNPLSGKWMLZPZ-GIFSMMMISA-N 0.000 description 1
- LDVVMCZRFWMZSG-OLQVQODUSA-N (3ar,7as)-2-(trichloromethylsulfanyl)-3a,4,7,7a-tetrahydroisoindole-1,3-dione Chemical compound C1C=CC[C@H]2C(=O)N(SC(Cl)(Cl)Cl)C(=O)[C@H]21 LDVVMCZRFWMZSG-OLQVQODUSA-N 0.000 description 1
- TZURDPUOLIGSAF-VCEOMORVSA-N (4S)-4-[[(2S)-2-[[(2S,3S)-2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-4-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-6-amino-2-[[(2S)-4-amino-2-[[(2S)-2-aminopropanoyl]amino]-4-oxobutanoyl]amino]hexanoyl]amino]-5-carbamimidamidopentanoyl]pyrrolidine-2-carbonyl]amino]-3-methylbutanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-3-methylpentanoyl]amino]-4-methylsulfanylbutanoyl]amino]acetyl]amino]-3-(1H-imidazol-5-yl)propanoyl]amino]-4-methylsulfanylbutanoyl]amino]-3-methylbutanoyl]amino]-4-oxobutanoyl]amino]propanoyl]amino]-3-methylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-5-oxopentanoyl]amino]-3-methylpentanoyl]amino]-3-carboxypropanoyl]amino]-5-[[(2S)-1-[[(2S)-1-[[(2S)-4-amino-1-[[(2S)-1-[[2-[[(2S)-1-[[(2S)-4-amino-1-[[(2S)-1-[[(2S,3S)-1-[[(2S)-3-carboxy-1-[[(2S,3R)-1-[[(2S)-3-carboxy-1-[[(2S)-1-[[(1S)-1-carboxy-2-hydroxyethyl]amino]-3-methyl-1-oxobutan-2-yl]amino]-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-1-oxopropan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-1,4-dioxobutan-2-yl]amino]-1-oxopropan-2-yl]amino]-2-oxoethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-1,4-dioxobutan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-5-oxopentanoic acid Chemical compound CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CNC(=O)[C@H](CCSC)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)N)C(C)C)[C@@H](C)CC)C(C)C)C(C)C)[C@@H](C)CC)C(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(O)=O TZURDPUOLIGSAF-VCEOMORVSA-N 0.000 description 1
- PPDBOQMNKNNODG-NTEUORMPSA-N (5E)-5-(4-chlorobenzylidene)-2,2-dimethyl-1-(1,2,4-triazol-1-ylmethyl)cyclopentanol Chemical compound C1=NC=NN1CC1(O)C(C)(C)CC\C1=C/C1=CC=C(Cl)C=C1 PPDBOQMNKNNODG-NTEUORMPSA-N 0.000 description 1
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- 125000004768 (C1-C4) alkylsulfinyl group Chemical group 0.000 description 1
- 125000004750 (C1-C6) alkylaminosulfonyl group Chemical group 0.000 description 1
- 125000006619 (C1-C6) dialkylamino group Chemical group 0.000 description 1
- PGOOBECODWQEAB-UHFFFAOYSA-N (E)-clothianidin Chemical compound [O-][N+](=O)\N=C(/NC)NCC1=CN=C(Cl)S1 PGOOBECODWQEAB-UHFFFAOYSA-N 0.000 description 1
- CFRPSFYHXJZSBI-DHZHZOJOSA-N (E)-nitenpyram Chemical compound [O-][N+](=O)/C=C(\NC)N(CC)CC1=CC=C(Cl)N=C1 CFRPSFYHXJZSBI-DHZHZOJOSA-N 0.000 description 1
- MPIPASJGOJYODL-SFHVURJKSA-N (R)-isoconazole Chemical compound ClC1=CC(Cl)=CC=C1[C@@H](OCC=1C(=CC=CC=1Cl)Cl)CN1C=NC=C1 MPIPASJGOJYODL-SFHVURJKSA-N 0.000 description 1
- RMOGWMIKYWRTKW-UONOGXRCSA-N (S,S)-paclobutrazol Chemical compound C([C@@H]([C@@H](O)C(C)(C)C)N1N=CN=C1)C1=CC=C(Cl)C=C1 RMOGWMIKYWRTKW-UONOGXRCSA-N 0.000 description 1
- ZFHGXWPMULPQSE-SZGBIDFHSA-N (Z)-(1S)-cis-tefluthrin Chemical compound FC1=C(F)C(C)=C(F)C(F)=C1COC(=O)[C@@H]1C(C)(C)[C@@H]1\C=C(/Cl)C(F)(F)F ZFHGXWPMULPQSE-SZGBIDFHSA-N 0.000 description 1
- HOKKPVIRMVDYPB-UVTDQMKNSA-N (Z)-thiacloprid Chemical compound C1=NC(Cl)=CC=C1CN1C(=N/C#N)/SCC1 HOKKPVIRMVDYPB-UVTDQMKNSA-N 0.000 description 1
- ZZXUZKXVROWEIF-UHFFFAOYSA-N 1,2-butylene carbonate Chemical compound CCC1COC(=O)O1 ZZXUZKXVROWEIF-UHFFFAOYSA-N 0.000 description 1
- JWUCHKBSVLQQCO-UHFFFAOYSA-N 1-(2-fluorophenyl)-1-(4-fluorophenyl)-2-(1H-1,2,4-triazol-1-yl)ethanol Chemical compound C=1C=C(F)C=CC=1C(C=1C(=CC=CC=1)F)(O)CN1C=NC=N1 JWUCHKBSVLQQCO-UHFFFAOYSA-N 0.000 description 1
- PXMNMQRDXWABCY-UHFFFAOYSA-N 1-(4-chlorophenyl)-4,4-dimethyl-3-(1H-1,2,4-triazol-1-ylmethyl)pentan-3-ol Chemical compound C1=NC=NN1CC(O)(C(C)(C)C)CCC1=CC=C(Cl)C=C1 PXMNMQRDXWABCY-UHFFFAOYSA-N 0.000 description 1
- VGPIBGGRCVEHQZ-UHFFFAOYSA-N 1-(biphenyl-4-yloxy)-3,3-dimethyl-1-(1,2,4-triazol-1-yl)butan-2-ol Chemical compound C1=NC=NN1C(C(O)C(C)(C)C)OC(C=C1)=CC=C1C1=CC=CC=C1 VGPIBGGRCVEHQZ-UHFFFAOYSA-N 0.000 description 1
- VXNZUUAINFGPBY-UHFFFAOYSA-N 1-Butene Chemical compound CCC=C VXNZUUAINFGPBY-UHFFFAOYSA-N 0.000 description 1
- XFRVVPUIAFSTFO-UHFFFAOYSA-N 1-Tridecanol Chemical compound CCCCCCCCCCCCCO XFRVVPUIAFSTFO-UHFFFAOYSA-N 0.000 description 1
- ZZVVDIVWGXTDRQ-UHFFFAOYSA-N 1-[(4-tert-butylphenyl)methylsulfanyl]-1-butylsulfanyl-n-pyridin-3-ylmethanimine Chemical compound C=1C=CN=CC=1N=C(SCCCC)SCC1=CC=C(C(C)(C)C)C=C1 ZZVVDIVWGXTDRQ-UHFFFAOYSA-N 0.000 description 1
- WKBPZYKAUNRMKP-UHFFFAOYSA-N 1-[2-(2,4-dichlorophenyl)pentyl]1,2,4-triazole Chemical compound C=1C=C(Cl)C=C(Cl)C=1C(CCC)CN1C=NC=N1 WKBPZYKAUNRMKP-UHFFFAOYSA-N 0.000 description 1
- ONBQEOIKXPHGMB-VBSBHUPXSA-N 1-[2-[(2s,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-4,6-dihydroxyphenyl]-3-(4-hydroxyphenyl)propan-1-one Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=CC(O)=C1C(=O)CCC1=CC=C(O)C=C1 ONBQEOIKXPHGMB-VBSBHUPXSA-N 0.000 description 1
- MGNFYQILYYYUBS-UHFFFAOYSA-N 1-[3-(4-tert-butylphenyl)-2-methylpropyl]piperidine Chemical compound C=1C=C(C(C)(C)C)C=CC=1CC(C)CN1CCCCC1 MGNFYQILYYYUBS-UHFFFAOYSA-N 0.000 description 1
- DZHFFMWJXJBBRG-UHFFFAOYSA-N 1-bromo-3,5-dichlorobenzene Chemical compound ClC1=CC(Cl)=CC(Br)=C1 DZHFFMWJXJBBRG-UHFFFAOYSA-N 0.000 description 1
- LDMOEFOXLIZJOW-UHFFFAOYSA-N 1-dodecanesulfonic acid Chemical class CCCCCCCCCCCCS(O)(=O)=O LDMOEFOXLIZJOW-UHFFFAOYSA-N 0.000 description 1
- YIKWKLYQRFRGPM-UHFFFAOYSA-N 1-dodecylguanidine acetate Chemical compound CC(O)=O.CCCCCCCCCCCCN=C(N)N YIKWKLYQRFRGPM-UHFFFAOYSA-N 0.000 description 1
- 125000006017 1-propenyl group Chemical group 0.000 description 1
- 125000000530 1-propynyl group Chemical group [H]C([H])([H])C#C* 0.000 description 1
- LEZWWPYKPKIXLL-UHFFFAOYSA-N 1-{2-(4-chlorobenzyloxy)-2-(2,4-dichlorophenyl)ethyl}imidazole Chemical compound C1=CC(Cl)=CC=C1COC(C=1C(=CC(Cl)=CC=1)Cl)CN1C=NC=C1 LEZWWPYKPKIXLL-UHFFFAOYSA-N 0.000 description 1
- KIPSRYDSZQRPEA-UHFFFAOYSA-N 2,2,2-trifluoroethanamine Chemical compound NCC(F)(F)F KIPSRYDSZQRPEA-UHFFFAOYSA-N 0.000 description 1
- FBKRJCSYOMDOKB-UHFFFAOYSA-N 2,3,4-triphenylphenol Chemical class C=1C=CC=CC=1C1=C(C=2C=CC=CC=2)C(O)=CC=C1C1=CC=CC=C1 FBKRJCSYOMDOKB-UHFFFAOYSA-N 0.000 description 1
- PPPLWSCWGIJMMF-UHFFFAOYSA-N 2,3-dimethoxy-2H-pyran Chemical compound COC1OC=CC=C1OC PPPLWSCWGIJMMF-UHFFFAOYSA-N 0.000 description 1
- YTOPFCCWCSOHFV-UHFFFAOYSA-N 2,6-dimethyl-4-tridecylmorpholine Chemical compound CCCCCCCCCCCCCN1CC(C)OC(C)C1 YTOPFCCWCSOHFV-UHFFFAOYSA-N 0.000 description 1
- RIFAZAXZBXNVNY-UHFFFAOYSA-N 2-(2,2,2-trifluoroethyl)benzamide Chemical compound NC(=O)C1=CC=CC=C1CC(F)(F)F RIFAZAXZBXNVNY-UHFFFAOYSA-N 0.000 description 1
- STMIIPIFODONDC-UHFFFAOYSA-N 2-(2,4-dichlorophenyl)-1-(1H-1,2,4-triazol-1-yl)hexan-2-ol Chemical compound C=1C=C(Cl)C=C(Cl)C=1C(O)(CCCC)CN1C=NC=N1 STMIIPIFODONDC-UHFFFAOYSA-N 0.000 description 1
- KWLVWJPJKJMCSH-UHFFFAOYSA-N 2-(4-chlorophenyl)-N-{2-[3-methoxy-4-(prop-2-yn-1-yloxy)phenyl]ethyl}-2-(prop-2-yn-1-yloxy)acetamide Chemical compound C1=C(OCC#C)C(OC)=CC(CCNC(=O)C(OCC#C)C=2C=CC(Cl)=CC=2)=C1 KWLVWJPJKJMCSH-UHFFFAOYSA-N 0.000 description 1
- YABFPHSQTSFWQB-UHFFFAOYSA-N 2-(4-fluorophenyl)-1-(1,2,4-triazol-1-yl)-3-(trimethylsilyl)propan-2-ol Chemical compound C=1C=C(F)C=CC=1C(O)(C[Si](C)(C)C)CN1C=NC=N1 YABFPHSQTSFWQB-UHFFFAOYSA-N 0.000 description 1
- BOTNFCTYKJBUMU-UHFFFAOYSA-N 2-[4-(2-methylpropyl)piperazin-4-ium-1-yl]-2-oxoacetate Chemical compound CC(C)C[NH+]1CCN(C(=O)C([O-])=O)CC1 BOTNFCTYKJBUMU-UHFFFAOYSA-N 0.000 description 1
- OWDLFBLNMPCXSD-UHFFFAOYSA-N 2-chloro-N-(2,6-dimethylphenyl)-N-(2-oxotetrahydrofuran-3-yl)acetamide Chemical compound CC1=CC=CC(C)=C1N(C(=O)CCl)C1C(=O)OCC1 OWDLFBLNMPCXSD-UHFFFAOYSA-N 0.000 description 1
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 description 1
- KMBMQZQZBOLJHN-UHFFFAOYSA-N 2-methyloxirane;oxolane Chemical compound CC1CO1.C1CCOC1 KMBMQZQZBOLJHN-UHFFFAOYSA-N 0.000 description 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
- 125000001494 2-propynyl group Chemical group [H]C#CC([H])([H])* 0.000 description 1
- SOUGWDPPRBKJEX-UHFFFAOYSA-N 3,5-dichloro-N-(1-chloro-3-methyl-2-oxopentan-3-yl)-4-methylbenzamide Chemical compound ClCC(=O)C(C)(CC)NC(=O)C1=CC(Cl)=C(C)C(Cl)=C1 SOUGWDPPRBKJEX-UHFFFAOYSA-N 0.000 description 1
- OVFHHJZHXHZIHT-UHFFFAOYSA-N 3-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-yl)quinazolin-4-one Chemical compound ClC1=CC(Cl)=CC=C1N1C(=O)C2=CC=CC=C2N=C1N1N=CN=C1 OVFHHJZHXHZIHT-UHFFFAOYSA-N 0.000 description 1
- FSCWZHGZWWDELK-UHFFFAOYSA-N 3-(3,5-dichlorophenyl)-5-ethenyl-5-methyl-2,4-oxazolidinedione Chemical compound O=C1C(C)(C=C)OC(=O)N1C1=CC(Cl)=CC(Cl)=C1 FSCWZHGZWWDELK-UHFFFAOYSA-N 0.000 description 1
- 239000003148 4 aminobutyric acid receptor blocking agent Substances 0.000 description 1
- NUKYPUAOHBNCPY-UHFFFAOYSA-N 4-aminopyridine Chemical compound NC1=CC=NC=C1 NUKYPUAOHBNCPY-UHFFFAOYSA-N 0.000 description 1
- CNPURSDMOWDNOQ-UHFFFAOYSA-N 4-methoxy-7h-pyrrolo[2,3-d]pyrimidin-2-amine Chemical compound COC1=NC(N)=NC2=C1C=CN2 CNPURSDMOWDNOQ-UHFFFAOYSA-N 0.000 description 1
- YHDYCZYTLHHPDT-UHFFFAOYSA-N 5-[5-(3,5-dichlorophenyl)-2-oxo-5-(trifluoromethyl)-1,3-oxazolidin-3-yl]-2-(1,2,4-triazol-1-yl)benzonitrile Chemical compound ClC=1C=C(C=C(C1)Cl)C1(CN(C(O1)=O)C=1C=CC(=C(C#N)C1)N1N=CN=C1)C(F)(F)F YHDYCZYTLHHPDT-UHFFFAOYSA-N 0.000 description 1
- HPWJUEZFOUOUEO-UHFFFAOYSA-N 5-chloro-2-nitrobenzonitrile Chemical compound [O-][N+](=O)C1=CC=C(Cl)C=C1C#N HPWJUEZFOUOUEO-UHFFFAOYSA-N 0.000 description 1
- YAGHBCYRHFCAOU-UHFFFAOYSA-N 5-phenyl-5-(trifluoromethyl)-1,3-oxazolidin-2-one Chemical compound C=1C=CC=CC=1C1(C(F)(F)F)CNC(=O)O1 YAGHBCYRHFCAOU-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 241001516607 Adelges Species 0.000 description 1
- 241000256111 Aedes <genus> Species 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 241001136265 Agriotes Species 0.000 description 1
- 241000566547 Agrotis ipsilon Species 0.000 description 1
- 241000449794 Alabama argillacea Species 0.000 description 1
- 241000902876 Alticini Species 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 239000005727 Amisulbrom Substances 0.000 description 1
- 241000242266 Amphimallon majalis Species 0.000 description 1
- 241000566553 Anagrapha falcifera Species 0.000 description 1
- 241001198505 Anarsia lineatella Species 0.000 description 1
- 241000663922 Anasa tristis Species 0.000 description 1
- 241001465677 Ancylostomatoidea Species 0.000 description 1
- 235000019737 Animal fat Nutrition 0.000 description 1
- 241001626719 Anoplocephala perfoliata Species 0.000 description 1
- 241000254175 Anthonomus grandis Species 0.000 description 1
- 241001600407 Aphis <genus> Species 0.000 description 1
- 241001151957 Aphis aurantii Species 0.000 description 1
- 241000952611 Aphis craccivora Species 0.000 description 1
- 241000566651 Aphis forbesi Species 0.000 description 1
- 241001095118 Aphis pomi Species 0.000 description 1
- 241000397721 Aphodius <genus> Species 0.000 description 1
- 235000017060 Arachis glabrata Nutrition 0.000 description 1
- 244000105624 Arachis hypogaea Species 0.000 description 1
- 235000010777 Arachis hypogaea Nutrition 0.000 description 1
- 235000018262 Arachis monticola Nutrition 0.000 description 1
- 241000238888 Argasidae Species 0.000 description 1
- 241001525898 Argyrotaenia velutinana Species 0.000 description 1
- 241001227734 Ataenius strigatus Species 0.000 description 1
- 241000220319 Athous Species 0.000 description 1
- 235000007319 Avena orientalis Nutrition 0.000 description 1
- 244000075850 Avena orientalis Species 0.000 description 1
- 239000005730 Azoxystrobin Substances 0.000 description 1
- 239000005734 Benalaxyl Substances 0.000 description 1
- 235000016068 Berberis vulgaris Nutrition 0.000 description 1
- 241000335053 Beta vulgaris Species 0.000 description 1
- 241000219310 Beta vulgaris subsp. vulgaris Species 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- 241000238659 Blatta Species 0.000 description 1
- 241000238658 Blattella Species 0.000 description 1
- 241000238657 Blattella germanica Species 0.000 description 1
- 241000929634 Blissus insularis Species 0.000 description 1
- 239000005739 Bordeaux mixture Substances 0.000 description 1
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 1
- 241000283725 Bos Species 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 241001113967 Bovicola ovis Species 0.000 description 1
- 241000058432 Brachycerus Species 0.000 description 1
- 235000014698 Brassica juncea var multisecta Nutrition 0.000 description 1
- 240000002791 Brassica napus Species 0.000 description 1
- 235000006008 Brassica napus var napus Nutrition 0.000 description 1
- 235000006618 Brassica rapa subsp oleifera Nutrition 0.000 description 1
- 244000188595 Brassica sinapistrum Species 0.000 description 1
- 241001643374 Brevipalpus Species 0.000 description 1
- 241000987201 Brevipalpus californicus Species 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- FIPWRIJSWJWJAI-UHFFFAOYSA-N Butyl carbitol 6-propylpiperonyl ether Chemical compound C1=C(CCC)C(COCCOCCOCCCC)=CC2=C1OCO2 FIPWRIJSWJWJAI-UHFFFAOYSA-N 0.000 description 1
- SSUFDOMYCBCHML-UHFFFAOYSA-N CCCCC[S](=O)=O Chemical class CCCCC[S](=O)=O SSUFDOMYCBCHML-UHFFFAOYSA-N 0.000 description 1
- 241000526185 Cacopsylla Species 0.000 description 1
- 241000257161 Calliphoridae Species 0.000 description 1
- 241000282832 Camelidae Species 0.000 description 1
- 241001491932 Camponotus atriceps Species 0.000 description 1
- 241001338038 Camponotus chromaiodes Species 0.000 description 1
- 241001491934 Camponotus pennsylvanicus Species 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- 235000002566 Capsicum Nutrition 0.000 description 1
- 239000005745 Captan Substances 0.000 description 1
- TWFZGCMQGLPBSX-UHFFFAOYSA-N Carbendazim Natural products C1=CC=C2NC(NC(=O)OC)=NC2=C1 TWFZGCMQGLPBSX-UHFFFAOYSA-N 0.000 description 1
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 1
- UGFAIRIUMAVXCW-UHFFFAOYSA-N Carbon monoxide Chemical compound [O+]#[C-] UGFAIRIUMAVXCW-UHFFFAOYSA-N 0.000 description 1
- 239000005746 Carboxin Substances 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 241001347512 Carposina Species 0.000 description 1
- 241001347511 Carposina sasakii Species 0.000 description 1
- 244000068645 Carya illinoensis Species 0.000 description 1
- 235000009025 Carya illinoensis Nutrition 0.000 description 1
- 241000700198 Cavia Species 0.000 description 1
- 241000717851 Cephus Species 0.000 description 1
- 241001609899 Ceratophyllus gallinae Species 0.000 description 1
- 241001094951 Chaetosiphon Species 0.000 description 1
- 241001166081 Chelisoches morio Species 0.000 description 1
- 241000661333 Chilo infuscatellus Species 0.000 description 1
- 241000694614 Chilo polychrysa Species 0.000 description 1
- 241000661320 Chilo sacchariphagus Species 0.000 description 1
- KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical compound ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 description 1
- 241001307956 Chorioptes bovis Species 0.000 description 1
- 241001367803 Chrysodeixis includens Species 0.000 description 1
- 241000191839 Chrysomya Species 0.000 description 1
- 241001124179 Chrysops Species 0.000 description 1
- 241001414836 Cimex Species 0.000 description 1
- 241001327638 Cimex lectularius Species 0.000 description 1
- 241000098277 Cnaphalocrocis Species 0.000 description 1
- 235000013162 Cocos nucifera Nutrition 0.000 description 1
- 244000060011 Cocos nucifera Species 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 241000218631 Coniferophyta Species 0.000 description 1
- 241000466845 Conyzicola lurida Species 0.000 description 1
- JJLJMEJHUUYSSY-UHFFFAOYSA-L Copper hydroxide Chemical compound [OH-].[OH-].[Cu+2] JJLJMEJHUUYSSY-UHFFFAOYSA-L 0.000 description 1
- 239000005750 Copper hydroxide Substances 0.000 description 1
- 239000005752 Copper oxychloride Substances 0.000 description 1
- 229910021595 Copper(I) iodide Inorganic materials 0.000 description 1
- 241001509962 Coptotermes formosanus Species 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- 241000867174 Cotinis nitida Species 0.000 description 1
- 241000122110 Crambinae Species 0.000 description 1
- 241000699800 Cricetinae Species 0.000 description 1
- 241001136984 Cryptophlebia Species 0.000 description 1
- 241000866584 Cryptotermes Species 0.000 description 1
- VMQMZMRVKUZKQL-UHFFFAOYSA-N Cu+ Chemical compound [Cu+] VMQMZMRVKUZKQL-UHFFFAOYSA-N 0.000 description 1
- 240000008067 Cucumis sativus Species 0.000 description 1
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 description 1
- 241000219122 Cucurbita Species 0.000 description 1
- 235000003392 Curcuma domestica Nutrition 0.000 description 1
- 244000008991 Curcuma longa Species 0.000 description 1
- 241001587738 Cyclocephala borealis Species 0.000 description 1
- 241001090151 Cyrtopeltis Species 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 241001128004 Demodex Species 0.000 description 1
- 241001480824 Dermacentor Species 0.000 description 1
- 241001124144 Dermaptera Species 0.000 description 1
- 241001641949 Desmia funeralis Species 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 241000489947 Diabrotica virgifera virgifera Species 0.000 description 1
- 241001000394 Diaphania hyalinata Species 0.000 description 1
- 241001012951 Diaphania nitidalis Species 0.000 description 1
- 241000586568 Diaspidiotus perniciosus Species 0.000 description 1
- 239000005762 Dimoxystrobin Substances 0.000 description 1
- 241000243988 Dirofilaria immitis Species 0.000 description 1
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical compound [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 1
- 239000005764 Dithianon Substances 0.000 description 1
- 239000005766 Dodine Substances 0.000 description 1
- 241001057636 Dracaena deremensis Species 0.000 description 1
- 241001581006 Dysaphis plantaginea Species 0.000 description 1
- 241000241133 Earias Species 0.000 description 1
- 241001572697 Earias vittella Species 0.000 description 1
- 241001549209 Echidnophaga gallinacea Species 0.000 description 1
- 241000462639 Epilachna varivestis Species 0.000 description 1
- 241000918644 Epiphyas postvittana Species 0.000 description 1
- 241000283074 Equus asinus Species 0.000 description 1
- 241000283073 Equus caballus Species 0.000 description 1
- 241000917109 Eriosoma Species 0.000 description 1
- 241000917107 Eriosoma lanigerum Species 0.000 description 1
- 241000402754 Erythranthe moschata Species 0.000 description 1
- OTMSDBZUPAUEDD-UHFFFAOYSA-N Ethane Chemical compound CC OTMSDBZUPAUEDD-UHFFFAOYSA-N 0.000 description 1
- 241000060469 Eupoecilia ambiguella Species 0.000 description 1
- 241000519875 Exomala orientalis Species 0.000 description 1
- 241000566572 Falco femoralis Species 0.000 description 1
- 241000953886 Fannia canicularis Species 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 239000005958 Fenamiphos (aka phenamiphos) Substances 0.000 description 1
- 239000005780 Fluazinam Substances 0.000 description 1
- 239000005781 Fludioxonil Substances 0.000 description 1
- 239000005782 Fluopicolide Substances 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- 239000005784 Fluoxastrobin Substances 0.000 description 1
- 239000005785 Fluquinconazole Substances 0.000 description 1
- 239000005786 Flutolanil Substances 0.000 description 1
- 239000005787 Flutriafol Substances 0.000 description 1
- 239000005789 Folpet Substances 0.000 description 1
- 241000720914 Forficula auricularia Species 0.000 description 1
- 239000005791 Fuberidazole Substances 0.000 description 1
- 241001660201 Gasterophilus intestinalis Species 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 241000257324 Glossina <genus> Species 0.000 description 1
- 241001502121 Glossina brevipalpis Species 0.000 description 1
- 241000322637 Goniocotes Species 0.000 description 1
- 235000004341 Gossypium herbaceum Nutrition 0.000 description 1
- 240000002024 Gossypium herbaceum Species 0.000 description 1
- 241001441330 Grapholita molesta Species 0.000 description 1
- 241001243087 Gryllotalpidae Species 0.000 description 1
- 241001480796 Haemaphysalis Species 0.000 description 1
- 241000257224 Haematobia Species 0.000 description 1
- 241000257232 Haematobia irritans Species 0.000 description 1
- 241000875835 Haematopinus asini Species 0.000 description 1
- 241000894055 Haematopinus eurysternus Species 0.000 description 1
- 241000243974 Haemonchus contortus Species 0.000 description 1
- 241000047428 Halter Species 0.000 description 1
- 241000255967 Helicoverpa zea Species 0.000 description 1
- 241000256244 Heliothis virescens Species 0.000 description 1
- 241001201672 Herpetogramma Species 0.000 description 1
- 241001000403 Herpetogramma licarsisalis Species 0.000 description 1
- 241000268921 Heterodoxus spiniger Species 0.000 description 1
- 241001466007 Heteroptera Species 0.000 description 1
- 241000771999 Hippobosca Species 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- 241001480803 Hyalomma Species 0.000 description 1
- 241001251958 Hyalopterus Species 0.000 description 1
- 241000562421 Hydrotaea irritans Species 0.000 description 1
- 241000257176 Hypoderma <fly> Species 0.000 description 1
- 241000543830 Hypoderma bovis Species 0.000 description 1
- 241000257174 Hypoderma lineatum Species 0.000 description 1
- 241001058149 Icerya Species 0.000 description 1
- 241000173801 Incisitermes minor Species 0.000 description 1
- 239000005796 Ipconazole Substances 0.000 description 1
- 244000017020 Ipomoea batatas Species 0.000 description 1
- 235000002678 Ipomoea batatas Nutrition 0.000 description 1
- 239000005867 Iprodione Substances 0.000 description 1
- 239000005797 Iprovalicarb Substances 0.000 description 1
- 241000520382 Iridomyrmex Species 0.000 description 1
- 241001569691 Ixodes brunneus Species 0.000 description 1
- 241000238889 Ixodidae Species 0.000 description 1
- NWUWYYSKZYIQAE-ZBFHGGJFSA-N L-(R)-iprovalicarb Chemical compound CC(C)OC(=O)N[C@@H](C(C)C)C(=O)N[C@H](C)C1=CC=C(C)C=C1 NWUWYYSKZYIQAE-ZBFHGGJFSA-N 0.000 description 1
- 235000003228 Lactuca sativa Nutrition 0.000 description 1
- 240000008415 Lactuca sativa Species 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 241001470016 Laodelphax Species 0.000 description 1
- 241000238866 Latrodectus mactans Species 0.000 description 1
- 241000255777 Lepidoptera Species 0.000 description 1
- 241000661779 Leptoglossus Species 0.000 description 1
- 240000007472 Leucaena leucocephala Species 0.000 description 1
- 235000010643 Leucaena leucocephala Nutrition 0.000 description 1
- 229920001732 Lignosulfonate Polymers 0.000 description 1
- 241000683448 Limonius Species 0.000 description 1
- 241001646976 Linepithema humile Species 0.000 description 1
- 241001113946 Linognathus vituli Species 0.000 description 1
- 235000004431 Linum usitatissimum Nutrition 0.000 description 1
- 240000006240 Linum usitatissimum Species 0.000 description 1
- 241000272317 Lipaphis erysimi Species 0.000 description 1
- 241000594036 Liriomyza Species 0.000 description 1
- 241000594031 Liriomyza sativae Species 0.000 description 1
- 241000966204 Lissorhoptrus oryzophilus Species 0.000 description 1
- 241000004742 Lithophane antennata Species 0.000 description 1
- 241001261104 Lobesia botrana Species 0.000 description 1
- 241000254022 Locusta migratoria Species 0.000 description 1
- 241000257166 Lucilia cuprina Species 0.000 description 1
- 241000736227 Lucilia sericata Species 0.000 description 1
- 241001414826 Lygus Species 0.000 description 1
- 241000721696 Lymantria Species 0.000 description 1
- 241000203984 Macrotermes Species 0.000 description 1
- 241001130335 Maladera castanea Species 0.000 description 1
- 241000555303 Mamestra brassicae Species 0.000 description 1
- 239000005802 Mancozeb Substances 0.000 description 1
- 239000005804 Mandipropamid Substances 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 240000004658 Medicago sativa Species 0.000 description 1
- 235000017587 Medicago sativa ssp. sativa Nutrition 0.000 description 1
- 241001415015 Melanoplus differentialis Species 0.000 description 1
- 241000243785 Meloidogyne javanica Species 0.000 description 1
- 241000771994 Melophagus ovinus Species 0.000 description 1
- 239000005956 Metaldehyde Substances 0.000 description 1
- 239000005868 Metconazole Substances 0.000 description 1
- 239000005809 Metiram Substances 0.000 description 1
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 1
- 241000721623 Myzus Species 0.000 description 1
- 241000512861 Myzus certus Species 0.000 description 1
- IUOKJNROJISWRO-UHFFFAOYSA-N N-(2-cyano-3-methylbutan-2-yl)-2-(2,4-dichlorophenoxy)propanamide Chemical compound CC(C)C(C)(C#N)NC(=O)C(C)OC1=CC=C(Cl)C=C1Cl IUOKJNROJISWRO-UHFFFAOYSA-N 0.000 description 1
- XFOXDUJCOHBXRC-UHFFFAOYSA-N N-Ethyl-N-methyl-4-(trifluoromethyl)-2-(3,4-dimethoxyphenyl)benzamide Chemical compound CCN(C)C(=O)C1=CC=C(C(F)(F)F)C=C1C1=CC=C(OC)C(OC)=C1 XFOXDUJCOHBXRC-UHFFFAOYSA-N 0.000 description 1
- 241000203988 Nasutitermes Species 0.000 description 1
- 241000406465 Neodiprion Species 0.000 description 1
- 241000084931 Neohydatothrips variabilis Species 0.000 description 1
- 241000400685 Neoleucinodes elegantalis Species 0.000 description 1
- 241001671709 Nezara viridula Species 0.000 description 1
- 241001556090 Nilaparvata Species 0.000 description 1
- 241000256259 Noctuidae Species 0.000 description 1
- 241000562094 Notoedres cati Species 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- 241000208639 Odontotermes obesus Species 0.000 description 1
- 241001446843 Oebalus pugnax Species 0.000 description 1
- 241000543819 Oestrus ovis Species 0.000 description 1
- 241000207836 Olea <angiosperm> Species 0.000 description 1
- 240000007817 Olea europaea Species 0.000 description 1
- 241000258913 Oncopeltus fasciatus Species 0.000 description 1
- 235000019502 Orange oil Nutrition 0.000 description 1
- 241001481099 Ornithodoros turicata Species 0.000 description 1
- 241001585678 Orthosia hibisci Species 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- KYGZCKSPAKDVKC-UHFFFAOYSA-N Oxolinic acid Chemical compound C1=C2N(CC)C=C(C(O)=O)C(=O)C2=CC2=C1OCO2 KYGZCKSPAKDVKC-UHFFFAOYSA-N 0.000 description 1
- 239000005985 Paclobutrazol Substances 0.000 description 1
- 241001441425 Pandemis heparana Species 0.000 description 1
- 241001060079 Pandemis pyrusana Species 0.000 description 1
- 241000497111 Paralobesia viteana Species 0.000 description 1
- 241000459456 Parapediasia teterrellus Species 0.000 description 1
- 208000030852 Parasitic disease Diseases 0.000 description 1
- 241000051771 Paratrechina longicornis Species 0.000 description 1
- 241000721451 Pectinophora gossypiella Species 0.000 description 1
- 241000721454 Pemphigus Species 0.000 description 1
- 239000005813 Penconazole Substances 0.000 description 1
- 239000006002 Pepper Substances 0.000 description 1
- KFSLWBXXFJQRDL-UHFFFAOYSA-N Peracetic acid Chemical compound CC(=O)OO KFSLWBXXFJQRDL-UHFFFAOYSA-N 0.000 description 1
- 241000256683 Peregrinus Species 0.000 description 1
- 241001510010 Periplaneta fuliginosa Species 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 241001406390 Pheidole Species 0.000 description 1
- CXOFVDLJLONNDW-UHFFFAOYSA-N Phenytoin Chemical compound N1C(=O)NC(=O)C1(C=1C=CC=CC=1)C1=CC=CC=C1 CXOFVDLJLONNDW-UHFFFAOYSA-N 0.000 description 1
- 241000257149 Phormia Species 0.000 description 1
- 241001439020 Phthorimaea Species 0.000 description 1
- 241001525654 Phyllocnistis citrella Species 0.000 description 1
- 241001190782 Phyllonorycter ringoniella Species 0.000 description 1
- 241001640279 Phyllophaga Species 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 235000016761 Piper aduncum Nutrition 0.000 description 1
- 240000003889 Piper guineense Species 0.000 description 1
- 235000017804 Piper guineense Nutrition 0.000 description 1
- 235000008184 Piper nigrum Nutrition 0.000 description 1
- 241000691880 Planococcus citri Species 0.000 description 1
- 241001456328 Platynota stultana Species 0.000 description 1
- 241000269978 Pleuronectiformes Species 0.000 description 1
- 241000500439 Plutella Species 0.000 description 1
- 239000004349 Polyvinylpyrrolidone-vinyl acetate copolymer Substances 0.000 description 1
- 241000193943 Pratylenchus Species 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 239000005821 Propamocarb Substances 0.000 description 1
- MKIMSXGUTQTKJU-UHFFFAOYSA-N Propamocarb hydrochloride Chemical compound [Cl-].CCCOC(=O)NCCC[NH+](C)C MKIMSXGUTQTKJU-UHFFFAOYSA-N 0.000 description 1
- 239000005822 Propiconazole Substances 0.000 description 1
- 239000005823 Propineb Substances 0.000 description 1
- 239000005824 Proquinazid Substances 0.000 description 1
- 241000736232 Prosimulium Species 0.000 description 1
- 241001481672 Protophormia Species 0.000 description 1
- 241001290151 Prunus avium subsp. avium Species 0.000 description 1
- 235000005805 Prunus cerasus Nutrition 0.000 description 1
- 241000721694 Pseudatomoscelis seriatus Species 0.000 description 1
- 241001649229 Psoroptes Species 0.000 description 1
- 244000294611 Punica granatum Species 0.000 description 1
- 235000014360 Punica granatum Nutrition 0.000 description 1
- 239000005925 Pymetrozine Substances 0.000 description 1
- 241000255893 Pyralidae Species 0.000 description 1
- 235000014443 Pyrus communis Nutrition 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- 241001509970 Reticulitermes <genus> Species 0.000 description 1
- 241001152954 Reticulitermes hesperus Species 0.000 description 1
- 241000125162 Rhopalosiphum Species 0.000 description 1
- 241001350474 Rhopalosiphum nymphaeae Species 0.000 description 1
- 241000125167 Rhopalosiphum padi Species 0.000 description 1
- 235000004443 Ricinus communis Nutrition 0.000 description 1
- 241001620634 Roger Species 0.000 description 1
- 244000181917 Rubus leucodermis Species 0.000 description 1
- 235000011036 Rubus leucodermis Nutrition 0.000 description 1
- 235000003942 Rubus occidentalis Nutrition 0.000 description 1
- 241000282849 Ruminantia Species 0.000 description 1
- 241000509427 Sarcoptes scabiei Species 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 241000290147 Scapteriscus borellii Species 0.000 description 1
- 241000254062 Scarabaeidae Species 0.000 description 1
- 241000130993 Scarabaeus <genus> Species 0.000 description 1
- 241000254030 Schistocerca americana Species 0.000 description 1
- 241001249129 Scirpophaga incertulas Species 0.000 description 1
- 241000098281 Scirpophaga innotata Species 0.000 description 1
- 241000545593 Scolytinae Species 0.000 description 1
- 241000239226 Scorpiones Species 0.000 description 1
- 241001157779 Scutigera Species 0.000 description 1
- 241000209056 Secale Species 0.000 description 1
- 235000007238 Secale cereale Nutrition 0.000 description 1
- 241000661452 Sesamia nonagrioides Species 0.000 description 1
- 235000003434 Sesamum indicum Nutrition 0.000 description 1
- 244000040738 Sesamum orientale Species 0.000 description 1
- 241000180219 Sitobion avenae Species 0.000 description 1
- 241000254179 Sitophilus granarius Species 0.000 description 1
- 241000176086 Sogatella furcifera Species 0.000 description 1
- 235000002597 Solanum melongena Nutrition 0.000 description 1
- 244000061458 Solanum melongena Species 0.000 description 1
- 241000517830 Solenopsis geminata Species 0.000 description 1
- 241000736128 Solenopsis invicta Species 0.000 description 1
- FBPFZTCFMRRESA-NQAPHZHOSA-N Sorbitol Polymers OCC(O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-NQAPHZHOSA-N 0.000 description 1
- 241000532885 Sphenophorus Species 0.000 description 1
- 241001015417 Sphenophorus parvulus Species 0.000 description 1
- 241000532887 Sphenophorus venatus Species 0.000 description 1
- 240000006698 Spigelia anthelmia Species 0.000 description 1
- 239000005929 Spinetoram Substances 0.000 description 1
- GOENIMGKWNZVDA-OAMCMWGQSA-N Spinetoram Chemical compound CO[C@@H]1[C@H](OCC)[C@@H](OC)[C@H](C)O[C@H]1OC1C[C@H]2[C@@H]3C=C4C(=O)[C@H](C)[C@@H](O[C@@H]5O[C@H](C)[C@H](CC5)N(C)C)CCC[C@H](CC)OC(=O)CC4[C@@H]3CC[C@@H]2C1 GOENIMGKWNZVDA-OAMCMWGQSA-N 0.000 description 1
- 239000005837 Spiroxamine Substances 0.000 description 1
- 241001521235 Spodoptera eridania Species 0.000 description 1
- 241000256250 Spodoptera littoralis Species 0.000 description 1
- 241000142883 Spodoptera ornithogalli Species 0.000 description 1
- 241000122938 Strongylus vulgaris Species 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 235000021536 Sugar beet Nutrition 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 241001649248 Supella longipalpa Species 0.000 description 1
- DRVWTOSBCBKXOR-ZLDLUXBVSA-N Supinine Chemical compound C1CC[C@H]2C(COC(=O)[C@@](O)([C@@H](C)O)C(C)C)=CCN21 DRVWTOSBCBKXOR-ZLDLUXBVSA-N 0.000 description 1
- 241001510031 Symploce pallens Species 0.000 description 1
- 241000255632 Tabanus atratus Species 0.000 description 1
- 241001638573 Tapinoma melanocephalum Species 0.000 description 1
- 241001157793 Tapinoma sessile Species 0.000 description 1
- 239000005839 Tebuconazole Substances 0.000 description 1
- 239000005658 Tebufenpyrad Substances 0.000 description 1
- 241001507681 Technomyrmex albipes Species 0.000 description 1
- 239000005939 Tefluthrin Substances 0.000 description 1
- 241001454295 Tetranychidae Species 0.000 description 1
- 241000488577 Tetranychus mcdanieli Species 0.000 description 1
- 244000152045 Themeda triandra Species 0.000 description 1
- 241000530360 Therioaphis Species 0.000 description 1
- 241000028626 Thermobia domestica Species 0.000 description 1
- 239000005940 Thiacloprid Substances 0.000 description 1
- 239000005941 Thiamethoxam Substances 0.000 description 1
- 241000663810 Tingidae Species 0.000 description 1
- 239000005845 Tolclofos-methyl Substances 0.000 description 1
- 241000244030 Toxocara canis Species 0.000 description 1
- 241000242541 Trematoda Species 0.000 description 1
- 241000869417 Trematodes Species 0.000 description 1
- 239000005846 Triadimenol Substances 0.000 description 1
- 239000005847 Triazoxide Substances 0.000 description 1
- 241001220308 Trichodorus Species 0.000 description 1
- 239000005857 Trifloxystrobin Substances 0.000 description 1
- 241001414858 Trioza Species 0.000 description 1
- 239000005859 Triticonazole Substances 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 241001389010 Tuta Species 0.000 description 1
- 241000611866 Tyrophagus putrescentiae Species 0.000 description 1
- 229910052770 Uranium Inorganic materials 0.000 description 1
- 229930195482 Validamycin Natural products 0.000 description 1
- 241000219094 Vitaceae Species 0.000 description 1
- 235000006574 Washingtonia filifera Nutrition 0.000 description 1
- 244000208876 Washingtonia filifera Species 0.000 description 1
- 241000908414 Wasmannia auropunctata Species 0.000 description 1
- 241000353223 Xenopsylla cheopis Species 0.000 description 1
- 241001310905 Xylocopinae Species 0.000 description 1
- 229920002494 Zein Polymers 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 239000005870 Ziram Substances 0.000 description 1
- 241001248766 Zonocyba pomaria Species 0.000 description 1
- 239000005863 Zoxamide Substances 0.000 description 1
- 239000001089 [(2R)-oxolan-2-yl]methanol Substances 0.000 description 1
- YKTSYUJCYHOUJP-UHFFFAOYSA-N [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] Chemical compound [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] YKTSYUJCYHOUJP-UHFFFAOYSA-N 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 150000001242 acetic acid derivatives Chemical class 0.000 description 1
- ZCZSIDMEHXZRLG-UHFFFAOYSA-N acetic acid heptyl ester Natural products CCCCCCCOC(C)=O ZCZSIDMEHXZRLG-UHFFFAOYSA-N 0.000 description 1
- CGIHPACLZJDCBQ-UHFFFAOYSA-N acibenzolar Chemical compound SC(=O)C1=CC=CC2=C1SN=N2 CGIHPACLZJDCBQ-UHFFFAOYSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- YBCVMFKXIKNREZ-UHFFFAOYSA-N acoh acetic acid Chemical class CC(O)=O.CC(O)=O YBCVMFKXIKNREZ-UHFFFAOYSA-N 0.000 description 1
- 239000011149 active material Substances 0.000 description 1
- 230000009056 active transport Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- 150000001345 alkine derivatives Chemical class 0.000 description 1
- 150000003973 alkyl amines Chemical class 0.000 description 1
- 125000002877 alkyl aryl group Chemical group 0.000 description 1
- 150000004791 alkyl magnesium halides Chemical class 0.000 description 1
- 239000011717 all-trans-retinol Substances 0.000 description 1
- 235000019169 all-trans-retinol Nutrition 0.000 description 1
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 1
- WYTGDNHDOZPMIW-RCBQFDQVSA-N alstonine Natural products C1=CC2=C3C=CC=CC3=NC2=C2N1C[C@H]1[C@H](C)OC=C(C(=O)OC)[C@H]1C2 WYTGDNHDOZPMIW-RCBQFDQVSA-N 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- BREATYVWRHIPIY-UHFFFAOYSA-N amisulbrom Chemical compound CN(C)S(=O)(=O)N1C=NC(S(=O)(=O)N2C3=CC(F)=CC=C3C(Br)=C2C)=N1 BREATYVWRHIPIY-UHFFFAOYSA-N 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 244000000054 animal parasite Species 0.000 description 1
- 230000002528 anti-freeze Effects 0.000 description 1
- 230000001315 anti-hyperlipaemic effect Effects 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 235000021016 apples Nutrition 0.000 description 1
- 239000008135 aqueous vehicle Substances 0.000 description 1
- 125000006615 aromatic heterocyclic group Chemical group 0.000 description 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
- 150000001499 aryl bromides Chemical class 0.000 description 1
- 238000006254 arylation reaction Methods 0.000 description 1
- AKNQMEBLVAMSNZ-UHFFFAOYSA-N azaconazole Chemical compound ClC1=CC(Cl)=CC=C1C1(CN2N=CN=C2)OCCO1 AKNQMEBLVAMSNZ-UHFFFAOYSA-N 0.000 description 1
- 229950000294 azaconazole Drugs 0.000 description 1
- WFDXOXNFNRHQEC-GHRIWEEISA-N azoxystrobin Chemical compound CO\C=C(\C(=O)OC)C1=CC=CC=C1OC1=CC(OC=2C(=CC=CC=2)C#N)=NC=N1 WFDXOXNFNRHQEC-GHRIWEEISA-N 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- RIOXQFHNBCKOKP-UHFFFAOYSA-N benomyl Chemical compound C1=CC=C2N(C(=O)NCCCC)C(NC(=O)OC)=NC2=C1 RIOXQFHNBCKOKP-UHFFFAOYSA-N 0.000 description 1
- MITFXPHMIHQXPI-UHFFFAOYSA-N benzoxaprofen Natural products N=1C2=CC(C(C(O)=O)C)=CC=C2OC=1C1=CC=C(Cl)C=C1 MITFXPHMIHQXPI-UHFFFAOYSA-N 0.000 description 1
- 235000019445 benzyl alcohol Nutrition 0.000 description 1
- 235000021028 berry Nutrition 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- VEMKTZHHVJILDY-UXHICEINSA-N bioresmethrin Chemical compound CC1(C)[C@H](C=C(C)C)[C@H]1C(=O)OCC1=COC(CC=2C=CC=CC=2)=C1 VEMKTZHHVJILDY-UXHICEINSA-N 0.000 description 1
- OIPMQULDKWSNGX-UHFFFAOYSA-N bis[[ethoxy(oxo)phosphaniumyl]oxy]alumanyloxy-ethoxy-oxophosphanium Chemical compound [Al+3].CCO[P+]([O-])=O.CCO[P+]([O-])=O.CCO[P+]([O-])=O OIPMQULDKWSNGX-UHFFFAOYSA-N 0.000 description 1
- CXNPLSGKWMLZPZ-UHFFFAOYSA-N blasticidin-S Natural products O1C(C(O)=O)C(NC(=O)CC(N)CCN(C)C(N)=N)C=CC1N1C(=O)N=C(N)C=C1 CXNPLSGKWMLZPZ-UHFFFAOYSA-N 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 229910052796 boron Inorganic materials 0.000 description 1
- ZADPBFCGQRWHPN-UHFFFAOYSA-N boronic acid Chemical compound OBO ZADPBFCGQRWHPN-UHFFFAOYSA-N 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- CURLHBZYTFVCRG-UHFFFAOYSA-N butan-2-yl n-(3-chlorophenyl)carbamate Chemical compound CCC(C)OC(=O)NC1=CC=CC(Cl)=C1 CURLHBZYTFVCRG-UHFFFAOYSA-N 0.000 description 1
- 239000001273 butane Substances 0.000 description 1
- IAQRGUVFOMOMEM-UHFFFAOYSA-N butene Natural products CC=CC IAQRGUVFOMOMEM-UHFFFAOYSA-N 0.000 description 1
- 125000004369 butenyl group Chemical class C(=CCC)* 0.000 description 1
- 125000004106 butoxy group Chemical group [*]OC([H])([H])C([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000000480 butynyl group Chemical class [*]C#CC([H])([H])C([H])([H])[H] 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 235000010216 calcium carbonate Nutrition 0.000 description 1
- 229920005551 calcium lignosulfonate Polymers 0.000 description 1
- 239000004490 capsule suspension Substances 0.000 description 1
- JHRWWRDRBPCWTF-OLQVQODUSA-N captafol Chemical compound C1C=CC[C@H]2C(=O)N(SC(Cl)(Cl)C(Cl)Cl)C(=O)[C@H]21 JHRWWRDRBPCWTF-OLQVQODUSA-N 0.000 description 1
- 229940117949 captan Drugs 0.000 description 1
- 150000004657 carbamic acid derivatives Chemical class 0.000 description 1
- 235000013877 carbamide Nutrition 0.000 description 1
- YZBQHRLRFGPBSL-RXMQYKEDSA-N carbapenem Chemical compound C1C=CN2C(=O)C[C@H]21 YZBQHRLRFGPBSL-RXMQYKEDSA-N 0.000 description 1
- 239000006013 carbendazim Substances 0.000 description 1
- JNPZQRQPIHJYNM-UHFFFAOYSA-N carbendazim Chemical compound C1=C[CH]C2=NC(NC(=O)OC)=NC2=C1 JNPZQRQPIHJYNM-UHFFFAOYSA-N 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 235000011089 carbon dioxide Nutrition 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 230000006315 carbonylation Effects 0.000 description 1
- 238000005810 carbonylation reaction Methods 0.000 description 1
- GYSSRZJIHXQEHQ-UHFFFAOYSA-N carboxin Chemical compound S1CCOC(C)=C1C(=O)NC1=CC=CC=C1 GYSSRZJIHXQEHQ-UHFFFAOYSA-N 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 229940082638 cardiac stimulant phosphodiesterase inhibitors Drugs 0.000 description 1
- RXDMAYSSBPYBFW-UHFFFAOYSA-N carpropamid Chemical compound C=1C=C(Cl)C=CC=1C(C)NC(=O)C1(CC)C(C)C1(Cl)Cl RXDMAYSSBPYBFW-UHFFFAOYSA-N 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 238000003889 chemical engineering Methods 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 235000019693 cherries Nutrition 0.000 description 1
- PSOVNZZNOMJUBI-UHFFFAOYSA-N chlorantraniliprole Chemical compound CNC(=O)C1=CC(Cl)=CC(C)=C1NC(=O)C1=CC(Br)=NN1C1=NC=CC=C1Cl PSOVNZZNOMJUBI-UHFFFAOYSA-N 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- HKMOPYJWSFRURD-UHFFFAOYSA-N chloro hypochlorite;copper Chemical compound [Cu].ClOCl HKMOPYJWSFRURD-UHFFFAOYSA-N 0.000 description 1
- PFIADAMVCJPXSF-UHFFFAOYSA-N chloroneb Chemical compound COC1=CC(Cl)=C(OC)C=C1Cl PFIADAMVCJPXSF-UHFFFAOYSA-N 0.000 description 1
- ALSTYHKOOCGGFT-UHFFFAOYSA-N cis-oleyl alcohol Natural products CCCCCCCCC=CCCCCCCCCO ALSTYHKOOCGGFT-UHFFFAOYSA-N 0.000 description 1
- 229960004022 clotrimazole Drugs 0.000 description 1
- VNFPBHJOKIVQEB-UHFFFAOYSA-N clotrimazole Chemical compound ClC1=CC=CC=C1C(N1C=NC=C1)(C=1C=CC=CC=1)C1=CC=CC=C1 VNFPBHJOKIVQEB-UHFFFAOYSA-N 0.000 description 1
- 239000008199 coating composition Substances 0.000 description 1
- 235000012716 cod liver oil Nutrition 0.000 description 1
- 239000003026 cod liver oil Substances 0.000 description 1
- 239000012230 colorless oil Substances 0.000 description 1
- 229940125797 compound 12 Drugs 0.000 description 1
- 229940126142 compound 16 Drugs 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 229910001956 copper hydroxide Inorganic materials 0.000 description 1
- 229910000365 copper sulfate Inorganic materials 0.000 description 1
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 1
- LSXDOTMGLUJQCM-UHFFFAOYSA-M copper(i) iodide Chemical compound I[Cu] LSXDOTMGLUJQCM-UHFFFAOYSA-M 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 229940099112 cornstarch Drugs 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 244000038559 crop plants Species 0.000 description 1
- 238000012272 crop production Methods 0.000 description 1
- 235000003373 curcuma longa Nutrition 0.000 description 1
- 238000007333 cyanation reaction Methods 0.000 description 1
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- HPXRVTGHNJAIIH-UHFFFAOYSA-N cyclohexanol Chemical compound OC1CCCCC1 HPXRVTGHNJAIIH-UHFFFAOYSA-N 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
- 125000004186 cyclopropylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C1([H])[H] 0.000 description 1
- 229940127089 cytotoxic agent Drugs 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 238000010511 deprotection reaction Methods 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- RAFNCPHFRHZCPS-UHFFFAOYSA-N di(imidazol-1-yl)methanethione Chemical compound C1=CN=CN1C(=S)N1C=CN=C1 RAFNCPHFRHZCPS-UHFFFAOYSA-N 0.000 description 1
- 125000004473 dialkylaminocarbonyl group Chemical group 0.000 description 1
- JYIMWRSJCRRYNK-UHFFFAOYSA-N dialuminum;disodium;oxygen(2-);silicon(4+);hydrate Chemical compound O.[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[Na+].[Na+].[Al+3].[Al+3].[Si+4] JYIMWRSJCRRYNK-UHFFFAOYSA-N 0.000 description 1
- 150000001470 diamides Chemical class 0.000 description 1
- BIXZHMJUSMUDOQ-UHFFFAOYSA-N dichloran Chemical compound NC1=C(Cl)C=C([N+]([O-])=O)C=C1Cl BIXZHMJUSMUDOQ-UHFFFAOYSA-N 0.000 description 1
- UWQMKVBQKFHLCE-UHFFFAOYSA-N diclomezine Chemical compound C1=C(Cl)C(C)=C(Cl)C=C1C1=NNC(=O)C=C1 UWQMKVBQKFHLCE-UHFFFAOYSA-N 0.000 description 1
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- AFABGHUZZDYHJO-UHFFFAOYSA-N dimethyl butane Natural products CCCC(C)C AFABGHUZZDYHJO-UHFFFAOYSA-N 0.000 description 1
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
- WXUZAHCNPWONDH-DYTRJAOYSA-N dimoxystrobin Chemical compound CNC(=O)C(=N\OC)\C1=CC=CC=C1COC1=CC(C)=CC=C1C WXUZAHCNPWONDH-DYTRJAOYSA-N 0.000 description 1
- 150000004844 dioxiranes Chemical class 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 229940099686 dirofilaria immitis Drugs 0.000 description 1
- YDEXUEFDPVHGHE-GGMCWBHBSA-L disodium;(2r)-3-(2-hydroxy-3-methoxyphenyl)-2-[2-methoxy-4-(3-sulfonatopropyl)phenoxy]propane-1-sulfonate Chemical compound [Na+].[Na+].COC1=CC=CC(C[C@H](CS([O-])(=O)=O)OC=2C(=CC(CCCS([O-])(=O)=O)=CC=2)OC)=C1O YDEXUEFDPVHGHE-GGMCWBHBSA-L 0.000 description 1
- 239000004491 dispersible concentrate Substances 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- PYZSVQVRHDXQSL-UHFFFAOYSA-N dithianon Chemical compound S1C(C#N)=C(C#N)SC2=C1C(=O)C1=CC=CC=C1C2=O PYZSVQVRHDXQSL-UHFFFAOYSA-N 0.000 description 1
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 1
- 235000021038 drupes Nutrition 0.000 description 1
- 238000009837 dry grinding Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 229960003913 econazole Drugs 0.000 description 1
- AWZOLILCOUMRDG-UHFFFAOYSA-N edifenphos Chemical compound C=1C=CC=CC=1SP(=O)(OCC)SC1=CC=CC=C1 AWZOLILCOUMRDG-UHFFFAOYSA-N 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 238000005538 encapsulation Methods 0.000 description 1
- 244000079386 endoparasite Species 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000012173 estrus Effects 0.000 description 1
- 239000012259 ether extract Substances 0.000 description 1
- 229940052303 ethers for general anesthesia Drugs 0.000 description 1
- LRMHFDNWKCSEQU-UHFFFAOYSA-N ethoxyethane;phenol Chemical compound CCOCC.OC1=CC=CC=C1 LRMHFDNWKCSEQU-UHFFFAOYSA-N 0.000 description 1
- ROBXZHNBBCHEIQ-BYPYZUCNSA-N ethyl (2s)-2-aminopropanoate Chemical compound CCOC(=O)[C@H](C)N ROBXZHNBBCHEIQ-BYPYZUCNSA-N 0.000 description 1
- KJHQVUNUOIEYSV-UHFFFAOYSA-N ethyl 3,3,3-trifluoro-2-oxopropanoate Chemical compound CCOC(=O)C(=O)C(F)(F)F KJHQVUNUOIEYSV-UHFFFAOYSA-N 0.000 description 1
- 125000006437 ethyl cyclopropyl group Chemical group 0.000 description 1
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 235000019387 fatty acid methyl ester Nutrition 0.000 description 1
- 239000010685 fatty oil Substances 0.000 description 1
- 230000004634 feeding behavior Effects 0.000 description 1
- ZCJPOPBZHLUFHF-UHFFFAOYSA-N fenamiphos Chemical compound CCOP(=O)(NC(C)C)OC1=CC=C(SC)C(C)=C1 ZCJPOPBZHLUFHF-UHFFFAOYSA-N 0.000 description 1
- JFSPBVWPKOEZCB-UHFFFAOYSA-N fenfuram Chemical compound O1C=CC(C(=O)NC=2C=CC=CC=2)=C1C JFSPBVWPKOEZCB-UHFFFAOYSA-N 0.000 description 1
- VDLGAVXLJYLFDH-UHFFFAOYSA-N fenhexamid Chemical compound C=1C=C(O)C(Cl)=C(Cl)C=1NC(=O)C1(C)CCCCC1 VDLGAVXLJYLFDH-UHFFFAOYSA-N 0.000 description 1
- FKLFBQCQQYDUAM-UHFFFAOYSA-N fenpiclonil Chemical compound ClC1=CC=CC(C=2C(=CNC=2)C#N)=C1Cl FKLFBQCQQYDUAM-UHFFFAOYSA-N 0.000 description 1
- WDQNIWFZKXZFAY-UHFFFAOYSA-M fentin acetate Chemical compound CC([O-])=O.C1=CC=CC=C1[Sn+](C=1C=CC=CC=1)C1=CC=CC=C1 WDQNIWFZKXZFAY-UHFFFAOYSA-M 0.000 description 1
- BFWMWWXRWVJXSE-UHFFFAOYSA-M fentin hydroxide Chemical compound C=1C=CC=CC=1[Sn](C=1C=CC=CC=1)(O)C1=CC=CC=C1 BFWMWWXRWVJXSE-UHFFFAOYSA-M 0.000 description 1
- WHDGWKAJBYRJJL-UHFFFAOYSA-K ferbam Chemical compound [Fe+3].CN(C)C([S-])=S.CN(C)C([S-])=S.CN(C)C([S-])=S WHDGWKAJBYRJJL-UHFFFAOYSA-K 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000007888 film coating Substances 0.000 description 1
- 238000009501 film coating Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000021323 fish oil Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- UZCGKGPEKUCDTF-UHFFFAOYSA-N fluazinam Chemical compound [O-][N+](=O)C1=CC(C(F)(F)F)=C(Cl)C([N+]([O-])=O)=C1NC1=NC=C(C(F)(F)F)C=C1Cl UZCGKGPEKUCDTF-UHFFFAOYSA-N 0.000 description 1
- MUJOIMFVNIBMKC-UHFFFAOYSA-N fludioxonil Chemical compound C=12OC(F)(F)OC2=CC=CC=1C1=CNC=C1C#N MUJOIMFVNIBMKC-UHFFFAOYSA-N 0.000 description 1
- GBOYJIHYACSLGN-UHFFFAOYSA-N fluopicolide Chemical compound ClC1=CC(C(F)(F)F)=CN=C1CNC(=O)C1=C(Cl)C=CC=C1Cl GBOYJIHYACSLGN-UHFFFAOYSA-N 0.000 description 1
- 238000000806 fluorine-19 nuclear magnetic resonance spectrum Methods 0.000 description 1
- UFEODZBUAFNAEU-NLRVBDNBSA-N fluoxastrobin Chemical compound C=1C=CC=C(OC=2C(=C(OC=3C(=CC=CC=3)Cl)N=CN=2)F)C=1C(=N/OC)\C1=NOCCO1 UFEODZBUAFNAEU-NLRVBDNBSA-N 0.000 description 1
- IJJVMEJXYNJXOJ-UHFFFAOYSA-N fluquinconazole Chemical compound C=1C=C(Cl)C=C(Cl)C=1N1C(=O)C2=CC(F)=CC=C2N=C1N1C=NC=N1 IJJVMEJXYNJXOJ-UHFFFAOYSA-N 0.000 description 1
- FQKUGOMFVDPBIZ-UHFFFAOYSA-N flusilazole Chemical compound C=1C=C(F)C=CC=1[Si](C=1C=CC(F)=CC=1)(C)CN1C=NC=N1 FQKUGOMFVDPBIZ-UHFFFAOYSA-N 0.000 description 1
- GNVDAZSPJWCIQZ-UHFFFAOYSA-N flusulfamide Chemical compound ClC1=CC([N+](=O)[O-])=CC=C1NS(=O)(=O)C1=CC=C(Cl)C(C(F)(F)F)=C1 GNVDAZSPJWCIQZ-UHFFFAOYSA-N 0.000 description 1
- PTCGDEVVHUXTMP-UHFFFAOYSA-N flutolanil Chemical compound CC(C)OC1=CC=CC(NC(=O)C=2C(=CC=CC=2)C(F)(F)F)=C1 PTCGDEVVHUXTMP-UHFFFAOYSA-N 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 239000004088 foaming agent Substances 0.000 description 1
- 239000003897 fog Substances 0.000 description 1
- HKIOYBQGHSTUDB-UHFFFAOYSA-N folpet Chemical compound C1=CC=C2C(=O)N(SC(Cl)(Cl)Cl)C(=O)C2=C1 HKIOYBQGHSTUDB-UHFFFAOYSA-N 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 235000021588 free fatty acids Nutrition 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 229940068517 fruit extracts Drugs 0.000 description 1
- ZEYJIQLVKGBLEM-UHFFFAOYSA-N fuberidazole Chemical compound C1=COC(C=2N=C3[CH]C=CC=C3N=2)=C1 ZEYJIQLVKGBLEM-UHFFFAOYSA-N 0.000 description 1
- 239000003517 fume Substances 0.000 description 1
- 239000002316 fumigant Substances 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 244000053095 fungal pathogen Species 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 230000035784 germination Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229960005150 glycerol Drugs 0.000 description 1
- 229940074076 glycerol formal Drugs 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 239000001087 glyceryl triacetate Substances 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 229940087559 grape seed Drugs 0.000 description 1
- 235000021021 grapes Nutrition 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 239000003630 growth substance Substances 0.000 description 1
- 239000003721 gunpowder Substances 0.000 description 1
- 239000010440 gypsum Substances 0.000 description 1
- 229910052602 gypsum Inorganic materials 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- JPXGPRBLTIYFQG-UHFFFAOYSA-N heptan-4-yl acetate Chemical compound CCCC(CCC)OC(C)=O JPXGPRBLTIYFQG-UHFFFAOYSA-N 0.000 description 1
- 125000001072 heteroaryl group Chemical group 0.000 description 1
- 125000006038 hexenyl group Chemical class 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000003707 hexyloxy group Chemical class [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])O* 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 150000004679 hydroxides Chemical class 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 150000008624 imidazolidinones Chemical class 0.000 description 1
- 150000003949 imides Chemical class 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 150000007529 inorganic bases Chemical class 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 238000007912 intraperitoneal administration Methods 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- QTYCMDBMOLSEAM-UHFFFAOYSA-N ipconazole Chemical compound C1=NC=NN1CC1(O)C(C(C)C)CCC1CC1=CC=C(Cl)C=C1 QTYCMDBMOLSEAM-UHFFFAOYSA-N 0.000 description 1
- FCOAHACKGGIURQ-UHFFFAOYSA-N iprobenfos Chemical compound CC(C)OP(=O)(OC(C)C)SCC1=CC=CC=C1 FCOAHACKGGIURQ-UHFFFAOYSA-N 0.000 description 1
- ONUFESLQCSAYKA-UHFFFAOYSA-N iprodione Chemical compound O=C1N(C(=O)NC(C)C)CC(=O)N1C1=CC(Cl)=CC(Cl)=C1 ONUFESLQCSAYKA-UHFFFAOYSA-N 0.000 description 1
- NWUWYYSKZYIQAE-WMCAAGNKSA-N iprovalicarb Chemical compound CC(C)OC(=O)N[C@@H](C(C)C)C(=O)NC(C)C1=CC=C(C)C=C1 NWUWYYSKZYIQAE-WMCAAGNKSA-N 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 1
- 238000003973 irrigation Methods 0.000 description 1
- 230000002262 irrigation Effects 0.000 description 1
- 239000001282 iso-butane Substances 0.000 description 1
- 229940117955 isoamyl acetate Drugs 0.000 description 1
- 229940035429 isobutyl alcohol Drugs 0.000 description 1
- 229960004849 isoconazole Drugs 0.000 description 1
- UFHLMYOGRXOCSL-UHFFFAOYSA-N isoprothiolane Chemical compound CC(C)OC(=O)C(C(=O)OC(C)C)=C1SCCS1 UFHLMYOGRXOCSL-UHFFFAOYSA-N 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 150000003893 lactate salts Chemical class 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 230000001418 larval effect Effects 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 231100001231 less toxic Toxicity 0.000 description 1
- 231100000518 lethal Toxicity 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 229920005610 lignin Polymers 0.000 description 1
- 229940087305 limonene Drugs 0.000 description 1
- 235000001510 limonene Nutrition 0.000 description 1
- YNESATAKKCNGOF-UHFFFAOYSA-N lithium bis(trimethylsilyl)amide Chemical compound [Li+].C[Si](C)(C)[N-][Si](C)(C)C YNESATAKKCNGOF-UHFFFAOYSA-N 0.000 description 1
- UBJFKNSINUCEAL-UHFFFAOYSA-N lithium;2-methylpropane Chemical compound [Li+].C[C-](C)C UBJFKNSINUCEAL-UHFFFAOYSA-N 0.000 description 1
- WGOPGODQLGJZGL-UHFFFAOYSA-N lithium;butane Chemical compound [Li+].CC[CH-]C WGOPGODQLGJZGL-UHFFFAOYSA-N 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 210000003563 lymphoid tissue Anatomy 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 229910001623 magnesium bromide Inorganic materials 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- GCOUTRKHWIHCHT-UHFFFAOYSA-M magnesium;1,3-dichlorobenzene-5-ide;bromide Chemical compound [Mg+2].[Br-].ClC1=C[C-]=CC(Cl)=C1 GCOUTRKHWIHCHT-UHFFFAOYSA-M 0.000 description 1
- CCERQOYLJJULMD-UHFFFAOYSA-M magnesium;carbanide;chloride Chemical compound [CH3-].[Mg+2].[Cl-] CCERQOYLJJULMD-UHFFFAOYSA-M 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 150000002689 maleic acids Chemical class 0.000 description 1
- YKSNLCVSTHTHJA-UHFFFAOYSA-L maneb Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S YKSNLCVSTHTHJA-UHFFFAOYSA-L 0.000 description 1
- 229920000940 maneb Polymers 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 239000008204 material by function Substances 0.000 description 1
- 230000013011 mating Effects 0.000 description 1
- 230000007758 mating behavior Effects 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- BCTQJXQXJVLSIG-UHFFFAOYSA-N mepronil Chemical compound CC(C)OC1=CC=CC(NC(=O)C=2C(=CC=CC=2)C)=C1 BCTQJXQXJVLSIG-UHFFFAOYSA-N 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- ZQEIXNIJLIKNTD-GFCCVEGCSA-N metalaxyl-M Chemical compound COCC(=O)N([C@H](C)C(=O)OC)C1=C(C)C=CC=C1C ZQEIXNIJLIKNTD-GFCCVEGCSA-N 0.000 description 1
- GKKDCARASOJPNG-UHFFFAOYSA-N metaldehyde Chemical compound CC1OC(C)OC(C)OC(C)O1 GKKDCARASOJPNG-UHFFFAOYSA-N 0.000 description 1
- XWPZUHJBOLQNMN-UHFFFAOYSA-N metconazole Chemical compound C1=NC=NN1CC1(O)C(C)(C)CCC1CC1=CC=C(Cl)C=C1 XWPZUHJBOLQNMN-UHFFFAOYSA-N 0.000 description 1
- VMVNZNXAVJHNDJ-UHFFFAOYSA-N methyl 2,2,2-trifluoroacetate Chemical compound COC(=O)C(F)(F)F VMVNZNXAVJHNDJ-UHFFFAOYSA-N 0.000 description 1
- CJPQIRJHIZUAQP-UHFFFAOYSA-N methyl N-(2,6-dimethylphenyl)-N-(phenylacetyl)alaninate Chemical compound CC=1C=CC=C(C)C=1N(C(C)C(=O)OC)C(=O)CC1=CC=CC=C1 CJPQIRJHIZUAQP-UHFFFAOYSA-N 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 150000004702 methyl esters Chemical class 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 description 1
- 229920000257 metiram Polymers 0.000 description 1
- HIIRDDUVRXCDBN-OBGWFSINSA-N metominostrobin Chemical compound CNC(=O)C(=N\OC)\C1=CC=CC=C1OC1=CC=CC=C1 HIIRDDUVRXCDBN-OBGWFSINSA-N 0.000 description 1
- 229960001952 metrifonate Drugs 0.000 description 1
- 239000010445 mica Substances 0.000 description 1
- 229910052618 mica group Inorganic materials 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 230000001617 migratory effect Effects 0.000 description 1
- 238000003801 milling Methods 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 229910052750 molybdenum Inorganic materials 0.000 description 1
- 239000011733 molybdenum Substances 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 210000000214 mouth Anatomy 0.000 description 1
- 229940105132 myristate Drugs 0.000 description 1
- IWWKIOTVAJOMJT-UHFFFAOYSA-N n-(2,2,2-trichloro-1-morpholin-4-ylethyl)formamide Chemical compound O=CNC(C(Cl)(Cl)Cl)N1CCOCC1 IWWKIOTVAJOMJT-UHFFFAOYSA-N 0.000 description 1
- TVMXDCGIABBOFY-UHFFFAOYSA-N n-Octanol Natural products CCCCCCCC TVMXDCGIABBOFY-UHFFFAOYSA-N 0.000 description 1
- FVLVBVSILSHUAF-UHFFFAOYSA-N n-benzyl-3,5-dimethyl-n-propan-2-ylbenzamide Chemical compound C=1C(C)=CC(C)=CC=1C(=O)N(C(C)C)CC1=CC=CC=C1 FVLVBVSILSHUAF-UHFFFAOYSA-N 0.000 description 1
- LWZDSXONSDJDOH-UHFFFAOYSA-N n-benzyl-n-methylpyridin-4-amine Chemical compound C=1C=NC=CC=1N(C)CC1=CC=CC=C1 LWZDSXONSDJDOH-UHFFFAOYSA-N 0.000 description 1
- IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- PSZYNBSKGUBXEH-UHFFFAOYSA-N naphthalene-1-sulfonic acid Chemical class C1=CC=C2C(S(=O)(=O)O)=CC=CC2=C1 PSZYNBSKGUBXEH-UHFFFAOYSA-N 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- DSOOGBGKEWZRIH-UHFFFAOYSA-N nereistoxin Chemical class CN(C)C1CSSC1 DSOOGBGKEWZRIH-UHFFFAOYSA-N 0.000 description 1
- 229940079888 nitenpyram Drugs 0.000 description 1
- 239000012299 nitrogen atmosphere Substances 0.000 description 1
- 229920000847 nonoxynol Polymers 0.000 description 1
- 230000000269 nucleophilic effect Effects 0.000 description 1
- 238000007344 nucleophilic reaction Methods 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 229920002113 octoxynol Polymers 0.000 description 1
- 239000004533 oil dispersion Substances 0.000 description 1
- 239000010502 orange oil Substances 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 238000006053 organic reaction Methods 0.000 description 1
- 125000001979 organolithium group Chemical group 0.000 description 1
- 125000002524 organometallic group Chemical group 0.000 description 1
- 125000000369 oxido group Chemical group [*]=O 0.000 description 1
- 229960000321 oxolinic acid Drugs 0.000 description 1
- AMEKQAFGQBKLKX-UHFFFAOYSA-N oxycarboxin Chemical compound O=S1(=O)CCOC(C)=C1C(=O)NC1=CC=CC=C1 AMEKQAFGQBKLKX-UHFFFAOYSA-N 0.000 description 1
- 239000003973 paint Substances 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 230000036281 parasite infection Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 235000020232 peanut Nutrition 0.000 description 1
- HHXMXAQDOUCLDN-RXMQYKEDSA-N penem Chemical compound S1C=CN2C(=O)C[C@H]21 HHXMXAQDOUCLDN-RXMQYKEDSA-N 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- LKPLKUMXSAEKID-UHFFFAOYSA-N pentachloronitrobenzene Chemical compound [O-][N+](=O)C1=C(Cl)C(Cl)=C(Cl)C(Cl)=C1Cl LKPLKUMXSAEKID-UHFFFAOYSA-N 0.000 description 1
- YWAKXRMUMFPDSH-UHFFFAOYSA-N pentene Chemical compound CCCC=C YWAKXRMUMFPDSH-UHFFFAOYSA-N 0.000 description 1
- 125000002255 pentenyl group Chemical class C(=CCCC)* 0.000 description 1
- 125000006194 pentinyl group Chemical class 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- 125000001148 pentyloxycarbonyl group Chemical group 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 150000004965 peroxy acids Chemical class 0.000 description 1
- 235000020030 perry Nutrition 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-M phenolate Chemical compound [O-]C1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-M 0.000 description 1
- 229940031826 phenolate Drugs 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- DHHVAGZRUROJKS-UHFFFAOYSA-N phentermine Chemical compound CC(C)(N)CC1=CC=CC=C1 DHHVAGZRUROJKS-UHFFFAOYSA-N 0.000 description 1
- 229960002036 phenytoin Drugs 0.000 description 1
- 239000002571 phosphodiesterase inhibitor Substances 0.000 description 1
- 150000003014 phosphoric acid esters Chemical class 0.000 description 1
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 229960005235 piperonyl butoxide Drugs 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 235000019448 polyvinylpyrrolidone-vinyl acetate copolymer Nutrition 0.000 description 1
- 235000015277 pork Nutrition 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- WZZLDXDUQPOXNW-UHFFFAOYSA-N propamocarb Chemical compound CCCOC(=O)NCCCN(C)C WZZLDXDUQPOXNW-UHFFFAOYSA-N 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- STJLVHWMYQXCPB-UHFFFAOYSA-N propiconazole Chemical compound O1C(CCC)COC1(C=1C(=CC(Cl)=CC=1)Cl)CN1N=CN=C1 STJLVHWMYQXCPB-UHFFFAOYSA-N 0.000 description 1
- KKMLIVYBGSAJPM-UHFFFAOYSA-L propineb Chemical compound [Zn+2].[S-]C(=S)NC(C)CNC([S-])=S KKMLIVYBGSAJPM-UHFFFAOYSA-L 0.000 description 1
- RUOJZAUFBMNUDX-UHFFFAOYSA-N propylene carbonate Chemical compound CC1COC(=O)O1 RUOJZAUFBMNUDX-UHFFFAOYSA-N 0.000 description 1
- FLVBXVXXXMLMOX-UHFFFAOYSA-N proquinazid Chemical compound C1=C(I)C=C2C(=O)N(CCC)C(OCCC)=NC2=C1 FLVBXVXXXMLMOX-UHFFFAOYSA-N 0.000 description 1
- 230000001012 protector Effects 0.000 description 1
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- QHMTXANCGGJZRX-WUXMJOGZSA-N pymetrozine Chemical compound C1C(C)=NNC(=O)N1\N=C\C1=CC=CN=C1 QHMTXANCGGJZRX-WUXMJOGZSA-N 0.000 description 1
- MIOBBYRMXGNORL-UHFFFAOYSA-N pyrifluquinazon Chemical compound C1C2=CC(C(F)(C(F)(F)F)C(F)(F)F)=CC=C2N(C(=O)C)C(=O)N1NCC1=CC=CN=C1 MIOBBYRMXGNORL-UHFFFAOYSA-N 0.000 description 1
- HNJBEVLQSNELDL-UHFFFAOYSA-N pyrrolidin-2-one Chemical compound O=C1CCCN1 HNJBEVLQSNELDL-UHFFFAOYSA-N 0.000 description 1
- 150000003242 quaternary ammonium salts Chemical class 0.000 description 1
- 229920005604 random copolymer Polymers 0.000 description 1
- 108020003175 receptors Proteins 0.000 description 1
- 102000005962 receptors Human genes 0.000 description 1
- 239000001044 red dye Substances 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 239000005871 repellent Substances 0.000 description 1
- 230000002940 repellent Effects 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 229940100486 rice starch Drugs 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical class C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 230000001932 seasonal effect Effects 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 239000003620 semiochemical Substances 0.000 description 1
- 238000003307 slaughter Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 229960001922 sodium perborate Drugs 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- SNOOUWRIMMFWNE-UHFFFAOYSA-M sodium;6-[(3,4,5-trimethoxybenzoyl)amino]hexanoate Chemical compound [Na+].COC1=CC(C(=O)NCCCCCC([O-])=O)=CC(OC)=C1OC SNOOUWRIMMFWNE-UHFFFAOYSA-M 0.000 description 1
- YKLJGMBLPUQQOI-UHFFFAOYSA-M sodium;oxidooxy(oxo)borane Chemical compound [Na+].[O-]OB=O YKLJGMBLPUQQOI-UHFFFAOYSA-M 0.000 description 1
- 239000008247 solid mixture Substances 0.000 description 1
- 239000004550 soluble concentrate Substances 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 108010092895 spinin Proteins 0.000 description 1
- PUYXTUJWRLOUCW-UHFFFAOYSA-N spiroxamine Chemical compound O1C(CN(CC)CCC)COC11CCC(C(C)(C)C)CC1 PUYXTUJWRLOUCW-UHFFFAOYSA-N 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000012258 stirred mixture Substances 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 125000005504 styryl group Chemical group 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 235000011044 succinic acid Nutrition 0.000 description 1
- 150000003444 succinic acids Chemical class 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 150000003445 sucroses Chemical class 0.000 description 1
- QWCJHSGMANYXCW-UHFFFAOYSA-N sulfaphenazole Chemical compound C1=CC(N)=CC=C1S(=O)(=O)NC1=CC=NN1C1=CC=CC=C1 QWCJHSGMANYXCW-UHFFFAOYSA-N 0.000 description 1
- 150000003460 sulfonic acids Chemical class 0.000 description 1
- RWSOTUBLDIXVET-UHFFFAOYSA-O sulfonium Chemical compound [SH3+] RWSOTUBLDIXVET-UHFFFAOYSA-O 0.000 description 1
- 150000003462 sulfoxides Chemical class 0.000 description 1
- YBBRCQOCSYXUOC-UHFFFAOYSA-N sulfuryl dichloride Chemical compound ClS(Cl)(=O)=O YBBRCQOCSYXUOC-UHFFFAOYSA-N 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 239000004548 suspo-emulsion Substances 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- ZZYSLNWGKKDOML-UHFFFAOYSA-N tebufenpyrad Chemical compound CCC1=NN(C)C(C(=O)NCC=2C=CC(=CC=2)C(C)(C)C)=C1Cl ZZYSLNWGKKDOML-UHFFFAOYSA-N 0.000 description 1
- CIHOLLKRGTVIJN-UHFFFAOYSA-N tert‐butyl hydroperoxide Chemical compound CC(C)(C)OO CIHOLLKRGTVIJN-UHFFFAOYSA-N 0.000 description 1
- TUNFSRHWOTWDNC-UHFFFAOYSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 1
- BSYVTEYKTMYBMK-UHFFFAOYSA-N tetrahydrofurfuryl alcohol Chemical compound OCC1CCCO1 BSYVTEYKTMYBMK-UHFFFAOYSA-N 0.000 description 1
- NWWZPOKUUAIXIW-FLIBITNWSA-N thiamethoxam Chemical compound [O-][N+](=O)\N=C/1N(C)COCN\1CC1=CN=C(Cl)S1 NWWZPOKUUAIXIW-FLIBITNWSA-N 0.000 description 1
- ZWZVWGITAAIFPS-UHFFFAOYSA-N thiophosgene Chemical compound ClC(Cl)=S ZWZVWGITAAIFPS-UHFFFAOYSA-N 0.000 description 1
- 230000009974 thixotropic effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- OBZIQQJJIKNWNO-UHFFFAOYSA-N tolclofos-methyl Chemical compound COP(=S)(OC)OC1=C(Cl)C=C(C)C=C1Cl OBZIQQJJIKNWNO-UHFFFAOYSA-N 0.000 description 1
- WPALTCMYPARVNV-UHFFFAOYSA-N tolfenpyrad Chemical compound CCC1=NN(C)C(C(=O)NCC=2C=CC(OC=3C=CC(C)=CC=3)=CC=2)=C1Cl WPALTCMYPARVNV-UHFFFAOYSA-N 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000009261 transgenic effect Effects 0.000 description 1
- 230000005945 translocation Effects 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- BAZVSMNPJJMILC-UHFFFAOYSA-N triadimenol Chemical compound C1=NC=NN1C(C(O)C(C)(C)C)OC1=CC=C(Cl)C=C1 BAZVSMNPJJMILC-UHFFFAOYSA-N 0.000 description 1
- IQGKIPDJXCAMSM-UHFFFAOYSA-N triazoxide Chemical compound N=1C2=CC=C(Cl)C=C2[N+]([O-])=NC=1N1C=CN=C1 IQGKIPDJXCAMSM-UHFFFAOYSA-N 0.000 description 1
- NFACJZMKEDPNKN-UHFFFAOYSA-N trichlorfon Chemical compound COP(=O)(OC)C(O)C(Cl)(Cl)Cl NFACJZMKEDPNKN-UHFFFAOYSA-N 0.000 description 1
- 229940029284 trichlorofluoromethane Drugs 0.000 description 1
- 125000003866 trichloromethyl group Chemical group ClC(Cl)(Cl)* 0.000 description 1
- LAYPMCGIWDGYKX-UHFFFAOYSA-N trichloromethyl hydrogen carbonate Chemical compound OC(=O)OC(Cl)(Cl)Cl LAYPMCGIWDGYKX-UHFFFAOYSA-N 0.000 description 1
- DQJCHOQLCLEDLL-UHFFFAOYSA-N tricyclazole Chemical compound CC1=CC=CC2=C1N1C=NN=C1S2 DQJCHOQLCLEDLL-UHFFFAOYSA-N 0.000 description 1
- ZDRNMODJXFOYMN-UHFFFAOYSA-N tridecyl acetate Chemical compound CCCCCCCCCCCCCOC(C)=O ZDRNMODJXFOYMN-UHFFFAOYSA-N 0.000 description 1
- 229940087291 tridecyl alcohol Drugs 0.000 description 1
- MCVUKOYZUCWLQQ-UHFFFAOYSA-N tridecylbenzene Chemical class CCCCCCCCCCCCCC1=CC=CC=C1 MCVUKOYZUCWLQQ-UHFFFAOYSA-N 0.000 description 1
- ZIBGPFATKBEMQZ-UHFFFAOYSA-N triethylene glycol Chemical compound OCCOCCOCCO ZIBGPFATKBEMQZ-UHFFFAOYSA-N 0.000 description 1
- ONCZDRURRATYFI-TVJDWZFNSA-N trifloxystrobin Chemical compound CO\N=C(\C(=O)OC)C1=CC=CC=C1CO\N=C(/C)C1=CC=CC(C(F)(F)F)=C1 ONCZDRURRATYFI-TVJDWZFNSA-N 0.000 description 1
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 description 1
- RROQIUMZODEXOR-UHFFFAOYSA-N triforine Chemical compound O=CNC(C(Cl)(Cl)Cl)N1CCN(C(NC=O)C(Cl)(Cl)Cl)CC1 RROQIUMZODEXOR-UHFFFAOYSA-N 0.000 description 1
- 238000001665 trituration Methods 0.000 description 1
- 235000013976 turmeric Nutrition 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 210000000689 upper leg Anatomy 0.000 description 1
- 238000003828 vacuum filtration Methods 0.000 description 1
- JARYYMUOCXVXNK-IMTORBKUSA-N validamycin Chemical compound N([C@H]1C[C@@H]([C@H]([C@H](O)[C@H]1O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)CO)[C@H]1C=C(CO)[C@H](O)[C@H](O)[C@H]1O JARYYMUOCXVXNK-IMTORBKUSA-N 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000004562 water dispersible granule Substances 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 239000004563 wettable powder Substances 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 229940100445 wheat starch Drugs 0.000 description 1
- 210000002268 wool Anatomy 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
- 239000005019 zein Substances 0.000 description 1
- 229940093612 zein Drugs 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- 235000014692 zinc oxide Nutrition 0.000 description 1
- DUBNHZYBDBBJHD-UHFFFAOYSA-L ziram Chemical compound [Zn+2].CN(C)C([S-])=S.CN(C)C([S-])=S DUBNHZYBDBBJHD-UHFFFAOYSA-L 0.000 description 1
- FJBGIXKIXPUXBY-UHFFFAOYSA-N {2-[3-(4-chlorophenyl)propyl]-2,4,4-trimethyl-1,3-oxazolidin-3-yl}(imidazol-1-yl)methanone Chemical compound C1=CN=CN1C(=O)N1C(C)(C)COC1(C)CCCC1=CC=C(Cl)C=C1 FJBGIXKIXPUXBY-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/30—Oxygen or sulfur atoms
- C07D233/32—One oxygen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/18—Oxygen atoms
- C07D263/20—Oxygen atoms attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D291/00—Heterocyclic compounds containing rings having nitrogen, oxygen and sulfur atoms as the only ring hetero atoms
- C07D291/02—Heterocyclic compounds containing rings having nitrogen, oxygen and sulfur atoms as the only ring hetero atoms not condensed with other rings
- C07D291/04—Five-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D419/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms
- C07D419/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D419/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
COMPOSTO, COMPOSIçãO, COMPOSIçãO DE CONTROLE DE PRAGAS INVERTEBRADAS, DE PULVERIZAçãO, DE ISCA, DISPOSITIVO DE ARMADILHA, MéTODOS DE CONTROLE, MéTODOS DE PROTEçãO, SEMENTE TRATADA E COMPOSIçãO DE PROTEçãO. São descritos compostos da Fórmula (1), incluindo todos os seus isómeros geométricos e estereoisómeros, N-óxidos e sais, em que G é O ou NR^ 3^; U é 0(=O), S(=O), 0(=S) ou S(O)~ 2~; Z é N ou CR^ 2^; R^ 1^ é ciano; ou alquila C~ 1~-C~ 6~, alquenila C~ 2~-C~ 6~, alquinila C~ 2~-C~ 6~, cicloalquila C~ 3~-C~ 6~, alquilcicloalquila C~ 4~-C~ 7~ ou cicloalquilalquila C~ 4~-C~ 7~, cada qual opcionalmente substituído com um ou mais substituintes selecionados independentemente a partir de R^ 17^; R^ 3^ é H, dano ou -CHO; ou alquila C~ 1~-C~ 6~, alquenila C~ 2~-C~ 6~, alquinila C~ 2~-C~ 6~, cicloalquila C~ 3~-C~ 6~, alquilcicloalquila C~ 4~-C~ 7~, cicloalquilaíquila C~ 4~-C~ 7~, fenila, alquilcarbonila C~ 2~-C~ 6~, alcoxicarbonila C~ 2~-C~ 6~, alquilaminocarbonila C~ 2~-C~ 6~, dialquilaminocarboflila C~ 3~-C~ 9~, cada qual opcionalmente substituido com um ou mais substituintes selecionados independentemente a partir de R~ 18 ~; é um heterociclo saturado ou insaturado com cinco ou seis membros opcionalmente substituido; ou Q é C(O)NR^ 12^R^ 13^, C (S)NR^ 12^R^ 13^, S(O)~ 2~NR^ 14^R^ 15^ ou R^ 16^; e R^ 2^, R^ 12^, R^ 13^, R^ 14^, R^ 15^, R^ 16^, R^ 17^, R^ 18^, A^ 1^, A^ 2^, A^ 3^, A^ 4^ e n são conforme definido no relatório descritivo. Também são descritas composições que contêm os compostos da Fórmula 1 e métodos de controle de pragas invertebradas que compreendem o contato da praga invertebrada ou seu ambiente com uma quantidade biologicamente eficaz de composto ou composição de acordo com a presente invenção.COMPOUND, COMPOSITION, COMPOSITION OF INVERTEBRATED PEST CONTROL, SPRAYING, BAIT, TRAP DEVICE, CONTROL METHODS, PROTECTION METHODS, TREATED SEED AND PROTECTION COMPOSITION. Compounds of Formula (1) are described, including all their geometric isomers and stereoisomers, N-oxides and salts, where G is O or NR ^ 3 ^; U is 0 (= O), S (= O), 0 (= S) or S (O) ~ 2 ~; Z is N or CR ^ 2 ^; R ^ 1 ^ is cyan; or C ~ 1 ~ -C ~ 6 ~ alkyl, C ~ 2 ~ -C ~ 6 ~ alkenyl, C ~ 2 ~ -C ~ 6 ~ alkynyl, C ~ 3 ~ -C ~ 6 ~ cycloalkyl, C ~ 4 ~ alkylcycloalkyl -C ~ 7 ~ or C ~ 4 ~ -C ~ 7 ~ cycloalkylalkyl, each optionally substituted with one or more substituents selected independently from R ^ 17 ^ ^; R ^ 3 ^ is H, damage or -CHO; or C ~ 1 ~ -C ~ 6 ~ alkyl, C ~ 2 ~ -C ~ 6 ~ alkenyl, C ~ 2 ~ -C ~ 6 ~ alkynyl, C ~ 3 ~ -C ~ 6 ~ cycloalkyl, C ~ 4 ~ alkylcycloalkyl -C ~ 7 ~, C ~ 4 ~ cycloalkylalkyl, -C ~ 7 ~, phenyl, C ~ 2 ~ -C ~ 6 ~ alkyl, C ~ 2 ~ -C ~ 6 ~ alkoxycarbonyl, C ~ 2 ~ -C ~ 6 alkylaminocarbonyl ~, C ~ 3 ~ -C ~ 9 ~ dialkylaminocarbophyl, each optionally substituted with one or more substituents selected independently from R ~ 18 ~; it is an optionally substituted five or six membered saturated or unsaturated heterocycle; or Q is C (O) NR ^ 12 ^ R ^ 13 ^, C (S) NR ^ 12 ^ R ^ 13 ^, S (O) ~ 2 ~ NR ^ 14 ^ R ^ 15 ^ or R ^ 16 ^; and R ^ 2 ^, R ^ 12 ^, R ^ 13 ^, R ^ 14 ^, R ^ 15 ^, R ^ 16 ^, R ^ 17 ^, R ^ 18 ^, A ^ 1 ^, A ^ 2 ^ , A ^ 3 ^, A ^ 4 ^ en are as defined in the specification. Also described are compositions containing the compounds of Formula 1 and invertebrate pest control methods that comprise contacting the invertebrate pest or its environment with a biologically effective amount of compound or composition according to the present invention.
Description
"COMPOSTO, COMPOSIÇÃO, COMPOSIÇÃO DE CONTROLE DE PRAGASINVERTEBRADAS, DE PULVERIZAÇÃO, DE ISCA, DISPOSITIVO DEARMADILHA, MÉTODOS DE CONTROLE, MÉTODOS DE PROTEÇÃO,SEMENTE TRATADA E COMPOSIÇÃO DE PROTEÇÃO""COMPOSITION, COMPOSITION, CONTROL COMPOSITION OF INVERTED, SPRAYING, Bait, PESTING DEVICE, CONTROL METHODS, PROTECTIVE METHODS, TREATED SEED AND PROTECTIVE COMPOSITION"
Campo da InvençãoField of the Invention
A presente invenção refere-se a certos derivados heterocíclicoscom cinco membros, seus N-óxidos, sais e composições apropriadas para usosagronômicos e não agronômicos, incluindo os usos relacionados abaixo, emétodos de seu uso para o controle de pragas invertebradas tais comoartrópodes em ambientes agronômicos e não agronômicos.The present invention relates to certain five membered heterocyclic derivatives, their N-oxides, salts and compositions suitable for agronomic and non-agronomic uses, including the uses listed below, and methods of their use for the control of invertebrate pests such as arthropods in agronomic environments. not agronomic.
Antecedentes da InvençãoBackground of the Invention
O controle de pragas invertebradas é extremamente importantepara atingir alta eficiência de produção. O dano por pragas invertebradas asafras agronômicas em cultivo e armazenadas pode causar reduçãosignificativa da produtividade e, desta forma, resultar em aumento de custospara o consumidor. O controle de pragas invertebradas em produtos florestais,safras de estufa, plantas ornamentais, safras de mudas, alimentosarmazenados e produtos de fibra, animais de criação, domésticos, gramados,produtos de madeira e saúde pública e animal também é importante. Muitosprodutos são disponíveis comercialmente para estes propósitos, maspermanece a necessidade de novos compostos que sejam mais eficazes,tenham custo mais baixo, sejam menos tóxicos, ambientalmente mais segurosou possuam diferentes modos de ação.Invertebrate pest control is extremely important to achieve high production efficiency. Damage by invertebrate pests to crop and stored crops may cause a significant reduction in yield and thus result in increased costs for the consumer. Control of invertebrate pests in forest products, greenhouse crops, ornamental plants, seedling crops, stored food and fiber products, livestock, domestic animals, lawns, wood products, and animal and public health is also important. Many products are commercially available for these purposes, but there remains a need for new compounds that are more effective, cost-effective, less toxic, environmentally safer, or have different modes of action.
A Patente PCT n° WO 93/22298 descreve derivados deoxazolidina e seus sais farmaceuticamente aceitáveis como anti-hiperlipidêmicos.PCT Patent No. WO 93/22298 describes deoxazolidine derivatives and their pharmaceutically acceptable salts as antihyperlipidemic.
A Patente Japonesa n° 03176476 descreve imidazolidinonascomo auxiliares quirais úteis para a produção de antibióticos penem oucarbapenem.Japanese Patent No. 03176476 describes imidazolidinones as chiral auxiliaries useful for the production of penem or carbapenem antibiotics.
A Patente Norte-Americana n0 4.186.129 descreve oxazolidinonasúteis como neurolépticos e inibidores de fosfodiesterase.U.S. Patent No. 4,186,129 describes oxazolidinonasubutives as neuroleptics and phosphodiesterase inhibitors.
Descrição Resumida da InvençãoA presente invenção refere-se a compostos da Fórmula 1,incluindo todos os seus isômeros geométricos e estereoisômeros, Λ/-όχidos esais, bem como composições agrícolas que os contêm e seu uso para ocontrole de pragas invertebradas:Brief Description of the Invention The present invention relates to compounds of Formula 1, including all geometric isomers and stereoisomers thereof, as well as agricultural compositions containing them and their use for invertebrate pest control:
<formula>formula see original document page 3</formula><formula> formula see original document page 3 </formula>
em que:on what:
G é O ou NR3;G is O or NR3;
U é C(=0), S(=0), C(=S) ou S(O)2;U is C (= 0), S (= 0), C (= S) or S (O) 2;
Z é N ou CR2;Z is N or CR2;
A1 é CR4 ou N;A1 is CR4 or N;
A2 é CR5 ou N;A2 is CR5 or N;
A3 é CR6 ou N;A3 is CR6 or N;
A4 é CR7 ou N;A4 is CR7 or N;
Q é um heterociclo saturado ou insaturado com cinco ouseis membros opcionalmente substituído com um ou mais substituintesselecionados independentemente a partir de halogênio, alquila C1-C6,haloalquila C1-C6, cicloalquila C3-C6) halocicloalquila C3-C6, alcóxi C1-C61haloalcóxi C1-C61 alquiltio C1-C61 haloalquiltio C1-C61 alquilsulfinila C1-C6,haloalquilsulfinila C1-C6, alquilsulfonila C1-C6, haloalquilsulfonila C1C61alquilamino C1-C6, dialquilamino C2-C8l ciano, nitro, C(O)NR8R91 C(O)OR101fenila e piridinila, em que cada fenila ou piridinila é opcionalmente substituídocom um ou mais substituintes selecionados independentemente a partir de R11;ouQ is a five or six membered saturated or unsaturated heterocycle optionally substituted with one or more substituents independently selected from halogen, C1-C6 alkyl, C1-C6 haloalkyl, C3-C6 cycloalkyl, C1-C6 alkoxy C1-C61haloalkoxy C61 C1-C61 haloalkylthio C1-C61 alquilsulfinila C1-C6 haloalquilsulfinila C1-C6 alquilsulfonila C1-C6 haloalquilsulfonila C1C61alquilamino C1-C6 dialkylamino, C2 C8l cyano, nitro, C (O) NR8R91 C (O) OR101fenila and pyridinyl wherein each phenyl or pyridinyl is optionally substituted with one or more substituents independently selected from R 11, or
-Q é C(O)NR12R131 C(S)NR12R131 S(O)2NR14R15 ou R16;-Q is C (O) NR12R131 C (S) NR12R131S (O) 2NR14R15 or R16;
-R1 é ciano; ou alquila C1-C6, alquenila C2-C6, alquinila C2-C6, cicloalquila C3-C6, alquilcicloalquila C4-C7 ou cicloalquilalquila C4-C7, cadaqual opcionalmente substituído com um ou mais substituintes selecionadosindependentemente a partir de R17;-R 1 is cyano; or C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C3-C6 cycloalkyl, C4-C7 alkylcycloalkyl or C4-C7 cycloalkylalkyl, each optionally substituted with one or more substituents independently selected from R17;
-cada R2 é, independentemente, H1 halogênio, alquila C1-C6,haloalquila Ci-C6, alcóxi C1-C6, haloalcóxi CrC6, alquiltio Ci-C6, haloalquiltioCi-C61 alquilsulfinila Ci-C61 haloalquilsulfinila C1-C61 alquilsulfonila CrC61haloalquilsulfonila CrC6l alquilamino C1-C61 dialquilamino C2-Cs,alcoxicarbonila C2-C4, alquilaminocarbonila C2-C4l dialquilaminocarbonila Ca-Cg1ciano ou nitro;each R2 is independently H1 halogen, C1-C6 alkyl, C1-C6 haloalkyl, C1-C6 alkoxy, C1-C6 haloalkoxy, C1-C6-alkylthio, C1-C61-alkylsulfinyl C1-C61-haloalkylsulfonyl-C1-C61-alkylsulfonyl-C1-6 alkylsulfonyl C61 -C2 dialkylamino, C2 -C4 alkoxycarbonyl, C2 -C4 alkylaminocarbonyl, C2 -C4 dialkylaminocarbonyl or nitro;
-R3 é H1 ciano ou -CHO; ou alquila C1-C61 alquenila C2-C61alquinila C2-C61 cicloalquila C3-C6l alquilcicloalquila C4-C7, cicloalquilalquila C4-C7, fenila, alquilcarbonila C1-C61 alcoxicarbonila C1-C61 alquilaminocarbonila C2-C6 ou dialquilaminocarbonila C3-C9l cada qual opcionalmente substituído comum ou mais substituintes selecionados independentemente a partir de R18;-R3 is cyano H1 or -CHO; or C1-C61 alkyl C2-C61 alkenyl C2-C61 alkynyl C3-C6 cycloalkyl C4-C7 alkylcycloalkyl, C4-C7 cycloalkylalkyl, phenyl, C1-C61 alkylcarbonyl C1-C61 alkylamino carbonyl or optionally substituted C3-C6 alkylamino or more substituents independently selected from R18;
-R41 R51 R6 e R7 são selecionados independentemente apartir de H1 halogênio, alquila C1-C6, haloalquila C1-C6, cicloalquila C3-C6,halocicloalquila C3-C6, alcóxi C1-C6, haloalcóxi C1-C6, alquiltio C1-C6,haloalquiltio C1-C6, alquilsulfinila C1-C6, haloalquilsulfinila C1-C6, alquilsulfonilaC1-C6, haloalquilsulfonila C1-C6, alquilamino C1-C6, dialquilamino C2-C6l ciano enitro; ou-R41 R51 R6 and R7 are independently selected from H1 halogen, C1-C6 alkyl, C1-C6 haloalkyl, C3-C6 cycloalkyl, C1-C6 halocycloalkyl, C1-C6 haloalkoxy, C1-C6 alkylthio, haloalkyl C 1 -C 6, C 1 -C 6 alkylsulfinyl, C 1 -C 6 haloalkylsulfinyl, C 1 -C 6 alkylsulfonyl, C 1 -C 6 haloalkylsulfonyl, C 1 -C 6 alkylamino, C 2 -C 6 dialkylamino cyano; or
- R6 e R7 são tomados em conjunto para formar um anelaromático fundido, em que o anel aromático fundido contém como membros deanéis, além dos átomos de cabeça de ponte A3 e A4, três átomos selecionadosa partir de um a dois átomos de carbono, zero a dois átomos de nitrogênio,zero a um átomo de oxigênio e zero a um átomo de enxofre ou quatro átomosselecionados a partir de dois a quatro átomos de carbono e zero a dois átomosde nitrogênio;- R 6 and R 7 are taken together to form a fused aromatic ring, wherein the fused aromatic ring contains, as the forward members, in addition to the bridgehead atoms A3 and A4, three atoms selected from one to two carbon atoms, zero to one. two nitrogen atoms, zero to one oxygen atom and zero to one sulfur atom, or four atoms selected from two to four carbon atoms and zero to two nitrogen atoms;
cada R^8, R^12 e R^14 é independentemente H1 alquila C1-C6,haloalquila C1-C6, alquenila C2-C6, alquinila C2-C6, cicloalquila C3-C6,alquilcicloalquila C4-C7, cicloalquilalquila C4-C7, alquilcarbonila C2-C7,alcoxialquila C2-C6 ou alcoxicarbonila C2-C7;each R 8, R 12 and R 14 are independently H 1 C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, C 3 -C 6 cycloalkyl, C 4 -C 7 cycloalkyl, C 4 -C 7 cycloalkyl, C 2 -C 7 alkylcarbonyl, C 2 -C 6 alkoxyalkyl or C 2 -C 7 alkoxycarbonyl;
cada R^9, R^10, R^13 e R^15 é independentemente H, alquila C1-C6, alquenila C2-C6, alquinila C2-C6, cicloalquila C3-C6, alquilcicloalquila C4-C7ou cicloalquilalquila C4-C7, cada qual opcionalmente substituído com um oumais substituintes selecionados independentemente a partir de R^19;each R 9, R 10, R 13 and R 15 are independently H, C 1 -C 6 alkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, C 3 -C 6 cycloalkyl, C 4 -C 7 alkylcycloalkyl or C 4 -C 7 cycloalkylalkyl each which is optionally substituted with one or more substituents independently selected from R 19;
cada R^11, R^23 e R^24 é independentemente halogênio, alquilaC1-C6, haloalquila C1-C6, alcóxi C1-C6, haloalcóxi C1-C6, alquiltio C1-C6,haloalquiltio C1-C6, alquilsulfinila C1-C6, haloalquilsulfinila C1-C6, alquilsulfonilaC1-C6, haloalquilsulfonila C1-C6, alquilaminossulfonila C1-C6l alquilamino C1-C8,dialquilamino C2-C8, alcoxicarbonila C2-C4, ciano ou nitro;each R 11, R 23 and R 24 are independently halogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 alkoxy, C 1 -C 6 haloalkoxy, C 1 -C 6 alkylthio, C 1 -C 6 haloalkyl, C 1 -C 6 alkylsulfinyl, C 1 -C 6 haloalkylsulfinyl, C 1 -C 6 alkylsulfonyl, C 1 -C 6 haloalkylsulfonyl, C 1 -C 6 alkylaminosulfonyl C 1 -C 8 alkylamino, C 2 -C 8 dialkylamino, C 2 -C 4 alkoxycarbonyl, cyano or nitro;
R^16 é halogênio, alquila C1-C6, haloalquila C1-C6,cicloalquila C3-C6, halocicloalquila C3-C6, alcóxi C1-C6, haloalcóxi C1-C6,alquiltio C1-C6, haloalquiltio C1-C6, alquilsulfinila C1-C6, haloalquilsulfinila C1-C6,alquilsulfonila C1-C6, haloalquilsulfonila C1-6, alquilamino C1-C6, dialquilaminoC2-C8, ciano ou nitro;R16 is halogen, C1-C6 alkyl, C1-C6 haloalkyl, C3-C6 cycloalkyl, C3-C6 halocycloalkyl, C1-C6 alkoxy, C1-C6 haloalkoxy, C1-C6 haloalkyl, C1-C6 alkylsulfinyl C1-C6 haloalkylsulfinyl, C1-C6 alkylsulfonyl, C1-6 haloalkylsulfonyl, C1-C6 alkylamino, C2-C8 dialkylamino, cyano or nitro;
cada R^17 e R^18 é independentemente halogênio, alquila C1-C6, alcóxi C1-C6, alquiltio C1-C6, alquilsulfinila C1-C6, alquilsulfonila C1-C6, cianoou nitro;each R 17 and R 18 are independently halogen, C 1 -C 6 alkyl, C 1 -C 6 alkoxy, C 1 -C 6 alkylthio, C 1 -C 6 alkylsulfinyl, C 1 -C 6 alkylsulfonyl, cyanoor nitro;
- cada R^19 é independentemente halogênio, alquila C1-C6,- each R 19 is independently halogen, C 1 -C 6 alkyl,
alcóxi C1-C6, alquiltio C1-C6, alquilsulfinila C1-C6, alquilsulfonila C1-C6,alquilcarbonila C2-C6, alcoxicarbonila C2-C6, trimetilsilila, ciano, nitro ou Q1;C1-C6 alkoxy, C1-C6 alkylthio, C1-C6 alkylsulfinyl, C1-C6 alkylsulfonyl, C2-C6 alkylcarbonyl, C2-C6 alkoxycarbonyl, trimethylsilyl, cyano, nitro or Q1;
cada Q^1 é independentemente um fenila ou um heterociclosaturado ou insaturado com cinco ou seis membros, cada qual opcionalmentesubstituído com um ou mais substituintes selecionados independentemente apartir de halogênio, alquila C1-C6, haloalquila C1-C6, cicloalquila C3-C6,halocicloalquila C3-C6, alcóxi C1-C6, haloalcóxi C1-C6, alquiltio C1-C6,haloalquiltio C1-C6, alquilsulfinila C1-C6, haloalquilsulfinila C1-C61 alquilsulfonilaC1-C61 haloalquilsulfonila C1-C6, alquilamino C1-C61 dialquilamino C2-C8l ciano,nitro, C(O)NR20R211 C(O)OR221 fenila ou piridinila, em que cada fenila oupiridinila é opcionalmente substituído com um ou mais substituintesselecionados independentemente a partir de R23;each Q 1 is independently a phenyl or a 5- or 6-membered heterocyclesaturated or unsaturated, each optionally substituted with one or more substituents independently selected from halogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 3 -C 6 cycloalkyl, C 3 halocycloalkyl -C6, C1-C6 alkoxy, C1-C6 haloalkoxy, C1-C6 alkylthio, C1-C6 haloalkylthio, C1-C6 alkylsulfinyl, C1-C61 haloalkylsulfinyl C1-C61 haloalkylsulfonyl C1-C6 alkylamino C1-C61 dialkylamino nitro, C (O) NR 20 R 21 C (O) OR 221 phenyl or pyridinyl, wherein each phenyl or pyridinyl is optionally substituted with one or more substituents independently selected from R 23;
- cada R20 é independentemente H1 alquila C1-C61 haloalquilaC1-C61 alquenila C2-C6, alquinila C2-C6, cicloalquila C3-C6l alquilcicloalquila C4-C7, cicloalquilalquila C4-C7l alquilcarbonila C2-C7 ou alcoxicarbonila C2-C7;- each R20 is independently H1 C1 -C61 alkyl halo C1 -C61 alkyl C2 -C6 alkenyl, C2 -C6 alkynyl, C3 -C6 cycloalkyl C4 -C7 alkylcycloalkyl C2 -C7 cycloalkyl C2 -C7 alkylcarbonyl;
cada R21 e R22 é independentemente H1 alquila C1-C6,haloalquila C1-C61 alquenila C2-C61 alquinila C2-C61 cicloalquila C3-C6lalquilcicloalquila C4-C7l cicloalquilalquila C4-C7l fenila ou piridinila; em que cadafenila ou piridinila é opcionalmente substituído com um ou mais substituintesselecionados independentemente a partir de R24; eeach R 21 and R 22 is independently H 1 C 1 -C 6 alkyl, C 1 -C 6 haloalkyl C 2 -C 6 alkenyl C 2 -C 6 alkynyl C 3 -C 6 cycloalkyl C 4 -C 7 cycloalkyl C 4 -C 7 cycloalkyl alkyl phenyl or pyridinyl; wherein each phenyl or pyridinyl is optionally substituted by one or more substituents independently selected from R 24; and
n é 1,2, 3 ou 4;n is 1,2, 3 or 4;
desde que R16 seja diferente de metóxi.provided that R16 is other than methoxy.
A presente invenção também fornece uma composição decontrole de pragas invertebradas que compreende uma quantidadebiologicamente eficaz de um composto da Fórmula 1, seu N-óxido ou sal e pelomenos um componente adicional selecionado a partir do grupo que consiste deum tensoativo, diluente sólido e diluente líquido, em que a mencionadacomposição compreende ainda opcionalmente uma quantidade biologicamenteeficaz de pelo menos um agente ou composto biologicamente ativo adicional.The present invention also provides an invertebrate pest control composition comprising a biologically effective amount of a compound of Formula 1, its N-oxide or salt and at least one additional component selected from the group consisting of a surfactant, solid diluent and liquid diluent, wherein said composition optionally further comprises a biologically effective amount of at least one additional biologically active agent or compound.
A presente invenção também fornece uma composição depulverização para controle de pragas invertebradas que compreende umaquantidade biologicamente eficaz de um composto da Fórmula 1, um de seussais ou A/-óxidos ou da composição descrita acima e um propelente. A presenteinvenção também fornece uma composição de isca para controlar pragasinvertebradas que compreende uma quantidade biologicamente eficaz de umcomposto da Fórmula 1, seu A/-óxido ou sal, ou da composição descrita acima,um ou mais materiais alimentícios, opcionalmente um atrativo e opcionalmenteum umectante.The present invention also provides an invertebrate pest control spray composition which comprises a biologically effective amount of a compound of Formula 1, one of its salts or Î ± -oxides or of the composition described above and a propellant. The present invention also provides a bait composition for controlling invertebrate pests comprising a biologically effective amount of a compound of Formula 1, its A / oxide or salt, or of the composition described above, one or more food materials, optionally an attractive and optionally a humectant.
A presente invenção fornece ainda um dispositivo de armadilhapara controle de pragas invertebradas que compreende a mencionadacomposição de isca e um abrigo adaptado para receber a mencionadacomposição de isca, em que o abrigo contém pelo menos uma aberturadimensionada para permitir que a praga invertebrada passe através daabertura, de forma que a praga invertebrada possa obter acesso à mencionadacomposição de isca a partir de um local fora do abrigo e em que o abrigo éadicionalmente adaptado para colocação em um local de atividade conhecidaou potencial para as pragas invertebradas ou perto dele.The present invention further provides an invertebrate pest control trap device comprising said bait composition and a shelter adapted to receive said bait composition, wherein the shelter contains at least one dimensioned opening to allow the invertebrate pest to pass through the aperture. so that the invertebrate pest can gain access to said bait composition from a location outside the shelter and where the shelter is further adapted for placement in a known activity site or potential for or near invertebrate pests.
A presente invenção também fornece um método de controle depragas invertebradas que compreende o contato da praga invertebrada ou seuambiente com uma quantidade biologicamente eficaz de um composto daFórmula 1, seu N-óxido ou sal (tal como uma composição descrita nopresente). A presente invenção também se refere a um método em que a pragainvertebrada ou seu ambiente é colocada em contato com uma composiçãoque compreende uma quantidade biologicamente eficaz de um composto daFórmula 1, seu N-óxido ou sal e pelo menos um componente adicionalselecionado a partir do grupo que consiste de um tensoativo, um diluente sólidoe um diluente líquido, em que a mencionada composição compreende aindaopcionalmente uma quantidade biologicamente eficaz de pelo menos umagente ou composto biologicamente ativo adicional.A presente invenção também fornece um método de proteção desementes contra pragas invertebradas que compreende o contato da sementecom uma quantidade biologicamente eficaz de um composto da Fórmula 1, seuN-óxido ou sal (tal como uma composição descrita no presente). A presenteinvenção também se refere à semente tratada. A presente invenção forneceainda um método de proteção de animais contra pragas parasitasinvertebradas que compreende a administração ao animal de uma quantidadeeficaz como parasiticida de um composto da Fórmula 1, seu A/-óxido ou sal (talcomo uma composição descrita no presente).The present invention also provides an invertebrate pest control method comprising contacting the invertebrate pest or its environment with a biologically effective amount of a compound of Formula 1, its N-oxide or salt (such as a composition described herein). The present invention also relates to a method wherein the pragainvertebrate or its environment is contacted with a composition comprising a biologically effective amount of a compound of Formula 1, its N-oxide or salt and at least one additional component selected from the group. consisting of a surfactant, a solid diluent and a liquid diluent, wherein said composition further optionally comprises a biologically effective amount of at least one additional biologically active compound or compound. The present invention also provides a method of protecting against invertebrate pests which comprises contact the seed with a biologically effective amount of a compound of Formula 1, its N-oxide or salt (such as a composition described herein). The present invention also relates to the treated seed. The present invention further provides a method of protecting animals against parasitic invertebrate pests comprising administering to the animal a parasiticidal effective amount of a compound of Formula 1, its A-oxide or salt (such as a composition described herein).
Descrição Detalhada da InvençãoDetailed Description of the Invention
Da forma utilizada no presente, as expressões "compreende","que compreende", "inclui", "que inclui", "tem", "que tem", "contém", "quecontém" ou qualquer de suas variações destinam-se a cobrir uma inclusão nãoexclusiva. Uma composição, mistura, processo, método, artigo ou aparelho quecompreende uma lista de elementos, por exemplo, não se limitanecessariamente apenas àqueles elementos, mas pode incluir outroselementos não relacionados expressamente ou inerentes a essa composição,mistura, processo, método, artigo ou aparelho. Além disso, a menos queindicado expressamente em contrário, "ou" indica inclusivo e não exclusivo.Uma condição A ou B é satisfeita, por exemplo, por qualquer dos seguintes: Aé verdadeiro (ou presente) e B é falso (ou ausente), A é falso (ou ausente) e Bé verdadeiro (ou presente) ou ambos, AeB, são verdadeiros (ou presentes).As used herein, the terms "comprises", "comprising", "includes", "including", "has", "has", "contains", "contains" or any of its variations are intended to cover non-exclusive inclusion. A composition, mixture, process, method, article or apparatus comprising a list of elements, for example, is not necessarily limited to those elements only, but may include other elements not expressly related to or inherent in that composition, mixture, process, method, article or apparatus. . In addition, unless expressly stated otherwise, "or" indicates inclusive and not exclusive. A condition A or B is met, for example, by any of the following: True air (or present) and B is false (or absent), A is false (or absent) and true B (or present) or both AeB are true (or present).
Além disso, os artigos indefinidos "um" e "uma" que precedem umelemento ou componente de acordo com a presente invenção destinam-se aser não restritivos com relação ao número de casos (ou seja, ocorrências) doelemento ou componente. "Um" ou "uma", portanto, deverá ser lido comoincluindo um ou pelo menos um e a forma da palavra no singular do elementoou componente também inclui o plural, a menos que o número se destineobviamente a ser singular.In addition, the undefined "one" and "one" articles preceding an element or component according to the present invention are intended to be non-restrictive with respect to the number of cases (ie occurrences) of the element or component. "One" or "one", therefore, should be read as including one or at least one, and the form of the element's singular word or component also includes the plural, unless the number is obviously intended to be singular.
Conforme indicado na presente, a expressão "praga invertebrada"inclui artrópodes, gastrópodes e nematóides de importância econômica comopragas. O termo "artrópode" inclui insetos, ácaros, espanhas, escorpiões,centopéias, miriápodes, cochonilhas e afídeos. O termo "gastrópode" incluicaracóis, Iesmas e outros estilomatóforos. O termo "helmíntios" inclui vermesdo filo dos nemaltelmíntios, platielmíntios e acantocéfalos tais como vermesredondos, parasitas cardíacos e nematóides fitófagos (nematóides), fascíolas(trematóides), céstodes (céstodes) e ctenóforos.As indicated herein, the term "invertebrate pest" includes arthropods, gastropods, and nematodes of economic importance as pests. The term "arthropod" includes insects, mites, spain, scorpions, centipedes, myriads, mealybugs and aphids. The term "gastropod" includes colens, ises, and other stylomatophores. The term "helminths" includes phylum worms of the nemaltelminths, platyelminths, and acanthocephalus such as roundworms, cardiac parasites, and phytophagous (nematode), fasciole (trematoid), cestode (cestode), and ctenophorous nematodes.
No contexto do presente relatório descritivo, "controle de pragasinvertebradas" indica a inibição do desenvolvimento de pragas invertebradas(incluindo mortalidade, redução da alimentação e/ou rompimento doacasalamento) e expressões relativas são definidas de forma análoga.In the context of this descriptive report, "control of invertebrate pests" indicates inhibition of the development of invertebrate pests (including mortality, reduced feeding and / or disruption of maturation) and relative expressions are defined analogously.
O termo "agronômico" indica a produção de safras de campo, taiscomo para alimentos e fibras, e inclui o crescimento de safras de milho, soja eoutros legumes, arroz, cereais (tais como trigo, aveia, cevada, centeio, arroz emilho branco), vegetais folhosos (tais como alface, repolho e outras safras decouve), legumes frutíferos (tais como tomates, pimenta, berinjela, crucíferas eabóboras), batatas, batatas doces, uvas, algodão, árvores frutíferas (tais comofrutas em pomos, drupas e cítricas), frutas pequenas (bagas, cerejas) e outrassafras especializadas (tais como canola, girassol, azeitonas). A expressão "nãoagronômico" indica aplicações em outras safras hortícolas (tais como plantasde estufa, mudas ou ornamentais não cultivadas em um campo), estruturasresidenciais e comerciais em ambientes urbanos e industriais, gramados (taiscomo plantações de grama, pastos, campos de golfe, gramados residenciais,campos esportivos de recreação etc.), produtos de madeira, produtosarmazenados, administração de vegetação e agroflorestal, saúde pública(humana) e saúde animal (tal como animais domesticados como animaisdomésticos, animais de criação e aves, animais não domesticados tais comovida selvagem).The term "agronomic" indicates the production of field crops, such as for food and fiber, and includes the growth of corn, soybean and other vegetables, rice, cereals (such as wheat, oats, barley, rye, white corn rice). , leafy vegetables (such as lettuce, cabbage and other decouve crops), fruit vegetables (such as tomatoes, pepper, eggplant, cruciferous and pumpkins), potatoes, sweet potatoes, grapes, cotton, fruit trees (such as pomegranate, drupe and citrus fruits ), small fruits (berries, cherries) and other specialized harvests (such as canola, sunflower, olives). The term "nonagronomic" indicates applications in other horticultural crops (such as greenhouse plants, seedlings or ornamentals not cultivated in a field), residential and commercial structures in urban and industrial environments, lawns (such as grass plantations, pastures, golf courses, lawns residences, recreational sports fields, etc.), wood products, stored products, vegetation and agroforestry management, public (human) health and animal health (such as domesticated animals such as domesticated animals, farmed animals and birds, undomesticated animals such as wild animals). ).
Nas descrições acima, o termo "alquila", utilizado isoladamente ouem palavras compostas tais como "alquiltio" ou "haloalquila", inclui alquila decadeia linear ou ramificado, tal como metila, etila, n-propila, i-propila ou osdiferentes isômeros de butila, pentila ou hexila. "Alquenila" inclui alquenos decadeia linear ou ramificados tais como etenila, 1-propenila, 2-propenila e osdiferentes isômeros de butenila, pentenila e hexenila. "Alquenila" também incluipolienos tais como 1,2-propadienila e 2,4-hexadienila. "Alquinila" inclui alquinasde cadeia linear ou ramificadas tais como etinila, 1-propinila, 2-propinila e osdiferentes isômeros de butinila, pentinila e hexinila. "Alquinila" pode tambémincluir porções compostas de diversas uniões triplas múltiplas, tais como 2,5-hexadiinila.In the above descriptions, the term "alkyl", used alone or in compound words such as "alkylthio" or "haloalkyl", includes straight or branched middle alkyl such as methyl, ethyl, n-propyl, i-propyl or the different butyl isomers. , pentyl or hexyl. "Alkenyl" includes straight or branched alkenes such as ethenyl, 1-propenyl, 2-propenyl and the different isomers of butenyl, pentenyl and hexenyl. "Alkenyl" also includes polyols such as 1,2-propadienyl and 2,4-hexadienyl. "Alkynyl" includes straight or branched chain alkynes such as ethynyl, 1-propynyl, 2-propynyl and the different isomers of butynyl, pentinyl and hexinyl. "Alkynyl" may also include portions composed of several multiple triple unions, such as 2,5-hexadiinyl.
"Alcóxi" inclui, por exemplo, metóxi, etóxi, n-propilóxi, isopropilóxie os diferentes isômeros de butóxi, pentóxi e hexilóxi. "Alquiltio" inclui porçõesalquiltio de cadeia linear ou ramificada tais como metiltio, etiltio e os diferentesisômeros de propiltio, butiltio, pentiltio e hexiltio. "Alquilsulfinila" inclui os doisenantiômeros de um grupo alquilsulfinila. Exemplos de "alquilsulfinila" incluemCH3S(O)-, CH3CH2S(O)-, CH3CH2CH2S(O)-, (CH3)2CHS(O)- e os diferentesisômeros de butilsulfinila, pentilsulfinila e hexilsulfinila. Exemplos de"alquilsulfonila" incluem CH3S(O)2-, CH3CH2S(O)2-, CH3CH2CH2S(O)2-,(CH3)2CHS(O)2- e os diferentes isômeros de butilsulfonila, pentilsulfonila ehexilsulfonila. "Alquilamino", "dialquilamino" e similares são definidos de formaanáloga aos exemplos acima. "Cicloalquila" inclui, por exemplo, ciclopropila,ciclobutila, ciclopentila e ciclohexila. O termo "alquilcicloalquila" indicasubstituição alquila sobre uma porção cicloalquila e inclui, por exemplo,etilciclopropila, i-propilciclobutila, 3-metilciclopentila e 4-metilciclohexila. Otermo "cicloalquilalquila" indica substituição cicloalquila sobre uma porçãoalquila. Exemplos de "cicloalquilalquila" incluem ciclopropilmetila, ciclopentiletilae outras porções cicloalquila unidas a grupos alquila de cadeia reta ouramificados."Alkoxy" includes, for example, methoxy, ethoxy, n-propyloxy, isopropyloxy the different isomers of butoxy, pentoxy and hexyloxy. "Alkylthio" includes straight or branched chain alkylthio moieties such as methylthio, ethylthio and the different isomers of propylthio, butylthio, pentylthio and hexylthio. "Alkylsulfinyl" includes the two enantiomers of an alkylsulfinyl group. Examples of "alkylsulfinyl" include CH3S (O) -, CH3CH2S (O) -, CH3CH2CH2S (O) -, (CH3) 2CHS (O) - and the different isomers of butylsulfinyl, pentylsulfinyl and hexylsulfinyl. Examples of "alkylsulfonyl" include CH3S (O) 2-, CH3CH2S (O) 2-, CH3CH2CH2S (O) 2 -, (CH3) 2CHS (O) 2- and the different isomers of butylsulfonyl, pentylsulfonyl and hexylsulfonyl. "Alkylamino", "dialkylamino" and the like are defined analogously to the above examples. "Cycloalkyl" includes, for example, cyclopropyl, cyclobutyl, cyclopentyl and cyclohexyl. The term "alkylcycloalkyl" denotes alkyl substitution on a cycloalkyl moiety and includes, for example, ethylcyclopropyl, i-propylcyclobutyl, 3-methylcyclopentyl and 4-methylcyclohexyl. The term "cycloalkylalkyl" denotes cycloalkyl substitution over a alkyl portion. Examples of "cycloalkylalkyl" include cyclopropylmethyl, cyclopentylethyl and other cycloalkyl moieties attached to straight chain or branched alkyl groups.
O termo "halogênio", seja isoladamente ou em palavrascompostas tais como "haloalquila", ou quando utilizado em descrições taiscomo "alquila substituído com halogênio", inclui flúor, cloro, bromo ou iodo.Além disso, quando utilizado em palavras compostas tais como "haloalquila", omencionado alquila pode ser parcial ou totalmente substituído com átomos dehalogênio que podem ser idênticos ou diferentes. Exemplos de "haloalquila" ou"alquila substituído com halogênio" incluem F3C-, CICH2-, CF3CH2- e CF3CCI2-.Os termos "halocicloalquila", "haloalcóxi", "haloalquiltio" e similares sãodefinidos de forma análoga ao termo "haloalquila". Exemplos de "haloalcóxi"incluem CF3O-, CCI3CH2O-, HCF2CH2CH2O- e CF3CH2O-. Exemplos de"haloalquiltio" incluem CCI3S-, CF3S-, CCI3CH2S- e CICH2CH2CH2S-. Exemplosde "haloalquilsulfinila" incluem CF3S(O)-, CCI3S(O)-, CF3CH2S(O)- eCF3CF2S(O)-. Exemplos de "haloalquilsulfonila" incluem CF3S(O)2-, CCI3S(O)2-,CF3CH2S(O)2- e CF3CF2S(O)2-.The term "halogen", either alone or in compound words such as "haloalkyl", or when used in descriptions such as "halogen substituted alkyl", includes fluorine, chlorine, bromine or iodine. In addition, when used in compound words such as " "haloalkyl", mentioned alkyl may be partially or fully substituted with halogen atoms which may be identical or different. Examples of "haloalkyl" or "halogen substituted alkyl" include F3C-, CICH2-, CF3CH2- and CF3CCI2-. The terms "halocycloalkyl", "haloalkoxy", "haloalkylthio" and the like are defined analogously to the term "haloalkyl". Examples of "haloalkoxy" include CF3O-, CCl3CH2O-, HCF2CH2CH2O- and CF3CH2O-. Examples of "haloalkylthio" include CCI3S-, CF3S-, CCI3CH2S- and CICH2CH2CH2S-. Examples of "haloalkylsulfinyl" include CF3S (O) -, CCl3S (O) -, CF3CH2S (O) - and CF3CF2S (O) -. Examples of "haloalkylsulfonyl" include CF3S (O) 2-, CCI3S (O) 2-, CF3CH2S (O) 2- and CF3CF2S (O) 2-.
"Alquilcarbonila" indica porções alquila de cadeia linear ouramificada unidas a uma porção C(=0). Exemplos de "alquilcarbonila" incluemCH3C(=0)-, CH3CH2CH2C(=0)- e (CH3)2CHC(=0)-. Exemplos de"alcoxicarbonila" incluem CH30C(=0)-, CH3CH20C(=0)-, CH3CH2CH20C(=0)-,(CH3)2CH0C(=0)- e os diferentes isômeros de butóxi ou pentoxicarbonila."Alkylcarbonyl" denotes straight chain or branched alkyl moieties attached to a C (= O) moiety. Examples of "alkylcarbonyl" include CH 3 C (= 0) -, CH 3 CH 2 CH 2 C (= 0) - and (CH 3) 2 CHC (= 0) -. Examples of "alkoxycarbonyl" include CH30C (= 0) -, CH3CH20C (= 0) -, CH3CH2CH20C (= 0) -, (CH3) 2CH0C (= 0) - and the different butoxy or pentoxycarbonyl isomers.
A quantidade total de átomos de carbono em grupo substituinte éindicada pelo prefixo "Ci-Cj", em que i e j são números inteiros de 1 a 9.Alquilsulfonila C1-C4, por exemplo, designa metilsulfonila até butilsulfonila;alcoxialquila C2 designa CH3OCH2; alcoxialquila C3 designa, por exemplo,CH3CH(OCH3), CH3OCH2CH2 ou CH3CH2OCH2; e alcoxialquila C4 designa osvários isômeros de um grupo alquila substituído com um grupo alcóxi quecontém um total de quatro átomos de carbono, em que exemplos incluemCH3CH2CH2OCH2 e CH3CH2OCH2CH2.The total amount of carbon atoms in the substituent group is indicated by the prefix "C1 -C1", where i and j are integers from 1 to 9. C1 -C4 alkylsulfonyl, for example, means methylsulfonyl to butylsulfonyl: C2 alkoxyalkyl denotes CH3OCH2; C 3 alkoxyalkyl means, for example, CH 3 CH (OCH 3), CH 3 OCH 2 CH 2 or CH 3 CH 2 OCH 2; and C4 alkoxyalkyl denotes the various isomers of an alkyl group substituted with an alkoxy group which contains a total of four carbon atoms, examples of which include CH3CH2CH2OCH2 and CH3CH2OCH2CH2.
Quando um composto for substituído com um substituinte que contémum subscrito que indica que o número dos mencionados substituintes pode exceder1, os mencionados substituintes (quando excederem 1) são selecionadosindependentemente a partir do grupo de substituintes definidos, tal como (R2)n, η é1, 2, 3 ou 4. Quando um grupo contiver um substituinte que pode ser hidrogênio, talcomo R2, quando esse substituinte for tomado como hidrogênio, reconhece-se queele é equivalente ao mencionado grupo que não é substituído.When a compound is substituted with a substituent containing a subscript indicating that the number of said substituents may exceed 1, said substituents (when exceeding 1) are independently selected from the group of defined substituents such as (R2) n, η is 1, 2, 3 or 4. When a group contains a substituent which may be hydrogen, such as R2, when that substituent is taken as hydrogen, it is recognized to be equivalent to said unsubstituted group.
O termo "heterociclo", "anel heterocíclico" ou "sistema de anéisheterocíclicos" indica anéis ou sistemas de anéis em que pelo menos umátomo de anel não é carbono, tal como nitrogênio, oxigênio ou enxofre.Tipicamente, um anel heterocíclico contém não mais de quatro nitrogênios, nãomais de dois oxigênios e não mais de dois enxofres. O anel heterocíclico podeser ligado por meio de qualquer carbono ou nitrogênio disponível porsubstituição de hidrogênio sobre o mencionado carbono ou nitrogênio. O anelheterocíclico pode ser um anel saturado, parcialmente insaturado ou totalmenteinsaturado. Quando um anel heterocíclico totalmente insaturado satisfizer a leide Hückel, o mencionado anel também é denominado um "anelheteroaromático" ou "anel heterocíclico aromático".The term "heterocycle", "heterocyclic ring" or "heterocyclic ring system" denotes rings or ring systems in which at least one ring atom is not carbon, such as nitrogen, oxygen or sulfur. Typically, a heterocyclic ring contains no more than four nitrogen, no more than two oxygen and no more than two sulfur. The heterocyclic ring may be attached via any available carbon or nitrogen by hydrogen substitution on said carbon or nitrogen. The heterocyclic ring may be a saturated, partially unsaturated or fully unsaturated ring. Where a fully unsaturated heterocyclic ring satisfies the Hückel leid, said ring is also referred to as a "heteroaromatic ring" or "aromatic heterocyclic ring".
A expressão "anel aromático" ou "sistema de anéis aromáticos"indica carbociclos e heterociclos totalmente insaturados em que pelo menosum anel do sistema de anéis policíclicos é aromático (em que aromático indicaque a lei de Hückel é satisfeita para o sistema de anéis). A expressão "sistemade anéis bicíclicos fundidos" indica que um sistema de anéis que contém doisanéis fundidos, no qual cada anel pode ser saturado, parcialmente saturado outotalmente insaturado. A expressão "sistema de anéis heterobicíclicos fundidos"indica um sistema de anéis que contém dois anéis fundidos em que pelomenos um átomo de anel não é carbono e que pode ser aromático ou nãoaromático, conforme definido acima.The term "aromatic ring" or "aromatic ring system" denotes fully unsaturated carbocycles and heterocycles wherein at least one ring of the polycyclic ring system is aromatic (where aromatic indicates that Hückel's law is satisfied for the ring system). The term "fused bicyclic ring system" indicates that a ring system containing two fused rings in which each ring may be saturated, partially saturated or fully unsaturated. The term "fused heterobicyclic ring system" means a ring system containing two fused rings wherein at least one ring atom is non-carbon and which may be aromatic or nonaromatic as defined above.
A expressão "opcionalmente substituído", com relação aos anéisheterocíclicos, indica grupos que não são substituídos ou contêm pelo menosum substituinte não de hidrogênio que não elimina a atividade biológicapossuída pelo análogo não substituído. Da forma utilizada no presente, aplicar-se-ão as definições a seguir a menos que indicado em contrário. A expressão"opcionalmente substituído" é utilizada de forma intercambiável com aexpressão "substituído ou não substituído" ou com a expressão "(não)substituído". A menos que indicado em contrário, um grupo opcionalmentesubstituído pode conter um substituinte em cada posição substituível do grupoe cada substituição é independente da outra.The term "optionally substituted" with respect to heterocyclic rings denotes groups that are unsubstituted or contain at least one non-hydrogen substituent that does not eliminate the bio-deficient activity of the unsubstituted analog. As used herein, the following definitions shall apply unless otherwise specified. The term "optionally substituted" is used interchangeably with the expression "substituted or unsubstituted" or the expression "(unsubstituted)". Unless otherwise indicated, an optionally substituted group may contain one substituent at each substitutable position in the group and each substitution is independent of the other.
Quando Q ou Q1 for um heterociclo que contém nitrogênio comcinco ou seis membros, ele pode ser ligado ao restante da Fórmula 1 por meiode qualquer átomo de anel de nitrogênio ou carbono disponível, a menos queindicado em contrário. Os técnicos no assunto reconhecem que "piridinila" e"piridila" são nomes alternativos equivalentes para um radical orgânico formadopor meio da remoção de um átomo de hidrogênio de um anel de piridina paraformar um ponto de ligação; conseqüentemente, "piridinila" e "piridila" sãoutilizados no presente como sinônimos.Where Q or Q1 is a five-membered five-membered nitrogen heterocycle, it may be attached to the remainder of Formula 1 by any available nitrogen or carbon ring atom unless otherwise indicated. Those skilled in the art recognize that "pyridinyl" and "pyridyl" are equivalent alternative names for an organic radical formed by removing a hydrogen atom from a pyridine ring to form a point of attachment; consequently, "pyridinyl" and "pyridyl" are used herein as synonyms.
Conforme ilustrado acima, Q1 pode ser (entre outros) fenilaopcionalmente substituído com um ou mais substituintes selecionados a partirde um grupo de substituintes conforme definido na Descrição Resumida daInvenção. Um exemplo de fenila opcionalmente substituído com um ou maissubstituintes é o anel ilustrado como U-1 na Ilustração 1, em que Rv é qualquersubstituinte conforme definido na Descrição Resumida da Invenção para Q1 e ré um número inteiro de 0 a 5.As illustrated above, Q1 may be (among others) phenyl optionally substituted with one or more substituents selected from a group of substituents as defined in the Invention's Summary Description. An example of phenyl optionally substituted with one or more substituents is the ring illustrated as U-1 in Illustration 1, wherein Rv is any substituent as defined in the Summary Description of the Invention for Q1 and r is an integer from 0 to 5.
Conforme indicado acima, Q ou Q1 podem ser (entre outros)heterociclos saturados ou insaturados com cinco ou seis membros opcionalmentesubstituídos com um ou mais substituintes selecionados a partir do grupo desubstituintes conforme definido na Descrição Resumida da Invenção. Exemplos deheterociclos aromáticos insaturados com cinco ou seis membros opcionalmentesubstituídos com um ou mais substituintes incluem os anéis U-2 a U-61 exibidos naIlustração 1 em que Rv é qualquer substituinte conforme definido na DescriçãoResumida da Invenção para Q ou Q1 e r é um número inteiro de 0 a 4. Observe-seque alguns grupos U somente podem ser substituídos com menos de quatro gruposRv (tais como U-2 a U-5, U-7 a IM8 e U-52 a U-61).As indicated above, Q or Q1 may be (but are not limited to) five or six membered saturated or unsaturated heterocycles optionally substituted with one or more substituents selected from the substituent group as defined in the Summary Description of the Invention. Examples of five- or six-membered unsaturated aromatic heterocycles optionally substituted with one or more substituents include the rings U-2 through U-61 shown in Illustration 1 wherein Rv is any substituent as defined in the Summary Description of the Invention for Q or Q1 and r is an integer of Note that some U groups can only be replaced with less than four Rv groups (such as U-2 to U-5, U-7 to IM8, and U-52 to U-61).
Embora os grupos Rv sejam exibidos nas estruturas U-1 a U-61,observa-se que eles não necessitam estar presentes, pois são substituintesopcionais. Observe-se que, quando Rv for H quando ligado a um átomo, este éidêntico a se o mencionado átomo não for substituído. Os átomos de nitrogênioque necessitam de substituição para preencher a sua valência são substituídoscom H ou Rv. Observe-se que, quando o ponto de ligação entre (Rv)r e o grupoU for ilustrado como flutuante, (Rv)r pode ser ligado a qualquer átomo decarbono ou átomo de nitrogênio disponível do grupo U.Although Rv groups are displayed in structures U-1 through U-61, it is noted that they do not need to be present as they are optional substituents. Note that when Rv is H when bonded to an atom, this is identical to if said atom is not substituted. Nitrogen atoms that need replacement to fill their valence are replaced with H or Rv. Note that when the bonding point between (Rv) r and group U is illustrated as floating, (Rv) r can be attached to any available carbon atom or nitrogen atom of group U.
<formula>formula see original document page 14</formula><formula>formula see original document page 15</formula><formula> formula see original document page 14 </formula> <formula> formula see original document page 15 </formula>
Observe-se que, quando Q ou Q1 for um heterociclo nãoaromático saturado ou insaturado com cinco ou seis membros opcionalmentesubstituídos com um ou mais substituintes selecionados a partir do grupo desubstituintes conforme definido na Descrição Resumida da Invenção for Q ouQ11 um ou dois membros de anéis de carbono do heterociclo podem estaropcionalmente na forma oxidada de uma porção carbonila. Exemplos deheterociclos insaturados não aromáticos ou saturados com cinco ou seismembros incluem os anéis Q-1 a Q-35, conforme exibido na Ilustração 2, emque Rv é qualquer substituinte conforme definido na Descrição Resumida daInvenção para Q1. Observe-se que, quando o ponto de ligação entre (Rv)r e ogrupo Q ou Q1 for ilustrado como flutuante, (Rv)r pode ser ligado a qualquerátomo de carbono ou átomo de nitrogênio disponível do grupo U. Observe-seque, quando o ponto de ligação sobre o grupo Q ou Q1 for ilustrado comoflutuante, o grupo Q ou Q1 pode ser ligado ao restante da Fórmula 1 por meiode qualquer carbono ou nitrogênio disponível do grupo Q ou Q1 por substituiçãode um átomo de hidrogênio. Os substituintes opcionais podem ser ligados aqualquer carbono ou nitrogênio disponível por meio da substituição de umátomo de hidrogênio.Note that when Q or Q1 is a five- or six-membered saturated or unsaturated nonaromatic heterocycle optionally substituted with one or more substituents selected from the substituent group as defined in the Summary Description of the Invention is Q or Q11 one or two ring members. carbon of the heterocycle may optionally be in the oxidized form of a carbonyl moiety. Examples of non-aromatic or saturated five- or six-membered unsaturated heterocycles include rings Q-1 to Q-35, as shown in Illustration 2, where Rv is any substituent as defined in the Invention's Summary Description for Q1. Note that when the bonding point between (Rv) Q or Q1 is shown as floating, (Rv) r can be attached to any available carbon atom or nitrogen atom of group U. Note that when The binding point on the group Q or Q1 is illustrated as floating, the group Q or Q1 may be attached to the remainder of Formula 1 by any available carbon or nitrogen group Q or Q1 by substitution of a hydrogen atom. Optional substituents may be attached to any available carbon or nitrogen by substitution of a hydrogen atom.
Observe-se que, quando Q ou Q1 compreender um anelselecionado a partir de Q-28 até Q-35, Q2 é selecionado a partir de O, S ou N.Observe-se que, quando Q2 for Ν, o átomo de nitrogênio pode completar a suavalência por meio de substituição com H ou os subsituintes definidos naDescrição Resumida da Invenção para Q ou Q1.Note that when Q or Q1 comprises an anelect from Q-28 through Q-35, Q2 is selected from O, S, or N. Note that when Q2 is Ν, the nitrogen atom can complete the suavalence by substituting with H or the substituents defined in the Summary Description of the Invention for Q or Q1.
Ilustração 2Illustration 2
<formula>formula see original document page 16</formula><formula>formula see original document page 17</formula><formula> formula see original document page 16 </formula> <formula> formula see original document page 17 </formula>
Os compostos de acordo com a presente invenção podem existirna forma de um ou mais estereoisômeros. Os diversos estereoisômerosincluem enantiômeros, diaestereômeros, atropisômeros e isômerosgeométricos. Os técnicos no assunto apreciarão que um estereoisômero podeser mais ativo e/ou pode exibir efeitos benéficos quando enriquecido comrelação ao(s) outro(s) estereoisômero(s) ou quando separado do(s) outro(s)estereoisômero(s). Além disso, os técnicos no assunto sabem como separar,enriquecer e/ou preparar seletivamente os mencionados estereoisômeros.The compounds according to the present invention may exist in the form of one or more stereoisomers. The various stereoisomers include enantiomers, diastereomers, atropisomers and geometry isomers. Those skilled in the art will appreciate that one stereoisomer may be more active and / or may exhibit beneficial effects when enriched with respect to other stereoisomer (s) or when separated from other stereoisomer (s). Further, those skilled in the art know how to selectively separate, enrich and / or prepare said stereoisomers.
Conseqüentemente, a presente invenção compreende compostos selecionadosa partir da Fórmula 1, seus N-óxidos e sais apropriados para uso agrícola. Oscompostos de acordo com a presente invenção podem estar presentes naforma de uma mistura de estereoisômeros, estereoisômeros individuais ou emuma forma oticamente ativa.Accordingly, the present invention comprises compounds selected from Formula 1, their N-oxides and salts suitable for agricultural use. The compounds according to the present invention may be present in the form of a mixture of stereoisomers, individual stereoisomers or in an optically active form.
Os técnicos no assunto apreciarão que nem todos os heterociclosque contêm nitrogênio podem formar N-óxidos, pois o nitrogênio requer um parisolado disponível para oxidação no oxido; os técnicos no assuntoreconhecerão os heterociclos que contêm nitrogênio que podem formar N-óxidos. Os técnicos no assunto também reconhecerão que aminas terciáriaspodem formar A/-óxidos. Os métodos sintéticos de preparação de A/-óxidos deheterociclos e aminas terciárias são muito bem conhecidos dos técnicos noassunto, incluindo a oxidação de heterociclos e aminas terciárias com ácidosperóxi tais como ácido peracético e m-cloroperbenzóico (MCPBA)1 peróxido dehidrogênio, hidroperóxidos de alquila tais como hidroperóxido de f-butila,perborato de sódio e dioxiranos tais como dimetidioxirano. Estes métodos depreparação de A/-óxidos foram extensamente descritos e analisados naliteratura; vide, por exemplo: T. L. Gilchrist em Comprehensive OrganicSynthesis, vol. 7, págs. 748-750, S. V. Ley (Ed.), Pergamon Press; M. Tisler eB. Stanovnik em Comprehensive Heterocyclic Chemistry, vol. 3, págs. 18-20, A.J. Boulton e A. McKiIIop, Eds., Pergamon Press; M. R. Grimmett e B. R. T.Keene em Advanees in Heterocyclie Chemistry, vol. 43, págs. 149-161, A. R.Katritzky (Ed.), Academic Press; M. Tisler e B. Stanovnik em Advanees inHeterocyclie Chemistry, vol. 9, págs. 285-291, A. R. Katritzky e A. J. Boulton,Eds., Academic Press; e G. W. H. Cheeseman e E. S. G. Werstiuk emAdvanees in Heterocyclie Chemistry, vol. 22, págs. 390-392, A. R. Katritzky e A.J. Boulton, Eds., Academic Press.Those skilled in the art will appreciate that not all nitrogen-containing heterocycles may form N-oxides, as nitrogen requires an available parisolate for oxidation to the oxide; technicians in the art will recognize nitrogen-containing heterocycles that can form N-oxides. Those skilled in the art will also recognize that tertiary amines may form A / oxides. Synthetic methods of preparing tertiary amine A-oxides and oxides are very well known to those skilled in the art, including oxidation of heterocycles and tertiary amines with peroxy acids such as peracetic and m-chloroperbenzoic acid (MCPBA) 1 hydrogen peroxide, alkyl hydroperoxides such as t-butyl hydroperoxide, sodium perborate and dioxiranes such as dimethoxypyran. These A / oxide preparation methods have been extensively described and analyzed in literature; see, for example: T. L. Gilchrist in Comprehensive Organic Synthesis, vol. 7, p. 748-750, S. V. Ley (Ed.), Pergamon Press; M. Tisler eB. Stanovnik in Comprehensive Heterocyclic Chemistry, vol. 3, p. 18-20, A.J. Boulton and A. McKiIIop, Eds., Pergamon Press; M. R. Grimmett and B. R. T. Keene in Advanees in Heterocycle Chemistry, vol. 43, p. 149-161, A. R. Katritzky (Ed.), Academic Press; M. Tisler and B. Stanovnik in Advanees in Heterocyclie Chemistry, vol. 9, p. 285-291, A. R. Katritzky and A. J. Boulton, Eds., Academic Press; and G. W. H. Cheeseman and E. S. G. Werstiuk in Advanees in Heterocycle Chemistry, vol. 22, p. 390-392, A. R. Katritzky and A. J. Boulton, Eds., Academic Press.
Os sais dos compostos de acordo com a presente invençãoincluem sais de adição de ácidos com ácidos orgânicos ou inorgânicos taiscomo ácido bromídrico, clorídrico, nítrico, fosfórico, sulfúrico, acético, butírico,fumárico, láctico, maleico, malônico, oxálico, propiônico, salicílico, tartárico, 4-toluenossulfônico ou valérico. Os sais dos compostos de acordo com apresente invenção também incluem os formados com bases orgânicas (taiscomo piridina, amônia ou trietilamina) ou bases inorgânicas (tais como hidretos,hidróxidos ou carbonatos de sódio, potássio, litio, cálcio, magnésio ou bário)quando o composto contiver uma porção ácida, tal como quando Q1 é fenilasubstituído com C(O)OR22 e R22 é Η.Salts of the compounds according to the present invention include acid addition salts with organic or inorganic acids such as hydrobromic, hydrochloric, nitric, phosphoric, sulfuric, acetic, butyric, fumaric, lactic, maleic, malonic, oxalic, propionic, salicylic acid, tartaric, 4-toluenesulfonic or valeric. Salts of the compounds of the present invention also include those formed with organic bases (such as pyridine, ammonia or triethylamine) or inorganic bases (such as sodium, potassium, lithium, calcium, magnesium or barium hydrides, hydroxides or carbonates) when The compound contains an acid moiety, such as when Q1 is phenyl substituted with C (O) OR22 and R22 is Η.
Conseqüentemente, a presente invenção compreende compostosselecionados a partir da Fórmula 1, seus N-óxidos e sais.Accordingly, the present invention comprises compounds selected from Formula 1, their N-oxides and salts.
Realizações da presente invenção conforme detalhado naDescrição Resumida da Invenção incluem:Embodiments of the present invention as detailed in the Summary Description of the Invention include:
Realização 1. Composto da Fórmula 1 em que G é O.Embodiment 1. A compound of Formula 1 wherein G is O.
Realização 2. Composto da Fórmula 1 em que G é NR3.Embodiment 2. A compound of Formula 1 wherein G is NR3.
Realização 3. Composto da Fórmula 1 em que R3 é H ou ciano;ou alquila C1-C4 opcionalmente substituído com um ou mais substituintesselecionados a partir de halogênio.Embodiment 3. A compound of Formula 1 wherein R 3 is H or cyano, or C 1 -C 4 alkyl optionally substituted with one or more substituents selected from halogen.
Realização 4. Composto da Realização 3 em que R3 é CH3,CH2CH3 ou CH2CF3.Embodiment 4. A compound of Embodiment 3 wherein R 3 is CH 3, CH 2 CH 3 or CH 2 CF 3.
Realização 5. Composto da Fórmula 1 em que U é C(=0).Embodiment 5. A compound of Formula 1 wherein U is C (= 0).
Realização 6. Composto da Fórmula 1 em que Z é CR2.Embodiment 6. A compound of Formula 1 wherein Z is CR2.
Realização 7. Composto da Fórmula 1 em que cada R2 éselecionado independentemente a partir de H1 halogênio ou haloalquila C1-C2.Embodiment 7. A compound of Formula 1 wherein each R2 is independently selected from H1 halogen or C1-C2 haloalkyl.
Realização 8. Composto da Realização 7 em que cada R2 éindependentemente H, halogênio ou CF3.Embodiment 8. A compound of Embodiment 7 wherein each R2 is independently H, halogen or CF3.
Realização 9. Composto da Fórmula 1 em que A1 é CR4.Embodiment 9. A compound of Formula 1 wherein A1 is CR4.
Realização 10. Composto da Fórmula 1 em que A2 é CR5.Embodiment 10. A compound of Formula 1 wherein A2 is CR5.
Realização 11. Composto da Fórmula 1 em que A3 é CR6.Embodiment 11. A compound of Formula 1 wherein A3 is CR6.
Realização 12. Composto da Fórmula 1 em que A3 é CR7.Embodiment 12. A compound of Formula 1 wherein A3 is CR7.
Realização 13. Composto da Fórmula 1 em que R4 e R5 sãoselecionados independentemente a partir de H1 halogênio, alquila C1-C3,haloalquila C1-C3, ciano e nitro.Embodiment 13. A compound of Formula 1 wherein R4 and R5 are independently selected from H1 halogen, C1-C3 alkyl, C1-C3 haloalkyl, cyano and nitro.
Realização 14. Composto da Fórmula 1 em que R6 e R7 sãoselecionados independentemente a partir de H1 halogênio, alquila C1-C3,haloalquila C1-C3, ciano e nitro; ou R6 e R7 são tomados em conjunto paraformar um anel aromático fundido, em que o anel aromático fundido contémcomo membros de anéis, além dos átomos de cabeça de ponte A3 e A41 quatroátomos selecionados a partir de três a quatro átomos e carbono e zero a umátomo de nitrogênio.Embodiment 14. A compound of Formula 1 wherein R 6 and R 7 are independently selected from H 1 halogen, C 1 -C 3 alkyl, C 1 -C 3 haloalkyl, cyano and nitro; or R 6 and R 7 are taken together to form a fused aromatic ring, wherein the fused aromatic ring contains as ring members, in addition to the bridgehead atoms A3 and A41 four atoms selected from three to four atoms and carbon and zero to one atom of nitrogen.
Realização 15. Composto da Realização 14 em que R6 e R7 sãoselecionados independentemente a partir de H, halogênio, alquila C1-C3,haloalquila C1-C3, ciano e nitro.Embodiment 15. A compound of Embodiment 14 wherein R6 and R7 are independently selected from H, halogen, C1-C3 alkyl, C1-C3 haloalkyl, cyano and nitro.
Realização 16. Composto da Realização 14 em que R6 e R7 sãotomados em conjunto para formar um anel aromático fundido, em que o anelaromático fundido contém como membros de anéis, além dos átomos decabeça de ponte A3 e A4, quatro átomos selecionados a partir de três a quatroátomos de carbono e zero a um átomo de nitrogênio.Embodiment 16. A compound of Embodiment 14 wherein R 6 and R 7 are taken together to form a fused aromatic ring, wherein the fused aromatic ring contains as ring members, in addition to the bridging atoms A3 and A4, four atoms selected from three to four carbon atoms and zero to one nitrogen atom.
Realização 17. Composto da Realização 14 ou 16 em que o anelaromático fundido contém quatro átomos de carbono como membros de anéisalém dos átomos de cabeça de ponte A3 e A4.Embodiment 17. A compound of Embodiment 14 or 16 wherein the fused annular aromatic contains four carbon atoms as ring members in addition to bridgehead atoms A3 and A4.
Realização 18. Composto da Fórmula 1 em que Q é um anelpiridinila, anel pirimidinila, anel triazinila, anel pirazolila, anel triazolila, anelimidazolila, anel oxazolila, anel isoxazolila, anel tiazolila ou anel isotiazolila, emque cada anel é opcionalmente substituído com um ou mais substituintesselecionados independentemente a partir de halogênio, alquila CrC6,haloalquila C1-C6, cicloalquila C3-C6, halocicloalquila C3-C6l alcóxi CrC6,haloalcóxi C1-C6, alquiltio C1-C61 haloalquiltio C1-C6l alquilsulfinila C1-C61haloalquilsulfinila C1-C6, alquilsulfonila C1-C6, haloalquilsulfonila C1-C6,alquilamino C1-C6, dialquilamino C2-C8, ciano, nitro, C(O)NR8R9, C(O)OR10,fenila e piridinila, em que cada fenila e piridinila é opcionalmente substituídocom um ou mais substituintes selecionados independentemente a partir de R11;ou Q é C(=0)NR12R13, S(O)2NR14R15 ou R16.Embodiment 18. The compound of Formula 1 wherein Q is a pyridinyl ring, pyrimidinyl ring, triazinyl ring, pyrazolyl ring, triazolyl ring, ringimidazolyl ring, oxazolyl ring, isoxazolyl ring, thiazolyl ring or isothiazolyl ring, wherein each ring is optionally substituted with one or more independently selected from halogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 3 -C 6 cycloalkyl, C 3 -C 6 alkoxyalkylC 1 C 6 haloalkoxy, C 1 -C 6 alkylthio C 1 -C 6 haloalkyl C 1 -C 6 alkylsulfinyl C 1 -C 6 alkylsulfinyl -C6, C1-C6 haloalkylsulfonyl, C1-C6 alkylamino, C2-C8 dialkylamino, cyano, nitro, C (O) NR8R9, C (O) OR10, phenyl and pyridinyl, wherein each phenyl and pyridinyl is optionally substituted with one or more substituents independently selected from R 11, or Q is C (= 0) NR 12 R 13, S (O) 2 NR 14 R 15 or R 16.
Realização 19. Composto da Realização 18 em que Q é um anelpiridinila, anel pirimidinila, anel triazinila, anel pirazolila, anel triazolila, anelimidazolila, anel oxazolila, anel isoxazolila, anel tiazolila ou anel isotiazolila, emque cada anel é opcionalmente substituído com um ou mais substituintesselecionados independentemente a partir de halogênio, alquila C1-C6,haloalquila C1-C6, cicloalquila C3-C6, halocicloalquila C3-C6, alcóxi C1C6,haloalcóxi C1-C6, alquiltio C1-C6, haloalquiltio C1-C61 alquilsulfinila C1-C6,haloalquilsulfinila C1-C6, alquilsulfonila C1-C6, haloalquilsulfonila C1-C61alquilamino C1-C61 dialquilamino C2-C8l ciano, nitro, C(O)NR8R91 C(O)OR101fenila e piridinila, em que cada fenila e piridinila é opcionalmente substituídocom um ou mais substituintes selecionados independentemente a partir de R11.Embodiment 19. Compound of Embodiment 18 wherein Q is a pyridinyl ring, pyrimidinyl ring, triazinyl ring, pyrazolyl ring, triazolyl ring, ringimidazolyl ring, oxazolyl ring, isoxazolyl ring, thiazolyl ring or isothiazolyl ring, wherein each ring is optionally substituted with one or more independently selected from halogen, C1-C6 alkyl, C1-C6 haloalkyl, C3-C6 cycloalkyl, C3-C6 halocycloalkyl, C1-C6 alkoxy, C1-C6-alkylthio, C1-C61-haloalkyl-C1-C6-alkylsulfinyl haloalkyl C1-C6, C1-C6 alkylsulfonyl, C1-C61 haloalkylsulfonyl C1-C61 alkylamino C2-C8l dialkylamino cyano, nitro, C (O) NR8R91 C (O) OR101phenyl and pyridinyl, wherein each phenyl and pyridinyl is optionally substituted by one or more substituents independently selected from R11.
Realização 20. Composto da Realização 19 em que Q é um anelpirazolila, anel triazolila ou anel imidazolila, em que cada anel é ligado por meiode nitrogênio e opcionalmente substituído com um ou mais substituintesselecionados independentemente a partir de halogênio, alquila C1-C4,haloalquila C1-C4l cicloalquila C3-C6, halocicloalquila C3-C6, alcóxi C1-C4,haloalcóxi C1-C4, alquilamino C1-C4, dialquilamino C2-C4, ciano, nitro,C(O)NR8R9, C(O)OR10, fenila e piridinila, em que cada fenila e piridinila éopcionalmente substituído com um ou mais substituintes selecionadosindependentemente a partir de R11.Embodiment 20. Compound of Embodiment 19 wherein Q is a ring pyrazolyl, triazolyl ring or imidazolyl ring, wherein each ring is nitrogen-bonded and optionally substituted with one or more substituents independently selected from halogen, C1-C4 alkyl, C1 haloalkyl C 3 -C 6 cycloalkyl C 3 -C 6 halocycloalkyl, C 1 -C 4 alkoxy, C 1 -C 4 haloalkoxy, C 1 -C 4 alkylamino, C 2 -C 4 dialkylamino, cyano, nitro, C (O) NR 8 R 9, C (O) OR 10, phenyl and pyridinyl, wherein each phenyl and pyridinyl is optionally substituted with one or more substituents independently selected from R 11.
Realização 21. Composto da Realização 20 em que Q é um anelpirazolila, anel triazolila ou anel imidazolila, em que cada anel é ligado por meiode nitrogênio e opcionalmente substituído com um ou mais substituintesselecionados independentemente a partir de halogênio, alquila C1-C4,haloalquila C1-C4, alcóxi C1-C4, haloalcóxi C1-C4l ciano, nitro, C(O)NR8R9 eC(O)OR10.Embodiment 21. Compound of Embodiment 20 wherein Q is a ring pyrazolyl, triazolyl ring or imidazolyl ring, wherein each ring is nitrogen-bonded and optionally substituted with one or more substituents independently selected from halogen, C1-C4 alkyl, C1 haloalkyl -C4, C1 -C4 alkoxy, C1 -C4 haloalkoxy cyano, nitro, C (O) NR8 R9 and C (O) OR10.
Realização 22. Composto da Realização 21 em que Q é um anelpirazolila, anel triazolila ou anel imidazolila, em que cada anel é ligado por meiode nitrogênio e opcionalmente substituído com um ou mais substituintesselecionados independentemente a partir de halogênio, alquila CrC3 ehaloalquila C1-C3.Embodiment 22. Compound of Embodiment 21 wherein Q is a ring pyrazolyl, triazolyl ring or imidazolyl ring, wherein each ring is nitrogen-bonded and optionally substituted with one or more substituents independently selected from halogen, C1 -C3 alkyl and C1 -C3 haloalkyl.
Realização 23. Composto da Realização 22 em que Q é um aneltriazolila ou anel imidazolila, em que cada anel é ligado por meio de nitrogênioe opcionalmente substituído com um ou mais substituintes selecionadosindependentemente a partir de halogênio, alquila C1-C3 e haloalquila C1-C3.Embodiment 23. Compound of Embodiment 22 wherein Q is a triazolyl ring or imidazolyl ring, wherein each ring is nitrogen bonded and optionally substituted with one or more substituents independently selected from halogen, C1-C3 alkyl and C1-C3 haloalkyl.
Realização 24. Composto da Fórmula 1 em que cada R8 éindependentemente H, alquila C1-C6, alquilcarbonila C2-C7 ou alcoxicarbonilaC2-C7.Embodiment 24. A compound of Formula 1 wherein each R 8 is independently H, C 1 -C 6 alkyl, C 2 -C 7 alkylcarbonyl or C 2 -C 7 alkoxycarbonyl.
Realização 25. Composto da Realização 24 em que cada R8 é H.Embodiment 25. A compound of Embodiment 24 wherein each R8 is H.
Realização 26. Composto da Fórmula 1 em que cada R9 éindependentemente H; ou alquila C1-C4, alquenila C2-C4, alquinila C2-C4,cicloalquila C3-C4, alquilcicloalquila C4-C7 ou cicloalquilalquila C4-C7, cada qualopcionalmente substituído com um ou mais substituintes selecionados a partirde R19.Embodiment 26. A compound of Formula 1 wherein each R 9 is independently H; or C 1 -C 4 alkyl, C 2 -C 4 alkenyl, C 2 -C 4 alkynyl, C 3 -C 4 cycloalkyl, C 4 -C 7 alkylcycloalkyl or C 4 -C 7 cycloalkylalkyl, each optionally substituted with one or more substituents selected from R 19.
Realização 27. Composto da Realização 26 em que cada R9 éindependentemente alquila C1-C4 opcionalmente substituído com um ou maissubstituintes selecionados a partir de R19.Embodiment 27. A compound of Embodiment 26 wherein each R 9 is independently C 1 -C 4 alkyl optionally substituted with one or more substituents selected from R 19.
Realização 28. Composto da Realização 27 em que cada R9 éindependentemente alquila C1-C4 opcionalmente substituído com um Q1 eopcionalmente substituído com um ou mais substituintes selecionados a partirde halogênio, alquila C1-C4, alcóxi CrC4, alquiltio C1-C4, alquilsulfonila C1-C4 eciano.Embodiment 28. A compound of Embodiment 27 wherein each R 9 is independently C 1 -C 4 alkyl optionally substituted with a Q 1 and optionally substituted with one or more substituents selected from halogen, C 1 -C 4 alkyl, C 1 -C 4 alkoxy, C 1 -C 4 alkylthio, C 1 -C 4 alkylsulfonyl ecian.
Realização 29. Composto da Fórmula 1 em que cada R10 éindependentemente H; ou alquila C1-C4, alquenila C2-C4, alquinila C2-C4,cicloalquila C3-C4, alquilcicloalquila C4-C7 ou cicloalquilalquila C4-C7l cada qualopcionalmente substituído com um ou mais substituintes selecionados a partirde R19.Realização 30. Composto da Realização 29 em que cada R10 éindependentemente alquila C1-C4 opcionalmente substituído com um ou maissubstituintes selecionados a partir de R19.Embodiment 29. A compound of Formula 1 wherein each R 10 is independently H; or C 1 -C 4 alkyl, C 2 -C 4 alkenyl, C 2 -C 4 alkynyl, C 3 -C 4 cycloalkyl, C 4 -C 7 alkylcycloalkyl or C 4 -C 7 cycloalkylalkyl each optionally substituted with one or more substituents selected from R 19. wherein each R10 is independently C1-C4 alkyl optionally substituted with one or more substituents selected from R19.
Realização 31. Composto da Realização 30 em que cada R10 éindependentemente alquila C1-C4 opcionalmente substituído com um Q1 eopcionalmente substituído com um ou mais substituintes selecionados a partirde halogênio, alquila C1-C4, alcóxi C1-C4, alquiltio C1-C4, alquilsulfonila C1-C4 eciano.Embodiment 31. A compound of Embodiment 30 wherein each R10 is independently C1-C4 alkyl optionally substituted with a Q1 and optionally substituted with one or more substituents selected from halogen, C1-C4 alkyl, C1-C4 alkoxy, C1-C4 alkylthio, C1-alkylsulfonyl -C4 cyan.
Realização 32. Composto da Fórmula 1 em que cada R19 éselecionado independentemente a partir de halogênio, alquila C1-C4, alcóxi C1-C4,alquiltio C1-C4,alquilsulfonila C1-C4,ciano, nitro e Q1.Embodiment 32. A compound of Formula 1 wherein each R19 is independently selected from halogen, C1-C4 alkyl, C1-C4 alkoxy, C1-C4 alkylthio, C1-C4 alkylsulfonyl, cyano, nitro and Q1.
Realização 33. Composto da Realização 32 em que cada R19 éselecionado independentemente a partir de halogênio, alquila C1-C4, alcóxi C1-C4, alquiltio C1-C4, alquilsulfonila C1-C4 e ciano.Embodiment 33. A compound of Embodiment 32 wherein each R19 is independently selected from halogen, C1-C4 alkyl, C1-C4 alkoxy, C1-C4 alkylthio, C1-C4 alkylsulfonyl and cyano.
Realização 34. Composto da Realização 18 em que Q éC(=0)NR12R13.Embodiment 34. A compound of Embodiment 18 wherein Q is C (= 0) NR 12 R 13.
Realização 35. Composto da Fórmula 1 em que R12 é H, alquilaC1-C6 alquilcarbonila C2-C7 ou alcoxicarbonila C2-C7.Embodiment 35. A compound of Formula 1 wherein R 12 is H, C 1 -C 6 alkyl C 2 -C 7 alkylcarbonyl or C 2 -C 7 alkoxycarbonyl.
Realização 36. Composto da Realização 35 em que R12 é H.Embodiment 36. A compound of Embodiment 35 wherein R12 is H.
Realização 37. Composto da Fórmula 1 e m que R 13 é H; oualquila C1-C4, alquenila C2-C4, alquinila C2-C4, cicloalquila C3-C4,alquilcicloalquila C4-Cy ou cicloalquilalquila C4-C7, cada qual opcionalmentesubstituído com um ou mais substituintes selecionados a partir de R19.Embodiment 37. A compound of Formula 1 and m wherein R 13 is H; C 1 -C 4 alkyl, C 2 -C 4 alkenyl, C 2 -C 4 alkynyl, C 3 -C 4 cycloalkyl, C 4 -C 7 alkylcycloalkyl or C 4 -C 7 cycloalkylalkyl, each optionally substituted by one or more substituents selected from R 19.
Realização 38. Composto da Realização 37 em que R13 é H; oualquila C1-C4 opcionalmente substituído com um ou mais substituintesselecionados a partir de R19.Embodiment 38. A compound of Embodiment 37 wherein R 13 is H; or C1-C4 alkyl optionally substituted with one or more substituents selected from R19.
Realização 39. Composto da Realização 38 em que R13 é H; oualquila C1-C4 opcionalmente substituído com um Q1 e opcionalmentesubstituído com um ou mais substituintes selecionados a partir de halogênio,alquila C1-C4, alcóxi C1-C4, alquiltio C1-C4, alquilsulfinila, alquilsulfonila C1-C4,alquilcarbonila C2-C4) alcoxicarbonila C2-C4 e ciano.Embodiment 39. A compound of Embodiment 38 wherein R 13 is H; or C1-C4 alkyl optionally substituted with Q1 and optionally substituted with one or more substituents selected from halogen, C1-C4 alkyl, C1-C4 alkoxy, C1-C4 alkylthio, C1-C4 alkylsulfonyl, C2-C4 alkylcarbonyl) alkoxycarbonyl C2 -C4 and cyano.
Realização 40. Composto da Realização 39 em que R13 é H; oualquila C1-C4 opcionalmente substituído com um Qi e opcionalmentesubstituído com um ou mais flúor.Embodiment 40. A compound of Embodiment 39 wherein R 13 is H; or C1-C4 alkyl optionally substituted with one Qi and optionally substituted with one or more fluorine.
Realização 41. Composto da Fórmula 1 em que cada R19 éselecionado independentemente a partir de halogênio, alquila C1-C4, alcóxi C1-C4l alquiltio C1-C4, alquilsulfinila C1-C4, alquilsulfonila C1-C4, alquilcarbonila C2-C4, alcoxicarbonila C2-C4, ciano, nitro e Q1.Embodiment 41. A compound of Formula 1 wherein each R19 is independently selected from halogen, C1-C4 alkyl, C1-C4 alkoxy, C1-C4 alkylthio, C1-C4 alkylsulfonyl, C1-C4 alkylcarbonyl, C2-C4 alkoxycarbonyl C4, cyano, nitro and Q1.
Realização 42. Composto da Realização 41 em que cada R19 éselecionado independentemente a partir de halogênio e Q1.Embodiment 42. A compound of Embodiment 41 wherein each R19 is independently selected from halogen and Q1.
Realização 43. Composto da Fórmula 1 em que cada Q1 éselecionado independentemente a partir de fenila, piridinila e tiazolila, cadaqual opcionalmente substituído com um ou mais substituintes selecionadosindependentemente a partir de halogênio, alquila C1-C3, haloalquila C1-C3,ciano, fenila e piridinila.Embodiment 43. A compound of Formula 1 wherein each Q1 is independently selected from phenyl, pyridinyl and thiazolyl, each optionally substituted with one or more substituents independently selected from halogen, C1-C3 alkyl, C1-C3 haloalkyl, cyano, phenyl and pyridinyl.
Realização 44. Composto da Realização 43 em que Q1 é fenila,piridinila ou tiazolila.Embodiment 44. A compound of Embodiment 43 wherein Q 1 is phenyl, pyridinyl or thiazolyl.
Realização 45. Composto da Realização 18 em que Q é R16.Embodiment 45. A compound of Embodiment 18 wherein Q is R16.
Realização 46. Composto da Realização 18 em que Q éS(O)2NR14R15.Embodiment 46. A compound of Embodiment 18 wherein Q is S (O) 2 NR 14 R 15.
Realização 47. Composto da Fórmula 1 em que R14 é H, alquilaC1-C6, alquilcarbonila C2-C7 ou alcoxicarbonila C2-C7.Embodiment 47. A compound of Formula 1 wherein R 14 is H, C 1 -C 6 alkyl, C 2 -C 7 alkylcarbonyl or C 2 -C 7 alkoxycarbonyl.
Realização 48. Composto da Realização 47 em que R14 é H.Embodiment 48. A compound of Embodiment 47 wherein R14 is H.
Realização 49. Composto da Fórmula 1 em que R15 é H; oualquila C1-C4, alquenila C2-C4l alquinila C2-C4l cicloalquila C3-C4,alquilcicloalquila C4-C7 ou cicloalquilalquila C4-C7, cada qual opcionalmentesubstituído com um ou mais substituintes selecionados a partir de R19.Embodiment 49. A compound of Formula 1 wherein R15 is H; C 1 -C 4 alkyl, C 2 -C 4 alkenyl C 2 -C 4 alkynyl C 3 -C 4 cycloalkyl, C 4 -C 7 alkylcycloalkyl or C 4 -C 7 cycloalkylalkyl, each optionally substituted by one or more substituents selected from R 19.
Realização 50. Composto da Realização 49 em que R15 é H; oualquila C1-C4 opcionalmente substituído com um ou mais substituintesselecionados a partir de R19.Embodiment 50. A compound of Embodiment 49 wherein R 15 is H; or C1-C4 alkyl optionally substituted with one or more substituents selected from R19.
Realização 51. Composto da Realização 50 em que cada R15 é H;ou alquila C1-C4 opcionalmente substituído com um ou mais substituintesselecionados a partir de halogênio, alquila Ci-C4l alcóxi CrC4, alquiltio Ci-C4,alquilsulfinila Ci-C4, alquilsulfonila Ci-C4l alquilcarbonila C2-C4, alcoxicarbonilaC2-C4, ciano e, no máximo, um Q1.Embodiment 51. Compound of Embodiment 50 wherein each R 15 is H, or C 1 -C 4 alkyl optionally substituted with one or more substituents selected from halogen, C 1 -C 4 alkyl, C 1 -C 4 alkoxy, C 1 -C 4 alkylsulfinyl, C 1 -C 4 alkylsulfonyl C 4 -C 2 alkylcarbonyl, C 2 -C 4 alkoxycarbonyl, cyano and at most one Q 1.
Realização 52. Composto da Realização 51 em que cada R15 é H;ou alquila Ci-C4 opcionOalmente substituído com um ou mais flúor e, nomáximo, um Q1.Embodiment 52. A compound of Embodiment 51 wherein each R 15 is H or C 1 -C 4 alkyl optionally substituted with one or more fluorine and, at most, one Q 1.
Realização 53. Composto da Fórmula 1 em que Q é diferente deR16.Embodiment 53. A compound of Formula 1 wherein Q is different from R16.
Realização 54. Composto da Fórmula 1 em que R16 é halogênio,haloalquila C1-C3, dialquilamino C2-C4, ciano ou nitro.Embodiment 54. A compound of Formula 1 wherein R 16 is halogen, C 1 -C 3 haloalkyl, C 2 -C 4 dialkylamino, cyano or nitro.
Realização 55. Composto da Fórmula 1 em que R1 é alquila C1-C3opcionalmente substituído com um ou mais substituintes selecionadosindependentemente a partir de R17.Embodiment 55. A compound of Formula 1 wherein R 1 is C 1 -C 3 alkyl optionally substituted with one or more substituents independently selected from R 17.
Realização 56. Composto da Realização 55 em que R1 é alquilaC1-C3 substituído com um ou mais halogênios.Embodiment 56. A compound of Embodiment 55 wherein R 1 is C 1 -C 3 alkyl substituted with one or more halogens.
Realização 57. Composto da Realização 56 em que R1 é CF3.Embodiment 57. A compound of Embodiment 56 wherein R1 is CF3.
Realização 58. Composto da Fórmula 1 em que η é 1 ou 2.Embodiment 58. A compound of Formula 1 wherein η is 1 or 2.
Realização 59. Composto da Fórmula 1 em que no máximo trêsdentre A1, A2, A3 e A4 são N.Embodiment 59. A compound of Formula 1 wherein at most three of A1, A2, A3 and A4 are N.
Realização 60. Composto da Realização 59 em que no máximodois dentre A1, A21 A3 e A4 são N.Embodiment 60. A compound of Embodiment 59 wherein at most A1, A21 A3 and A4 are N.
Realização 61. Composto da Realização 60 em que no máximoum dentre A1, A21 A3 e A4 é N.Achievement 61. A compound of Achievement 60 wherein at most A1, A21 A3 and A4 is N.
Realização 62. Composto da Realização 61 em que cada umdentre A1, A2, A3 e A4 é diferente de N.Embodiment 62. A compound of Embodiment 61 wherein each of A1, A2, A3 and A4 is different from N.
Realização 63. Composto da Fórmula 1 em que, quando Z for CHe um R2 for ligado ao anel fenila na posição 4, o mencionado R2 é diferente dealcóxi C1-C6.Embodiment 63. A compound of Formula 1 wherein, when Z is CH and R2 is attached to the phenyl ring at position 4, said R2 is different from C1-C6 alkoxy.
Realização 64. Composto da Fórmula 1 em que, quando U forC(=0) e G for NR31 R3 é diferente de H.Embodiment 64. A compound of Formula 1 wherein when U is C (= 0) and G is NR31 R3 is different from H.
As realizações da presente invenção, incluindo as Realizações 1a 64 acima bem como quaisquer outras realizações descritas no presente,podem ser combinadas de qualquer forma e as descrições de variáveis nasrealizações referem-se não apenas aos compostos da Fórmula 1 mas tambémaos compostos de partida e compostos intermediários. Além disso, realizaçõesda presente invenção, incluindo as Realizações 1 a 64 acima bem comoquaisquer outras realizações descritas no presente e qualquer de suascombinações, referem-se às composições e métodos de acordo com apresente invenção.The embodiments of the present invention, including Embodiments 1a 64 above as well as any other embodiments described herein, may be combined in any way and the descriptions of the embodiments variables relate not only to the compounds of Formula 1 but also starting compounds and compounds. intermediaries. Further, embodiments of the present invention, including Embodiments 1 to 64 above as well as any other embodiments described herein and any combination thereof, relate to the compositions and methods according to the present invention.
Combinações das Realizações 1 a 64 são ilustradas por:Combinations of Achievements 1 through 64 are illustrated by:
Realização A. Composto da Fórmula 1 em que:Embodiment A. A compound of Formula 1 wherein:
Q é um anel piridinila, anel pirimidinila, anel triazinila, anelpirazolila, anel triazolila, anel imidazolila, anel oxazolila, anel isoxazolila, aneltiazolila ou anel isotiazolila, em que cada anel é opcionalmente substituído comum ou mais substituintes selecionados independentemente a partir dehalogênio, alquila C1-C6, haloalquila C1-C6, cicloalquila C3-C6, halocicloalquilaC3-C6, alcóxi C1-C6l haloalcóxi C1-C6 alquiltio C1-C6 haloalquiltio C1-C6 alquilsulfinila C1-C6l haloalquilsulfinila C1-C6, alquilsulfonila C1-C6,haloalquilsulfonila C1-C6, alquilamino C1-C6 dialquilamino C2-C8, ciano, nitro,C(O)NR8R9, C(O)OR101 fenila e piridinila, em que cada fenila ou piridinila éopcionalmente substituído com um ou mais substituintes selecionadosindependentemente a partir de R11; ou Q é C(O)NR12R13, S(O)2NR14R15 ou R16;Q is a pyridinyl ring, pyrimidinyl ring, triazinyl ring, ringpyrazolyl ring, triazolyl ring, imidazolyl ring, oxazolyl ring, isoxazolyl ring, ringthiazolyl or isothiazolyl ring, wherein each ring is optionally substituted with one or more substituents independently selected from halogen, C1-alkyl C1-C6 haloalkyl, C1-C6 cycloalkyl, C1-C6 halocycloalkyl, C1-C6 alkoxy C1-C6 haloalkoxy C1-C6 alkylthio C1-C6 alkylsulfinyl C1-C6l haloalkyl C1-C6-alkylsulfonyl halo C6, C1 -C6 alkylamino C2 -C8 dialkylamino, cyano, nitro, C (O) NR8 R9, C (O) OR101 phenyl and pyridinyl, wherein each phenyl or pyridinyl is optionally substituted with one or more substituents independently selected from R11; or Q is C (O) NR 12 R 13, S (O) 2 NR 14 R 15 or R 16;
Z é CR2;Z is CR2;
R1 é alquila C1-C3 opcionalmente substituído com um oumais substituintes selecionados independentemente a partir de R17;R 1 is C 1 -C 3 alkyl optionally substituted with one or more substituents independently selected from R 17;
cada R2 é selecionado independentemente a partir de H1halogênio ou haloalquila C1-C2;each R2 is independently selected from H1halogen or C1-C2 haloalkyl;
R3 é H ou ciano; ou alquila C1-C4 opcionalmente substituídocom um ou mais substituintes selecionados a partir de halogênio; - R4 e R5 são selecionados independentemente a partir deR3 is H or cyano; or optionally substituted C1-C4 alkyl with one or more substituents selected from halogen; - R4 and R5 are independently selected from
halogênio, alquila C1-C3, haloalquila C1-C3, ciano e nitro;halogen, C1-C3 alkyl, C1-C3 haloalkyl, cyano and nitro;
R6 e R7 são selecionados independentemente a partir dehalogênio, alquila C1-C3, haloalquila C1-C3, ciano e nitro; ou R6 e R7 sãotomados em conjunto para formar um anel aromático fundido, em que o anelaromático fundido contém como membros de anéis, além dos átomos decabeça de ponte A3 e A41 quatro átomos selecionados a partir de três a quatroátomos de carbono e zero a um átomo de nitrogênio;R6 and R7 are independently selected from halogen, C1-C3 alkyl, C1-C3 haloalkyl, cyano and nitro; or R 6 and R 7 are taken together to form a fused aromatic ring, wherein the fused aromatic ring contains as ring members, in addition to the bridgehead atoms A3 and A41 four atoms selected from three to four carbon atoms and zero to one atom of nitrogen;
cada R8 é independentemente H, alquila Ci-Ce,alquilcarbonila C2-C7 ou alcoxicarbonila C2-C7; - cada R9 e R10 é independentemente H, alquila C-1-C4,alquenila C2-C4, alquinila C2-C4, cicloalquila C3-C4, alquilcicloalquila C4-C7 oucicloalquilalquila C4-C7, cada qual opcionalmente substituído com um ou maissubstituintes selecionados a partir de R19;each R 8 is independently H, C 1 -C 6 alkyl, C 2 -C 7 alkylcarbonyl or C 2 -C 7 alkoxycarbonyl; - each R 9 and R 10 is independently H, C 1 -C 4 alkyl, C 2 -C 4 alkenyl, C 2 -C 4 alkynyl, C 3 -C 4 cycloalkyl, C 4 -C 7 alkylcycloalkyl or C 4 -C 7 cycloalkylalkyl, each optionally substituted with one or more substituents selected from from R19;
R12 e R14 são independentemente H, alquila C1-C6,alquilcarbonila C2-C7 ou alcoxicarbonila C2-C7;R 12 and R 14 are independently H, C 1 -C 6 alkyl, C 2 -C 7 alkylcarbonyl or C 2 -C 7 alkoxycarbonyl;
R13 e R15 é independentemente H1 alquila C1-C4, alquenilaC2-C4, alquinila C2-C4, cicloalquila C3-C4, alquilcicloalquila C4-C7 oucicloalquilalquila C4-C7, cada qual opcionalmente substituído com um ou maissubstituintes selecionados a partir de R19;R13 and R15 are independently H1 C1 -C4 alkyl, C2 -C4 alkenyl, C2 -C4 alkynyl, C3 -C4 cycloalkyl, C4 -C7 alkylcycloalkyl or C4 -C7 cycloalkylalkyl, each optionally substituted with one or more substituents selected from R19;
R16 é halogênio, haloalquila Ci-C6, dialquilamino C2-C4,ciano ou nitro;R16 is halogen, C1 -C6 haloalkyl, C2 -C4 dialkylamino, cyano or nitro;
cada R19 é selecionado independentemente a partir dehalogênio, alquila C1-C4, alcóxi C1-C4, alquiltio C1-C4, alquilsulfonila C1-C4,ciano, nitro e Q1;each R19 is independently selected from halogen, C1-C4 alkyl, C1-C4 alkoxy, C1-C4 alkylthio, C1-C4 alkylsulfonyl, cyano, nitro and Q1;
cada Q1 é selecionado independentemente a partir defenila, piridinila e tiazolila, cada qual opcionalmente substituído com um oumais substituintes selecionados independentemente a partir de halogênio,alquila C1-C3, haloalquila C1-C3, ciano, fenila e piridinila; eeach Q1 is independently selected from defenyl, pyridinyl and thiazolyl, each optionally substituted with one or more substituents independently selected from halogen, C1-C3 alkyl, C1-C3 haloalkyl, cyano, phenyl and pyridinyl; and
η é 1 ou 2;η is 1 or 2;
desde que no máximo 1 dentre A11 A21 A3 e A4 seja N.provided that a maximum of 1 out of A11 A21 A3 and A4 is N.
Realização B. Composto da Realização A em que:Achievement B. A compound of Achievement A wherein:
R1 é alquila C1-C3 substituído com halogênio; eR1 is halogen substituted C1-C3 alkyl; and
- U é C(=0).- U is C (= 0).
Realização C. Composto da Realização B em que:Achievement C. A compound of Achievement B wherein:
Q é um anel pirazolila, anel triazolila ou anel imidazolila, emque cada anel é ligado por meio de nitrogênio e opcionalmente substituído comum ou mais substituintes selecionados independentemente a partir dehalogênio, alquila C1-C4, haloalquila C1-C4, alcóxi C1-C4, haloalcóxi C1-C4,ciano, nitro, C(O)NR8R9 e C(O)OR10; ou Q é C(O)NR12R13;Q is a pyrazolyl ring, triazolyl ring or imidazolyl ring, wherein each ring is nitrogen bonded and optionally substituted with one or more substituents independently selected from halogen, C1-C4 alkyl, C1-C4 haloalkyl, C1-C4 alkoxy, haloalkoxy C 1 -C 4, cyano, nitro, C (O) NR 8 R 9 and C (O) OR 10; or Q is C (O) NR 12 R 13;
R1 é CF3;R1 is CF3;
R6 e R7 são selecionados independentemente a partir de H1halogênio, alquila C1-C3, haloalquila C1-C3l ciano e nitro; ou R6 e R7 sãotomados em conjunto para formar um anel aromático fundido, em que o anelaromático fundido contém quatro átomos de carbono como membros de anéisalém dos átomos de cabeça de ponte A3 e A4;R6 and R7 are independently selected from H1halogen, C1-C3 alkyl, C1-C3l haloalkyl cyano and nitro; or R 6 and R 7 are taken together to form a fused aromatic ring, wherein the fused aromatic ring contains four carbon atoms as ring members in addition to the bridgehead atoms A3 and A4;
cada R8 é H ;cada R9 e R10 é independentemente alquila Ci-C4opcionalmente substituído com um Q1 e opcionalmente substituído com um oumais substituintes selecionados a partir de halogênio, alquila C1-C4, alcóxi C1-C4, alquiltio Ci-C4, alquilsulfonila Ci-C4 e ciano;each R 8 is H, each R 9 and R 10 is independently C 1 -C 4 alkyl optionally substituted with one Q 1 and optionally substituted with one or more substituents selected from halogen, C 1 -C 4 alkyl, C 1 -C 4 alkoxy, C 1 -C 4 alkylthio, C 1 -C 6 alkylsulfonyl C4 and cyano;
R12 éH;R12 is H;
R13 é H ou alquila Ci-C4 opcionalmente substituído com umou mais substituintes selecionados a partir de R19; eR13 is H or C1 -C4 alkyl optionally substituted with one or more substituents selected from R19; and
cada R19 é selecionado independentemente a partir dehalogênio e Q1.Each R19 is independently selected from halogen and Q1.
Realização D. Composto da Realização C em que:cada R2 é independentemente H1 halogênio ou CF3; eR3 é CH3, CH2CH3 ou CH2CF3.Embodiment D. A compound of Embodiment C wherein: each R 2 is independently H 1 halogen or CF 3; eR 3 is CH 3, CH 2 CH 3 or CH 2 CF 3.
Realização E. Composto da Realização D em que:G é O;desde que A11 A21 A3 e A4 sejam diferentes de N.Embodiment E. A compound of Embodiment D wherein: G is O, provided that A11 A21 A3 and A4 are different from N.
Realizações específicas incluem compostos da Fórmula 1selecionados a partir do grupo que consiste de:Specific embodiments include compounds of Formula 1 selected from the group consisting of:
4-[5-(3,5-diclorofenil)-2-oxo-5-(trifluorometil)-3-oxazolidinil]-2-metil-N-(2-piridinilmetil)benzamida;4- [5- (3,5-dichlorophenyl) -2-oxo-5- (trifluoromethyl) -3-oxazolidinyl] -2-methyl-N- (2-pyridinylmethyl) benzamide;
4-[5-(3,5-diclorofenil)-2-oxo-5-(trifluorometil)-3-oxazolidinil]-2-metil-N-(2,2,2-trifluoroetil)benzamida;4- [5- (3,5-dichlorophenyl) -2-oxo-5- (trifluoromethyl) -3-oxazolidinyl] -2-methyl-N- (2,2,2-trifluoroethyl) benzamide;
4-[5-(3,5-diclorofenil)-2-óxido-5-(trifluorometil)-1,2,3-oxatiazolidin-3-il]-2-metil-N-(2-piridinilmetil)benzamida;4- [5- (3,5-dichlorophenyl) -2-oxide-5- (trifluoromethyl) -1,2,3-oxathiazolidin-3-yl] -2-methyl-N- (2-pyridinylmethyl) benzamide;
2-nitro-5-[2-oxo-5-fenil-5-(trifluorometil)-3-oxazolidinil]benzonitrila;2-nitro-5- [2-oxo-5-phenyl-5- (trifluoromethyl) -3-oxazolidinyl] benzonitrile;
4-[4-(3,5-diclorofenil)-2-oxo-4-(trifluorometil)-1-imidazolidinil]-2-metil-N-(2-piridinilmetil)benzamida;4- [4- (3,5-dichlorophenyl) -2-oxo-4- (trifluoromethyl) -1-imidazolidinyl] -2-methyl-N- (2-pyridinylmethyl) benzamide;
4-[4-(3,5-diclorofenil)-3-metil-2-oxo-4-(trifluorometil)-1 -imidazolidinil]-2-metil-A/-(2-piridinilmetil)benzamida;4- [4- (3,5-dichlorophenyl) -3-methyl-2-oxo-4- (trifluoromethyl) -1-imidazolidinyl] -2-methyl-N- (2-pyridinylmethyl) benzamide;
4-[5-(3,4-diclorofenil)-2-oxo-5-(trifluorometil)-3-oxazolidinil]-2-metil-/\/-(2-píridinilmetil)benzamida;4- [5- (3,4-dichlorophenyl) -2-oxo-5- (trifluoromethyl) -3-oxazolidinyl] -2-methyl- [2- (2-pyridinylmethyl) benzamide;
5-[5-(3,5-diclorofenil)-2-oxo-5-(trifluorometil)-3-oxazolidinil]-2-(1 H-1,2,4-triazol-1 -il)benzonitrila;5- [5- (3,5-dichlorophenyl) -2-oxo-5- (trifluoromethyl) -3-oxazolidinyl] -2- (1H-1,2,4-triazol-1-yl) benzonitrile;
4-[5-(3,5-diclorofenil)-2,2-dióxido-5-(trifluorometil)-1,2,3-oxatiazolidin-3-il]-2-metil-A/-(2-piridinilmetil)benzamida; e4- [5- (3,5-dichlorophenyl) -2,2-dioxide-5- (trifluoromethyl) -1,2,3-oxathiazolidin-3-yl] -2-methyl-A / - (2-pyridinylmethyl) benzamide; and
4-[5-(3,5-diclorofenil)-2-oxo-5-(trifluorometil)-3-oxazolidinil]-2-metil-A/-[1 -(2-piridinil)etil]benzamida.4- [5- (3,5-dichlorophenyl) -2-oxo-5- (trifluoromethyl) -3-oxazolidinyl] -2-methyl-N- [1- (2-pyridinyl) ethyl] benzamide.
Realizações específicas adicionais incluem qualquer combinaçãodos compostos da Fórmula 1 selecionados a partir do grupo imediatamenteacima.Additional specific embodiments include any combination of the compounds of Formula 1 selected from the group immediately above.
Merecem observação compostos de acordo com a presenteinvenção que são caracterizados por padrões metabólicos e/ou residuais nosolo favoráveis e exibem atividade de controle de um espectro de pragasinvertebradas agronômicas e não agronômicas.Compounds according to the present invention which are characterized by favorable soil metabolic and / or residual patterns and exhibit control activity of a spectrum of agronomic and non-agronomic pests deserve observation.
Merece observação específica, por motivos de importânciaeconômica e espectro de controle de pragas invertebradas, que a proteção desafras agronômicas contra lesões ou danos causados por pragas invertebradaspor meio do controle de pragas invertebradas é uma realização da presenteinvenção. Os compostos de acordo com a presente invenção, devido às suaspropriedades de translocação favoráveis ou sistemicidade em plantas, tambémprotegem partes foliares ou outras de plantas que não são colocadasdiretamente em contato com um composto da Fórmula 1 ou uma composiçãoque compreende o composto.It deserves specific observation, for reasons of economic importance and spectrum of invertebrate pest control, that the protection of agronomic defects against injury or damage caused by invertebrate pests through invertebrate pest control is an accomplishment of the present invention. The compounds according to the present invention, due to their favorable translocation properties or plant systemicity, also protect leaf or other plant parts that are not directly contacted with a compound of Formula 1 or a composition comprising the compound.
Também merecem observação como realizações da presenteinvenção composições de controle de pragas invertebradas que compreendemuma quantidade biologicamente eficaz de um composto de acordo comqualquer das realizações anteriores, bem como quaisquer outras realizaçõesdescritas no presente e quaisquer de suas combinações, e pelo menos umcomponente adicional selecionado a partir do grupo que consiste de umtensoativo, diluente sólido e diluente líquido, em que a mencionada composiçãocompreende ainda opcionalmente uma quantidade biologicamente eficaz depelo menos um agente ou composto biologicamente ativo adicional.Realizações da presente invenção incluem ainda métodos de controle depragas invertebradas que compreendem o contato da praga invertebrada ouseu ambiente com uma quantidade biologicamente eficaz de um composto deacordo com qualquer das realizações anteriores (tais como na forma de umacomposição descrita no presente).Also noted as embodiments of the present invention are invertebrate pest control compositions comprising a biologically effective amount of a compound according to any of the foregoing embodiments, as well as any other embodiments described herein and any combinations thereof, and at least one additional component selected from the above. a group consisting of a surfactant, solid diluent and liquid diluent, wherein said composition optionally further comprises a biologically effective amount of at least one additional biologically active agent or compound. Embodiments of the present invention further include invertebrate control methods comprising pest contact. invertebrate or its environment with a biologically effective amount of a compound according to any of the foregoing embodiments (such as in the composition described herein).
Realizações da presente invenção também incluem umacomposição que compreende um composto de acordo com qualquer dasrealizações anteriores, na forma de formulação líquida para encharcamento dosolo. Realizações da presente invenção incluem ainda métodos de controle depragas invertebradas que compreendem o contato do solo com umacomposição líquida na forma de encharcamento do solo que compreende umaquantidade biologicamente eficaz de um composto de acordo com qualquerdas realizações anteriores.Embodiments of the present invention also include a composition comprising a compound according to any of the foregoing embodiments, in the form of liquid soil-soaking formulation. Embodiments of the present invention further include invertebrate pest control methods comprising contacting the soil with a soil-soaking liquid composition comprising a biologically effective amount of a compound according to any of the foregoing embodiments.
Realizações da presente invenção também incluem umacomposição de pulverização para controle de pragas invertebradas quecompreende uma quantidade biologicamente eficaz de um composto de acordocom qualquer das realizações anteriores e um propelente. Realizações dapresente invenção incluem ainda uma composição de isca para controle depragas invertebradas que compreende uma quantidade biologicamente eficazde um composto de acordo com qualquer das realizações anteriores, um oumais materiais alimentícios, opcionalmente um atrativo e opcionalmente umumectante. Realizações da presente invenção também incluem um dispositivode controle de pragas invertebradas que compreende a mencionadacomposição de isca e um abrigo adaptado para receber a mencionadacomposição de isca, em que o abrigo possui pelo menos uma aberturadimensionada para permitir que a praga invertebrada passe através daabertura, de forma que a praga invertebrada possa ter acesso à mencionadacomposição de isca a partir de um local fora do abrigo e em que o abrigo éadicionalmente adaptado para colocação em um local de atividade conhecidaou potencial para a praga invertebrada ou perto dele.Embodiments of the present invention also include an invertebrate pest control spray composition comprising a biologically effective amount of a compound according to any of the foregoing embodiments and a propellant. Embodiments of the present invention further include an invertebrate pest control bait composition comprising a biologically effective amount of a compound according to any of the foregoing embodiments, one or more food materials, optionally an attractive and optionally a humectant. Embodiments of the present invention also include an invertebrate pest control device comprising said bait composition and a shelter adapted to receive said bait composition, wherein the shelter has at least one dimensioned opening to allow the invertebrate pest to pass through the aperture. that the invertebrate pest may have access to the said bait composition from a location outside the shelter and where the shelter is further adapted for placement in a known activity site or potential for or near the invertebrate pest.
Os compostos da Fórmula 1 podem ser preparados por meio deum ou mais dos métodos e variações a seguir conforme descrito nosEsquemas 1 a 14. As definições de R1, R2, A1, A2, A3, A4, G, U, Q, Z e η noscompostos das Fórmulas 1 a 24 abaixo são conforme definido acima naDescrição Resumida da Invenção. As Fórmulas 1a e 1b são subconjuntos daFórmula 1 e a Fórmula 2a é um subconjunto da Fórmula 2.The compounds of Formula 1 may be prepared by one or more of the following methods and variations as described in Schemes 1 to 14. The definitions of R1, R2, A1, A2, A3, A4, G, U, Q, Z and η The compounds of Formulas 1 to 24 below are as defined above in the Summary Description of the Invention. Formulas 1a and 1b are subsets of Formula 1 and Formula 2a is a subset of Formula 2.
Conforme exibido no Esquema 1, pode-se preparar um compostoda Fórmula 1 por meio do tratamento de uma amina da Fórmula 2 com umreagente apropriado da Fórmula 3 (em que L é um grupo residual de reaçãonucleofílica apropriado tal como halogênio ou imidazol) na presença de umabase (tal como trietilamina, N,N-diisopropiletilamina ou hidrogênio carbonato desódio). Também são úteis como bases extratores ácidos sustentados porpolímero tais como equivalentes unidos por polímero de N,N-diisopropiletilamina e 4-(dimetilamino)piridina, tais como polímero de N-[(4-etenilfenil]-metil)]-N-metil-4-piridinamina com dietenilbenzeno e etenilbenzeno(Registro CAS n° 82942-26-5, identificado a seguir como "PS-DMAP"). Ométodo do Esquema 1 pode ser realizado com uma variedade ampla dereagentes da Fórmula 3 tal como 1,1'-carbonildiimidazol, fosgênio, cloroformatode triclorometila, trifosgene (ou seja, quando U é C(=0)), tiofosgene, 1,1'-tiocarbonildiimidazol (ou seja, quando U é C(=S)), cloreto de tionila (ou seja,quando U é S(=O)) e cloreto de sulfurila (ou seja, quando U é S(O)2).As shown in Scheme 1, a Formula 1 compound can be prepared by treating a Formula 2 amine with an appropriate Formula 3 reagent (where L is an appropriate nucleophilic reaction group such as halogen or imidazole) in the presence of a base (such as triethylamine, N, N-diisopropylethylamine or hydrogen carbonate sodium). They are also useful as polymer-supported acidic extractant bases such as N, N-diisopropylethylamine and 4- (dimethylamino) pyridine polymer-joined equivalents, such as N - [(4-ethenylphenyl] methyl)] -N-methyl-2-polymer. 4-pyridinamine with dietenylbenzene and ethenylbenzene (CAS Registry No. 82942-26-5, hereinafter referred to as "PS-DMAP"). The method of Scheme 1 may be carried out with a wide variety of Formula 3 reagents such as 1,1'-carbonyldiimidazole, phosgene, trichloromethyl chloroformate, triphosgene (ie when U is C (= 0)), thiophosgene, 1,1 ' -thiocarbonyl diimidazole (ie when U is C (= S)), thionyl chloride (ie when U is S (= O)) and sulfuryl chloride (ie when U is S (O) 2).
<formula>formula see original document page 33</formula><formula> formula see original document page 33 </formula>
A reação pode ser conduzida pura ou em um solvente tal comodiclorometano, clorofórmio, tetraidrofuran, acetonitrila ou 1,2-dicloroetano. Astemperaturas para esta reação podem variar de 0 a 90 °C. O método doEsquema 1 é ilustrado na Etapa F do Exemplo 1, Etapa D do Exemplo 2 eExemplo 3.The reaction may be conducted neat or in a solvent such as dichloromethane, chloroform, tetrahydrofuran, acetonitrile or 1,2-dichloroethane. Temperatures for this reaction may range from 0 to 90 ° C. The method of Scheme 1 is illustrated in Step F of Example 1, Step D of Example 2 and Example 3.
Os compostos da Fórmula 2a (Fórmula 2 em que G é O) podemser elaborados por meio da abertura de anéis de um epóxido apropriado daFórmula 4 por meio de tratamento com uma amina da Fórmula 5 em umsolvente tal como metanol, etanol, clorofórmio, tetraidrofuran, acetonitrila ou1,2-dicloroetano sob temperaturas que variam de 25 a 90 °C, conformeilustrado no Esquema 2. O método do Esquema 2 é ilustrado na Etapa E doExemplo 1 e na Etapa C do Exemplo 2.The compounds of Formula 2a (Formula 2 wherein G is O) may be made by ring-ringing an appropriate Formula 4 epoxide by treatment with an Formula 5 amine in a solvent such as methanol, ethanol, chloroform, tetrahydrofuran, acetonitrile or 1,2-dichloroethane at temperatures ranging from 25 to 90 ° C as illustrated in Scheme 2. The method of Scheme 2 is illustrated in Step E of Example 1 and Step C of Example 2.
Esquema 2Scheme 2
<formula>formula see original document page 33</formula><formula> formula see original document page 33 </formula>
Os epóxidos da Fórmula 4 podem ser preparados a partir decetonas da Fórmula 6 por meio de tratamento com um ileto de sulfônio, que étipicamente gerado in situ por meio da reação de um haleto detrimetilsulfoxônio da Fórmula 7 com uma base apropriada tal como hidreto desódio, hidreto de potássio ou ferc-butóxido de sódio, em um solventeapropriado tal como sulfóxido de dimetila, N,N-dimetilformamida ou terc-butanol, conforme ilustrado no Esquema 3. O método do Esquema 3 é ilustradona Etapa D do Exemplo 1.The epoxides of Formula 4 may be prepared from Formula 6 ketones by treatment with a sulfonium ylide, which is typically generated in situ by reacting a Formula 7 detrimethylsulfoxon halide with an appropriate base such as sodium hydride, hydride, hydride. potassium or sodium tert-butoxide in a suitable solvent such as dimethyl sulfoxide, N, N-dimethylformamide or tert-butanol as illustrated in Scheme 3. The method of Scheme 3 is illustrated in Step D of Example 1.
Haletos de trimetilsulfoxônio da Fórmula 7 são disponíveiscomercialmente.Trimethylsulfoxon halides of Formula 7 are commercially available.
Esquema 3Scheme 3
<formula>formula see original document page 34</formula><formula> formula see original document page 34 </formula>
Conforme ilustrado no Esquema 4, cetonas da Fórmula 6podem ser obtidas por meio do tratamento de compostos da Fórmula 8 comlítio metálico, um reagente de organolítio tal como n-butil lítio, sec-butil lítioou ferc-butil lítio, ou um haleto de alquilmagnésio tal como cloreto oubrometo de etil ou metil magnésio sob temperaturas tipicamente de -78 0Cà temperatura ambiente, para formar o intermediário lítio ou Grignard,respectivamente. Este intermediário é reagido em seguida com umreagente da Fórmula 9, em que L1 é um grupo residual tal como Cl, Br1OCH3 ou OCOCF3 para gerar a cetona da Fórmula 6. A reação é conduzidaem um solvente orgânico, preferencialmente tetraidrofuran ou dietil éter. Ométodo do Esquema 4 é ilustrado na Etapa C do Exemplo 1.Esquema 4As shown in Scheme 4, ketones of Formula 6 may be obtained by treating compounds of Formula 8 with metallic lithium, an organolithium reagent such as n-butyllithium, sec-butyl lithium or tert-butyl lithium, or an alkylmagnesium halide such as as ethyl or methyl magnesium chloride or bromide at temperatures typically from -78 ° C to room temperature to form the lithium or Grignard intermediate, respectively. This intermediate is then reacted with a reagent of Formula 9, wherein L1 is a residual group such as Cl, Br1OCH3 or OCOCF3 to generate the ketone of Formula 6. The reaction is conducted in an organic solvent, preferably tetrahydrofuran or diethyl ether. The method of Scheme 4 is illustrated in Step C of Example 1. Scheme 4
<formula>formula see original document page 35</formula><formula> formula see original document page 35 </formula>
Alternativamente, os compostos da Fórmula 1a (Fórmula 1 emque G é O e U é C(=O)) podem ser preparados a partir de oxazolidinonas daFórmula 10 por meio de reação com intermediários de haletos aromáticos daFórmula 11 (em que L2 é um grupo residual tal como F ou CI), conformeilustrado no Esquema 5.Alternatively, compounds of Formula 1a (Formula 1 wherein G is O and U is C (= O)) may be prepared from oxazolidinones of Formula 10 by reaction with aromatic halide intermediates of Formula 11 (wherein L2 is a group). such as F or CI) as shown in Scheme 5.
Esquema 5Scheme 5
<formula>formula see original document page 35</formula><formula> formula see original document page 35 </formula>
Nesta reação, a oxazolidinona da Fórmula 10 é colocada emcontato com uma base, tal como hidreto de sódio ou íerc-butóxido de potássio,e tratada em seguida com um composto da Fórmula 11 tipicamente em umsolvente (tal como N,N-dimetilformamida ou sulfóxido de dimetila). O métododo Esquema 5 é ilustrado na Etapa B do Exemplo 4. Alternativamente, quandoa Fórmula 11 for um brometo de arila (ou seja, L2 é BR), a reação pode serconduzida com dois equivalentes de uma base tal como carbonato de potássioe na presença de um catalisador de cobre (I) tal como iodeto de cobre (I)(tipicamente, 3 a 5% molar) e frans-ciclohexanodiamina (para solubilizar o Cul)utilizando o método descrito em Organic Letters 2003, 5, 963-965.In this reaction, the oxazolidinone of Formula 10 is contacted with a base, such as sodium hydride or potassium tert-butoxide, and then treated with a compound of Formula 11 typically in a solvent (such as N, N-dimethylformamide or sulfoxide). of dimethyl). The method of Scheme 5 is illustrated in Step B of Example 4. Alternatively, when Formula 11 is an aryl bromide (ie L 2 is BR), the reaction may be conducted with two equivalents of a base such as potassium carbonate in the presence of a copper (I) catalyst such as copper (I) iodide (typically 3 to 5 mol%) and frans-cyclohexanediamine (to solubilize Cul) using the method described in Organic Letters 2003, 5, 963-965.
Conforme ilustrado no Esquema 6, compostos da Fórmula 1apodem também ser preparados por meio de uma reação de arilação N mediadapor cobre de uma oxazolidinona da Fórmula 10 com um composto da Fórmula12, em que M é um grupo tal como ácido borônico, éster borônico,biarilbismutano, trialquilestanhano ou trialquilsiloxano. A reação pode serconduzida em um solvente tal como diclorometano, clorofórmio outetraidrofuran e na presença de um sal de cobre tal como acetato de cobre (II)e uma base (tal como trietilamina ou piridina), conforme ilustrado no Esquema6. Para procedimentos gerais deste tipo de reação, vide Ley1 S. V.; Thomas, A.W., Angewandte Chemie, International Edition 2003, 42, 5400-5449.As shown in Scheme 6, compounds of Formula 1 may also be prepared by a copper-mediated N arylation reaction of an oxazolidinone of Formula 10 with a compound of Formula 12, wherein M is a group such as boronic acid, boronic ester, biarylbismutane. trialkylstannane or trialkylsiloxane. The reaction may be conducted in a solvent such as dichloromethane, chloroform outetrahydrofuran and in the presence of a copper salt such as copper (II) acetate and a base (such as triethylamine or pyridine) as shown in Scheme 6. For general procedures of this type of reaction, see Ley1 S. V .; Thomas, A.W., Angewandte Chemie, International Edition 2003, 42, 5400-5449.
Esquema 6Scheme 6
<formula>formula see original document page 36</formula><formula> formula see original document page 36 </formula>
Oxazolidinonas da Fórmula 10 podem ser preparadas por meio dareação de aminoálcoois da Fórmula 13 com trifosgene ou substitutos detrifogene que resultam na carbonilação (tal como difosgene, fosgene, carbonatode (bis)triclorometila ou 1,1'-carbonil-diimidazol). A reação é conduzida em um15 solvente orgânico apropriado, tal como diclorometano, 1,2-dicloroetano outetraidrofuran na presença de uma base tal como trietilamina, hidrogêniocarbonato de sódio ou carbonato de sódio, conforme ilustrado no Esquema 7.Oxazolidinones of Formula 10 may be prepared by daring amino alcohols of Formula 13 with triphosgene or detrifogene substitutes which result in carbonylation (such as diphosgene, phosgene, (bis) trichloromethyl carbonate or 1,1'-carbonyl diimidazole). The reaction is conducted in an appropriate organic solvent such as dichloromethane, 1,2-dichloroethane outetrahydrofuran in the presence of a base such as triethylamine, sodium hydrogen carbonate or sodium carbonate as illustrated in Scheme 7.
Esquema 7Scheme 7
<formula>formula see original document page 36</formula><formula> formula see original document page 36 </formula>
Aminoálcoois da Fórmula 13 podem ser preparados por meio daredução de cianoidrinas da Fórmula 14 com um agente redutor tal comotetraidroaluminato de lítio em um solvente orgânico apropriado tal como dietiléter ou tetraidrofuran, conforme ilustrado no Esquema 8. Os métodos dosEsquemas 7 e 8 são ilustrados na Etapa A do Exemplo 4.Amino alcohols of Formula 13 may be prepared by reducing the cyanohydrins of Formula 14 with a reducing agent such as lithium tetrahydroaluminate in an appropriate organic solvent such as diethylether or tetrahydrofuran as illustrated in Scheme 8. The methods of Schemes 7 and 8 are illustrated in Step A of Example 4.
Esquema 8Scheme 8
<formula>formula see original document page 37</formula><formula> formula see original document page 37 </formula>
As cianoidrinas da Fórmula 14 podem ser preparadas a partir dascetonas correspondentes (ou seja, Fórmula 6) por meio de um dentre umasérie de métodos de cianação bem conhecidos na técnica (vide, por exemplo,North, M., Science of Synthesis 2004, 19, 235-284).Cyanohydrins of Formula 14 may be prepared from the corresponding ketones (i.e. Formula 6) by one of a number of cyanation methods well known in the art (see, for example, North, M., Science of Synthesis 2004, 19 , 235-284).
Os compostos da Fórmula 1b (ou seja, Fórmula 1 em que G é NR3 eU é C(=0)) podem ser preparados por meio de redução da imida da Fórmula 15com boroidreto de sódio em um solvente apropriado tal como metanol e da reduçãoem seguida do intermediário 5-hidróxi resultante com boroidreto de sódio e ácidotrifluoroacético. Métodos de redução de cetonas e alcoóis são bem documentadosna técnica. Vide, por exemplo, Mehrotra, Μ. M. et al, JoumaIofMedicinaI Chemistry2004, 47, 2037-2061 e Johnson, M. R.; Rickborn, B.; Journal of Organic Chemistry1970, 35, 1041-1045. O método do Esquema 9 é ilustrado no Exemplo 5, Etapas Ee F, bem como no Exemplo 6, Etapas B e C.The compounds of Formula 1b (i.e. Formula 1 wherein G is NR 3 and U is C (= 0)) may be prepared by reducing the imide of Formula 15 with sodium borohydride in an appropriate solvent such as methanol and then reducing. of the resulting 5-hydroxy intermediate with sodium borohydride and trifluoroacetic acid. Ketone and alcohol reduction methods are well documented in the art. See, for example, Mehrotra, Μ. M. et al., JoumaIofMedicinaI Chemistry2004, 47, 2037-2061 and Johnson, M. R .; Rickborn, B .; Journal of Organic Chemistry1970, 35, 1041-1045. The method of Scheme 9 is illustrated in Example 5, Steps E and F, as well as Example 6, Steps B and C.
Esquema 9Scheme 9
<formula>formula see original document page 37</formula>Conforme exibido no Esquema 10, os compostos da Fórmula 15podem ser preparados a partir da ciclização de uréias da Fórmula 16 por meiode tratamento com ácido clorídrico aquoso de acordo com o método geraldescrito por Cook1 A. H.; Hunter1 G. D.; Journal of the Chemical Society 1952,3789-3796. Para compostos da Fórmula 15 em que R3 é diferente de H,realiza-se em seguida tratamento do intermediário ciclizado (em que R3 é H)com L^3-R^3 (em que L^3 é um grupo residual) na presença de uma baseapropriada tal como hidreto de sódio para gerar compostos da Fórmula 15. Asegunda etapa do método do Esquema 10 é ilustrada no Exemplo 6, Etapa A.<formula> formula see original document page 37 </formula> As shown in Scheme 10, compounds of Formula 15 may be prepared by cyclizing urea from Formula 16 by treatment with aqueous hydrochloric acid according to the general method described by Cook1. AH; Hunter1 G. D .; Journal of the Chemical Society 1952,3789-3796. For compounds of Formula 15 wherein R3 is other than H, the cyclized intermediate (where R3 is H) is then treated with L3-R3 (where L3 is a residual group) in the presence of of an appropriate base such as sodium hydride to generate compounds of Formula 15. The second step of the method of Scheme 10 is illustrated in Example 6, Step A.
Esquema 10Figure 10
<formula>formula see original document page 38</formula><formula> formula see original document page 38 </formula>
Conforme exibido no Esquema 11, os compostos da Fórmula 16podem ser obtidos por meio de reação de α-aminonitrilas da Fórmula 17 comisocianatos da Fórmula 18 de acordo com o método geral de Van Dort1 M. E.;Junt, Y.-W.; Bioorganic & Medicinal Chemistry Letters 2004, 14 (21), 5285-5288.As shown in Scheme 11, compounds of Formula 16 may be obtained by reacting Formula 17 α-aminonitriles with Formula 18 comisocyanates according to the general method of Van Dort1 M. E.; Junt, Y.-W .; Bioorganic & Medicinal Chemistry Letters 2004, 14 (21), 5285-5288.
Esquema 11Scheme 11
<formula>formula see original document page 38</formula><formula> formula see original document page 38 </formula>
Os compostos da Fórmula 17 podem ser obtidos por meio daconversão de cetonas da Fórmula 6 nas iminas correspondentes 20, seguidapela adição de uma fonte de cianeto (tal como HCN) aos intermediários imina,seguida pela adição de cianeto, o que é bem documentado na técnica (vide,por exemplo, Organic Reactions 2002, 59, 1-714 e Koos, M.; Mosher, H. S.;Tetrahedron 1993, 49, 1541-1546).The compounds of Formula 17 may be obtained by converting ketones of Formula 6 into the corresponding imines 20, followed by the addition of a cyanide source (such as HCN) to the imine intermediates, followed by the addition of cyanide, which is well documented in the art. (see, for example, Organic Reactions 2002, 59, 1-714 and Koos, M .; Mosher, HS; Tetrahedron 1993, 49, 1541-1546).
O método exibido no Esquema 12 é particularmente útil para apreparação das iminas 20 quando R1 for CF3.The method shown in Scheme 12 is particularly useful for preparing imines 20 when R1 is CF3.
Esquema 12Figure 12
<formula>formula see original document page 39</formula><formula> formula see original document page 39 </formula>
Conforme exibido acima, uma cetona da Fórmula 6 é tratada emprimeiro lugar com bis(trimetilsilil)amida de lítio, o que resulta na formação deum intermediário de imina 19, que é solvolizado em seguida em metanol paragerar uma imina estável 20 de acordo com o método geral de Gosselin, F. et al,Organic Letters 2005, 7, 355-358.As shown above, a ketone of Formula 6 is first treated with lithium bis (trimethylsilyl) amide, which results in the formation of an imine intermediate 19, which is then solvolized to methanol to give a stable imine 20 according to the method. Gosselin, F. et al., Organic Letters 2005, 7, 355-358.
Alternativamente, compostos da Fórmula 15 podem serpreparados por meio do aquecimento de compostos da Fórmula 21 comaminas da Fórmula 5 (vide Esquema 13) na presença de um catalisador talcomo 4-(dimetilamino)piridina ou ácido trifluoroacético. As hidantoínasciclizadas formadas podem ser tratadas em seguida com L3-R3 na presença deuma base tal como hidreto de sódio para formar compostos da Fórmula 15.Como referência, vide Pozzo, A. D. et al, Tetrahedron 1998, 6019-6028. Ométodo do Esquema 3 é ilustrado no Exemplo 5, Etapa D.Alternatively, compounds of Formula 15 may be prepared by heating compounds of Formula 21 with Formula 5 amines (see Scheme 13) in the presence of a catalyst such as 4- (dimethylamino) pyridine or trifluoroacetic acid. The formed hydantoinasciclised can then be treated with L3-R3 in the presence of a base such as sodium hydride to form compounds of Formula 15. As reference, see Pozzo, A. D. et al, Tetrahedron 1998, 6019-6028. The method of Scheme 3 is illustrated in Example 5, Step D.
Esquema 13Figure 13
<formula>formula see original document page 39</formula>Conforme exibido no Esquema 14, compostos da Fórmula 21podem ser obtidos por meio da reação de α-cetoésteres da Fórmula 22 comcarbamato de benzila, após a desidratação, para formar iminas da Fórmula 23,seguida pela adição dos intermediários Grignard 24, que podem ser derivadosde compostos da Fórmula 8 conforme descrito anteriormente para o método doEsquema 4. Para referência geral, vide Dessipri, E.; Tirrell, D. A.;Macromolecules 1994, 27, 5463-5470. O método do Esquema 14 é ilustrado no<formula> formula see original document page 39 </formula> As shown in Scheme 14, compounds of Formula 21 can be obtained by reacting Formula 22 α-ketoesters with benzyl carbamate, after dehydration, to form Formula 23 imines. followed by the addition of Grignard intermediates 24, which may be derived from compounds of Formula 8 as described above for the method of Scheme 4. For general reference, see Dessipri, E .; Tirrell, D.A. Macromolecules 1994, 27, 5463-5470. The method of Scheme 14 is illustrated in
Exemplo 5, Etapas A-C.Example 5, Steps A-C.
Esquema 14Scheme 14
<formula>formula see original document page 40</formula><formula> formula see original document page 40 </formula>
Os técnicos no assunto reconhecerão que compostos da Fórmula1 e os intermediários descritos no presente podem ser submetidos a váriasreações eletrofílicas, nucleofílicas, radicais, organometálicas, de oxidação e deredução para adicionar substituintes ou modificar substituintes existentes.Também se reconhece que alguns reagentes e condições de reação descritosacima para a preparação de compostos da Fórmula 1 podem não sercompatíveis com certas funcionalidades presentes nos intermediários. Nestescasos, a incorporação de seqüências de proteção e desproteção ouinterconversões de grupos funcionais na síntese auxiliará na obtenção dosprodutos desejados. O uso e a seleção dos grupos protetores serão evidentespara os técnicos no assunto de síntese química (vide, por exemplo, Greene1 T.W.; Wuts1 P. G. M., Protective Groups in Organic Synthesis, segunda edição;Wiley: Nova Iorque, 1991). Os técnicos no assunto reconhecerão que, emalguns casos, após a introdução de um dado reagente na forma em que éilustrao em qualquer esquema individual, pode ser necessário realizar etapassintéticas de rotina adicionais não descritas em detalhes para completar asíntese de compostos da Fórmula 1. Os técnicos no assunto tambémreconhecerão que pode ser necessário realizar uma combinação das etapasilustradas nos esquemas acima em uma ordem diferente da indicada pelaseqüência específica apresentada para preparar os compostos da Fórmula 1.Those skilled in the art will recognize that compounds of Formula 1 and the intermediates described herein may be subjected to various electrophilic, nucleophilic, radicals, organometallic, oxidation and deduction reactions to add existing substituents or modify substituents. It is also recognized that some reagents and reaction conditions described above for the preparation of compounds of Formula 1 may not be compatible with certain functionalities present in the intermediates. In these cases, the incorporation of protection and deprotection sequences or functional group interconversions in the synthesis will assist in obtaining the desired products. The use and selection of protecting groups will be apparent to those skilled in the art of chemical synthesis (see, for example, Greene1 T.W .; Wuts1 P. G. M., Protective Groups in Organic Synthesis, Second Edition; Wiley: New York, 1991). Those skilled in the art will recognize that, in some cases, upon introduction of a given reagent as illustrated in any individual scheme, it may be necessary to perform additional routine step synthetics not described in detail to complete the synthesis of Formula 1 compounds. It will also be appreciated in the art that a combination of the steps illustrated in the above schemes may be required in a different order from that indicated by the specific sequence presented to prepare the compounds of Formula 1.
Sem elaboração adicional, acredita-se que os técnicos noassunto, utilizando o relatório descritivo acima, possam utilizar a presenteinvenção até o máximo possível. Os Exemplos a seguir devem, portanto, serconsiderados meramente ilustrativos e não limitadores do relatório descritivo denenhuma forma. Os espectros de NMR 1H são relatados em ppm a partir detetrametilsilano; os espectros de NMR 19F são relatados em PPM utilizandotriclorofluorometano como referência; "s" indica isolado, "d" indica dupla, "t"indica trio, "m" indica múltiplo, "dd" indica par de duplas, "dt" indica par de trios,"br s" indica isolado amplo e "br t" indica triplo amplo.Without further elaboration, it is believed that the subject matter, using the above descriptive report, may utilize this invention to the fullest extent possible. The following Examples should therefore be considered merely illustrative and not limiting the descriptive report in any way. 1 H NMR spectra are reported in ppm from tetramethylsilane; 19F NMR spectra are reported in PPM using trichlorofluoromethane as a reference; "s" indicates isolated, "d" indicates double, "t" indicates triple, "m" indicates multiple, "dd" indicates pair of doubles, "dt" indicates pair of trios, "br s" indicates broad isolate and "br t "indicates broad triple.
Exemplo 1Example 1
Preparação de 4-r5-(3,5-dicl0r0feniü-2-0x0-5-(triflu0r0metil)-3-oxazolidinil1-2-metil-/V-(2,2.2-trifluoroetil)benzamidaEtapa A: preparação de 4-(acetilamino)-2-meth_-/V-(2.2.2-trifluoroetiübenzamidaPreparation of 4-5- (3,5-dichloro-phenyl-2-0x0-5- (trifluoromethyl) -3-oxazolidinyl-2-methyl- / V- (2,2,2-trifluoroethyl) benzamide Step A: Preparation of 4- (acetylamino) ) -2-meth- / V- (2,2,2-trifluoroethylbenzamide
A uma solução agitada de ácido 4-(acetilamino)-2-metilbenzóico(Aldrich, 1,9 g, 9,8 mmol) em tetraidrofuran (9 ml) à temperatura ambiente,adicionou-se 1,1'-carbonildiimidazol (1,65 g, 10,1 mmol). Após dezoito horas,adicionou-se 2,2,2-trifluoroetanamina (1,6 g, 16,0 mmol), seguida por umaquantidade catalítica de 4-(dimetilamino)piridina (também conhecida como N1N-dimetil-4-piridinamina). Após 24 horas, adicionou-se água à mistura de reaçãoe o precipitado resultante foi recolhido por meio de filtragem e seco parafornecer o composto título na forma de pó branco (2,1 g).To a stirred solution of 4- (acetylamino) -2-methylbenzoic acid (Aldrich, 1.9 g, 9.8 mmol) in tetrahydrofuran (9 ml) at room temperature was added 1,1'-carbonyldiimidazole (1, 65 g, 10.1 mmol). After eighteen hours, 2,2,2-trifluoroethanamine (1.6 g, 16.0 mmol) was added, followed by a catalytic amount of 4- (dimethylamino) pyridine (also known as N1N-dimethyl-4-pyridinamine). After 24 hours, water was added to the reaction mixture and the resulting precipitate was collected by filtration and dried to provide the title compound as white powder (2.1 g).
25NMR 1H (DMSO-Cfe): δ 10,01 (s, 1Η), 8,80 (t, 1 Η), 7,46 (d, 1Η),7,45 (s, 1Η), 7,31 (d, 1H), 4,02 (m, 2H), 2,31 (s, 3H), 2,05 (s, 3H).1 H NMR (DMSO-Cfe): δ 10.01 (s, 1Η), 8.80 (t, 1Η), 7.46 (d, 1Η), 7.45 (s, 1Η), 7.31 ( d, 1H), 4.02 (m, 2H), 2.31 (s, 3H), 2.05 (s, 3H).
etapa B: preparação de 4-amino-2-metil-AM2,2.2-trifluoroetil)benzamida·Step B: Preparation of 4-Amino-2-Methyl-AM2,2,2-Trifluoroethyl) Benzamide ·
A 4-(acetilamino)-2-metil-A/-(2,2,2-trifluoroetil)benzamida (ouseja, o produto da Etapa A), adicionou-se ácido clorídrico concentrado e amistura de reação foi aquecida a 100 0C por duas horas. A mistura dereação foi resfriada utilizando um banho externo de água com gelo eadicionou-se hidróxido de sódio aquoso (50% em peso, 20 ml) até que amistura de reação fosse neutralizada, causando precipitação de um sólido.O sólido foi filtrado, lavado com água e seco em um forno a vácuo a 60 0Cpor uma noite para fornecer o composto título na forma de pó branco (0,89g)·To 4- (acetylamino) -2-methyl-A / - (2,2,2-trifluoroethyl) benzamide (ie, the product of Step A), concentrated hydrochloric acid was added and the reaction mixture was heated to 100 ° C for two hours. The reaction mixture was cooled using an external ice-water bath and aqueous sodium hydroxide (50 wt.%, 20 ml) was added until the reaction mixture was neutralized, causing a solid to precipitate. The solid was filtered, washed with water and dried in a vacuum oven at 60 ° C overnight to provide the title compound as a white powder (0.89g).
NMR 1H (DMSO-cfe) δ 8,42 (t, 1H), 7,18 (d, 1H), 6,38 (s, 1H), 6,39(d, 2H), 5,43 (br s, 2H), 3,96 (m, 2H), 2,57 (s, 3H).1 H NMR (DMSO-cfe) δ 8.42 (t, 1H), 7.18 (d, 1H), 6.38 (s, 1H), 6.39 (d, 2H), 5.43 (br s 2H), 3.96 (m, 2H), 2.57 (s, 3H).
Etapa C: preparação de 1-(3.5-diclorofenil)-2,2,2-trifluoroetanona:Step C: Preparation of 1- (3,5-dichlorophenyl) -2,2,2-trifluoroethanone:
A uma calda agitada de 1-bromo-3,5-diclorobenzeno (Aldrich, 15,0g, 65,1 mmol) em éter anidro (300 ml) a -70 0C, adicionou-se A7-butil lítio (2,5 Mem hexano, 26,0 ml, 65,0 mmol) em gotas por trinta minutos. Após cincominutos, adicionou-se trifluoroacetato de metila (9,17 g, 71,6 mmol) em éter (7ml) em gotas por 45 minutos. Após 45 minutos adicionais, a mistura de reaçãofoi aquecida a 0 0C1 despejada em seguida em uma solução saturada de di-hidrogênio fosfato de potássio aquoso (50 g em 200 ml de água) e agitada portrinta minutos à temperatura ambiente. As camadas foram separadas e acamada orgânica foi lavada com cloreto de sódio saturado (100 ml), seca(MgSO4) e concentrada sob pressão reduzida para fornecer o composto títulona forma de óleo amarelo (13,0 g).To a stirred mixture of 1-bromo-3,5-dichlorobenzene (Aldrich, 15.0g, 65.1 mmol) in anhydrous ether (300 mL) at -70 ° C was added A7-butyl lithium (2.5 Mem. hexane, 26.0 ml, 65.0 mmol) in drops for thirty minutes. After five minutes, methyl trifluoroacetate (9.17 g, 71.6 mmol) in ether (7 mL) was added dropwise over 45 minutes. After an additional 45 minutes, the reaction mixture was warmed to 0 ° C and then poured into saturated aqueous potassium dihydrogen phosphate solution (50 g in 200 ml water) and stirred for 30 minutes at room temperature. The layers were separated and the organic layer was washed with saturated sodium chloride (100 mL), dried (MgSO4) and concentrated under reduced pressure to afford the title compound as yellow oil (13.0 g).
NMR 1H (CDCI3) δ 7,74 (s, 2H), 7,44 (s, 1H). NMR 19F (CDCI3): δ -76,82.Etapa D: preparação de 2-(3.5-diclorofeniU-2-(trifluorometil)oxirano.1 H NMR (CDCl 3) δ 7.74 (s, 2H), 7.44 (s, 1H). 19 F NMR (CDCl 3): δ -76.82. Step D: Preparation of 2- (3,5-dichlorophenyl-2- (trifluoromethyl) oxirane.
Adicionou-se hidreto de sódio (60%, 0,36 g, 9,0 mmol) a umasolução agitada de iodeto de trimetilsulfoxônio (1,88 g, 8,5 mmol) em sulfóxidode dimetila (17 ml) sob uma atmosfera de nitrogênio. Após agitação por meiahora, a solução foi adicionada em gotas por cinco minutos a uma solução de 1-(3,5-diclorofenil)-2,2,2-trifluoroetanona (ou seja, o produto da Etapa C) (1,7 g,7,0 mmol) em tetraidrofuran. A calda amarela resultante foi agitada por cincominutos e, em seguida, a mistura de reação foi repartida entre éter (100 ml) eágua (50 ml). A camada orgânica foi separada e a camada aquosa foi extraídacom éter (70 ml). Os extratos de éter combinados foram lavados com água (40ml) e secos (MgSO4). A solução de éter foi filtrada e o solvente foi concentradosob pressão reduzida para fornecer o composto título na forma de óleo laranja(1,71 g). O produto bruto (70-80% por meio de NMR 1H) foi utilizado sempurificação.Sodium hydride (60%, 0.36 g, 9.0 mmol) was added to a stirred solution of trimethylsulfoxonium iodide (1.88 g, 8.5 mmol) in dimethyl sulfoxide (17 ml) under a nitrogen atmosphere. . After stirring for half an hour, the solution was added dropwise over five minutes to a solution of 1- (3,5-dichlorophenyl) -2,2,2-trifluoroethanone (i.e. the product of Step C) (1.7 g , 7.0 mmol) in tetrahydrofuran. The resulting yellow syrup was stirred for five minutes and then the reaction mixture was partitioned between ether (100 mL) and water (50 mL). The organic layer was separated and the aqueous layer was extracted with ether (70 ml). The combined ether extracts were washed with water (40ml) and dried (MgSO4). The ether solution was filtered and the solvent was concentrated under reduced pressure to afford the title compound as orange oil (1.71 g). The crude product (70-80% by 1 H NMR) was used without purification.
NMR 1H (CDCI3): δ 7,42 (m, 3H), 3,43 (d, 1H), 2,91 (m, 1H). NMR19F (CDCI3): δ -74,57.1 H NMR (CDCl 3): δ 7.42 (m, 3H), 3.43 (d, 1H), 2.91 (m, 1H). NMR 19 F (CDCl 3): δ -74.57.
ETAPA Ε: 4-rr2-(3,5-DICLOROFENIL)-2-HIDRÓXI-3.3.3-TRIFLUOROPROPILlAMINOl-2-METIL-/V-(2.2,2-TRIFLUOROETIL)BENZAMIDA.STEP Ε: 4-rr2- (3,5-DICHLOROPHENYL) -2-HYDROXY-3,3.3-TRIFLUOROPROPYLAMINO1-2-METHYL / V- (2,2,2-TRIFLUOROETHYL) BENZAMIDE.
Uma solução de 2-(3,5-diclorofenil)-2-(trifluorometil)oxirano (ouseja, o produto da Etapa D) (0,82 g) e 4-amino-2-metil-/V-(2,2,2-trifluoroetil)benzamida (ou seja, o produto da Etapa B) (0,42 g, 1,7 mmol) emetanol anidro (8 ml) foi aquecida a 75 0C por dezoito horas. Após resfriamento,o solvente foi concentrado sob pressão reduzida. O resíduo foi purificado pormeio de cromatografia de sílica gel sob média pressão utilizando acetato deetila e hexanos (2:3) como eluente para fornecer o composto título na forma desólido vítreo esbranquiçado (0,36 g).A solution of 2- (3,5-dichlorophenyl) -2- (trifluoromethyl) oxirane (ie, the product of Step D) (0.82 g) and 4-amino-2-methyl- / V- (2.2 2-trifluoroethyl) benzamide (i.e. the product of Step B) (0.42 g, 1.7 mmol) in anhydrous ethanol (8 ml) was heated at 75 ° C for eighteen hours. After cooling, the solvent was concentrated under reduced pressure. The residue was purified by medium pressure silica gel chromatography using ethyl acetate and hexanes (2: 3) as eluent to afford the title compound as off-white vitreous desolide (0.36 g).
NMR 1H (CDCI3): δ 7,51 (s, 2H), 7,37 (s, 1H), 7,18 (d, 1H), 6,42(m, 2H), 6,30 (s, 1H), 6,29 (d, 1H), 5,13 (s, 1H), 3,96 (m, 2H), 3,74 (dd, 1H),3,62 (dd, 1 Η), 2,00 (s, 3Η). NMR 19F (CDCI3): δ -72,80, -78,47.1H NMR (CDCl3): δ 7.51 (s, 2H), 7.37 (s, 1H), 7.18 (d, 1H), 6.42 (m, 2H), 6.30 (s, 1H) ), 6.29 (d, 1H), 5.13 (s, 1H), 3.96 (m, 2H), 3.74 (dd, 1H), 3.62 (dd, 1 Η), 2, 00 (s, 3Η). 19 F NMR (CDCl 3): δ -72.80, -78.47.
etapa F: 4-[5-[3,5-diclorofenil]-2-oxo-5-(trifluorometil)-3-oxazolidinil]-2-metil-N-(2,2.2-trifluoroetil)benzamidaStep F: 4- [5- [3,5-Dichlorophenyl] -2-oxo-5- (trifluoromethyl) -3-oxazolidinyl] -2-methyl-N- (2,2,2-trifluoroethyl) benzamide
Uma calda de 4-[[2-(3,5-diclorofenil)-2-hidróxi-3,3,3-trifluoropropil]amino]-2-metil-N-(2,2,2-trifluoroetil)benzamida (ou seja, o produtoda Etapa E) (0,28 g, 0,57 mmol), 1,1'-carbonildiimidazol (0,15 g, 0,93 mmol) ePS-DMAP (Riley Co., 1,4 mmol/g) (0,085 g, 0,12 mmol) em diclorometano (7ml) foi agitada à temperatura ambiente por cinco horas. Adicionou-se mais 1,1'-carbonildiimidazol (0,05 g, 0,31 mmol). Após agitação por 22 horas, adicionou-se mais 1,1'-carbonildiimiazol (0,047 g, 0,28 mmol) e PS-DMAP (0,10 g, 0,14mmol). Após agitação por quatro horas, a mistura de reação foi concentradasob pressão reduzida e o resíduo resultante foi dissolvido em acetato de etila(60 ml), lavado com água (3 χ 30 ml), filtrado através de um cartucho ChemElut cheio com terra diatomácea (fabricado pela Varian) e concentrado sobpressão reduzida para gerar um sólido. O sólido bruto foi purificado por meio decromatografia de sílica gel sob média pressão utilizando acetato de etila ehexanos (2:3) como eluente para fornecer o produto título, composto de acordocom a presente invenção, na forma de sólido esbranquiçado (0,20 g).4 - [[2- (3,5-Dichlorophenyl) -2-hydroxy-3,3,3-trifluoropropyl] amino] -2-methyl-N- (2,2,2-trifluoroethyl) benzamide (or the product of Step E) (0.28 g, 0.57 mmol), 1,1'-carbonyldiimidazole (0.15 g, 0.93 mmol) and PS-DMAP (Riley Co., 1.4 mmol / g ) (0.085 g, 0.12 mmol) in dichloromethane (7 mL) was stirred at room temperature for five hours. Additional 1,1'-carbonyldiimidazole (0.05 g, 0.31 mmol) was added. After stirring for 22 hours, additional 1,1'-carbonyldiimiazole (0.047 g, 0.28 mmol) and PS-DMAP (0.10 g, 0.14 mmol) were added. After stirring for four hours, the reaction mixture was concentrated under reduced pressure and the resulting residue was dissolved in ethyl acetate (60 mL), washed with water (3 x 30 mL), filtered through a ChemElut cartridge filled with diatomaceous earth ( manufactured by Varian) and concentrated under reduced pressure to generate a solid. The crude solid was purified by medium pressure silica gel chromatography using ethyl acetate and hexanes (2: 3) as eluent to afford the title product, compound according to the present invention, as an off-white solid (0.20 g). .
NMR 1H (CDCI3): δ 7,48 (m, 3H), 7,41 (d, 1H), 7,37 (d, 1H), 7,31(s, 1H), 6,38 (br s, 1H), 4,62 (d, 1H), 4,30 (d, 1H), 4,07 (m, 2H), 2,43 (s, 3H).NMR 19F (CDCI3): δ-72,79, -81,57.1H NMR (CDCl3): δ 7.48 (m, 3H), 7.41 (d, 1H), 7.37 (d, 1H), 7.31 (s, 1H), 6.38 (br s, 1H), 4.62 (d, 1H), 4.30 (d, 1H), 4.07 (m, 2H), 2.43 (s, 3H). 19 F NMR (CDCl3): δ-72.79 , -81.57.
Exemplo 2Example 2
Preparação de 4-r5-(3.5-diclorofenil)-2-0x0-5-(trifluorometil)-3-oxazolidinill-2-metil-N-(2-piridinilmetil)benzamidaPreparation of 4- (5- (3,5-dichlorophenyl) -2-0x0-5- (trifluoromethyl) -3-oxazolidinyl-2-methyl-N- (2-pyridinylmethyl) benzamide
Etapa A: preparação de 4-(acetilamino)-2-metil-N-(2-piridinilmetiübenzamidaStep A: Preparation of 4- (acetylamino) -2-methyl-N- (2-pyridinylmethyl) benzamide
Uma mistura de ácido 4-(acetilamino)-2-metilbenzóico (5,0 g, 25,9mmol), 2-piridinometanamina (2,94 g, 2,8 ml, 27,2 mmol) e monocloridrato deN'-íetilcarbonimidoiO-N.N-dimetil-1,3-ropanodiamina (5,2 g, 27,1 mmol) emdiclorometano (250 ml) foi agitada à temperatura ambiente por uma noite.Adicionou-se água em seguida à mistura de reação e as duas camadasresultantes foram separadas. A camada de diclorometano foi passada atravésde um cartucho Chem Elut cheio com terra diatomácea (fabricado pela Varian)e concentrado sob pressão reduzida. O óleo âmbar resultante foi triturado comdiclorometano, cloreto de π-butila e hexanos para fornecer o composto título naforma de sólido amarelo claro (5,5 g).A mixture of 4- (acetylamino) -2-methylbenzoic acid (5.0 g, 25.9 mmol), 2-pyridinomethanamine (2.94 g, 2.8 mL, 27.2 mmol) and N'-ethylcarbonimidoyl monohydrochloride NN-dimethyl-1,3-ropanediamine (5.2 g, 27.1 mmol) in dichloromethane (250 mL) was stirred at room temperature overnight. Water was then added to the reaction mixture and the two resulting layers were separated. . The dichloromethane layer was passed through a Chem Elut cartridge filled with diatomaceous earth (manufactured by Varian) and concentrated under reduced pressure. The resulting amber oil was triturated with dichloromethane, π-butyl chloride and hexanes to afford the title compound as a pale yellow solid (5.5 g).
NMR 1H (CDCI3) δ 8,53 (d, 1H), 7,92 (br s, 1H), 7,69 (m, 1H),7,42-7,16 (m, 6H), 4,72 (d, 2H), 2,42 (s, 3H), 2,15 (s, 3H).1H NMR (CDCl3) δ 8.53 (d, 1H), 7.92 (br s, 1H), 7.69 (m, 1H), 7.42-7.16 (m, 6H), 4.72 (d, 2H), 2.42 (s, 3H), 2.15 (s, 3H).
Etapa B: preparação de 4-amino-2-metil-N-(2-piridinilmetiübenzamidaStep B: Preparation of 4-Amino-2-methyl-N- (2-pyridinylmethyl) benzamide
Uma mistura de 4-(acetilamino)-2-metil-N-(2-piridinilmetil)benzamida (ou seja, o produto da Etapa A) (5,5 g, 19,4 mmol) eácido clorídrico concentrado (100 ml) foi agitada e aquecida sob refluxo poruma hora. Após resfriamento, adicionou-se gelo e o pH foi ajustado em 10adicionando-se hidróxido de sódio aquoso (50% em peso). A mistura de reaçãofoi filtrada para recolher o precipitado sólido, que foi lavado com água e secopara fornecer o composto título na forma de sólido amarelo claro (4,02 g).A mixture of 4- (acetylamino) -2-methyl-N- (2-pyridinylmethyl) benzamide (i.e. the product of Step A) (5.5 g, 19.4 mmol) and concentrated hydrochloric acid (100 mL) was stirred and heated under reflux for one hour. After cooling, ice was added and the pH adjusted to 10 by adding aqueous sodium hydroxide (50 wt%). The reaction mixture was filtered to collect the solid precipitate, which was washed with water and dried to afford the title compound as a light yellow solid (4.02 g).
NMR 1H (DMSO-cfe) δ 8,49 (d, 1H), 8,41 (br s, 1H), 7,76 (m, 1H),7,31 (d, 1H), 7,22-7,27 (m, 2H), 6,36-6,40 (m, 2H), 5,36 (s, 2H), 4,47 (s, 2H),2,28 (s, 3H).1H NMR (DMSO-cfe) δ 8.49 (d, 1H), 8.41 (br s, 1H), 7.76 (m, 1H), 7.31 (d, 1H), 7.22-7 , 27 (m, 2H), 6.36-6.40 (m, 2H), 5.36 (s, 2H), 4.47 (s, 2H), 2.28 (s, 3H).
Etapa C: preparação de 4-rr2-(3,5-diclorofenil)-2-HiDRÓxi-3,3.3-trifluoropropillaminol-2-metil-A/-(2-plrldinilmetil)benzamidaStep C: Preparation of 4-R 2 - (3,5-Dichlorophenyl) -2-Hydroxy-3,3,3-trifluoropropylaminol-2-methyl-A / - (2-pyrrhenylmethyl) benzamide
Uma solução de 2-(3,5-diclorofenil)-2-(trifluorometil)oxirano (ouseja, o produto do Exemplo 1, Etapa D) (0,75 g) e 4-amino-2-metil-/\/-(2-piridinilmetil)benzamida (ou seja, o produto da Etapa B) (0,39 g, 1,7 mmol) emetanol anidro (6 ml) foi aquecida a 65 0C por setenta horas. A mistura de reaçãofoi concentrada sob pressão reduzida e o resíduo foi purificado por meio decromatografia de sílica gel sob média pressão utilizando acetato de etila ehexanos (6:8) como eluente para fornecer o composto título na forma de sólidovítreo esbranquiçado (0,28 g).A solution of 2- (3,5-dichlorophenyl) -2- (trifluoromethyl) oxirane (i.e. the product of Example 1, Step D) (0.75 g) and 4-amino-2-methyl - / - (2-pyridinylmethyl) benzamide (i.e. the product of Step B) (0.39 g, 1.7 mmol) in anhydrous ethanol (6 mL) was heated at 65 ° C for seventy hours. The reaction mixture was concentrated under reduced pressure and the residue was purified by medium pressure silica gel chromatography using ethyl acetate and hexanes (6: 8) as eluent to afford the title compound as off-white solid (0.28 g). .
NMR 1H (CDCI3): δ 8,50 (d, 1H), 7,70 (t, 1H), 7,52 (s, 2H), 7,40 (s,1H), 7,31 (m, 2H), 7,21 (m, 1H), 7,08 (brt, 1H), 6,37 (s, 1H), 6,36 (d, 1H), 5,02(br s, 1H), 4,68 (d, 2H), 3,88 (t, 1H), 3,81 (dd, 1H), 3,61 (dd, 1H), 2,39 (s, 3H).NMR 19F (CDCI3): δ -78,43.1H NMR (CDCl3): δ 8.50 (d, 1H), 7.70 (t, 1H), 7.52 (s, 2H), 7.40 (s, 1H), 7.31 (m, 2H ), 7.21 (m, 1H), 7.08 (brt, 1H), 6.37 (s, 1H), 6.36 (d, 1H), 5.02 (br s, 1H), 4, 68 (d, 2H), 3.88 (t, 1H), 3.81 (dd, 1H), 3.61 (dd, 1H), 2.39 (s, 3H). 19M NMR (CDCl3): δ -78.43.
Etapa D: preparação de 4-[5-(3,5-DICLOROFENIL)-2-οxο-5-(TRIFLUROMETIL)-3-oxazolidinil-2-metil-N-(2-PIRIDINILMETIL)benzamida.Step D: Preparation of 4- [5- (3,5-Dichlorophenyl) -2-οxο-5- (TRIFLUROMETILE) -3-oxazolidinyl-2-methyl-N- (2-pyridinylmethyl) benzamide.
4-[[2-(3,5-Diclorofenil)-2-hidróxi-3,3,3-trifluoropropil]amino-2-metil-N-(2-piridinilmetil)benzamida (ou seja, o produto da Etapa C) (0,21 g, 0,42mmol), 1,1 '-carbonildiimidazol (0,13 g, 0,79 mmol), PS-DMAP (Riley Co., 0,065g, 0,12 mmol) e diclorometano (7 ml) foram combinados e agitados àtemperatura ambiente por cinco horas. Adicionou-se mais 1,1'-carbonildiimidazol (0,05 g, 0,31 mmol). Após agitação por 22 horas, adicionou-se mais 1,1'-carbonildiimidazol (0,15 g, 0,92 mmol) e PS-DMAP (0,31 g, 0,43mmol). Após agitação por 24 horas, a mistura de reação foi concentrada sobpressão reduzida e purificada por meio de cromatografia de sílica gel sobmédia pressão utilizando acetato de etila e hexanos (6:8) como eluente parafornecer o produto título, um composto de acordo com a presente invenção, naforma de sólido vítreo esbranquiçado (0,20 g).4 - [[2- (3,5-Dichlorophenyl) -2-hydroxy-3,3,3-trifluoropropyl] amino-2-methyl-N- (2-pyridinylmethyl) benzamide (i.e. the product of Step C) (0.21 g, 0.42 mmol), 1,1'-carbonyldiimidazole (0.13 g, 0.79 mmol), PS-DMAP (Riley Co., 0.065g, 0.12 mmol) and dichloromethane (7 mL ) were combined and stirred at room temperature for five hours. Additional 1,1'-carbonyldiimidazole (0.05 g, 0.31 mmol) was added. After stirring for 22 hours, additional 1,1'-carbonyldiimidazole (0.15 g, 0.92 mmol) and PS-DMAP (0.31 g, 0.43 mmol) were added. After stirring for 24 hours, the reaction mixture was concentrated under reduced pressure and purified by medium pressure silica gel chromatography using ethyl acetate and hexanes (6: 8) as eluent to provide the title product, a compound according to the present. invention as an off-white glassy solid (0.20 g).
NMR 1H (CDCI3): δ 8,52 (d, 1H), 7,71 (t, 1H), 7,54-7,20 (m,9H), 4,73 (d, 2H), 4,63 (d, 1H), 4,30 (d, 1H), 2,51 (s, 3H). NMR 19F (CDCI3):δ-81,52.1H NMR (CDCl3): δ 8.52 (d, 1H), 7.71 (t, 1H), 7.54-7.20 (m, 9H), 4.73 (d, 2H), 4.63 (d, 1H), 4.30 (d, 1H), 2.51 (s, 3H). 19 F NMR (CDCl 3): δ-81.52.
Exemplo 3Example 3
Preparação de 4-Γ5-(3,5-diclorofeniü-2-óxido-5-(trifluorometil)-1,2,3-oxatiazolidin-3-IL]-2-metil-N-(2-piridinilmetil)benzamidaPreparation of 4--5- (3,5-dichlorophenyl-2-oxide-5- (trifluoromethyl) -1,2,3-oxathiazolidin-3-IL] -2-methyl-N- (2-pyridinylmethyl) benzamide
A uma solução agitada de 4-[[2-(3,5-diclorofenil)-2-hidróxi-3,3,3-trifluoro-propil]amino]-2-metil-N-(2-piridinilmetil)benzamida (ou seja, o produtodo Exemplo 2, Etapa C) (0,11 g, 0,22 mmol), trietilamina (0,096 g, 0,95 mmol) e4-(dimetilamino)piridina (0,022 g, 0,018 mmol) em diclorometano (2 ml),adicionou-se cloreto de tionila (0,043 g, 0,36 mmol) em gotas. Após agitaçãopor uma hora à temperatura ambiente, adicionou-se mais cloreto de tionila(0,026 g, 0,22 mmol). Após agitação por mais uma hora, a mistura de reaçãofoi concentrada sob pressão reduzida e o produto bruto foi purificado por meiode cromatografia de sílica gel sob média pressão utilizando acetato de etila ehexanos (3:6) como eluente para fornecer o produto título (mistura 1:1 dediaestereoisômeros), um composto de acordo com a presente invenção, naforma de sólido esbranquiçado (0,04 g).To a stirred solution of 4 - [[2- (3,5-dichlorophenyl) -2-hydroxy-3,3,3-trifluoro-propyl] amino] -2-methyl-N- (2-pyridinylmethyl) benzamide (or Example 2, Step C) (0.11 g, 0.22 mmol), triethylamine (0.096 g, 0.95 mmol) and 4- (dimethylamino) pyridine (0.022 g, 0.018 mmol) in dichloromethane (2 mL ), thionyl chloride (0.043 g, 0.36 mmol) was added dropwise. After stirring for one hour at room temperature, more thionyl chloride (0.026 g, 0.22 mmol) was added. After stirring for a further hour, the reaction mixture was concentrated under reduced pressure and the crude product was purified by medium pressure silica gel chromatography using ethyl acetate and hexanes (3: 6) as eluent to afford the title product (mixture 1 : 1 of stereoisomers), a compound according to the present invention, as an off-white solid (0.04 g).
NMR 1H (CDCI3) δ 8,50 (m, 1H), 7,69 (brt, 1H), 7,49 (m, 4H), 7,33(m, 1H), 7,22 (m, 2H), 6,93 (m, 2H), 4,73 (d, 1H), 4,41 (d, 1H), 4,70 (d, 0,5H),4,56 (d, 0,5H), 4,38 (d, 0,5H), 4,20 (d, 0,5H), 2,50 (s, 1,5H), 2,47 (s, 1,5H).NMR 19F (CDCI3): δ -76,31, -79,67.1H NMR (CDCl3) δ 8.50 (m, 1H), 7.69 (brt, 1H), 7.49 (m, 4H), 7.33 (m, 1H), 7.22 (m, 2H) , 6.93 (m, 2H), 4.73 (d, 1H), 4.41 (d, 1H), 4.70 (d, 0.5H), 4.56 (d, 0.5H), 4.38 (d, 0.5H), 4.20 (d, 0.5H), 2.50 (s, 1.5H), 2.47 (s, 1.5H). 19 F NMR (CDCl3): δ -76.31, -79.67.
Exemplo 4Example 4
PREPARAÇÃO DE 2-NiTR0-5-r2-0X0-5-FENiL-5-(TRiFLU0RQMETiL)-3-OXAZOLIDINILlBENZONITRILAPREPARATION OF 2-NiTR0-5-r2-0X0-5-FENiL-5- (TRiFLU0RQMETiL) -3-OXAZOLIDINYLBENZONITRIL
Etapa A: preparação de 5-fenil-5-(trifluorometil)-2-oxazolidinqnaStep A: Preparation of 5-phenyl-5- (trifluoromethyl) -2-oxazolidine
A uma solução fria (abaixo de 20 °C) de tetraidroaluminato delítio (10,0 ml, solução de 1,0 M em dietil éter), adicionou-se uma solução dea-hidróxi-a-(trifluorometil)benzenoacetonitrila (Aldrich, 2,01 g, 10,0 mmol)em dietil éter anidro (10 ml). A suspensão resultante foi agitada àtemperatura ambiente por três horas. À mistura de reação, adicionou-seseqüencialmente água (0,38 ml), solução aquosa de hidróxido de sódio(15% em peso, 0,38 ml) e mais água (1,14 ml). A mistura de reação foifiltrada através de uma frita de vidro e o filtrado foi concentrado sobpressão reduzida para gerar um sólido branco (1,89 g). O sólido branco(1,23 g, 6,0 mmol) foi dissolvido em diclorometano (15 ml) e adicionado auma solução aquosa saturada agitada de hidrogênio carbonato de sódio(15 ml). Em seguida, adicionou-se em gotas uma solução de trifosgenecarbonato de (bis) triclorometila (0,63 g, 2,17 mmol) em diclorometano porvários minutos. A mistura de reação foi agitada à temperatura ambiente poruma hora. As fases de solvente foram separadas e a fase orgânica foilavada com água, 1 N ácido clorídrico aquoso e solução aquosa saturadade cloreto de sódio. Os extratos orgânicos foram secos (MgSO4)1 filtrados eo solvente foi concentrado sob pressão reduzida para fornecer o compostotítulo na forma de sólido branco (1,35 g).To a cold solution (below 20 ° C) of tetrahydroaluminate delithium (10.0 ml, 1.0 M solution in diethyl ether) was added a solution of deahydroxy-α- (trifluoromethyl) benzeneacetonitrile (Aldrich, 2 0.1 g, 10.0 mmol) in anhydrous diethyl ether (10 mL). The resulting suspension was stirred at room temperature for three hours. To the reaction mixture was subsequently added water (0.38 ml), aqueous sodium hydroxide solution (15 wt%, 0.38 ml) and more water (1.14 ml). The reaction mixture was filtered through a glass frit and the filtrate was concentrated under reduced pressure to give a white solid (1.89 g). The white solid (1.23 g, 6.0 mmol) was dissolved in dichloromethane (15 mL) and added to a stirred saturated aqueous sodium hydrogen carbonate solution (15 mL). Then a solution of (bis) trichloromethyl triphosgenecarbonate (0.63 g, 2.17 mmol) in dichloromethane was added dropwise over several minutes. The reaction mixture was stirred at room temperature for one hour. The solvent phases were separated and the organic phase was washed with water, 1 N aqueous hydrochloric acid and saturated aqueous sodium chloride solution. The organic extracts were dried (MgSO 4), filtered and the solvent was concentrated under reduced pressure to afford the compound as a white solid (1.35 g).
NMR 1H (CDCI3) δ 7,5-7,4 (m, 5H), 5,95 (br s, 1H), 4,26 (d, 1H),3,93 (d, 1H).1H NMR (CDCl3) δ 7.5-7.4 (m, 5H), 5.95 (br s, 1H), 4.26 (d, 1H), 3.93 (d, 1H).
ETAPA B: PREPARAÇÃO DE 2-NITRO-5-r2<>XO-5-FENIL-5-(TRIFLUOROMETIL)-3-OXAZOLIDINILlBENZONITRILA.STEP B: PREPARATION OF 2-NITRO-5-R2 <> XO-5-PHENYL-5- (TRIFLUOROMETILE) -3-OXAZOLIDINYLBENZONITRIL.
A uma solução agitada de 5-fenil-5-(trifluorometil)-2-oxazolidinona(ou seja, o produto da Etapa A) (0,97 g, 4,2 mmol) em /V,A/-dimetilformamida(20 ml) sob atmosfera de nitrogênio, adicionou-se hidreto de sódio em umaparcela (60%, 0,21 g, 5,2 mmol). Após 0,33 horas, adicionou-se 5-cloro-2-nitrobenzonitrila (1,15 g, 6,3 mmol) à mistura de reação. A mistura de reação foiagitada por dezesseis horas, diluída com água e extraída com éter (100 ml) eacetato de etila (100 ml). Os extratos orgânicos combinados foram lavados comágua (4 χ 75 ml), secos (MgSO4), filtrados e concentrados sob pressãoreduzida para gerar um sólido, que foi purificado por meio de cromatografia desílica gel e de trituração com 20% éter/hexanos para gerar o produto título, umcomposto de acordo com a presente invenção, na forma de sólido branco(0,235 g).To a stirred solution of 5-phenyl-5- (trifluoromethyl) -2-oxazolidinone (i.e. the product of Step A) (0.97 g, 4.2 mmol) in t / V, Î ± -dimethylformamide (20 ml ) under nitrogen atmosphere, sodium hydride was added in one portion (60%, 0.21 g, 5.2 mmol). After 0.33 hours, 5-chloro-2-nitrobenzonitrile (1.15 g, 6.3 mmol) was added to the reaction mixture. The reaction mixture was stirred for sixteen hours, diluted with water and extracted with ether (100 ml) and ethyl acetate (100 ml). The combined organic extracts were washed with water (4 χ 75 ml), dried (MgSO4), filtered and concentrated under reduced pressure to give a solid, which was purified by silica gel chromatography and trituration with 20% ether / hexanes to give the title compound. title product, a compound according to the present invention, as a white solid (0.235 g).
NMR 1H (CDCI3) δ 8,4 (m, 1H), 8,1 (m, 1H), 8,07 (s, 1H), 7,6-7,45(m, 5H), 4,75 (d, 1H), 4,41 (d, 1H).Exemplo 5PREPERACAO 4-[4-(3,5-DICLOROFENIL)-2-OXO-4-(TRIFLUOROMETIL)-1-IMIDAZOLIDINIL]-2-METIL-N-(2-PIRIDINILMETIL)BENZAMIDA1H NMR (CDCl3) δ 8.4 (m, 1H), 8.1 (m, 1H), 8.07 (s, 1H), 7.6-7.45 (m, 5H), 4.75 ( d, 1H), 4.41 (d, 1H). Example 5 PREPARATION 4- [4- (3,5-Dichlorophenyl) -2-oxo-4- (trifluoromethyl) -1-imidazolidinyl] -2-methyl-N- (2-PYRIDINYLMETHYL) BENZAMIDE
Etapa A: PREPERACAO DE ETIL ESTER DE 3,3,3-TRIFLUORO-2-HIDROXI-N-[FENILMETÓXl)CARBQNIL]ALANINAStep A: PREPARATION FOR 3,3,3-TRIFLUORO-2-HYDROXY-N- [PHENYLMETOXY) CARBONYL] ALANINE ESTER
Uma solução de etil éster de ácido 3,3,3-trifluoro-2-oxo-propiônico(Alfa Chem. Co., 12,0 g, 70,6 mmol) e carbamato de benzila (9,78 g, 64,8mmol) em cloreto de metileno (55 ml) foi agitada por 66 horas à temperaturaambiente sob nitrogênio. O solvente foi removido sob pressão reduzida.Adicionou-se hexano (100 ml) à mistura bruta e a calda resultante foi mantidaem repouso por uma noite. O sólido foi recolhido por meio de filtragem a vácuo,lavado com hexano e seco com ar para fornecer o composto título na forma desólido branco (20,4 g).A solution of 3,3,3-trifluoro-2-oxo-propionic acid ethyl ester (Alfa Chem. Co., 12.0 g, 70.6 mmol) and benzyl carbamate (9.78 g, 64.8 mmol ) in methylene chloride (55 ml) was stirred for 66 hours at room temperature under nitrogen. The solvent was removed under reduced pressure. Hexane (100 ml) was added to the crude mixture and the resulting slurry was allowed to stand overnight. The solid was collected by vacuum filtration, washed with hexane and air dried to provide the title compound as white solid (20.4 g).
NMR 1H (CDCI3) δ 7,35 (m, 5H), 5,98 (s, 1H), 5,35 (s, 1H), 5,23 (s,2H), 4,36 (m, 2H), 1,30 (t, 3H).1H NMR (CDCl3) δ 7.35 (m, 5H), 5.98 (s, 1H), 5.35 (s, 1H), 5.23 (s, 2H), 4.36 (m, 2H) 1.30 (t, 3H).
Etapa B: preparação de 3,3.3-trifluoro-2-Step B: Preparation of 3,3,3-trifluoro-2-
rr(FENILMETÓXl)CARBONILllMINQlPROPANOATO DE ETILArr (PHENYLMETOXY) ETHYL CARBONYLLINMINQROPANOATE
A uma solução de etil éster de 3,3,3-trifluoro-2-hidróxi-A/-[(fenilmetóxi)carbonil]alanina (ou seja, o produto da Etapa A) (15,4 g, 48 mmol)e piridina (7,9 g, 50 mmol) em dietil éter anidro (200 ml) em temperatura debanho de gelo, adicionou-se anidrido trifluoroacético (10,75 g, 51,1 mmol) emgotas. A calda resultante foi aquecida à temperatura ambiente e agitada poruma hora e meia. A mistura de reação foi filtrada para remover um sólidobranco. O filtrado foi concentrado a vácuo para gerar uma calda. Adicionou-sehexano (150 ml) à calda, que foi novamente filtrada para remover um sólidobranco. O filtrado foi concentrado a vácuo para gerar o produto título na formade óleo incolor (14,2 g).To a solution of 3,3,3-trifluoro-2-hydroxy-A / - [(phenylmethoxy) carbonyl] alanine ethyl ester (i.e. the product of Step A) (15.4 g, 48 mmol) and pyridine (7.9 g, 50 mmol) in anhydrous diethyl ether (200 mL) at ice temperature, trifluoroacetic anhydride (10.75 g, 51.1 mmol) was added in stock. The resulting syrup was warmed to room temperature and stirred for an hour and a half. The reaction mixture was filtered to remove a white solid. The filtrate was concentrated in vacuo to give a slurry. Hexane (150 mL) was added to the syrup, which was filtered again to remove a white solid. The filtrate was concentrated in vacuo to afford the title product as colorless oil (14.2g).
NMR 1H (CDCI3): δ 7,41 (m, 5H), 5,33 (s, 2H), 4,31 (q, 2H), 1,30 (t,3Η).1H-NMR (CDCl3): δ 7.41 (m, 5H), 5.33 (s, 2H), 4.31 (q, 2H), 1.30 (t, 3Η).
Etapa C: PREPARAÇÃO DE 3.5-DICLORO-α-[[(FENILMETÓXl)CARBONILlAMINOl-α-Step C: PREPARATION OF 3,5-DICHLOR-α - [[(PHENYLMETOX1) CARBONYLAMINOl-α-
(TRIFLUOROMETIL)BENZENOACETATO DE ETILA.(TRIFLUOROMETIL) ETHYL BENZENOACTATE.
A uma solução de 3,3,3-trifluoro-2-[[(fenilmetóxi)carbonil]imino]propanoato de etila (ou seja, o produto da Etapa B)(7,36 g, 24,3 mmol) em tetraidrofuran anidro (10 ml), resfriada com um banhode gelo seco, adicionou-se uma solução de brometo de 3,5-diclorofenilmagnésio (Aldrich Chem. Co., 0,5 M em tetraidrofuran, 50 ml, 25 mmol) por 45minutos. A mistura de reação opaca foi agitada por uma hora e aquecida emseguida à temperatura ambiente. A essa solução amarela, adicionou-se 1 Nácido clorídrico (37 ml). O volume do tetraidrofuran foi removido a vácuo. Oresíduo foi repartido entre acetato de etila (170 ml) e água (100 ml). A camadaaquosa foi extraída com acetato de etila (50 ml). As camadas orgânicascombinadas foram filtradas através de um cartucho Chem Elut cheio com terradiatomácea (fabricado pela Varian) e concentradas sob pressão reduzida paragerar o composto título na forma de óleo amarelo (11,1 g).To a solution of ethyl 3,3,3-trifluoro-2 - [[(phenylmethoxy) carbonyl] imino] propanoate (i.e. the product of Step B) (7.36 g, 24.3 mmol) in anhydrous tetrahydrofuran (10 ml), cooled with a dry ice bath, was added a solution of 3,5-dichlorophenyl magnesium bromide (Aldrich Chem. Co., 0.5 M in tetrahydrofuran, 50 ml, 25 mmol) over 45 minutes. The opaque reaction mixture was stirred for one hour and then warmed to room temperature. To this yellow solution was added 1 hydrochloric acid (37 ml). The volume of tetrahydrofuran was removed in vacuo. The residue was partitioned between ethyl acetate (170 mL) and water (100 mL). The aqueous layer was extracted with ethyl acetate (50 mL). The combined organic layers were filtered through a Terradiatom-filled Chem Elut cartridge (manufactured by Varian) and concentrated under reduced pressure to give the title compound as yellow oil (11.1 g).
NMR 1H (CDCI3): δ 7,34 (m, 8H), 6,10 (s, 1H), 5,07 (s, 2H), 4,28(m, 2H), 1,21 (t, 3H). NMR 19F (CDCI3): δ-71,03.1H NMR (CDCl3): δ 7.34 (m, 8H), 6.10 (s, 1H), 5.07 (s, 2H), 4.28 (m, 2H), 1.21 (t, 3H ). 19 F NMR (CDCl 3): δ-71.03.
Etapa D: PREPARACAO DE 4-[4-(3,5-DICLOROFENIL-)-2,5-DIOXO-4-(TRIFLUOROMETIL)-1-IMIDAZOLIDINIL-2-METIL-N-(2-PIRIDINILMETIL)BENZAMIDAStep D: Preparation of 4- [4- (3,5-Dichlorophenyl -) - 2,5-Dioxo-4- (trifluoromethyl) -1-imidazolidinyl-2-methyl-N- (2-pyridinylmethyl) benzamide
Uma solução de 3,5-dicloro-α-[[(fenilmetóxi)carbonil]amino]-α-(trifluorometil)benzenoacetato de etila (ou seja, o produto da Etapa C) (1,11 g, 2,5mmol), 4-amino-2-metil-N-(2-piridinilmetil)benzamida (ou seja, o produto da Etapa Bdo Exemplo 2) (0,474 g, 1,95 mmol), 4-(dimetilamino)piridina (68 mg, 0,55 mmol)em N-metil-2-pirrolidinona (NMP) foi aquecida a 200 °C por meio de irradiação demicroondas por 350 segundos. Outra condução foi realizada com 0,99 g do produtoda etapa C, 0,44 g do produto da Etapa B do Exemplo 2 e 71 mg de 4-dimetilaminopiridina em NMP (2 ml) sob as mesmas condições. As misturas dereação das duas conduções foram combinadas e diluídas com acetato de etila (100ml), lavadas com água (3 χ 50 ml), filtradas através de um cartucho Chem Elut cheiocom terra diatomácea (fabricado pela Varian) e concentradas sob pressão reduzidapara gerar um óleo escuro. Este foi purificado por meio de cromatografia de sílicagel sob média pressão utilizando acetato de etila e hexanos (45% - 85%) comoeluente para gerar o composto título na forma de sólido marrom (0,84 g).A solution of ethyl 3,5-dichloro-α - [[(phenylmethoxy) carbonyl] amino] -α- (trifluoromethyl) benzeneacetate (i.e. the product of Step C) (1.11 g, 2.5mmol), 4-amino-2-methyl-N- (2-pyridinylmethyl) benzamide (i.e. the product of Step B of Example 2) (0.474 g, 1.95 mmol), 4- (dimethylamino) pyridine (68 mg, 0, 55 mmol) in N-methyl-2-pyrrolidinone (NMP) was heated to 200 ° C by demicrowave irradiation for 350 seconds. Another conduction was performed with 0.99 g of the product of step C, 0.44 g of the product of Step B of Example 2 and 71 mg of 4-dimethylaminopyridine in NMP (2 ml) under the same conditions. The mixtures of the two conductions were combined and diluted with ethyl acetate (100ml), washed with water (3 χ 50ml), filtered through a Chem Elut filled with diatomaceous earth cartridge (manufactured by Varian) and concentrated under reduced pressure to generate a dark oil. This was purified by medium pressure silica gel chromatography using ethyl acetate and hexanes (45% - 85%) as eluent to give the title compound as a brown solid (0.84 g).
NMR 1H (DMSO-Cf6): δ 10,65 (s, 1H), 8,99 (t, 1H), 8,52 (d, 1H),7,89 (br s, 3H), 7,80 (dt, 1H), 7,54 (d, 1H), 7,39 (d, 1H), 7,32-7,27 (m, 3H), 4,54(d, 2H), 2,39 (s, 3H).1H NMR (DMSO-C6): δ 10.65 (s, 1H), 8.99 (t, 1H), 8.52 (d, 1H), 7.89 (br s, 3H), 7.80 ( dt, 1H), 7.54 (d, 1H), 7.39 (d, 1H), 7.32-7.27 (m, 3H), 4.54 (d, 2H), 2.39 (s , 3H).
Etapa E: preparação de 4-r4-(3.5-diclorofenil)-5-hidróxi-2-qxo-4-(trifluorometil)-1-imidazolidinil1-2-metil-/v-(2-piridinilmetil)benzamidaStep E: Preparation of 4- (4- (3,5-dichlorophenyl) -5-hydroxy-2-oxo-4- (trifluoromethyl) -1-imidazolidinyl-2-methyl- / v- (2-pyridinylmethyl) benzamide
A uma calda de 4-[4-(3,5-diclorofenil)-2,5-dioxo-4-(trifluorometil)-1-imidazolidinil]-2-metil-N-(2-piridinilmetil)benzamida (ou seja, o produto da EtapaD) (0,66 g, 1,23 mmol) em metanol (18 ml) em temperatura de banho de gelo,adicionou-se boroidreto de sódio (0,275 g, 7,3 mmol) em pequenas bateladaspor três minutos. A solução laranja resultante foi agitada à temperaturaambiente por dezoito horas. O solvente foi removido a vácuo e o resíduo foirepartido entre acetato de etila (50 ml) e água (50 ml). A camada aquosa foiextraída com acetato de etila (35 ml). As camadas orgânicas combinadas foramfiltradas através de um cartucho Chem Elut cheio com terra diatomácea(fabricado pela Varian) e concentradas sob pressão reduzida para gerar ocomposto título na forma de sólido marrom (0,59 g).To a 4- [4- (3,5-dichlorophenyl) -2,5-dioxo-4- (trifluoromethyl) -1-imidazolidinyl] -2-methyl-N- (2-pyridinylmethyl) benzamide (i.e. the product from Step D) (0.66 g, 1.23 mmol) in methanol (18 mL) at ice bath temperature, sodium borohydride (0.275 g, 7.3 mmol) was added in small batches for three minutes. The resulting orange solution was stirred at room temperature for eighteen hours. The solvent was removed in vacuo and the residue partitioned between ethyl acetate (50 mL) and water (50 mL). The aqueous layer was extracted with ethyl acetate (35 mL). The combined organic layers were filtered through a diatomaceous earth filled Chem Elut cartridge (manufactured by Varian) and concentrated under reduced pressure to give the title compound as a brown solid (0.59 g).
NMR 1H (DMSO-qf6): δ 9,17 (s, 1H), 8,78 (t, 1H), 8,52 (d, 1H), 7,79(dt, 1H), 7,75 (t, 1H), 7,61 (m, 3H), 7,52 (d, 1H), 7,45 (d, 1H), 7,37 (d, 1H), 7,27(dd, 1H), 6,91 (d, 1H), 6,12 (d, 1H), 4,52 (d, 2H), 2,39 (s, 3H).1H NMR (DMSO-q6): δ 9.17 (s, 1H), 8.78 (t, 1H), 8.52 (d, 1H), 7.79 (dt, 1H), 7.75 (t , 1H), 7.61 (m, 3H), 7.52 (d, 1H), 7.45 (d, 1H), 7.37 (d, 1H), 7.27 (dd, 1H), 6 , 91 (d, 1H), 6.12 (d, 1H), 4.52 (d, 2H), 2.39 (s, 3H).
Etapa F: preparação de 4-r4-(3,5-diclorofenil)-2-oxo-4-(trifluorometil)-1-imidazolidinil1-2-metil-a/-(2-piridinilmetil)benzamidaStep F: Preparation of 4- (4- (3,5-Dichlorophenyl) -2-oxo-4- (trifluoromethyl) -1-imidazolidinyl-2-methyl-α / (2-pyridinylmethyl) benzamide
A uma solução de 4-[4-(3,5-diclorofenil)-5-hidróxi-2-oxo-4-(trifluorometil)-1-imidazolidinil]-2-metil-A/-(2-piridinilmetil)ben (ou seja, oproduto da Etapa E) (0,18 g, 0,33 mmol) em ácido trifluoroacético (4 ml) sobtemperatura de banho de gelo, adicionou-se boroidreto de sódio (0,10 g, 2,6mmol) em duas bateladas. Após o término da reação vigorosa inicial, a misturade reação foi agitada à temperatura ambiente. Adicionou-se uma bateladaadicional de boroidreto de sódio (0,048 g) após duas horas. A mistura dereação foi agitada por dezoito horas e adicionou-se água (5 ml) em seguida. Amistura de reação foi resfriada com um banho de água e gelo externo e, emseguida, adicionou-se uma solução de hidróxido de sódio (4,1 g de soluçãoaquosa a 50% e 10 ml de água). A mistura de reação foi extraída com acetatode etila (2 χ 25 ml) e as camadas orgânicas combinadas foram filtradas atravésde um cartucho Chem Elut cheio com terra diatomácea (fabricado pela Varian)e concentradas sob pressão reduzida para gerar um sólido em forma de goma.Outra condução foi realizada utilizando 90 mg de produto da Etapa E, 2 ml deácido trifluoroacético e 67 mg de boroidreto de sódio sob condições similares.Os produtos brutos destas duas conduções foram combinados e purificadospor meio de cromatografia de sílica gel sob média pressão utilizando acetato deetila e hexanos (45% - 65%) como eluente para gerar o composto título, umcomposto de acordo com a presente invenção, na forma de sólidoesbranquiçado (0,18 g).To a solution of 4- [4- (3,5-dichlorophenyl) -5-hydroxy-2-oxo-4- (trifluoromethyl) -1-imidazolidinyl] -2-methyl-A / - (2-pyridinylmethyl) ben ( the product from Step E) (0.18 g, 0.33 mmol) in trifluoroacetic acid (4 mL) at ice bath temperature, sodium borohydride (0.10 g, 2.6 mmol) was added in two batches. After completion of the initial vigorous reaction, the reaction mixture was stirred at room temperature. An additional batch of sodium borohydride (0.048 g) was added after two hours. The reaction mixture was stirred for eighteen hours and then water (5 ml) was added thereto. The reaction mixture was cooled with an external ice-water bath and then sodium hydroxide solution (4.1 g of 50% aqueous solution and 10 ml of water) was added. The reaction mixture was extracted with ethyl acetate (2 x 25 ml) and the combined organic layers were filtered through a Chem Elut cartridge filled with diatomaceous earth (manufactured by Varian) and concentrated under reduced pressure to give a gum solid. Another conduction was performed using 90 mg of Step E product, 2 ml of trifluoroacetic acid and 67 mg of sodium borohydride under similar conditions. The crude products of these two conditions were combined and purified by medium pressure silica gel chromatography using ethyl acetate. and hexanes (45% - 65%) as eluent to give the title compound, a compound according to the present invention, as an off-white solid (0.18 g).
NMR 1H (CDCI3): δ 8,51 (d, 1H), 7,70 (dt, 1H), 7,52-7,30 (m, 8H),7,23 (dd, 1H), 6,65 (s, 1H), 4,74 (d, 2H), 4,52 (d, 1H), 4,13 (d, 1H), 2,51 (s, 3H).1H NMR (CDCl3): δ 8.51 (d, 1H), 7.70 (dt, 1H), 7.52-7.30 (m, 8H), 7.23 (dd, 1H), 6.65 (s, 1H), 4.74 (d, 2H), 4.52 (d, 1H), 4.13 (d, 1H), 2.51 (s, 3H).
Exemplo 6Example 6
Preparação de 4-[4-(3.5-diclorofenil)-3-metil-2-qxo-4-(trifluorometil)-1-imidazolidinil1-2-metil-N-(2-piridinilmetil)benzamidaPreparation of 4- [4- (3,5-dichlorophenyl) -3-methyl-2-oxo-4- (trifluoromethyl) -1-imidazolidinyl-2-methyl-N- (2-pyridinylmethyl) benzamide
Etapa A: preparação de 4-[4-(3,5-diclorofenil)-3-meth--2,5-diqxo-4-ometilM-imidazolidinil1-2-metil-N-(2-piridinilmetil)benzamidaStep A: Preparation of 4- [4- (3,5-dichlorophenyl) -3-meth-2,5-dixy-4-methyl-imidazolidinyl-1-2-methyl-N- (2-pyridinylmethyl) benzamide
A uma solução de 4-[4-(3,5-diclorofenil)-2,5-dioxo-4-(trifluorometil)-1-imidazolidinil]-2-metil-A/-(2-piridinilmetil)benzam (ou seja, oproduto da Etapa D do Exemplo 5) (0,39 g, 0,73 mmol) em N,N-dimetilformamida (4 ml), adicionou-se hidreto de sódio (dispersão em óleo a60%, 0,0335 g, 2,3 mmol). Após agitação por quinze minutos, adicionou-seiodometano (0,179 g, 1,26 mmol). A mistura de reação foi agitada por 45minutos e, em seguida, repartida entre acetato de etila (50 ml) e água (25 ml).A camada orgânica foi lavada com água (2 χ 25 ml) e filtrada através de umcartucho Chem Elut cheio com terra diatomácea (fabricado pela Varian) econcentrada sob pressão reduzida para gerar o composto título na forma desólido vítreo (0,39 g).To a solution of 4- [4- (3,5-dichlorophenyl) -2,5-dioxo-4- (trifluoromethyl) -1-imidazolidinyl] -2-methyl-N- (2-pyridinylmethyl) benzam (i.e. (Example D, Step D product) (0.39 g, 0.73 mmol) in N, N-dimethylformamide (4 mL) was added sodium hydride (60% oil dispersion, 0.0335 g, 2 0.3 mmol). After stirring for fifteen minutes, dihydromethane (0.179 g, 1.26 mmol) was added. The reaction mixture was stirred for 45 minutes and then partitioned between ethyl acetate (50 mL) and water (25 mL). The organic layer was washed with water (2 x 25 mL) and filtered through a filled Chem Elut cartridge. with diatomaceous earth (manufactured by Varian) and concentrated under reduced pressure to yield the title compound in vitreous desolate form (0.39 g).
NMR 1H (DMSO-de) δ 9,00 (t, 1H), 8,53 (d, 1H), 7,93 (s, 1H), 7,80(dt, 1H), 7,69 (s, 2H), 7,56 (s, 1H), 7,39 (m, 3H), 7,28 (dd, 1H), 4,56 (d, 2H),3,00 (s, 3H), 2,40 (s, 3H).1H NMR (DMSOd6) δ 9.00 (t, 1H), 8.53 (d, 1H), 7.93 (s, 1H), 7.80 (dt, 1H), 7.69 (s, 2H), 7.56 (s, 1H), 7.39 (m, 3H), 7.28 (dd, 1H), 4.56 (d, 2H), 3.00 (s, 3H), 2, 40 (s, 3H).
Etapa B: preparação de 4-r4-(3,5-diclqrofenil)-5-HiDRÓxi-3-metil-2-oxo-4-(trifluorometil)-1-imidazolidinill-2-metil-yy-(2-piridinilmetil)benzamidaStep B: Preparation of 4- [4- (3,5-dichlophenyl) -5-hydroxy-3-methyl-2-oxo-4- (trifluoromethyl) -1-imidazolidinyl-2-methyl-yy- (2-pyridinylmethyl) benzamide
A uma solução opaca de 4-[4-(3,5-diclorofenil)-3-metil-2,5-dioxo-4-(trifluorometil)-1-imidazolidinil]-2-metil-A/-(2-piridinilmetil)benzamida (ou seja, oproduto da Etapa A) (0,37 g, 0,67 mmol) em metanol (10 ml), adicionou-seboroidreto de sódio (0,167 g, 4,42 mmol) em pequenas bateladas ao longo decinco minutos. Após agitação por 4,5 horas, metanol foi removido a vácuo e oresíduo foi repartido entre acetato de etila (50 ml) e água (50 ml). A camadaaquosa foi extraída com acetato de etila (35 ml) e as camadas orgânicascombinadas foram filtradas através de um cartucho Chem Elut cheio com terradiatomácea (fabricado pela Varian) e concentradas sob pressão reduzida paragerar o composto título na forma de sólido marrom (0,32 g).To an opaque solution of 4- [4- (3,5-dichlorophenyl) -3-methyl-2,5-dioxo-4- (trifluoromethyl) -1-imidazolidinyl] -2-methyl-A / - (2-pyridinylmethyl) ) benzamide (i.e. Step A product) (0.37 g, 0.67 mmol) in methanol (10 mL), sodium borohydride (0.167 g, 4.42 mmol) was added in small batches over five minutes. . After stirring for 4.5 hours, methanol was removed in vacuo and the residue was partitioned between ethyl acetate (50 mL) and water (50 mL). The aqueous layer was extracted with ethyl acetate (35 ml) and the combined organic layers were filtered through a Terradiatom-filled Chem Elut cartridge (manufactured by Varian) and concentrated under reduced pressure to give the title compound as a brown solid (0.32 g).
NMR 1H (DMSO-dg): δ 8,75 (t, 1H), 8,50 (d, 1H), 7,81 (s, 1H), 7,78(dt, 1H), 7,56 (d, 1H), 7,46-7,31 (m, 6H), 7,26 (dd, 1H), 5,81 (d, 1H), 4,51 (d,2H), 2,97 (s, 3H), 2,34 (s, 3H).Etapa C: preparação de 4-[4-(3,5-diclorofeni)-3-metil-2-oxo-4-(trifluorometil)-1-imidazolidinil]-2-metil-N-(2-piridinilmetil)benzamida1H NMR (DMSO-d6): δ 8.75 (t, 1H), 8.50 (d, 1H), 7.81 (s, 1H), 7.78 (dt, 1H), 7.56 (d , 1H), 7.46-7.31 (m, 6H), 7.26 (dd, 1H), 5.81 (d, 1H), 4.51 (d, 2H), 2.97 (s, 3H), 2.34 (s, 3H). Step C: Preparation of 4- [4- (3,5-dichlorophenyl) -3-methyl-2-oxo-4- (trifluoromethyl) -1-imidazolidinyl] -2 -methyl-N- (2-pyridinylmethyl) benzamide
A uma solução de 4-[4-(3,5-diclorofenil)-5-hidróxi-3-metil-2-oxo-4-(trifluorometil)-1-imidazolidinil]-2-metil-N-(2-piridinilmetil)benzamida (ou seja, o produto da Etapa B) (0,25 g, 0,45 mmol) em ácidotrifluoroacético (6 ml), adicionou-se boroidreto de sódio (0,14 g, 3,7 mmol)em bateladas por três minutos. Após agitação por uma hora à temperaturaambiente, agregou-se uma quantidade adicional de boroidreto de sódio(0,104 g, 2,7 mmol). Após agitação por dezoito horas adicionais, adicionou- se água (10 ml). A mistura de reação foi resfriada com um banho de águacom gelo externo e, em seguida, adicionou-se uma solução de hidróxido desódio (6 ml de solução aquosa a 50% e 20 ml de água). A mistura dereação foi extraída com acetato de etila (1 χ 50 ml, 1 χ 35 ml) e ascamadas orgânicas combinadas foram filtradas através de um cartucho Chem Elut cheio com terra diatomácea (fabricado pela Varian) econcentradas sob pressão reduzida para gerar um sólido em forma degoma, que foi purificado por meio de cromatografia de sílica gel sob médiapressão utilizando acetato de etila e hexanos (45% - 65%) como eluentepara fornecer o composto título, composto de acordo com a presente invenção, na forma de sólido branco (0,20 g).To a solution of 4- [4- (3,5-dichlorophenyl) -5-hydroxy-3-methyl-2-oxo-4- (trifluoromethyl) -1-imidazolidinyl] -2-methyl-N- (2-pyridinylmethyl) ) benzamide (i.e. the product of Step B) (0.25 g, 0.45 mmol) in trifluoroacetic acid (6 ml), sodium borohydride (0.14 g, 3.7 mmol) was added in batches by three minutes. After stirring for one hour at room temperature, additional sodium borohydride (0.104 g, 2.7 mmol) was added. After stirring for an additional eighteen hours, water (10 ml) was added. The reaction mixture was cooled with an external ice water bath and then sodium hydroxide solution (6 ml of 50% aqueous solution and 20 ml of water) was added. The reaction mixture was extracted with ethyl acetate (1 x 50 ml, 1 x 35 ml) and the combined organic layers were filtered through a diatom earth-filled Chem Elut cartridge (manufactured by Varian) and concentrated under reduced pressure to give a solid in degome, which was purified by medium pressure silica gel chromatography using ethyl acetate and hexanes (45% - 65%) as eluent to afford the title compound, compound according to the present invention, as a white solid (0 , 20 g).
NMR 1H (CDCI3): δ 8,53 (d, 1H), 7,69 (dt, 1H), 7,51 (d, 1H),7,45 (m, 2H), 7,34 (m, 4H), 7,22 (dd, 1H), 7,13 (br t, 1H), 4,73 (d, 2H), 4,31(d, 1H), 3,83 (d, 1H), 2,90 (s, 3H), 2,51 (s, 3H).1H NMR (CDCl3): δ 8.53 (d, 1H), 7.69 (dt, 1H), 7.51 (d, 1H), 7.45 (m, 2H), 7.34 (m, 4H ), 7.22 (dd, 1H), 7.13 (br t, 1H), 4.73 (d, 2H), 4.31 (d, 1H), 3.83 (d, 1H), 2, 90 (s, 3H), 2.51 (s, 3H).
Por meio dos procedimentos descritos no presente, junto com métodos conhecidos na técnica, podem ser preparados os compostos aseguir das Tabelas 1 a 15. As abreviações a seguir são utilizadas nasTabelas que se seguem: CN indica ciano, NO2 indica nitro, Ph indica fenila,Py indica piridinila, Me indica metila, Et indica etila, i-Pr indica isopropila eOMe indica metóxi. (R2)m, conforme exibido, designa a combinação de(R2)n quando Z é CR2, conforme especificado para a Fórmula 1.By the procedures described herein, together with methods known in the art, the following compounds can be prepared from Tables 1 to 15. The following abbreviations are used in the following Tables: CN indicates cyano, NO2 indicates nitro, Ph indicates phenyl, Py indicates pyridinyl, Me indicates methyl, Et indicates ethyl, Pr indicates isopropyl and MEe indicates methoxy. (R2) m, as shown, means the combination of (R2) n when Z is CR2, as specified for Formula 1.
Tabela 1Table 1
<table>table see original document page 55</column></row><table><table>table see original document page 56</column></row><table><table>table see original document page 57</column></row><table><table>table see original document page 58</column></row><table><table> table see original document page 55 </column> </row> <table> <table> table see original document page 56 </column> </row> <table> <table> table see original document page 57 < / column> </row> <table> <table> table see original document page 58 </column> </row> <table>
Tabela 2Table 2
<table>table see original document page 58</column></row><table><table>table see original document page 59</column></row><table><table>table see original document page 60</column></row><table><table> table see original document page 58 </column> </row> <table> <table> table see original document page 59 </column> </row> <table> <table> table see original document page 60 < / column> </row> <table>
Tabela 3Table 3
<formula>formula see original document page 60</formula><formula> formula see original document page 60 </formula>
<table>table see original document page 60</column></row><table><table>table see original document page 61</column></row><table><table>table see original document page 62</column></row><table><table>table see original document page 63</column></row><table><table>table see original document page 64</column></row><table><table>table see original document page 65</column></row><table><table>table see original document page 66</column></row><table><table> table see original document page 60 </column> </row> <table> <table> table see original document page 61 </column> </row> <table> <table> table see original document page 62 < / column> </row> <table> <table> table see original document page 63 </column> </row> <table> <table> table see original document page 64 </column> </row> <table> <table> table see original document page 65 </column> </row> <table> <table> table see original document page 66 </column> </row> <table>
<formula>formula see original document page 66</formula><formula> formula see original document page 66 </formula>
<table>table see original document page 66</column></row><table><table>table see original document page 67</column></row><table><table> table see original document page 66 </column> </row> <table> <table> table see original document page 67 </column> </row> <table>
Tabela 6Table 6
<table>table see original document page 67</column></row><table><table>table see original document page 68</column></row><table><table>table see original document page 69</column></row><table><table>table see original document page 70</column></row><table><table> table see original document page 67 </column> </row> <table> <table> table see original document page 68 </column> </row> <table> <table> table see original document page 69 < / column> </row> <table> <table> table see original document page 70 </column> </row> <table>
Tabela 8Table 8
<table>table see original document page 70</column></row><table><table>table see original document page 71</column></row><table><table>table see original document page 72</column></row><table><table>table see original document page 73</column></row><table>Tabela 10<table> table see original document page 70 </column> </row> <table> <table> table see original document page 71 </column> </row> <table> <table> table see original document page 72 < / column> </row> <table> <table> table see original document page 73 </column> </row> <table> Table 10
<table>table see original document page 74</column></row><table>Tabela 11<table> table see original document page 74 </column> </row> <table> Table 11
<table>table see original document page 75</column></row><table>Tabela 12<table> table see original document page 75 </column> </row> <table> Table 12
<table>table see original document page 76</column></row><table><table>table see original document page 77</column></row><table><table> table see original document page 76 </column> </row> <table> <table> table see original document page 77 </column> </row> <table>
Tabela 14Table 14
<formula>formula see original document page 77</formula><formula> formula see original document page 77 </formula>
em que m é 1, 2, 3, 4 ou 5.where m is 1, 2, 3, 4 or 5.
<table>table see original document page 77</column></row><table><table>table see original document page 78</column></row><table><table> table see original document page 77 </column> </row> <table> <table> table see original document page 78 </column> </row> <table>
<formula>formula see original document page 78</formula><formula> formula see original document page 78 </formula>
<table>table see original document page 78</column></row><table><table>table see original document page 79</column></row><table><table>table see original document page 80</column></row><table><table> table see original document page 78 </column> </row> <table> <table> table see original document page 79 </column> </row> <table> <table> table see original document page 80 < / column> </row> <table>
Formulação/utilidadeFormulation / utility
Os compostos de acordo com a presente invenção podem sergeralmente utilizados como ingrediente ativo para controle de pragas em umacomposição, ou seja formulação, com um veículo apropriado para usosagronômicos ou não agronômicos que compreende pelo menos um dentre umdiluente líquido, diluente sólido ou tensoativo. Os ingredientes da formulaçãoou composição são selecionados de forma a serem consistentes com aspropriedades físicas do ingrediente ativo, modo de aplicação e fatoresambientais, tais como tipo de solo, umidade e temperatura.The compounds of the present invention may generally be used as an active ingredient for pest control in a composition, i.e. formulation, with a carrier suitable for agronomic or non-agronomic uses comprising at least one of a liquid diluent, solid diluent or surfactant. The formulation or composition ingredients are selected to be consistent with the physical properties of the active ingredient, mode of application and environmental factors such as soil type, humidity and temperature.
As formulações úteis incluem líquidos tais como soluções(incluindo concentrados emulsionáveis), suspensões, emulsões (incluindomicroemulsões e/ou suspoemulsões) e similares, que podem seropcionalmente espessados na forma de géis. Os tipos gerais de composiçõeslíquidas aquosas são concentrados solúveis, concentrados em suspensão,suspensão de cápsulas, emulsão concentrada, microemulsão e suspoemulsão.Os tipos gerais de composições líquidas não aquosas são concentradosemulsionáveis, concentrados microemulsionáveis, concentrados dispersíveis edispersões em óleo.Useful formulations include liquids such as solutions (including emulsifiable concentrates), suspensions, emulsions (including micromemulsions and / or suspoemulsions) and the like, which may optionally be thickened as gels. General types of aqueous liquid compositions are soluble concentrates, suspension concentrates, capsule suspension, concentrated emulsion, microemulsion and suspoemulsion. General types of non-aqueous liquid compositions are emulsifiable concentrates, microemulsifiable concentrates, dispersible concentrates and oil dispersions.
Os tipos gerais de composições sólidas são poeiras, pós,grânulos, pelotas, pílulas, pastilhas, filmes preenchidos (incluindo revestimentode sementes) e similares, que podem ser dispersíveis em água ("molháveis")ou hidrossolúveis. Os filmes e revestimentos formados a partir de soluçõesformadoras de filme ou suspensões fluidas são particularmente úteis para otratamento de sementes. O ingrediente ativo pode ser (micro)encapsulado eadicionalmente moldado em forma de suspensão ou formulação sólida;alternativamente, toda a formulação de ingrediente ativo pode ser encapsulada(ou "sobrerrevestida"). A encapsulação pode controlar ou retardar a liberaçãodo ingrediente ativo. Grânulos emulsionáveis combinam as vantagens de umaformulação de concentrado emulsionável e uma formulação granular seca.Composições de alta resistência podem ser principalmente utilizadas comointermediários para formulação adicional.General types of solid compositions are dust, powders, granules, pellets, pills, tablets, filled films (including seed coating) and the like, which may be water dispersible ("wettable") or water soluble. Films and coatings formed from film forming solutions or fluid suspensions are particularly useful for seed treatment. The active ingredient may be (micro) encapsulated and further molded into a suspension or solid formulation, alternatively the entire active ingredient formulation may be encapsulated (or "overcoated"). Encapsulation may control or delay the release of the active ingredient. Emulsifiable granules combine the advantages of an emulsifiable concentrate formulation and a dry granular formulation. High strength compositions can be mainly used as intermediates for further formulation.
As formulações pulverizáveis são tipicamente estendidas em ummeio apropriado antes da pulverização. Essas formulações líquidas e sólidassão elaboradas para que sejam facilmente diluídas no meio de pulverização,normalmente água. Os volumes de pulverização podem variar de cerca de uma vários milhares de litros por hectare, mas encontram-se mais tipicamente nafaixa de cerca de dez a várias centenas de litros por hectare. Formulaçõespulverizáveis podem ser misturadas em tanque com água ou um outro meioapropriado para tratamento foliar por meio de aplicação terrestre ou aérea, oupara aplicação ao meio de crescimento da planta. Formulações secas elíquidas podem ser medidas diretamente em sistemas de irrigação porgotejamento ou medidas na cova durante o plantio. Formulações líquidas esólidas podem ser aplicadas sobre sementes de safras e outra vegetaçãodesejável como tratamentos de sementes antes do plantio para proteger raízesem desenvolvimento e outras partes de plantas subterrâneas e/ou folhagempor meio de absorção sistêmica.Sprayable formulations are typically extended in an appropriate medium prior to spraying. These liquid and solid formulations are designed to be easily diluted in the spray medium, usually water. Spray volumes may range from about one to several thousand liters per hectare, but are most typically in the range of about ten to several hundred liters per hectare. Sprayable formulations may be mixed in a tank with water or another suitable medium for foliar treatment by terrestrial or aerial application, or for application to plant growth medium. Dry eliquid formulations can be measured directly in drip irrigation systems or measured in the pit during planting. Solid liquid formulations can be applied to crop seeds and other desirable vegetation as pre-planting seed treatments to protect developing roots and other parts of underground plants and / or foliage by systemic absorption.
As formulações conterão tipicamente quantidades eficazes deingrediente ativo, diluente e tensoativo dentro das faixas aproximadas a seguir,que somam 100% em peso.The formulations will typically contain effective amounts of active ingredient, diluent and surfactant within the approximate ranges below, which add up to 100% by weight.
<table>table see original document page 82</column></row><table><table> table see original document page 82 </column> </row> <table>
Diluentes sólidos incluem, por exemplo, argilas tais comobentonita, montmorilonita, atapulgita e caulim, gesso, celulose, dióxido detitânio, óxido de zinco, amido, dextrina, açúcares (tais como Iactose esacarose), sílica, talco, mica, terra diatomácea, uréia, carbonato de cálcio,carbonato e bicarbonato de sódio e sulfato de sódio. Diluentes sólidos típicossão descritos em Watkins et al, Handbook of Insecticide Dust Diluents andCarriers, segunda edição, Dorland Books, Caldwell, Nova Jérsei.Solid diluents include, for example, clays such asobentonite, montmorillonite, attapulgite and kaolin, gypsum, cellulose, detitanium dioxide, zinc oxide, starch, dextrin, sugars (such as lactose esaccharose), silica, talcum, mica, diatomaceous earth, urea , calcium carbonate, sodium carbonate and bicarbonate and sodium sulfate. Typical solid diluents are described in Watkins et al, Handbook of Insecticide Dust Diluents and Carriers, Second Edition, Dorland Books, Caldwell, New Jersey.
Diluentes líquidos incluem, por exemplo, água, N,N-dimetilalcanamidas (tais como N,N-dimetilformamida), limoneno, sulfóxido dedimetila,N-alquilpirrolidonas (tais como N-metilpirrolidinona), etileno glicol,trietileno glicol, propileno glicol, dipropileno glicol, polipropileno glicol, carbonatode propileno, carbonato de butileno, parafinas (tais como óleos mineraisbrancos, parafinas normais, isoparafinas), alquilbenzenos, alquilnaftalenos,glicerina, triacetato de glicerol, sorbitol, triacetina, hidrocarbonetos aromáticos,alifáticos desaromatizados, alquilbenzenos, alquilnaftalenos, cetonas tais comociclohexanona, 2-heptanona, isoforona e 4-hidróxi-4-metil-2-pentanona,acetatos tais como acetato de isoamila, acetato de hexila, acetato de heptila,acetato de octila, acetato de nonila, acetato de tridecila e acetato de isobornila,outros ésteres tais como ésteres de Iactato alquilados, ésteres dibásicos e γ-butirolactona, e alcoóis, que podem ser lineares, ramificados, saturados ouinsaturados, tais como metanol, etanol, n-propanol, álcool isopropílico, n-butanol, álcool isobutílico, n-hexanol, 2-etil hexanol, n-octanol, decanol, álcoolisodecílico, isooctadecanol, álcool cetílico, álcool laurílico, álcool tridecílico,álcool oleílico, ciclohexanol, álcol tetraidrofurfurílico, álcool de diacetona eálcool benzílico. Diluentes líquidos também incluem glicerol ésteres de ácidosgraxos saturados e insaturados (tipicamente C6-C22), tais como óleos de frutase sementes de plantas (por exemplo, óleos de oliva, mamona, linhaça,gergelim, milho, amendoim, girassol, semente de uva, açafrão, semente dealgodão, soja, colza, coco e semente de palma), gorduras de fontes animais(tais como sebo de boi, sebo de porco, banha, óleo de fígado de bacalhau, óleode peixe) e suas misturas. Diluentes líquidos também incluem ácidos graxosalquilados (tais como metilados, etilados e butilados), em que os ácidos graxospodem ser obtidos por meio de hidrólide de glicerol ésteres de fontes vegetaise animais e podem ser purificados por meio de destilação. Diluentes líquidostípicos são descritos em Marsden, Solvents Guide, segunda edição,Interscience, Nova Iorque, 1950. McCutcheon's Detergents and EmulsifiersAnnual, Allured Publ. Corp., Ridgewood, Nova Jérsei, bem como Sisely eWood, Encyclopedia of Surface Active Agents, Chemical Publ. Co., Inc., Novalorque, 1964, relacionam tensoativos e utilizações recomendadas.As composições sólidas e líquidas de acordo com a presenteinvenção freqüentemente incluem um ou mais tensoativos. Quandoadicionados a um líquido, tensoativos (também conhecidos como "agentesativos na superfície") geralmente modificam, mais freqüentemente reduzem atensão superficial do líquido. Dependendo da natureza dos grupos hidrofílicos elipofílicos em uma molécula de tensoativo, os tensoativos podem ser úteiscomo agentes umectantes, dispersantes, emulsificantes ou agentesdesespumantes.Liquid diluents include, for example, water, N, N-dimethylalkamides (such as N, N-dimethylformamide), limonene, dimethyl sulfoxide, N-alkylpyrrolidones (such as N-methylpyrrolidinone), ethylene glycol, triethylene glycol, propylene glycol, dipropylene glycol, polypropylene glycol, propylene carbonate, butylene carbonate, paraffins (such as white mineral oils, normal paraffins, isoparaffins), alkylbenzenes, alkylnaphthalenes, glycerine, glycerol triacetate, sorbitol, triacetin, aromatic hydrocarbons, dearomatized alkenates, alkylbenzenes such as cyclohexanone, 2-heptanone, isophorone and 4-hydroxy-4-methyl-2-pentanone, acetates such as isoamyl acetate, hexyl acetate, heptyl acetate, octyl acetate, nonyl acetate, tridecyl acetate and isobornyl, other esters such as alkylated lactate esters, dibasic esters and γ-butyrolactone, and alcohols, which may be linear, branched, saturated or unsaturated, such as methanol, ethanol, n-propanol, isopropyl alcohol, n-butanol, isobutyl alcohol, n-hexanol, 2-ethyl hexanol, n-octanol, decanol, alcoholsodecyl, isooctadecanol, cetyl alcohol, lauryl alcohol, tridecyl alcohol, oleic alcohol, cyclohexanol, tetrahydrofurfuryl alcohol, diacetone alcohol and benzyl alcohol. Liquid diluents also include glycerol saturated and unsaturated fatty acid esters (typically C6-C22), such as plant seed fruit oils (e.g., olive, castor, flax, sesame, corn, peanut, sunflower, grape seed, turmeric, cottonseed, soybean, rapeseed, coconut and palm kernel), fats from animal sources (such as beef tallow, pork tallow, lard, cod liver oil, fish oil) and mixtures thereof. Liquid diluents also include alkylated fatty acids (such as methylated, ethylated and butylated), wherein the fatty acids may be obtained by glycerol hydride esters from plant and animal sources and may be purified by distillation. Liquid-typical diluents are described in Marsden, Solvents Guide, Second Edition, Interscience, New York, 1950. McCutcheon's Detergents and Emulsifiers Annual, Allured Publ. Corp., Ridgewood, New Jersey, as well as Sisely eWood, Encyclopedia of Surface Active Agents, Chemical Publ. Co., Inc., New York, 1964, list surfactants and recommended uses. Solid and liquid compositions according to the present invention often include one or more surfactants. When added to a liquid, surfactants (also known as "surface active agents") generally modify, more often reducing surface tension of the liquid. Depending on the nature of the ellipophilic hydrophilic groups in a surfactant molecule, surfactants may be useful as wetting, dispersing, emulsifying or defoaming agents.
Os tensoativos podem ser classificados como não iônicos,aniônicos ou catiônicos. Os tensoativos não iônicos úteis para as composiçõesdo presente incluem, mas sem limitar-se a: alcoxilados álcoois tais comoalcoxilados álcoois baseados em álcoois naturais e sintéticos (que podem serlineares ou ramificados) e preparados a partir dos álcoois e óxido de etileno,óxido de propileno, óxido de butileno ou suas misturas; etoxilados amina,alcanolamidas e alcanolamidas etoxiladas; triglicérides alcoxilados, tais comoóleos de soja, mamona e colza etoxilados; alcoxilados de alquilfenol, tais comoetoxilados de octilfenol, etoxilados de nonilfenol, etoxilados de dinonil fenol eetoxilados de dodecil fenol (preparados a partir dos fenóis e óxido de etileno,óxido de propileno, óxido de butileno ou suas misturas); polímeros de blocopreparados a partir de óxido de etileno ou óxido de propileno e polímeros debloco reversos em que os blocos terminais são preparados a partir de óxido depropileno; ácidos graxos etoxilados; óleos e ésteres graxos etoxilados; metilésteres etoxilados; triestirilfenol etoxilado (incluindo os preparados a partir deóxido de etileno, óxido de propileno, óxido de butileno ou suas misturas);ésteres de ácidos graxos, glicerol ésteres, derivados com base em lanolina,ésteres polietoxilados tais como ésteres de ácidos graxos de sorbitanpolietoxilado, ésteres de ácido graxo de sorbitol polietoxilado e ésteres deácidos graxos de glicerol polietoxilado; outros derivados de sorbitan tais comoésteres de sorbitan; tensoativos poliméricos, tais como copolímeros aleatórios,copolímeros de bloco, resinas peguiladas alquiladas (polietileno glicol),polímeros de enxerto ou de pente e polímeros estrelados; polietileno glicóis(pegs); ésteres de ácidos graxos de polietileno glicol; tensoativos com base emsilicone; e derivados de açúcar, tais como ésteres de sacarose, alquilpoliglicosídeos e alquil polissacarídeos.Surfactants can be classified as nonionic, anionic or cationic. Nonionic surfactants useful for the compositions herein include, but are not limited to: alkoxylated alcohols such as alkoxylated alcohols based on natural and synthetic alcohols (which may be linear or branched) and prepared from alcohols and ethylene oxide, propylene oxide butylene oxide or mixtures thereof; ethoxylated amine, alkanolamides and ethoxylated alkanolamides; alkoxylated triglycerides, such as ethoxylated soybean, castor oil and rapeseed oils; alkylphenol alkoxylates such as octylphenol ethoxylates, nonylphenol ethoxylates, dodecyl phenol ethoxylated dinonyl ethoxylates (prepared from phenols and ethylene oxide, propylene oxide, butylene oxide or mixtures thereof); block polymers prepared from ethylene oxide or propylene oxide and reverse block polymers wherein the terminal blocks are prepared from depropylene oxide; ethoxylated fatty acids; ethoxylated fatty oils and esters; ethoxylated methyl esters; ethoxylated triphenylphenol (including those prepared from ethylene oxide, propylene oxide, butylene oxide or mixtures thereof) fatty acid esters, glycerol esters, lanolin-based esters, polyethoxylated esters such as sorbitanpolyethoxylated fatty acid esters, polyethoxylated sorbitol fatty acid and polyethoxylated glycerol fatty acid esters; other sorbitan derivatives such as sorbitan esters; polymeric surfactants, such as random copolymers, block copolymers, alkylated pegylated resins (polyethylene glycol), graft or comb polymers and starry polymers; polyethylene glycols (pegs); polyethylene glycol fatty acid esters; silicone-based surfactants; and sugar derivatives such as sucrose esters, alkyl polyglycosides and alkyl polysaccharides.
Tensoativos aniônicos úteis incluem, mas sem limitar-se a: ácidosalquilaril sulfônicos e seus sais; álcool carboxilado ou etoxilados de alquilfenol;derivados de sulfonato de difenila; Iignina e derivados de lignina, tais comolignossulfonatos; ácidos maleico ou succínico ou seus anidridos; sulfonatos deolefina; ésteres de fosfato tais como fosfato ésteres de alcoxilados álcoois,fosfato ésteres de alcoxilados de alquilfenol e fosfato ésteres de etoxilados deestiril fenol; tensoativos com base em proteína; derivados de sarcosina; étersulfato de estiril fenol; sulfatos e sulfonatos de óleos e ácidos graxos; sulfatos esulfonatos de alquilfenóis etoxilados; sulfatos de álcoois; sulfatos de álcooisetoxilados; sulfonatos de aminas e amidas tais como tauratos de N,N-alquila;sulfonatos de benzeno, cumeno, tolueno, xileno e dodecil e tridecilbenzenos;sulfonatos de naftalenos condensados; sulfonatos de naftaleno e alquilnaftaleno; sulfonatos de petróleo fracionado; sulfussuccinamatos; esulfossuccinatos e seus derivados, tais como sais de sulfossuccinato dedialquila.Useful anionic surfactants include, but are not limited to: alkylalkyl sulfonic acids and their salts; carboxylated alcohol or alkylphenol ethoxylates; diphenyl sulfonate derivatives; Iignin and lignin derivatives, such as lignosulfonates; maleic or succinic acids or their anhydrides; deolefin sulfonates; phosphate esters such as phosphate alkoxylated alcohol esters, phosphate alkylphenol alkoxylated esters and phosphate estyryl phenol ethoxylated esters; protein based surfactants; sarcosine derivatives; styryl phenol ether sulfate; sulfates and sulfonates of oils and fatty acids; ethoxylated alkylphenols sulfonate sulfates; sulfates of alcohols; alcohol ethoxylated sulfates; amine and amide sulfonates such as N, N-alkyl taurates; benzene, cumene, toluene, xylene and dodecyl sulfonates and tridecylbenzenes; condensed naphthalene sulfonates; naphthalene and alkylnaphthalene sulfonates; fractionated petroleum sulfonates; sulfussuccinamates; sulfosuccinates and their derivatives, such as salts of dedialkyl sulfosuccinate.
Tensoativos catiônicos úteis incluem, mas sem limitar-se a:amidas e amidas etoxiladas; aminas, tais como A/-alquil propanodiaminas,tripropilenotriaminas e dipropilenotetraminas, e aminas etoxiladas, diaminasetoxiladas e aminas propoxiladas (preparadas a partir das aminas e óxido deetileno, óxido de propileno, óxido de butileno ou suas misturas); sais de amina,tais como acetatos de amina e sais de diamina; sais de amônio quaternário,tais como sais quaternários, sais quaternários etoxilados e sais diquaternários;e óxidos de amina, tais como óxidos de alquildimetilamina e óxidos de bis-(2-hidroxietil)-alquilamina.Useful cationic surfactants include, but are not limited to: ethoxylated amides and amides; amines, such as Î ± -alkyl propanediamines, tripropylenetriamines and dipropylenetetramines, and ethoxylated amines, diaminethoxylated and propoxylated amines (prepared from amines and ethylene oxide, propylene oxide, butylene oxide or mixtures thereof); amine salts, such as amine acetates and diamine salts; quaternary ammonium salts such as quaternary salts, ethoxylated quaternary salts and diquaternary salts, and amine oxides such as alkyl dimethylamine oxides and bis (2-hydroxyethyl) alkylamine oxides.
Também são úteis para as composições do presente misturas detensoativos aniônicos e não iônicos ou misturas de tensoativos não iônicos ecatiônicos. Tensoativos não iônicos, aniônicos e catiônicos e seus usosrecomendados são descritos em uma série de referências publicadas queincluem McCutcheon's Emulsifiers and Detergents, edições anuais norte-americanas e internacionais publicadas pela Divisão McCutcheon's, TheManufacturing Confectioner Publishing Co.; Sisely e Wood, Encyclopedia ofSurface Active Agents, Chemical Publ. Co., Inc., Nova Iorque, 1964; e A. S.Davidson e B. Milwidsky, Synthetie Detergents, sétima edição, John Wiley andSons, Nova Iorque, 1987.Also useful for the compositions of the present are anionic and nonionic detensive mixtures or ecathionic nonionic surfactant mixtures. Nonionic, anionic and cationic surfactants and their recommended uses are described in a series of published references including McCutcheon's Emulsifiers and Detergents, annual US and international issues published by McCutcheon's Division, TheManufacturing Confectioner Publishing Co .; Sisely and Wood, Encyclopedia of Surface Active Agents, Chemical Publ. Co., Inc., New York, 1964; and A. S.Davidson and B. Milwidsky, Synthetie Detergents, Seventh Edition, John Wiley and Sounds, New York, 1987.
As composições de acordo com a presente invenção podemtambém conter aditivos e auxiliares de formulação, conhecidos dos técnicos noassunto como auxiliares de formulação (alguns dos quais podem serconsiderados como também funcionando como diluentes sólidos, diluenteslíquidos ou tensoativos). Esses aditivos e auxiliares de formulação podemcontrolar: pH (tampões), formação de espuma durante o processamento(antiespumantes tais como poliorganossiloxanos), sedimentação deingredientes ativos (agentes formadores de suspensão), viscosidade(espessantes tixotrópicos), crescimento microbiano em recipientes(antimicrobianos), congelamento de produto (anticongelantes), cor(tinturas/dispersões de pigmento), lavagem (formadores de filme ouaglutinantes), evaporação (retardantes da evaporação) e outros atributos daformulação. Os formadores de filme incluem, por exemplo, acetatos depolivinila, copolímeros de acetato de polivinila, copolímero de acetato de vinilae polivinilpirrolidona, álcoois polivinílicos, copolímeros de álcool polivinílico eceras. Exemplos de aditivos e auxiliares de formulação incluem os relacionadosem McCutcheon's Volume 2: Functional Materials, edições anuaisinternacionais e norte-americanas publicadas pela Divisão McCutcheon, TheManufacturing Confectioner Publishing Co. e Patente PCT n0 WO 03/024222.Compositions according to the present invention may also contain additives and formulation aids, known to those skilled in the art as formulation aids (some of which may be considered as also functioning as solid diluents, liquid diluents or surfactants). These additives and formulation aids can control: pH (buffers), foaming during processing (defoamers such as polyorganosiloxanes), sedimentation of active ingredients (suspending agents), viscosity (thixotropic thickeners), microbial growth in containers (antimicrobials), product freezing (antifreeze), color (pigment dyes / dispersions), washing (film-forming or binding agents), evaporation (evaporation retardants) and other formulation attributes. Film formers include, for example, polyvinyl acetate acetates, polyvinyl acetate copolymers, polyvinylpyrrolidone vinyl acetate copolymer, polyvinyl alcohols, and polyvinyl alcohol copolymers and the like. Examples of additives and formulation aids include those related to McCutcheon's Volume 2: Functional Materials, annual international and US editions published by McCutcheon Division, TheManufacturing Confectioner Publishing Co. and PCT Patent No. WO 03/024222.
O composto da Fórmula 1 e quaisquer outros ingredientes ativossão tipicamente incorporados às composições do presente por meio dedissolução do ingrediente ativo em um solvente ou por moagem em umdiluente seco ou líquido. Soluções, que incluem concentrados emulsionáveis,podem ser preparadas por meio da simples mistura dos ingredientes. Casoo solvente de uma composição líquida destinado a uso como concentradoemulsionável seja imiscível em água, é tipicamente adicionado umemulsificante para emulsificar o solvente que contém ativo mediantediluição com água. Caldas de ingredientes ativos, com diâmetros departículas de até 2000 μιτι, podem ser moídas úmidas utilizando moinhosde meios para obter partículas com diâmetros médios de menos de 3 μιτι.Caldas aquosas podem ser elaboradas em concentrados de suspensãoterminados (vide, por exemplo, a Patente Norte-Americana n° 3.060.084)ou processadas adicionalmente por meio de secagem por pulverizaçãopara formar grânulos dispersíveis em água. Formulações secasnormalmente necessitam de processos de moagem seca, que produzemdiâmetros médios de partícula na faixa de 2 a 10 μιτι. Pós e pós secospodem ser preparados por meio de mistura e, normalmente, moagem(como em moinho martelo ou moinho de energia fluida). Grânulos e pelotaspodem ser preparados por meio de pulverização do material ativo sobreveículos granulares formados previamente ou por meio de métodos deaglomeração. Vide Browning, Agglomeration, Chemical Engineering, quatrode dezembro de 1967, págs. 147-48, Perry's Chemical Engineer'sHandbook, quarta edição, McGraw-HiII1 Nova Iorque, 1963, págs. 8-57 eseguintes, e WO 91/13546. Pelotas podem ser preparadas conformedescrito em US 4.172.714. Grânulos dispersíveis em água e hidrossolúveispodem ser preparados conforme ensinado em US 4.144.050, US 3.920.442e DE 3.246.493. Pastilhas podem ser preparadas conforme ensinado emUS 5.180.587, US 5.232.701 e US 5.208.030. Filmes podem serpreparados conforme ensinado em GB 2.095.558 e US 3.299.566.The compound of Formula 1 and any other active ingredients are typically incorporated into the compositions herein by dissolving the active ingredient in a solvent or by grinding in a dry or liquid diluent. Solutions, which include emulsifiable concentrates, may be prepared by simply mixing the ingredients. Where the solvent of a liquid composition intended for use as a emulsifiable concentrate is immiscible in water, an emulsifier is typically added to emulsify the solvent containing active medium dilution with water. Active ingredient syrups, with departmental diameters up to 2000 μιτι, can be wet milled using media mills to obtain particles with average diameters of less than 3 μιτι. Aqueous syrups can be made up into terminated suspension concentrates (see, for example, the North Patent American No. 3,060,084) or further processed by spray drying to form water dispersible granules. Dry formulations usually require dry milling processes, which produce average particle diameters in the range of 2 to 10 μιτι. Dry powders and powders can be prepared by mixing and usually milling (as in hammer mill or fluid energy mill). Granules and pellets may be prepared by spraying the active material on previously formed granular supersicles or by agglomeration methods. See Browning, Agglomeration, Chemical Engineering, December 1967, p. 147-48, Perry's Chemical Engineer's Handbook, fourth edition, McGraw-HiII New York, 1963, p. Following 8-57, and WO 91/13546. Pellets may be prepared as described in US 4,172,714. Water-dispersible, water-soluble granules may be prepared as taught in US 4,144,050, US 3,920,442, and DE 3,246,493. Tablets may be prepared as taught in US 5,180,587, US 5,232,701 and US 5,208,030. Films may be prepared as taught in GB 2,095,558 and US 3,299,566.
Para informações adicionais referentes ao método deformulação, vide T. S. Woods, The Formulator's Toolbox - Product Formsfor Modern Agriculture em Pesticide Chemistry and Bioscience, The Food-Environment Challenge1 T. Brooks e T. R. Roberts, Eds., Proceedings ofthe 9th International Congress on Pesticide Chemistry, The Royal Societyof Chemistry, Cambridge, 1999, págs. 120-133. Vide tambémUS 3.235.361, Col. 6, linha 16 até Col. 7, linha 19 e Exemplos 10 a 41;US 3.309.192, Col. 5, linha 43 até Col. 7, linha 62 e Exemplos 8, 12, 15,39, 41, 52, 53, 58, 132, 138-140, 162-164, 166, 167 e 169-182;US 2.891.855, Col. 3, linha 66 até Col. 5, linha 17 e Exemplos 1 a 4;Klingman, Weed Control as a Science, John Wiley and Sons, Inc., NovaIorque, 1961, págs. 81-96; Hance et al, Weed Control Handbook, oitavaedição, Blackwell Scientific Publications, Oxford, 1989; e Developments inFormulation Technology, PJB Publications, Richmond, Grã-Bretanha, 2000.For additional information regarding the deformulation method, see TS Woods, The Formulator's Toolbox - Product Forms for Modern Agriculture in Pesticide Chemistry and Bioscience, The Food-Environment Challenge1 T. Brooks and TR Roberts, Eds., Proceedings of the 9th International Congress on Pesticide Chemistry, The Royal Society of Chemistry, Cambridge, 1999, p. 120-133. See also US 3,235,361, Col. 6, line 16 to Col. 7, line 19 and Examples 10 to 41, US 3,309,192, Col. 5, line 43 to Col. 7, line 62 and Examples 8, 12, 15 , 39, 41, 52, 53, 58, 132, 138-140, 162-164, 166, 167 and 169-182; US 2,891,855, Col. 3, line 66 to Col. 5, line 17 and Examples 1 4; Klingman, Weed Control as Science, John Wiley and Sons, Inc., New York, 1961, p. 81-96; Hance et al, Weed Control Handbook, eighth edition, Blackwell Scientific Publications, Oxford, 1989; and Developments in Formulation Technology, PJB Publications, Richmond, Great Britain, 2000.
Nos Exemplos a seguir, todos os percentuais são em peso etodas as formulações são preparadas de formas convencionais. Osnúmeros dos compostos designam compostos nas Tabelas índice AaD.Sem elaboração adicional, acredita-se que os técnicos no assunto,utilizando a descrição acima, possam utilizar a presente invenção aomáximo possível. Os Exemplos a seguir devem, portanto, ser interpretadoscomo meramente ilustrativos e não limitadores do relatório descritivo denenhuma forma. Os percentuais são em peso, exceto quando indicado emcontrário.Exemplo AIn the following Examples, all percentages are by weight and all formulations are prepared in conventional ways. Compound numbers designate compounds in the AaD Index Tables. Without further elaboration, it is believed that those skilled in the art, using the above description, can utilize the present invention to the fullest extent possible. The following Examples should therefore be construed as merely illustrative and not limiting the descriptive report in any way. Percentages are by weight unless otherwise indicated. Example A
Concentrado de Alta ResistênciaHigh Strength Concentrate
Composto 2 98,5%Compound 2 98.5%
SiIica aerogel 0,5%Silica airgel 0.5%
Silica fina amorfa sintética 1,0%Synthetic Amorphous Fine Silica 1.0%
Exemplo BExample B
Pó molhávelWettable powder
Composto 12 65,0%Compound 12 65.0%
Dodecilfenol polietileno glicol éter 2,0%Dodecylphenol polyethylene glycol ether 2.0%
Ligninossulfonato de sódio 4,0%Sodium lignin sulfonate 4.0%
Silicoaluminato de sódio 6,0%Sodium Silicoaluminate 6.0%
Montmorilonita (calcinada) 23,0%Montmorillonite (calcined) 23.0%
Exemplo CExample C
GrânulosGranules
Composto 16 10,0%Compound 16 10.0%
grânulos de atapulgita (matéria de baixavolatilidade, 0,71/0,30 mm; peneiras padrãonorte-americano n° 25-50) 90,0%attapulgite granules (low volatility matter, 0.71 / 0.30 mm; North American Standard Sieves No. 25-50) 90.0%
Exemplo DExample D
Pelotas extrudadasExtruded Pellets
Composto 18 25,0%Compound 18 25.0%
Sulfato de sódio anidro 10,0%Anhydrous sodium sulfate 10.0%
Ligninossulfonato de cálcio bruto 5,0%Crude calcium lignin sulfonate 5.0%
Alquilnaftalenossulfonato de sódio 1,0%Sodium alkylnaphthalenesulfonate 1.0%
Bentonita de cálcio/magnésio 59,0%Calcium / Magnesium Bentonite 59.0%
Exemplo EExample E
Concentrado emulsionávelEmulsifiable Concentrate
Composto 19 10,0%Hexoleato de polioxietileno sorbitol 20,0%Compound 19 10.0% Polyoxyethylene sorbitol hexoleate 20.0%
Metil éster de ácido graxo C6-C10 70,0%C6-C10 fatty acid methyl ester 70.0%
Exemplo FExample F
MicroemulsãoMicroemulsion
Composto 2 5,0%Compound 2 5.0%
Copolímero de polivinilpirrolidona e acetatoPolyvinylpyrrolidone and acetate copolymer
de vinila 30,0%30.0% vinyl
Alquilpoliglicosídeo 30,0%Alkylpolyglycoside 30.0%
Monooleatodeglicerila 15,0%Monooleatodeglyceryl 15.0%
Água 20,0%Water 20.0%
Exemplo GExample G
Tratamento de sementesSeed Treatment
Composto 18 20,00%Compound 18 20.00%
Copolímero de polivinilpirrolidona e acetato de vinila 5,00%Polyvinylpyrrolidone and vinyl acetate copolymer 5.00%
Cera ácida de Montana 5,00%Montana Acid Wax 5.00%
Ligninossulfonato de cálcio 1,00%Calcium Lignosulfonate 1.00%
Copolímeros de bloco de polioxietileno ePolyoxyethylene block copolymers and
polioxipropileno 1,00% Álcool estearílico (POE 20) 2,00%polyoxypropylene 1.00% Stearyl alcohol (POE 20) 2.00%
Poliorganossilano 0,20%Polyorganosilane 0.20%
Tintura corante vermelha 0,05%Red dye 0.05%
Água 65,75%Water 65.75%
Exemplo HExample H
Bastão fertilizanteFertilizer stick
Composto 19 2,5%Compound 19 2.5%
Copolímero de pirrolidona e estireno 4,8%Pyrrolidone and styrene copolymer 4.8%
16-Etoxilato de triestirilfenila 2,3%Triestyryl phenyl 16-ethoxylate 2.3%
Talco 0,8%<table>table see original document page 91</column></row><table>Talc 0.8% <table> table see original document page 91 </column> </row> <table>
Os compostos de acordo com a presente invenção exibematividade contra um amplo espectro de pragas invertebradas. Essas pragasincluem invertebrados que habitam uma série de ambientes, tais comofolhagem de plantas, raízes, solo, safras colhidas ou outros alimentos,estruturas de construção ou tegumentos animais. Essas pragas incluem, porexemplo, alimentação de invertebrados sobre folhagem (incluindo folhas,hastes, flores e frutas), sementes, madeira, fibras têxteis ou sangue ou tecidosanimais, de forma a causar lesões ou danos, por exemplo, a safrasagronômicas em crescimento ou armazenadas, florestas, safras de estufa,plantas ornamentais, safras de viveiros, alimentos ou produtos de fibraarmazenados ou casas ou outras estruturas ou seus conteúdos, ou serprejudiciais à saúde animal ou saúde pública. Os técnicos no assuntoapreciarão que nem todos os compostos são igualmente eficazes contra todosos estágios de crescimento de todas as pragas.The compounds of the present invention will exhibit activity against a broad spectrum of invertebrate pests. These pests include invertebrates that inhabit a variety of environments, such as leafy plants, roots, soil, harvested crops or other food, building structures or animal integuments. Such pests include, for example, feeding on foliage invertebrates (including leaves, stems, flowers and fruits), seeds, wood, textile fibers or blood or animal tissues to cause injury or damage to, for example, growing or stored harvests , forests, greenhouse crops, ornamental plants, nursery crops, stored food or fiber products or houses or other structures or their contents, or be harmful to animal or public health. Those skilled in the art will appreciate that not all compounds are equally effective against all stages of growth of all pests.
Os compostos e composições do presente são, portanto, úteisagronomicamente para a proteção de safras de campo contra pragasinvertebradas fitófagas, bem como não agronomicamente para a proteção deoutras safras hortícolas e plantas contra pragas invertebradas fitófagas. Estautilidade inclui a proteção de safras e outras plantas (ou seja, agronômicas enão agronômicas) que contenham material genético introduzido por meio deengenharia genética (ou seja, transgênicas) ou modificadas por meio demutagênese para fornecer características vantajosas. Exemplos dessascaracterísticas incluem tolerância a herbicidas, resistência a pragas fitófagas(tais como insetos, ácaros, afídeos, aranhas, nematóides, caracóis, fungospatogênicos de plantas, bactérias e vírus), crescimento vegetal aprimorado,maior tolerância a condições de cultivo adversas tais como temperaturas altasou baixas, umidade do solo baixa ou alta e alta salinidade, aumento daformação de flores ou frutos, maiores rendimentos de colheita, maturação maisrápida, melhor qualidade e/ou valor nutricional do produto colhido ou melhorespropriedades de processo ou armazenagem dos produtos colhidos. As plantastransgênicas podem ser modificadas para expressar diversas características.Exemplos de plantas que possuem características fornecidas por meio deengenharia genética ou mutagênese incluem variedades de milho, algodão,soja e batata que expressam toxina de Bacillus thuringiensis inseticida taiscomo YIELD GARD®, KNOCKOUT®, STARLINK®, BOLLGARD®, NuCOTN®e NEWLEAF® e variedades tolerantes a herbicidas de milho, algodão, soja ecolza, tais como ROUNDUP READY®, LIBERTY LINK®, IMI(S)1 STS® eCLEARFIELD®, bem como safras que expressam /V-acetiltransferase (GAT)para fornecer resistência a herbicida glifosato, ou safras que contêm o geneHRA que fornece resistência a herbicidas que inibem acetolactato sintase(ALS). Os compostos e composições do presente podem interagir de formasinérgica com características introduzidas por meio de engenharia genética oumodificadas por meio de mutagênese, de forma a aumentar a expressãofenotípica ou eficácia das características ou aumento da eficácia do controle depragas invertebradas dos compostos e composições do presente.Particularmente, os compostos e composições do presente podem interagirsinergicamente com a expressão fenotípica de proteínas ou outros produtosnaturais tóxicos para pragas invertebradas para fornecer controle maior que oaditivo dessas pragas.The compounds and compositions herein are therefore useful agronomically for the protection of field crops against phytophagous invertebrate pests, as well as non-agronomically for the protection of other horticultural crops and plants against phytophagous invertebrate pests. This includes the protection of crops and other (ie agronomic and non-agronomic) plants that contain genetic material introduced by genetic (ie transgenic) engineering or modified by demutagenesis to provide advantageous characteristics. Examples of these characteristics include herbicide tolerance, resistance to phytophagous pests (such as insects, mites, aphids, spiders, nematodes, snails, plant fungospatogens, bacteria and viruses), improved plant growth, increased tolerance to adverse crop conditions such as high temperatures or low, high or low soil moisture and high salinity, increased flower or fruit deformation, higher crop yields, faster maturation, better quality and / or nutritional value of the harvested product or better process or storage properties of harvested products. Plantastransgenic plants can be modified to express various characteristics.Examples of plants that have characteristics provided by genetic engineering or mutagenesis include varieties of corn, cotton, soybeans, and potatoes that express Bacillus thuringiensis insecticide toxin such as YIELD GARD®, KNOCKOUT®, STARLINK® , BOLLGARD®, NuCOTN® and NEWLEAF® and herbicide tolerant varieties of maize, cotton, soybeans and ecolza such as ROUNDUP READY®, LIBERTY LINK®, IMI (S) 1 STS® eCLEARFIELD® as well as / V- acetyltransferase (GAT) to provide resistance to glyphosate herbicide, or crops containing the geneHRA that provide resistance to herbicides that inhibit acetolactate synthase (ALS). The present compounds and compositions may interact in an energetic manner with traits introduced by genetic engineering or modified by mutagenesis in order to increase the phenotypic expression or efficacy of the characteristics or increase the effectiveness of invertebrate control of the present compounds and compositions. , the compounds and compositions herein may interact synergistically with phenotypic expression of proteins or other natural products toxic to invertebrate pests to provide greater than additive control of these pests.
As composições de acordo com a presente invenção podemtambém compreender opcionalmente nutrientes vegetais, tais como umacomposição fertilizante que compreende pelo menos um nutriente vegetalselecionado a partir de nitrogênio, fósforo, potássio, enxofre, cálcio, magnésio,ferro, cobre, boro, manganês, zinco e molibdênio. Merecem observaçãocomposições que compreendem pelo menos uma composição fertilizante quecompreende pelo menos um nutriente vegetal selecionado a partir denitrogênio, fósforo, potássio, enxofre, cálcio e magnésio. Composições deacordo com a presente invenção que compreendem adicionalmente pelomenos um nutriente vegetal podem apresentar-se na forma de líquidos ousólidos. Merecem observação formulações sólidas na forma de grânulospequenos bastões ou pastilhas. Formulações sólidas que compreendem umacomposição fertilizante podem ser preparadas por meio de mistura docomposto ou composição de acordo com a presente invenção com acomposição fertilizante junto com ingredientes de formulação e, em seguida,preparação da formulação por meio de métodos tais como granulação ouextrusão. Alternativamente, podem ser preparadas formulações sólidas pormeio de pulverização de uma solução ou suspe nsão de um composto oucomposição de acordo com a presente invenção em um solvente volátil sobreuma composição fertilizante preparada anteriormente na forma de misturascom dimensões estáveis, tais como grânulos, pequenos bastões ou pastilhas eevaporação do solvente em seguida.Compositions according to the present invention may also optionally comprise plant nutrients such as a fertilizer composition comprising at least one plant nutrient selected from nitrogen, phosphorus, potassium, sulfur, calcium, magnesium, iron, copper, boron, manganese, zinc and molybdenum. Deserve to be aware of compositions comprising at least one fertilizer composition comprising at least one plant nutrient selected from nitrogen, phosphorus, potassium, sulfur, calcium and magnesium. Compositions according to the present invention which further comprise at least one plant nutrient may be in the form of liquid or solid. Note solid formulations in the form of granules, small sticks or tablets. Solid formulations comprising a fertilizer composition may be prepared by mixing the composition or composition according to the present invention with fertilizer composition together with formulation ingredients and then preparing the formulation by methods such as granulation or extrusion. Alternatively, solid formulations may be prepared by spraying a solution or suspect of a compound or composition according to the present invention into a volatile solvent over a previously prepared fertilizer composition such as stable sized mixtures such as granules, small sticks or lozenges. and evaporation of the solvent thereafter.
Usos não agronômicos indicam controle de pragas invertebradasnas áreas diferentes de campos de plantas de safra. Os usos não agronômicosdos compostos e composições do presente incluem o controle de pragasinvertebradas em grãos, cereais e outros alimentos armazenados e emprodutos têxteis tais como roupas e tapetes. Usos não agronômicos doscompostos e composições do presente também incluem o controle de pragasinvertebradas em plantas ornamentais, florestas, jardins, ao longo deacostamentos de rodovias e direitos de tráfego de ferrovias e sobre gramados,tais como campos de grama, campos de golfe e pastagens. Os usos nãoagronômicos dos compostos e composições do presente também incluem ocontrole de pragas invertebradas em casas e outras construções que podemser ocupadas por seres humanos e/ou animais de companhia, fazenda, rancho,zoológico ou outros. Os usos não agronômicos dos compostos e composiçõesdo presente também incluem o controle de pragas tais como cupins que podemdanificar madeira ou outros materiais estruturais utilizados em construções.Non-agronomic uses indicate control of invertebrate pests in different areas of crop fields. Non-agronomic uses of the present compounds and compositions include the control of invertebrate pests in grains, cereals and other stored foods and textile products such as clothing and rugs. Non-agronomic uses of the present compounds and compositions also include the control of invertebrate pests on ornamental plants, forests, gardens, along roadside and rail and on-road traffic rights such as grass fields, golf courses and pastures. Nonagronomic uses of the present compounds and compositions also include the control of invertebrate pests in houses and other constructions that may be occupied by humans and / or pets, farm, ranch, zoo or others. Non-agronomic uses of the compounds and compositions herein also include pest control such as termites that can damage wood or other structural materials used in constructions.
Os usos não agronômicos dos compostos e composições dopresente também incluem a proteção da saúde humana e animal por meio docontrole de pragas invertebradas que são parasitas ou transmitem doençasinfecciosas. O controle de parasitas animais inclui o controle de parasitasexternos que são parasíticos para a superfície do corpo do animal hospedeiro(tal como ombros, axilas, abdômen, parte interna das coxas) e parasitasinternos que são parasíticos para o lado interno do corpo do animal hospedeiro(tal como estômago, intestino, pulmão, veias, sob a pele, tecido linfático).Pragas transmissoras de doenças ou parasitas externas incluem, por exemplo,chiques, carrapatos, piolhos, mosquitos, moscas, sarna, ácaros e pulgas.Parasitas internos incluem parasitas cardíacos, ancilóstomos e helmíntios.Compostos e composições de acordo com a presente invenção sãoapropriados para controle sistêmico e/ou não sistêmico de infestações ouinfecções por parasitas sobre animais. Compostos e composições de acordocom a presente invenção são particularmente apropriados para o combate apragas transmissoras de doenças ou parasíticas externas. Os compostos ecomposições de acordo com a presente invenção são apropriados para ocombate a parasitas que infestam animais de trabalho agrícola, tais como bois,carneiros, cabras, cavalos, porcos, burros, camelos, búfalos, coelhos, galinhas,perus, patos, gansos e abelhas; animais domésticos e animais de estimação,tais como cães, gatos, pássaros de estimação e peixes de aquário; bem comoos chamados animais experimentais, tais como hamsters, cobaias, ratos ecamundongos. Combatendo estes parasitas, as fatalidades e a redução dodesempenho (em termos de carne, leite, lã, pele, ovos, mel etc.) são reduzidas,de forma que a aplicação de uma composição que compreende um compostode acordo com a presente invenção permite acasalamento de animais maissimples e econômico.Non-agronomic uses of the present compounds and compositions also include the protection of human and animal health through the control of invertebrate pests that are parasitic or transmit infectious diseases. Control of animal parasites includes control of external parasites that are parasitic to the surface of the host animal's body (such as shoulders, armpits, abdomen, inner thighs) and internal parasites that are parasitic to the inner side of the host animal's body ( such as stomach, intestines, lungs, veins, under the skin, lymphatic tissue). Diseases that transmit disease or external parasites include, for example, chic, ticks, lice, mosquitoes, flies, scabies, mites and fleas. Internal parasites include parasites cardiac compounds, hookworms and helminths. Compounds and compositions according to the present invention are suitable for systemic and / or non-systemic control of infestations or parasite infections in animals. Compounds and compositions according to the present invention are particularly suitable for combating disease-transmitting or external parasitic pests. The compounds and compositions according to the present invention are suitable for combating parasites infesting farm animals such as oxen, sheep, goats, horses, pigs, donkeys, camels, buffalo, rabbits, chickens, turkeys, ducks, geese and bees; domestic animals and pets such as dogs, cats, pet birds and aquarium fish; as well as so-called experimental animals such as hamsters, guinea pigs, mice and mice. By combating these parasites, fatalities and reduced performance (in terms of meat, milk, wool, skin, eggs, honey, etc.) are reduced, so that application of a composition comprising a compound according to the present invention allows mating. of simpler and economical animals.
Exemplos de pragas invertebradas agronômicas ou nãoagronômicas incluem ovos, larvas e adultos da ordem dos lepidópteros, taiscomo lagartas dos cereais, gramiolas, larvas das geometrídeas e heliotinas dafamília dos noctuídeos (por exemplo, broca rosa das hastes (Sesamia inferens,Walker), broca das hastes do milho (Sesamia nonagrioides, Lefebvre), lagartado sul (Spodoptera eridania, Cramer), lagarta dos cereais do outono(Spodoptera fugiperda, J. E. Smith), lagarta da beterraba (Spodoptera exígua,Hübner), lagarta das folhas do algodão (Spodoptera littoralis, Boisduval),lagarta de listas amarelas (Spodoptera ornithogalli, Guenée), lagarta negra doscereais (Agrotis ipsilon, Hufnagel), grilo dos grãos de veludo (Anticarsiagemmataiis, Hübner), verme das frutas verdes (Lithophane antennata, Walker),lagarta do repolho (Barathra brassicae, Linnaeus), gramiola da soja(,Pseudoplusia includens, Walker), gramiola do repolho (Trichoplusia ni,Hübner), larva dos botões de fumo (Heliothis virescens, Fabricius)); brocas,besouros, vermes de teias, vermes das coníferas, vermes do repolho e insetoscarniceiros da família dos piralídeos (por exemplo, broca do milho européia(Ostrinia nubilalis, Hübner), verme da laranja de umbigo (Amyelois transitella,Walker), verme de teias da raiz do milho (Crambus caliginosellus, Clemens),vermes das teias dos gramados (piralídeos: Crambinae), tais como verme dosgramados (Herpetogramma licarsisalis, Walker)), broca da haste da cana deaçúcar (Chilo infuscatellus, Snellen), broca pequena do tomate (Neoleucinodeselegantalis, Guenée), cigarreiro verde (Cnaphalocerus medinalis), traça da uva(,Desmia funeralis, Hübner), verme do melão (Diaphania nitidalis), lagarta docentro do repolho (Helluala hydralis, Guenée), broca das hastes amarela(.Scirpophaga incertulas, Walker), broca dos brotos precoces (Scirpophagainfuscatellus, Snellen), broca das hastes branca (Scirpophaga innotata,Walker), broca dos brotos superiores (Scirpophaga nivella, Fabricius), broca doarroz de cabeça preta (Chilo polychrysus, Meyrick), grilo do cacho de repolho(Croeidolomia binotalis, English)); vermes das folhas, vermes dos botões,vermes das sementes e vermes das frutas da família dos tortricídeos (porexemplo, traça pequena (Cydia pomonella, Linnaeus), traça das uvas(Endopiza viteana, Clemens), traça das frutas oriental (Grapholita molesta,Busck) traça da maçã falsa dos cítricos (Cryptophlebia leueotreta, Meyrick),broca dos cítricos (Eedylotopha aurantiana, Lima), traça de faixas vermelhas(,Argyrotaenia velutinana, Walker), traça de faixas oblíquas (Choristoneurarosaeeana, Harris), traça das maçãs marrom pequena (Epiphyas postvittana,Walker), traça das uvas européia (Eupoecilia ambiguella, Hübner), traça dosbotões da maçã (Pandemis pyrusana, Kearfott), traça onívora (Platynotastultana, Walsingham), traça das árvores frutíferas listrada (Pandemiseerasana, Hübner), traça marrom das maçãs (Pandemis heparana, Denis &Schiffermüller)); e muitos outros lepidópteros economicamente importantes (porexemplo, traça das crucíferas (Plutella xylostella, Linnaeus), lagarta rosa doalgodão (Peetinophora gossypiella, Saunders), ocnéria (Lymantria díspar,Linnaeus), broca das frutas de pêssego (Carposina niponensis, Walsingham),broca dos ramos de pêssego (Anarsia lineatella, Zeller), larva dos tubérculos dabatata (Phthorimaea opereulella, Zeller), lagarta teniforme manchada(Lithocolletis blaneardella, Fabricius), lagarta das maçãs asiática (Lithocolletisringoniella, Matsumura), cigarreiro do arroz (Lerodea eufala, Edwards), lagartadas maçãs (Leueoptera seitella, Zeller)); ovos, ninfas e adultos da ordem dosblatódeos, incluindo baratas das famílias dos blatelídeos e dos blatídeos (porexemplo, barata oriental (Blatta oríentalis, Linnaeus), barata asiática (Blatellaasahinai, Mizukubo), barata alemã (Blatella germaniea, Linnaeus), barata defaixas marrons (Supella longipalpa, Fabricius), barata americana (Periplanetaamericana, Linnaeus), barata marrom (Periplaneta brunnea, Burmeister),barata da Madeira (Leucophaea maderae, Fabricius)), barata marrom opaca(Periplaneta fuliginosa, Service), barata australiana (Periplaneta australasiae,Fabr.), barata lagosta (Nauphoeta cinerea, Olivier) e barata mole (Symplocepallens, Stephens)); ovos, larvas que se alimentam de folhas, que sealimentam de frutos, que se alimentam de raízes, que se alimentam desementes e que se alimentam de tecido vesicular e adultos da ordem doscoleópteros, incluindo gorgulhos das famílias dos antribídeos, bruquídeos ecurculionídeos (por exemplo, gorgulho do algodão (Anthonomus grandis,Boheman), gorgulho d'água do arroz (Lissorhoptrus oryzophilus, Kuschel),gorgulho dos cereais (Sitophilus granarius, Linnaeus), gorgulho do arroz(Sitophilus oryzae, Linnaeus)); gorgulho da grama azul anual (Listronotusmaculicollis, Dietz), gorgulho da grama azul (Sphenophorus parvulus,Gyllenhal), gorgulho caçador (Sphenophorus venatus vestitus), gorgulho deDenver (Sphenophorus cicatristriatus, Fahraeus)); besouros pulga, besourosdos pepinos, larvas das raízes, besouros das folhas, besouros das batatas elagartas das folhas da família dos crisomelídeos (por exemplo, besouro dabatata do Colorado (Leptinotarsa decemlineata, Say), larvas das raízes demilho do oeste (Diabrotica virgifera virgifera, LeConte)); escaravelhos e outrosbesouros da família dos escaribeídeos (por exemplo, besouro japonês (Popilliajaponica, Newman), besouro oriental (Anômala oríentalis, Waterhouse,Exomala oríentalis (Waterhouse), Baraud), escaravelho mascarado do norte(Cyclocephala borealis, Arrow), escaravelho mascarado do sul (Cyclocephalaimmaeulata, Olivier, ou C. lurida, Bland), besouro do esterco e larva branca(Aphodius spp), larva preta da grama azul (Ataenius spretulus, Haldeman),besouro verde de junho (Cotinis nitida, Linnaeus), besouro do jardim asiático(Maladera castanea, Arrow), besouros de maio e junho (Phyllophaga spp) eescaravelho europeu (Rhizotrogus majalis, Razoumowsky)); besouros dostapetes da família dos dermestídeos; larvas dos fios da família dos elaterídeos;Examples of agronomic or nonagronomic invertebrate pests include eggs, larvae and adults of the order lepidoptera, such as cereal caterpillars, gramiolas, geometrideal larvae, and noctuid family heliotins (eg, pink stem borer (Sesamia inferens, Walker), corn stalks (Sesamia nonagrioides, Lefebvre), southern lizard (Spodoptera eridania, Cramer), autumn cereals caterpillar (Spodoptera fugiperda, JE Smith), sugar beet caterpillar (Spodoptera exigua, Hübner), cotton leaf caterpillar (Spodoptera littoralis) , Boisduval), Yellow-list caterpillar (Spodoptera ornithogalli, Guenée), Cerebral black caterpillar (Agrotis ipsilon, Hufnagel), Velvet Grain Cricket (Anticarsiagemmataiis, Hübner), Green Fruit Worm (Lithophane antennata, Walker), Cabbage Caterpillar (Barathra brassicae, Linnaeus), Soybean Gramiola (, Pseudoplusia includens, Walker), Cabbage Gramiola (Trichoplusia ni, Hübner), Smoke Buds Larva (Heliothis virescens, Fabricius)); weevils, beetles, webworms, conifer worms, cabbage worms and insects of the pyralid family (eg European corn borer (Ostrinia nubilalis, Hübner), navel orange worm (Amyelois transitella, Walker), maize rootwebs (Crambus caliginosellus, Clemens), grassworm worms (pyralids: Crambinae) such as wormgrass (Herpetogramma licarsisalis, Walker)), sugarcane stem borer (Chilo infuscatellus, Snellen), small borer (Neoleucinodeselegantalis, Guenée), Green cigarette (Cnaphalocerus medinalis), Grape moth (, Desmia funeralis, Hübner), Melon worm (Diaphania nitidalis), Cabbage caterpillar (Helluala hydralis, Guenée), Yellow stalk borer ( .Scirpophaga incertulas, Walker), Early Sprouts Drill (Scirpophagainfuscatellus, Snellen), White Stems Drill (Scirpophaga innotata, Walker), Upper Sprouts Drill (Donate Drill) black-headed roz (Chilo polychrysus, Meyrick), cabbage bunch cricket (Croeidolomia binotalis, English)); leafworm, budworm, seedworm and fruitworm of the family of the tortricids (eg, small moth (Cydia pomonella, Linnaeus), grape moth (Endopiza viteana, Clemens), eastern fruit moth (Grapholita molesta, Busck ) citrus false apple moth (Cryptophlebia leueotreta, Meyrick), citrus borer (Eedylotopha aurantiana, Lima), red stripe moth (, Argyrotaenia velutinana, Walker), oblique strip moth (Choristoneurarosaeean, Harris moth) small (Epiphyas postvittana, Walker), European grape moth (Eupoecilia ambiguella, Hübner), apple button moth (Pandemis pyrusana, Kearfott), omnivorous moth (Platynotastultana, Walsingham), striped fruit tree moth (Pandemiseerasana, Hübner) apple brown (Pandemis heparana, Denis &Schiffermüller)); and many other economically important lepidopterans (eg, cruciferous moth (Plutella xylostella, Linnaeus), cotton pink caterpillar (Peetinophora gossypiella, Saunders), ocheria (Lymantria disparis, Linnaeus), peach fruit borer (Carposina brisalis, niponens), peach twigs (Anarsia lineatella, Zeller), tuber dabatata larvae (Phthorimaea opereulella, Zeller), spotted teniform caterpillar (Lithocolletis blaneardella, Fabricius), Asian apple caterpillar (Lithocolletisringoniella, Matsumura), rice cigarette holder (Edodeafala euudala) ), lizard apples (Leueoptera seitella, Zeller)); eggs, nymphs and adults of the order of the blatods, including cockroaches from the blatelid and blatid families (eg Eastern cockroach (Blatta oríentalis, Linnaeus), Asian cockroach (Blatellaasahinai, Mizukubo), German cockroach (Blatella germaniea, Linnaeus), Brown cockroach (Supella longipalpa, Fabricius), American cockroach (Periplanetaamericana, Linnaeus), Brown cockroach (Periplaneta brunnea, Burmeister), Madeira cockroach (Leucophaea maderae, Fabricius)), Opaque brown cockroach (Periplaneta fuliginosa, Service), Australian cockroach (Periplaneta australasiae) , Fabr.), Lobster cockroach (Nauphoeta cinerea, Olivier) and soft cockroach (Symplocepallens, Stephens)); eggs, leaf-feeding, fruit-feeding, root-feeding, seed-feeding larvae, vesicular tissue-feeding, and adult of the coleopteran order, including weevils of the antribid families, ecurculionid bruquids (eg cotton weevil (Anthonomus grandis, Boheman), rice weevil (Lissorhoptrus oryzophilus, Kuschel), cereal weevil (Sitophilus granarius, Linnaeus), rice weevil (Sitophilus oryzae, Linnaeus)); annual blue grass weevil (Listronotusmaculicollis, Dietz), blue grass weevil (Sphenophorus parvulus, Gyllenhal), hunter weevil (Sphenophorus venatus vestitus), DENVER weevil (Sphenophorus cicatristriatus, Fahraeus)); flea beetles, cucumber beetles, root larvae, leaf beetles, potato leaf beetles of the Chrysomelid family (for example, Colorado dabatata beetle (Leptinotarsa decemlineata, Say), western daylike larvae (Diabrotica virgifera virgifera, LeConte)); scarab beetles and other beetles of the scarab family (eg Japanese beetle (Popilliajaponica, Newman), eastern beetle (Anomal orientalis, Waterhouse, Exomala orientalis (Waterhouse), Baraud), Northern masked beetle (Cyclocephala borealis, Arrow) (Cyclocephalaimmaeulata, Olivier, or C. lurida, Bland), Dung Beetle and White Larva (Aphodius spp), Black Blue Grass Larva (Ataenius spretulus, Haldeman), June Green Beetle (Cotinis nitida, Linnaeus), Asian garden (Maladera castanea, Arrow), May and June beetles (Phyllophaga spp) and European beetle (Rhizotrogus majalis, Razoumowsky)); dostapete beetles of the dermestid family; wire larvae of the elaterid family;
besouros das cascas das árvores da família dos escolitídeos e besouros dafarinha, da família dos tenebrionídeos. Adicionalmente, as pragas agronômicase não agronômicas incluem: ovos, adultos e larvas da ordem dos dermápteros,incluindo lacraias da família dos forficulídeos (por exemplo, lacraias européias(Forficula auricularia, Linnaeus), lacraias negras (Chelisoches morio,Fabricius)); ovos, imaturos, adultos e ninfas das ordens dos hemípteros ehomópteros, tais como besouros das plantas da família dos mirídeos, cigarrasda família dos cicadídeos, gafanhotos das folhas (por exemplo, Empoascaspp.) da família dos cicadelídeos, besouros das camas (por exemplo, Cimexlectularius, Linnaeus) da família dos cimicídeos, gafanhotos das plantas dasfamílias dos fulgoroídeos e delfacídeos, gafanhotos das árvores da família dosmembracídeos, psilídeos da família dos psilídeos, moscas brancas da famíliados aleirodídeos, afídeos da família dos afídeos, filoxeras da família dosfiloxerídeos, besouros das farinhas da família dos pseudococcídeos, mede-palmos das famílias dos coccídeos, diaspidídeos e margarodídeos, besourosde renda da família dos tingídeos, besouros de mau cheiro da família dospentatomídeos, besouros da cilha (por exemplo, besouro peludo da cilha(Blissus Ieucopterus hirtus, Montandon) e besouro da cilha do sul (Blissusinsularis, Barber)) e outros besouros das sementes da família dos ligeídeos,besouros da saliva da família dos cercopídeos, besouros da abóbora da famíliados coreídeos, besouros vermelhos e besouros do algodão da família dospirrocorídeos. Também são incluídos ovos, larvas, ninfas e adultos da ordemdos ácaros (ácaros), tais como ácaros aranha e ácaros vermelhos da famíliados tetraniquídeos (por exemplo, ácaro vermelho europeu (Panonychus ulmi,Koch), ácaro aranha de duas manchas (Tetranychus urticae, Koch), ácaro deMcDanieI (Tetranychus mcdanieli, McGregor)), ácaros chatos da família dostenuipalpídeos (por exemplo, ácaro chato dos cítricos (Brevipalpus lewisi,McGregor)), ferrugem e ácaros dos botões da família dos eriofídeos, outrosácaros que se alimentam de folhas e ácaros importantes em saúde humana eanimal, ou seja, ácaros da poeira da família dos epidermoptídeos, ácaros defolículos da família dos demodicídeos, ácaros dos cereais da família dosglicifagídeos, carrapatos da ordem dos ixodídeos, conhecidos como carrapatosduros (por exemplo, carrapato dos cervos (Ixodes scapularis, Say), carrapatode paralisia australiano (Ixodes holocyclus, Neumann), carrapato dos cãesamericano (Dermacentor variabilis, Say), carrapato estrela solitário(Amblyomma amerícanum, Linnaeus) e carrapatos da família dos argasídeos,comumente conhecidos como carrapatos moles (tais como carrapato da febrerecorrente (Ornithodoros turicata), carrapato das aves comum (Argasradiatus)); ácaros da crosta e de coceira das famílias dos psoroptídeos,piemotídeos e sarcoptídeos; ovos, adultos e imaturos da ordem dos ortópteros,incluindo gafanhotos, Iocustas e grilos (por exemplo, gafanhotos migratórios(por exemplo, Melanoplus sanguinipes, Fabricius, M. differentialis, Thomas),gafanhotos americanos (por exemplo, Schistocerca americana, Drury),gafanhoto do deserto (Schistocerea gregaría, Forskal), gafanhoto migratório(,Loeusta migratória, Linnaeus), gafanhoto dos arbustos (Zonoeerus spp), grilodoméstico (Aeheta domestieus, Linnaeus), grilos-toupeira (tais como grilotoupeira fulvo (Seapteríseus vieinus, Scudder) e grilo toupeira do sul(Seapteriseus borellii, Giglio-Tos)); ovos, adultos e imaturos da ordem dosdípteros, incluindo lagartas (por exemplo, Liriomyza spp como lagarta dosvegetais serpentina (Liriomyza sativae, Blanchard)), mosquitos-pólvora,moscas das frutas (tefritídeos), moscas das fritas (por exemplo, Oseinella frit,Linnaeus), larvas de moscas do solo, moscas domésticas (por exemplo, Museadomestica, Linnaeus), moscas domésticas menores (por exemplo, Fanniacanicularis, Linnaeus, F. femoralis, Stein), moscas dos estábulos (por exemplo,Stomoxys calcitrans, Linnaeus), moscas do rosto, moscas do chifre, moscasvarejeiras (por exemplo, Chrysomya spp, Phormia spp) e outras pragasmoscóides, moscas dos cavalos (por exemplo, Tabanus spp), moscas do berne(por exemplo, Gastrophilus spp, Oestrus spp), lagartas do gado (por exemplo,Hypoderma spp), moscas dos cervos (por exemplo, Chrysops spp), piolhos (porexemplo, Meiophagus ovinus, Linnaeus) e outros braquíceros, mosquitos (porexemplo, Aedes spp, Anopheies spp, Cuiex spp), moscas negras (por exemplo,Prosimulium spp, Simulium spp), mosquitos-pólvora, moscas da areia, moscasdo cogumelo e outros nematóceros; ovos, imaturos e adultos da ordem dostisanópteros, incluindo tripés da cebola (Thrips tabaci, Lindeman), tripés dasflores (Frankliniella spp) e outros tripés que se alimentam de folhas; insetospragas da ordem dos himenópteros, incluindo formigas da família dosformicídeos, que incluem a formiga carpinteira da Flórida (Camponotusfloridanus, Buckley), formiga carpinteira vermelha (Camponotus ferrugineus,Fabricius), formiga carpinteira preta (Camponotus pennsylvanicus, De Geer),formiga de pés brancos (Technomyrmex albipes fr. Smith), formiga de cabeçagrande (Pheidole sp), formiga fantasma (Tapinoma melanocephalum,Fabricius); formiga faraó (Monomorium pharaonis, Linnaeus), formiga-brasapequena (Wasmannia auropunctata, Roger), formiga-brasa (Solenopsisgeminata, Fabricius), formiga-brasa importada vermelha (Solenopsis invicta,Buren), formiga argentina (Iridomyrmex humilis, Mayr), formiga louca(Paratrechina longicornis, Latreille), formiga dos pavimentos (Tetramoriumcaespitum, Linnaeus), formiga dos campos de milho (Lasius alienus, Fõrster) eformiga doméstica odorífera (Tapinoma sessile, Say). Outros himenópterosincluem abelhas (incluindo abelhas carpinteiras), vespões, vespas americanas,vespas e moscas de serra (Neodiprion spp; Cephus spp); insetos pragas daordem dos isópteros, incluindo cupins das famílias dos termicídeos (tais comoMacrotermes sp, Odontotermes obesus, Rambur), calotermicídeos (tais comoCryptotermes sp) e rinotermicídeos (tais como Reticulitermes sp, Coptotermessp, Heterotermes tenuis, Hagen), cupim subterrâneo oriental (Reticulitermesflavipes, Kollar), cupim subterrâneo ocidental (Reticulitermes hesperus, Banks),cupim subterrâneo de Taiwan (Coptotermes formosanus, Shiraki), cupim damadeira seca do oeste da índia (Ineisitermes immigrans, Snyder), cupim do pó(Cryptotermes brevis, Walker), cupim de madeira seca (Ineisitermes snyderi,Light), cupim subterrâneo do sudeste (Retieulitermes virginieus, Banks), cupimde madeira seca do oeste (Ineisitermes minor, Hagen), cupins das árvores, taiscomo Nasutitermes sp e outros cupins de importância econômica; insetospragas da ordem dos tisanúreos, tais como traça dos livros (Lepismasaeeharina, Linnaeus) e tesourinhas (Thermobia domestica, Packard); insetospragas da ordem dos malófagos, incluindo piolho humano (Pedieulus humanuseapitis, De Geer), piolho do corpo (Pedieulus humanus, Linnaeus), piolho dasgalinhas (Menaeanthus stramineus, Nitszch), piolho dos cães (Triehodeetescanis, De Geer), piolho da penugem (Goniocotes gallinae, De Geer), piolho doscarneiros (Bovicola ovis, Schrank), piolho bovino de nariz curto (Haematopinuseurysternus, Nitzsch), piolho bovino de nariz longo (Linognathus vituli,Linnaeus) e outros piolhos parasíticos sugadores e mordedores que atacam ohomem e os animais; insetos pragas da ordem dos sifonópteros, incluindo apulga dos ratos oriental (Xenopsylla cheopis, Rothschild), pulga dos gatos(Ctenocephalides felis, Bouche), pulga dos cães (Ctenocephalides canis,Curtis), pulga das aves (Ceratophyllus gallinae, Schrank), pulga das galinhas(Echidnophaga gallinacea, Westwood), pulga humana (Pulex irritans, Linnaeus)e outras pulgas que afligem os mamíferos e as aves. Pragas artrópodesadicionais cobertas incluem: aranhas da ordem das aranhas, tais como aaranha reclusa marrom (Loxosceles reclusa, Gertsch e Mulaik) e a aranhaviúva negra (Latrodectus mactans, Fabricius) e centopéias da ordem dosescutigeromorfos, tais como a centopéia doméstica (Scutigera coleoptrata,Linnaeus). Os compostos de acordo com a presente invenção tambémapresentam atividade sobre membros das classes dos nematóides, céstodes,trematóides e acantocéfalos, incluindo membros economicamente importantesdas ordens dos estrongilídeos, ascaridídeos, oxiurídeos, rabditídeos,espirurídeos e enóplidos, tais como, mas sem limitar-se a pragas agrícolaseconomicamente importantes (ou seja, nematóides dos nós das raízes dogênero Meloidogyne, nematóides de lesões do gênero Pratylenchus,nematóides das raízes grossas do gênereo Trichodorus etc.) e pragas desaúde humana e animal (ou seja, todos os vermes, solitárias e Iombrigaseconomicamente importantes, tais como Strongylus vulgaris em cavalos,Toxocara canis em cães, Haemonchus contortus em carneiros, Dirofilariaimmitis Leidy em cães, Anoplocephala perfoliata em cavalos, Fasciola hepaticaLinnaeus em ruminantes etc.).beetles of bark beetles of the family of scolithids and beetle beetles of the tenebrionid family. In addition, non-agronomic agronomic and pests include: eggs, adults, and larvae of the order of the dermápteros, including forficulid family (ie, European (Forficula auricularia, Linnaeus), black (Chelisoches morio, Fabricius)); eggs, immatures, adults and nymphs of the order of the hemiptera and homopterans, such as beetles of the myrid family, cicada family cicadas, leaf locusts (eg Empoascaspp.), cicadidae family, bed beetles (eg Cimexlectularius, Linnaeus) of the scimicid family, grasshopper of the family of the fulgoroid and delfacid family, grasshopper of the member of the brachid family, psyllid family psyllid, aphid family whitefly, aphid family phylloxera, phylloxerid family phylloxera pseudococcid family flours, hand-spanners of coccid, diaspidid, and margarodid families, tingid family lace beetles, stinkpentomid family stink beetles, hairy beetle (eg hairy hairy beetle (Blissus Ieucopterus hirtus, Montandon ) and Southern Bark Beetle (Blissusinsularis, Barber)) and other ligeid family seed beetles, cercopid family saliva beetles, choreid family pumpkin beetles, red beetles, and pyrochorid family cotton beetles. Also included are eggs, larvae, nymphs and adults of the order mites (mites) such as spider mites and red tetraniquid mites (eg European red mite (Panonychus ulmi, Koch), two-spotted spider mite (Tetranychus urticae, Koch), McDanieI mite (Tetranychus mcdanieli, McGregor)), flatfish mites of the dostenuipalpidae family (eg citrus flat mite (Brevipalpus lewisi, McGregor)), rust and bud mites of the eriophid-eating family, other leaf-eating mites and mites important for human and animal health, ie epidermoptid family dust mites, demodicide family defolicle mites, ixodid family cereal mites, known as hard ticks (eg deer tick ( Ixodes scapularis, Say), Australian paralysis tick (Ixodes holocyclus, Neumann), American dog tick (Dermacen tor variabilis, Say), solitary star tick (Amblyomma amerícanum, Linnaeus) and argasid family ticks, commonly known as soft ticks (such as febrerecurrent tick (Ornithodoros turicata), common bird tick (Argasradiatus)); crust and itch mites from families of psoroptids, piemotids and sarcoptids; eggs, adults and immatures of the order of the orthoptera, including grasshoppers, yocustas and crickets (eg migratory locusts (eg Melanoplus sanguinipes, Fabricius, M. differentialis, Thomas), american locusts (eg Schistocerca americana, Drury), Desert Grasshopper (Schistocerea gregaría, Forskal), Migratory Grasshopper (, Migratory Loeusta, Linnaeus), Shrub Grasshopper (Zonoeerus spp), House Grouse (Aeheta domestieus, Linnaeus), Mole Crickets (such as grilotoupeus fulseusulea) and Southern Mole Cricket (Seapteriseus borellii, Giglio-Tos)), adult, immature eggs of the order Diptera, including caterpillars (eg Liriomyza spp as a serpentine caterpillar (Liriomyza sativae, Blanchard)), gnats, flies fruits (tephritids), fries flies (eg Oseinella frit, Linnaeus), soil fly larvae, houseflies (eg Museadomestica, Linnaeus), smaller houseflies (po (eg Fanniacanicularis, Linnaeus, F. femoralis, Stein), Stable flies (eg Stomoxys calcitrans, Linnaeus), Face flies, Horn flies, Blow flies (eg Chrysomya spp, Phormia spp), and other pests; horse flies (eg Tabanus spp), berne flies (eg Gastrophilus spp, Oestrus spp), cattle caterpillars (eg Hypoderma spp), deer flies (eg Chrysops spp), lice (eg , Meiophagus ovinus, Linnaeus) and other brachycerus, mosquitoes (eg, Aedes spp, Anopheies spp, Cuiex spp), blackflies (eg Prosimulium spp, Simulium spp), sandflies, sand flies, mushroom flies and other nematocers ; dostisanopteran eggs, immatures and adults, including onion tripods (Thrips tabaci, Lindeman), flower tripods (Frankliniella spp) and other leaf-feeding tripods; insect pests of the order Hymenoptera, including ants of the family of the formicides, including the Florida Carpenter Ant (Camponotusfloridanus, Buckley), Red Carpenter Ant (Camponotus ferrugineus, Fabricius), Black Carpenter Ant (Camponotus pennsylvanicus, De Geer) (Technomyrmex albipes fr. Smith), large-headed ant (Pheidole sp), phantom ant (Tapinoma melanocephalum, Fabricius); pharaoh ant (Monomorium pharaonis, Linnaeus), red-bellied ant (Wasmannia auropunctata, Roger), red ant (Solenopsisgeminata, Fabricius), red imported red ant (Solenopsis invicta, Buren), Argentine ant (Iridomyrmex humiliga, Mayr) (Paratrechina longicornis, Latreille), Pavement ant (Tetramoriumcaespitum, Linnaeus), Cornfield ant (Lasius alienus, Forster) and odorous domestic ant (Tapinoma sessile, Say). Other hymenopterans include bees (including carpenter bees), hornets, hornets, wasps and saw flies (Neodiprion spp; Cephus spp); insect pests of the isopteran disorder, including termites of the termicid families (such as Macrotermes sp, Odontotermes obesus, Rambur), calotermicides (such as Cryptotermes sp) and rhinotermicides (such as Reticulitermes sp, Coptotermessp, Heterotermes tenuis, Hagen) , Kollar), Western underground termite (Reticulitermes hesperus, Banks), Taiwan underground termite (Coptotermes formosanus, Shiraki), West Indian drywood termite (Ineisitermes immigrans, Snyder), Powder termite (Cryptotermes brevis, Walker), termite drywood (Ineisitermes snyderi, Light), southeastern subterranean termite (Retieulitermes virginieus, Banks), western drywood termite (Ineisitermes minor, Hagen), tree termites, such as Nasutitermes sp and other economically important termites; pest insects of the order of tisanúreos, such as book moths (Lepismasaeeharina, Linnaeus) and earwigs (Thermobia domestica, Packard); insect pests of the order malophagus, including human louse (Pedieulus humanuseapitis, De Geer), body louse (Pedieulus humanus, Linnaeus), lice (Menaeanthus stramineus, Nitszch), dog louse (Triehodeetescanis, De Geer) Goniocotes gallinae, De Geer), Dander louse (Bovicola ovis, Schrank), Short-nosed louse (Haematopinuseurysternus, Nitzsch), Long-nosed louse (Linognathus vituli, Linnaeus) and other sucking and biting parasitic lice that attack oh animals; insect pests of the order Siphonoptera, including eastern rat blight (Xenopsylla cheopis, Rothschild), cat flea (Ctenocephalides felis, Bouche), dog flea (Ctenocephalides canis, Curtis), bird flea (Ceratophyllus gallinae, Schrank) chickens (Echidnophaga gallinacea, Westwood), human fleas (Pulex irritans, Linnaeus) and other fleas that afflict mammals and birds. Covered arthropod pests include: spiders of the order of the spiders, such as the brown recluse spider (Loxosceles reclusa, Gertsch and Mulaik) and the black spider (Latrodectus mactans, Fabricius) and scutigeromorphic centipedes, such as the domestic centipede (Scutigera coleopeus). ). The compounds according to the present invention also exhibit activity on members of the nematode, cestode, trematoid and acanthocephalus classes, including economically important members of the orders of strongylides, ascaridides, oxyurides, rhabditids, spirurides and enolides, such as, but not limited to economically important agricultural pests (ie root knot nematodes Meloidogyne, lesions of the genus Pratylenchus, thick root nematodes of the genus Trichodorus etc.) and human and animal health pests (ie all worms, solitary and worms) , such as Strongylus vulgaris in horses, Toxocara canis in dogs, Haemonchus contortus in sheep, Dirofilariaimmitis Leidy in dogs, Anoplocephala perfoliata in horses, Fasciola hepaticaLinnaeus in ruminants etc.).
Os compostos de acordo com a presente invenção exibematividade particularmente alta contra pragas da ordem dos lepidópteros (porexemplo, Alabama argillaeea Hübner (larva das folhas de algodão), Arehipsargyrospila Walker (lagarta das folhas das árvores frutíferas), A. rosanaLinnaeus (lagarta das folhas européia) e outras espécies de Arehips, Chilosupressalis Walker (broca do caule de arroz), Cnaphalocrosis medinalisGuenée (lagarta da folha de arroz), Crambus ealiginosellus Clemens (verme deteias de raiz de milho), Crambus teterrellus Zincken (verme de teias de capimdo campo), Cydia pomonella Linnaeus (traça das frutas), Earias insulanaBoisduval (larva de mariposa espinhosa), Earias vittella Fabricius (larva demariposa manchada), Helieoverpa armigera Hübner (larva de mariposaamericana), Helieoverpa zea Boddie (larva de mariposa do milho), Heliothisvireseens Fabricius (verme dos botões de fumo), Herpetogramma liearsisalisWalker (verme de teias do gramado), Lobesia botrana Denis e Schiffermüller(traça da uva), Pectinophora gossypiella Saunders (larva de mariposa rosa),Phyllocnistis citrella Stainton (lagarta dos cítricos), Pieris brassicae Linnaeus(borboleta branca grande), Pieris rapae Linnaeus (borboleta branca pequena),Plutella xylostella Linnaeus (traça das crucíferas), Spodoptera exígua Hübner(lagarta da beterraba), Spodoptera Iitura Fabricius (gramiola do fumo, lagartados cachos), Spodoptera frugiperda J. E. Smith (lagarta do outono),Trichoplusia ni Hübner (larva do repolho) e Tuta absoluta Meyrick (lagarta dotomate)).The compounds according to the present invention exhibit particularly high activity against lepidopteran pests (eg, Alabama argillaeea Hübner (cottonworm), Arehipsargyrospila Walker, A. rosanaLinnaeus (European leafworm). ) and other species of Arehips, Chilosupressalis Walker (rice stalk borer), Cnaphalocrosis medinalisGuenée (rice leaf caterpillar), Crambus ealiginosellus Clemens (maize root worm), Crambus teterrellus Zincken (field grassworm) , Cydia pomonella Linnaeus (fruit moth), Earias insulanaBoisduval (spiny moth larva), Earias vittella Fabricius (spotted moth larva), Helieoverpa armigera Hübner (Helieoverpa zea Boddie (Helipot larvae), Helieoverpa zea Boddie (smoke bud worm), Herpetogramma liearsisalisWalker (lawn web worm), Lobesia botrana Den is and Schiffermüller (grape moth), Pectinophora gossypiella Saunders (pink moth larva), Phyllocnistis citrella Stainton (citrus caterpillar), Pieris brassicae Linnaeus (large white butterfly), Pieris rapae Linnaeus (small white butterfly), Plutella xylostella Linyl (Moth of the cruciferous), Spodoptera exigua Hübner (beet caterpillar), Spodoptera Iitura Fabricius (smoke gramiola, lizards bunches), Spodoptera frugiperda JE Smith (autumn caterpillar), Trichoplusia ni Hübner (cabbage larva) and Tuta Absolute Meyrick (lagoon). dotomate)).
Os compostos de acordo com a presente invenção tambémapresentam atividade significativa sobre membros da ordem dos homópteros,que incluem: Acyrthosiphon pisum Harris (afídeo da ervilha), Aphis craccivoraKoch (afídeo do feijão-fradinho), Aphis fabae Scopoli (afídeo do feijão preto),Aphis gossypii Glover (afídeo do algodão, afídeo do melão), Aphis pomi DeGeer (afídeo da maçã), Aphis spiraecola Patch (afídeo da parte superior),Aulacorthum solani Kaltenbach (afídeo da dedaleira), Chaetosiphon fragaefoliiCockerell (afídeo do morango), Diuraphis noxia Kurdjumov/Mordvilko (afídeo dotrigo russo), Dysaphis plantaginea Paaserini (afídeo da maçã rosada),Eriosoma Ianigerum Hausmann (afídeo da maçã lanosa), Hyalopterus pruniGeoffroy (afídeo da ameixa farinácea), Lipaphis erysimi Kaltenbach (afídeo donabo), Metopolophium dirrhodum Walker (afídeo dos cereais), Maerosiphumeuphorbiae Thomas (afídeo da batata), Myzus persieae Sulzer (afídeo dabatata-pêssego, afídeo do pêssego verde), Nasonovia ribisnigri Mosley (afídeoda alface), Pemphigus spp. (afídeos das raízes e afídeos da galha),Rhopalosiphum maidis Fitch (afídeo da folha de milho), Rhopalosiphum padiLinnaeus (afídeo da aveia-cereja de pássaros), Sehizaphis graminum Rondani(besouro verde), Sitobion avenae Fabricius (afídeo dos cereais inglês),Therioaphis maeulata Buckton (afídeo da alfafa manchado), Toxoptera aurantiiBoyer de Fonscolombe (afídeo negro dos cítricos) e Toxoptera citrícida Kirkaldy(afídeo marrom dos cítricos); Adelges spp. (adelgídeos); Phylloxera devastatríxPergande (filoxera da noz pecã), Bemisia tabaci Gennadius (mosca branca dofumo, mosca branca da batata-doce), Bemisia argentifolii Bellows e Perring(mosca branca da folha de prata), Dialeurodes citri Ashmead (mosca brancados cítricos) e Trialeurodes vaporariorum Westwood (mosca branca da estufa);Empoasca fabae Harris (gafanhoto das folhas de batata), Laodelphax striatellusFallen (gafanhoto das plantas marrom menor), Macrolestes quadrilineatusForbes (gafanhoto das folhas de áster), Nephotettix cinticeps Uhler (gafanhotoverde das folhas), Nephotettix nigropictus Stál (gafanhoto das folhas de arroz),Nilaparvata Iugens Stâl (gafanhoto marrom das plantas), Peregrinus maidisAshmead (gafanhoto das plantas de milho), Sogatella furcifera Horvath(gafanhoto das plantas de costas brancas), Sogatodes orizicola Muir(delfacídeo de arroz), Typhlocyba pomaria McAtee (gafanhoto branco dasfolhas de maçã), Erythroneoura spp. (gafanhotos das folhas de uva);Magicidada septendecim Linnaeus (cigarra de estação); Icerya purchasiMaskell (mede-palmos do algodão), Quadraspidiotus perniciosus Comstock(mede-palmos de São José), Planococcus citri Risso (besouro farináceo doscítricos), Pseudoeoceus spp. (outro complexo de besouro farináceo),Cacopsylla pyrieola Foerster (psila da pêra), Trioza diospyri Ashmead (psila dedióspiro).The compounds according to the present invention also exhibit significant activity on members of the order of homopterans, including: Acyrthosiphon pisum Harris (pea aphid), Aphis craccivoraKoch (cowpea aphid), Aphis fabae Scopoli (black bean aphid), Aphis gossypii Glover (cotton aphid, melon aphid), Aphis pomi DeGeer (apple aphid), Aphis spiraecola Patch (top aphid), Aulacorthum solani Kaltenbach (foxglove aphid), Chaetosiphon fragaefoliiCockerell (Strawberry aphid), noxia Kurdjumov / Mordvilko (Russian dotrigo aphid), Dysaphis plantaginea Paaserini (pink apple aphid), Eriosoma Ianigerum Hausmann (woolly apple aphid), Hyalopterus pruniGeoffroy (Farinaceous plum aphid), Lipaphis erysimi donophidridi walkerbach (cereal aphid), Maerosiphumeuphorbiae Thomas (potato aphid), Myzus persieae Sulzer (peach dabatata aphid, aphid aphid) green peach), Nasonovia ribisnigri Mosley (lettuce aphid), Pemphigus spp. (root aphids and gall aphids), Rhopalosiphum maidis Fitch (corn leaf aphid), Rhopalosiphum padiLinnaeus (bird cherry aphid), Sehizaphis graminum Rondani (green beetle), Sitobion avenae Fabricius (English cereal aphid) , Therioaphis maeulata Buckton (spotted alfalfa aphid), Fonscolombe Toxoptera aurantiiBoyer (citrus black aphid) and Kirkaldy citrus toxoptera (brown aphid); Adelges spp. (adelgids); Phylloxera devastatríxPergande (Pecan Phylloxera), Bemisia tabaci Gennadius (Smoke Whitefly, Sweetpotato Whitefly), Bemisia argentifolii Bellows and Perring (Silver Leaf Whitefly), Dialeurodes citri Ashmead (Citrus Whitefly Fly) and Trialeurodes vaporariorum Westwood (Greenhouse Whitefly); Empoasca fabae Harris (Potato Leaf Grasshopper), Laodelphax striatellusFallen (Lesser Brown Plant Grasshopper), Macrolestes quadrilineatusForbes (Aster Leaf Grasshopper), Nephotettix cinticeps Uhler (Leaf Grasshopper Nepigret), Nephotettix cinticeps Stál (rice leaf grasshopper), Nilaparvata Iugens Stál (brown plant grasshopper), Peregrinus maidisAshmead (corn plant grasshopper), Sogatella furcifera Horvath (White-backed plant grasshopper), Sogatodes orizicola Muir (rice delfacid), Typhlocyba pomaria McAtee (White Apple Leaf Grasshopper), Erythroneoura spp. (locusts of grape leaves); Magicidada septendecim Linnaeus (seasonal cicada); Icerya purchasiMaskell (cotton palm), Quadraspidiotus perniciosus Comstock (San Jose palm), Planococcus citri Risso (Dairy Farinaceous Beetle), Pseudoeoceus spp. (another farinaceous beetle complex), Cacopsylla pyrieola Foerster (Pear Psila), Trioza diospyri Ashmead (Diospiro Psila).
Os compostos de acordo com a presente invenção tambémapresentam atividade sobre membros da ordem dos hemípteros, que incluem:Aerosternum hilare Say (besouro verde de mau cheiro), Anasa tristis De Geer(besouro da abóbora), Blissus leueopterus leueopterus Say (besouropercevejo), Cimex Ieetularius Linnaeus (besouro do leito), Corythuea gossypiiFabricius (besouro de renda de algodão), Cyrtopeltis modesta Distant (besourodo tomate), Dysdereus suturellus Herrich-Schaffer (besouro do algodão),Euchistus servus Say (besouro marrom de mau cheiro), Euchistus variolariusPalisot de Beauvois (besouro de mau cheiro com uma mancha), Graptosthetusspp. (complexo de besouros de sementes), Leptoglossus corculus Say(besouro de sementes de pinho em folhas), Lygus Iineolaris Palisot deBeauvois (besouro de plantas manchado), Nezara virídula Linnaeus (besouroverde de mau cheiro do sul), Oebalus pugnax Fabricius (besouro de mau cheirodo arroz), Oncopeltus fasciatus Dallas (besouro grande de plantas leitosas),Pseudatomoscelis seriatus Reuter (gafanhoto-pulga do algodão). Outrasordens de insetos controladas por compostos de acordo com a presenteinvenção incluem tisanópteros (por exemplo, Frankliniella occidentalisPergande (tripé das flores do oeste), Scirthothrips citri Moulton (tripé doscítricos), Sericothrips variabilis Beach (tripé da soja) e Thrips tabaci Lindeman(tripé da cebola)); e a ordem dos coleópteros (por exemplo, Leptinotarsadeeemlineata Say (besouro da batata do Colorado), Epilaehna varivestisMulsant (besouro do feijão mexicano) e larvas dos fios do gênero Agriotes,Athous ou Limonius).The compounds according to the present invention also have activity on members of the order of the hemiptera, which include: Aerosternum hilare Say (foul green beetle), Anasa tristis De Geer (pumpkin beetle), Blissus leueopterus Say (besouropercevejo), Cimex Ieetularius Linnaeus (Bed Beetle), Corythuea gossypiiFabricius (Cotton Lace Beetle), Cyrtopeltis Modest Distant (Tomato Beetle), Dysdereus suturellus Herrich-Schaffer (Cotton Beetle), Euchistus servus Say (Euchiusotus variol) de Beauvois (stink beetle), Graptosthetusspp. (seed beetle complex), Leptoglossus corculus Say (leaf pine seed beetle), Lygus Iineolaris Palisot deBeauvois (spotted plant beetle), Nezara viridula Linnaeus (southern stink beetle), Oebalus pugnax Fabricius bad smelling rice), Oncopeltus fasciatus Dallas (large milky beetle), Pseudatomoscelis seriatus Reuter (cottonseed flea). Other compound-controlled insect orders according to the present invention include tisanoptera (eg, Frankliniella occidentalisPergande (western flower tripod), Scirthothrips citri Moulton (oscillary tripod), Sericothrips variabilis Beach (soybean tripod) and Thrips tabaci Lindeman (soybean tripod). onion)); and the order of beetles (eg Leptinotarsadeeemlineata Say (Colorado potato beetle), Epilaehna varivestisMulsant (Mexican bean beetle) and wire larvae of the genus Agriotes, Athous or Limonius).
Observe-se que alguns sistemas de classificaçãocontemporâneos colocam os homópteros como subordem da ordem doshemípteros.It should be noted that some contemporary classification systems place the homoptera as a suborder of the order of the heteroptera.
Merece observação o uso de compostos de acordo com apresente invenção para o controle de traça das crucíferas (Plutella xylostella).Merece observação o uso de compostos de acordo com a presente invençãopara controlar lagarta dos cereais de outono (Spodoptera frugiperda). Mereceobservação o uso de compostos de acordo com a presente invenção para ocontrole de tripé das flores do oeste (Frankliniella occidentalis). Mereceobservação o uso de compostos de acordo com a presente invenção paracontrole de gafanhoto das batatas (Empoasca fabae). Merece observação ouso de compostos de acordo com a presente invenção para o controle deafídeo do melão e algodão (Aphis gossypii). Merece observação o uso decompostos de acordo com a presente invenção para controlar afídeo dopêssego verde (Myzus persicae).Note the use of compounds according to the present invention for the control of cruciferous moths (Plutella xylostella). Note the use of compounds according to the present invention to control autumn cereal caterpillar (Spodoptera frugiperda). Note the use of compounds according to the present invention for the control of the western flower tripod (Frankliniella occidentalis). Note the use of compounds according to the present invention for the control of potato grasshopper (Empoasca fabae). The use of compounds according to the present invention for the control of the melon and cotton (Aphis gossypii) deserves observation. The use of the present invention to control green peach aphid (Myzus persicae) is of note.
Os compostos de acordo com a presente invenção podemtambém ser misturados com um ou mais agentes ou compostos biologicamenteativos diferentes, que incluem inseticidas, fungicidas, nematicidas, bactericidas,acaricidas, herbicidas, reguladores do crescimento tais como estimulantes doenraizamento, quimioesterilizadores, semioquímicos, repelentes, atrativos,feromônios, estimulantes da alimentação, outros compostos biologicamenteativos ou vírus, fungos ou bactérias entomopatogênicas para formar umpesticida com múltiplos componentes, oferecendo espectro ainda mais amplode utilidade agronômica e não agronômica. Desta forma, a presente invençãotambém se refere a uma composição que compreende uma quantidadebiologicamente eficaz de um composto da Fórmula 1, seu N-óxido ou sal e umaquantidade eficaz de pelo menos um agente ou composto biologicamente ativoadicional e pode compreender ainda pelo menos um dentre tensoativos,diluentes sólidos ou diluentes líquidos. Para as misturas de acordo com apresente invenção, os demais agentes ou compostos biologicamente ativospodem ser formulados junto com os compostos do presente, incluindo oscompostos da Fórmula 1, para formar uma mistura prévia, ou os outros agentesou compostos biologicamente ativos podem ser formulados separadamentedos compostos do presente, incluindo os compostos da Fórmula 1 e as duasformulações combinadas entre si antes da aplicação (tal como em um tanquede pulverização) ou, alternativamente, aplicadas sucessivamente.The compounds of the present invention may also be mixed with one or more different biologically active agents or compounds, which include insecticides, fungicides, nematicides, bactericides, acaricides, herbicides, growth regulators such as rooting stimulants, chemoesterilizers, semiochemicals, repellents, attractants. , pheromones, dietary stimulants, other biologically active compounds or entomopathogenic viruses, fungi or bacteria to form a multi-component pesticide, providing an even broader spectrum of agronomic and non-agronomic utility. Accordingly, the present invention also relates to a composition comprising a biologically effective amount of a compound of Formula 1, its N-oxide or salt and an effective amount of at least one additional biologically active agent or compound and may further comprise at least one of the surfactants. , solid diluents or liquid diluents. For mixtures according to the present invention, the other biologically active agents or compounds may be formulated together with the compounds of the present, including the compounds of Formula 1, to form a premix, or the other biologically active agents or compounds may be formulated separately from the compounds of the present invention. present, including the compounds of Formula 1 and the two formulations combined prior to application (as in a spray tank) or alternatively applied successively.
Outros agentes ou compostos biologicamente ativos úteis nascomposições de acordo com a presente invenção podem ser selecionados apartir de agentes de controle de pragas invertebradas que possuem um modode ação diferente ou uma classe química diferente, incluindo lactonasmacrocíclicas, neonicotinóides, Iigantes receptores de octopamina, Iigantesreceptores de rianodina, agonistas de ecdisona, moduladores de canais desódio, inibidores da síntese de chitina, análogos de nereisotoxina, inibidores dotransporte de elétrons mitocôndricos, inibidores da colinesterase, inseticidas deciclodieno, inibidores de exúvio, bloqueadores de canais de cloreto reguladospor GABA (ácido γ-aminobutírico), imitadores de hormônios juvenis, inibidoresda biossíntese de lipídios e agentes biológicos que incluem nucleopoliedrovírus(NPV)1 membros de Bacillus thuringiensis, delta-endotoxinas encapsuladas deBacillus thuringiensis; e outros vírus inseticidas de ocorrência natural ougeneticamente modificados.Other biologically active agents or compounds useful in the compositions according to the present invention may be selected from invertebrate pest control agents that have a different mode of action or a different chemical class, including lactonasmacrocyclics, neonicotinoids, octopamine receptor binders, ryanodine receptors , ecdisone agonists, disodium channel modulators, chitin synthesis inhibitors, nereisotoxin analogs, mitochondrial electron transport inhibitors, cholinesterase inhibitors, decyclodiene insecticides, exudate inhibitors, GABA (γ-aminobut acid) -regulated chloride channel blockers , juvenile hormone mimics, lipid biosynthesis inhibitors, and biological agents including nucleopoliedrovirus (NPV) 1 members of Bacillus thuringiensis, encapsulated delta-endotoxins of Bacillus thuringiensis; and other naturally occurring or genetically modified insecticidal viruses.
Merecem observação agentes ou compostos biologicamenteativos adicionais selecionados a partir de inseticidas do grupo que consiste depiretróides, carbamatos, neonicotinóides, bloqueadores de canais de sódioneuronais, Iactonas macrocíclicas inseticidas, antagonistas de ácido γ-aminobutírico, uréias inseticidas e imitadores de hormônios juvenis, ummembro de Bacillus thuringiensis, uma delta-endotoxina de Bacillusthuringiensis e um inseticida de ocorrência natural ou geneticamentemodificado.Additional biologically active agents or compounds selected from the insecticides of the group consisting of pyrethroids, carbamates, neonicotinoids, sodioneuronal channel blockers, insecticidal macrocyclic Iactones, γ-aminobutyric acid antagonists, urea insecticides and juvenile hormone mimics deserve to be noted. thuringiensis, a Bacillusthuringiensis delta-endotoxin and a naturally occurring or genetically modified insecticide.
Exemplos desses agentes ou compostos biologicamente ativoscom os quais os compostos de acordo com a presente invenção podem serformulados são: inseticidas tais como abamectina, acefato, acetamiprid,acetoprol, amidoflumet (S-1955), avermectina, azadiractina, azinfós-metil,bifentrina, bifenazato, bistrifluron, buprofezina, carbofuran, cartap, clorfenapir,clorfuazuron, clorantraniliprol (DPX-E2Y45), clorpirifós, clorpirifós-metil,cromafenozida, clotianidina, ciflumetofen, ciflutrina, beta-ciflutrina, cialotrina,gama-cialotrina, lambda-cialotrina, cipermetrina, ciromazina, deltametrina,diafentiuron, diazinon, dieldrina, diflubenzuron, dimeflutrina, dimetoato,dinotefuran, diofenolan, emamectina, endossulfan, esfenvarelato, etiprol,fenotiocarb, fenoxicarb, fenpropatrina, fenvarelato, fipronil, flonicamid,flubendiamida, flucitrinato, tau-fluvalinato, flufenerim (UR-50701), flufenoxuron,fonofós, halofenozida, hexaflumuron, hidrametilnon, imidacloprid, indoxacarb,isofenfós, lufenuron, malation, metaflumizona, metaldeído, metamidofós,metidation, metomil, metoprene, metoxiclor, metoflutrina, monocrotofós,metoxifenozida, monocrotofós, nitenpiram, nitiazina, novaluron, noviflumuron(XDE-007), oxamil, paration, paration-metil, permetrina, forato, fosalona,fosmet, fosfamidon, pirimicarb, profenofós, proflutrina, protrifenbuta,pimetrozina, pirafluprol, piretrina, piridalil, pirifluquinazon, piriprol, piriproxifen,rotenona, rianodina, espinetoram, espinosad, espirodiclofen, espiromesifen(BSN 2060), espirotetramat, sulprofós, tebufenozida, teflubenzuron, teflutrina,terbufós, tetraclorvinfós, tiacloprid, tiametoxam, tiodicarb, tiossultap-sódio,tolfenpirad, tralometrina, triazamato, triclorfon e triflumuron; fungicidas, taiscomo acibenzolar, aldimorf, amisulbrom, azaconazol, azoxistrobina, benalaxil,benomil, bentiavalicarb, bentiavalicarb-isopropila, binomial, bifenila, bitertanol,blasticidina-S, mistura de Bordéus (sulfato de cobre tribásico),boscalid/nicobifen, bromuconazol, bupirimato, butiobato, carboxina,carpropamid, captafol, captan, carbendazim, cloroneb, clorotalonil, clozolinato,clotrimazol, oxicloreto de cobre, sais de cobre tais como sulfato de cobre ehidróxido de cobre, ciazofamid, ciflunamid, cimoxanil, ciproconazol, ciprodinil,diclofuanid, diclocimet, diclomezina, dicloran, dietofencarb, difenoconazol,dimetomorf, dimoxistrobina, diniconazol, diniconazol-M, dinocap, dicostrobina,ditianon, dodemorf, dodina, econazol, etaconazol, edifenfós, epoxiconazol,etaboxam, etirimol, etridiazol, famoxadona, fenamidona, fenarimol,fenbuconazol, fencaramid, fenfuram, fenhexamida, fenoxanil, fenpiclonil,fenpropidina, fenpropimorf, acetato de fentina, hidróxido de fentina, ferbam,ferfurazoato, ferinzona, fluazinam, fludioxonil, flumetover, fluopicolida,fluoxastrobina, fluquinconazol, flusilazol, flusulfamida, flutolanil, flutriafol, folpet,fosetil-alumínio, fuberidazol, furalaxil, furametapir, hexaconazol, himexazol,guazatina, imazalil, imibenconazol, iminoctadina, iodicarb, ipconazol,iprobenfós, iprodiona, iprovalicarb, isoconazol, isoprotiolano, casugamicina,cresoxim-metil, mancozeb, mandipropamid, maneb, mapanipirina, mefenoxam,mepronil, metalaxil, metconazol, metasulfocarb, metiram,metominostrobina/fenominostrobina, mepanipirim, metrafenona, miconazol,miclobutanil, neo-asozina (metanoarsonato férrico), nuarimol, octilinona,ofurace, orisastrobina, oxadixil, ácido oxolínico, oxpoconazol, oxicarboxina,paclobutrazol, penconazol, pencicuron, pentiopirad, perfurazoato, ácidofosfônico, ftalida, picobenzamid, picoxistrobina, polioxina, probenazol,procloraz, procimidona, propamocarb, cloridrato de propamocarb, propiconazol,propineb, proquinazid, protioconazol, piraclostrobina, priazofós, pirifenox,pirimetanil, pirifenox, pirolnitrina, piroquilon, quinconazol, quinoxifen,quintozene, siltiofam, simeconazol, espiroxamina, estreptomicina, enxofre,tebuconazol, tecrazene, tecloftalam, tecnazene, tetraconazol, tiabendazol,tifluzamida, tiofanato, tiofanato-metil, tiram, tiadinil, tolclofós-metil, tolifluanid,triadimefon, triadimenol, triarimol, triazóxido, tridemorf, trimorfamida, triciclazol,trifloxistrobina, triforina, triticonazol, uniconazol, validamicina, vinclozolina,zineb, ziram e zoxamida; nematicidas, tais como aldicarb, imiciafós, oxamil efenamifós; bactericidas, tais como estreptomicina; acaricidas, tais comoamitraz, chinometionat, clorobenzilato, cihexatina, dicofol, dienoclor, etoxazol,fenazaquina, oxido de fenbutatina, fenpropatrina, fenpiroximato, hexitiazox,propargita, piridaben e tebufenpirad; e agentes biológicos incluindo bactériasentomopatogênicas, tais como Bacillus thuringiensis subespécie aizawai,Bacillus thuringiensis subespécie kurstaki e as delta-endotoxinas encapsuladasde Bacillus thuringiensis (tais como Cellcap, MPV1 MPVII); fungosentomopatogênicos, tais como fungo muscardina verde; e vírusentomopatogênicos que incluem bacilovírus, nucleopoliedrovírus (NPV) taiscomo nucleopoliedrovírus de Helicoverpa zea (HzNPV)1 nucleopoliedrovírus deAnagrapha falcifera (AfNPV); e vírus granulose (GV) tal como vírus granulosede Cydia pomonella (CpGV).Examples of such biologically active agents or compounds with which the compounds according to the present invention may be formulated are: insecticides such as abamectin, acefate, acetamiprid, acetoprol, amidoflumet (S-1955), avermectin, azadiractin, azinfos-methyl, bifenthazine, bifenazate , bistrifluron, buprofezin, carbofuran, cartap, chlorfenapyr, chlororfuazuron, chlorantraniliprol (DPX-E2Y45), chlorpyrifos, chlorpyrifos-methyl, chromafenozide, clothianidine, cyflumruth, beta-cyrothruthin, beta-cyrothruthin, beta-cyrothruthin, cyromazine, deltamethrin, diafentiuron, diazinon, dieldrin, diflubenzuron, dimeflutrin, dimethoate, dinotefuran, diophenolan, emamectin, endosulfan, etiprol, fenotiocarb, phenoxycarb, fenoxycarb, fenpropatrin, fluvulaminate, fluvinamide UR-50701), flufenoxuron, phonophos, halofenozide, hexaflumuron, hydramethylnon, imidacloprid, indoxacarb, isofenphos, lufenuron, m alation, metaflumizone, metaldehyde, metamidophos, metidation, methomyl, metoprene, methoxychlor, metofluthrin, monocrotophos, methoxyphenozide, monocrotophos, nitenpyram, nitiazine, novaluron, noviflumuron (XDE-007), oxamalone paratonin, , fosmet, phosphamidon, pirimicarb, profenophos, profluthrin, protrifenbuta, pimetrozine, pirafluprol, pyrethrin, pyridalyl, pyrifluquinazon, pyriprole, pyriproxifen, rotenone, rianodine, spinin, spinosad, spirodiclofen, spiromesefen tiben, sulphenefen, tb tefluthrin, terbufos, tetrachlorvinphos, tiacloprid, thiamethoxam, thiodicarb, thiosultap-sodium, tolfenpirad, tralometrine, triazamate, trichlorphon and triflumuron; fungicides, such as acibenzolar, aldimorf, amisulbrom, azaconazole, azoxystrobin, benalaxyl, benomyl, bentiavalicarb, bentiavalicarb-isopropyl, binomial, biphenyl, bitertanol, blasticidin-S, Bordeaux mixture (bipasomal birbucidum, bifalidum, sulphenazole, , butiobate, carboxin, carpropamid, captafol, captan, carbendazim, chloroneb, chlorothalonyl, clozolinate, clotrimazole, copper oxychloride, copper salts such as copper sulfate and copper hydroxide, ciazofamid, ciflunamid, cimoxanil, ciproconazole, dicyclidyl , diclomezine, dichloran, dietofencarb, diphenoconazole, dimetomorph, dimoxystrobin, diniconazole, diniconazole-M, dinocap, dicostrobin, dithianon, dodemorf, dodine, econazole, ethaconazole, edifenphos, etaboxam, phenidimidazole, ethadoxazol, ethadoxazole , fencaramid, fenfuram, fenhexamide, fenoxanil, fenpiclonil, fenpropidine, fenpropimorf, fentin acetate, fentin hydroxide, ferbam, ferfurazo act, ferinzone, fluazinam, fludioxonil, flumetover, fluopicolide, fluoxastrobin, fluquinconazole, flusilazole, flusulfamide, flutolanil, flutriafol, folpet, fosetyl aluminum, fuberidazole, furalaxil, furametapyr, hexaconazole, himexazole, imazicarbazole, ixazalazole, ipconazole, iprobenfos, iprodione, iprovalicarb, isoconazole, isoprothiolane, casugamycin, cresoxim-methyl, mancozeb, mandipropamid, maneb, mapanipyrine, mefenoxam, mepronil, metallaxyl, metconazole, metasulfocarb, metiram, metominostrobin / mepanitrinone, mepanitrinone neo-asozine (ferric methanarsonate), nuarimol, octylinone, ofurace, orisastrobin, oxadixil, oxolinic acid, oxpoconazole, oxicarboxin, paclobutrazol, penconazole, pencicuron, pentiopirad, perforate acid, phthazidazole, picalidone, procalidone , propamocarb, propamocarb hydrochloride, propiconazole, propineb, proquinazid, protioconazole, piraclo strobin, priazophos, pyrifenox, pyrimetanil, pyrifenox, pyrolnitrin, pyrokylon, quinconazole, quinoxifen, quintozene, siltiofam, simeconazole, spiroxamine, streptomycin, sulfur, tebuconazole, tecrazene, keyboardophthalam, technazene, tetraconazole, thetraconazole, tetraconazole tiram, thiadinyl, tolclofos-methyl, tolifluanid, triadimephon, triadimenol, triarimol, triazoxide, tridemorf, trimorfamide, tricyclazole, trifloxystrobin, triforine, triticonazole, uniconazole, validamycin, vinclozoline, zineb, ziram and zoxamide; nematicides such as aldicarb, imicyaphos, oxamyl efenamiphos; bactericides such as streptomycin; acaricides such as amitraz, chinomethionat, chlorobenzylate, cyhexatin, dicofol, dienochlor, ethoxazole, phenazaquin, fenbutatin oxide, fenpropatrin, fenpyroximate, hexithiazox, propargite, pyridaben and tebufenpyrad; and biological agents including pathogenic bacteria, such as Bacillus thuringiensis subspecies aizawai, Bacillus thuringiensis subspecies kurstaki and the encapsulated Bacillus thuringiensis delta-endotoxins (such as Cellcap, MPV1 MPVII); pathogenic fungi, such as green muscardine fungus; and pathogenic viruses including bacilloviruses, nucleopoliedvirus (NPV) such as Helicoverpa zea nucleopoliedvirus (HzNPV) 1 Anagrapha falcifera nucleopoliedrovirus (AfNPV); and granulose virus (GV) such as Cydia pomonella granular virus (CpGV).
Os compostos de acordo com a presente invenção e suascomposições podem ser aplicados a plantas geneticamente transformadaspara expressar proteínas tóxicas para pragas invertebradas (tais como delta-endotoxinas de Bacillus thuringiensis). O efeito dos compostos de controle depragas invertebradas aplicados de forma exógena de acordo com a presenteinvenção pode ser sinérgico com as proteínas de toxina expressas. As referências gerais para estes protetores agrícolas (ou seja,inseticidas, fungicidas, nematicidas, acaricidas, herbicidas e agentesbiológicos) incluem The Pesticide Manual, 13a edição, C. D. S. Tomlin, ed.,British Crop Protection Council, Farnham1 Surrey, Reino Unido, 2003, e TheBioPesticide Manual, segunda edição, L. G. Copping, Ed., British CropProtection Council, Farnham, Surrey, Reino Unido, 2001.The compounds according to the present invention and their compositions may be applied to genetically transformed plants to express toxic proteins for invertebrate pests (such as Bacillus thuringiensis delta-endotoxins). The effect of exogenously applied invertebrate control compounds according to the present invention may be synergistic with the expressed toxin proteins. General references for these agricultural protectors (ie insecticides, fungicides, nematicides, acaricides, herbicides and biological agents) include The Pesticide Manual, 13th edition, CDS Tomlin, ed., British Crop Protection Council, Farnham1 Surrey, United Kingdom, 2003, and TheBioPesticide Manual, second edition, LG Copping, Ed., British Crop Protection Council, Farnham, Surrey, UK, 2001.
Merece observação uma composição de acordo com a presenteinvenção em que pelo menos um agente ou composto biologicamente ativoadicional é selecionado a partir do grupo que consiste de abamectina, acefato,acetamiprid, acetoprol, aldicarb, amidoflumet, amitraz, avermectina,azadiractina, azinfós-metil, bifentrina, bifenazato, bistrifluron, buprofezina,carbofuran, cartap, chinometionat, clorfenapir, clorfluazuron, clorantraniliprol,clorpirifós, clorpirifós-metil, clorobenzilato, cromafenozida, clotianidina,ciflumetofen, ciflutrina, beta-ciflutrina, cialotrina, gama-cialotrina, Iambda-cialotrina, cihexatina, cipermetrina, ciromazina, deltametrina, diafentiuron,diazinon, dicofol, dieldrina, dienoclor, diflubenzuron, dimeflutrina, dimetoato,dinotefuran, diofenolan, emamectina, endosulfan, esfenvarelato, etiprol,etoxazol, fenamifós, fenazaquina, oxido de fenbutatina, fenotiocarb, fenoxicarb,fenpropatrina, fenpiroximato, fenvarelato, fipronil, flonicamid, flubendiamida,flucitrinato, tau-fluvalinato, flufenerim, flufenoxuron, fonofós, halofenozida,hexaflumuron, hexitiazox, hidrametilnon, imiciafós, imidacloprid, indoxacarb,isofenfós, lufenuron, malation, metaflumizona, metaldeído, metamidofós,metidation, metomil, metoprene, metoxiclor, metoxifenozida, metoflutrina,monocrotofós, nitenpiram, nitiazina, novaluron, noviflumuron, oxamil, paration,paration-metil, permetrina, forato, fosalona, fosmet, fosfamidon, pirimicarb,profenofós, proflutrina, propargita, protrifenbute, pimetrozina, pirafluprol,piretrina, piridaben, piridalil, pirifluquinazon, piriprol, piriproxifen, rotenona,rianodina, espinetoram, espinosad, espiridiclofen, espiromesifen,espirotetramat, sulprofós, tebufenozida, tebufenpirad, teflubenzuron, teflutrina,terbufós, tetraclorvinfós, tiacloprid, tiametoxam, tiodicarb, tiosultap-sódio,tolfenpirad, tralometrina, triazamato, triclorfon, triflumuron, Bacillus thuringiensissubsp. aizawai, Bacillus thuringiensis subsp. kurstaki, nucleopoliedrovírus,delta-endotoxina encapsulada de Bacillus thuringiensis, bacilovírus, bactériasentomopatogênicas, vírus entomopatogênicos e fungos entomopatogênicos.A composition according to the present invention in which at least one additional biologically active agent or compound is selected from the group consisting of abamectin, acephate, acetamiprid, acetoprol, aldicarb, amidoflumet, amitraz, avermectin, azadiractin, azinphos-methyl, deserves observation. bifenthrin, bifenazate, bistrifluron, buprofezin, carbofuran, cartap, chinomethionat, chlorfenapyr, chlorfluazuron, chlorantraniliprol, chlorpyrifos, chlorpyrifos-methyl, chlorobenzylate, chromaphenzid, cyphlumethrin, ciflumethrin, cifluthrin, cifluthrin cyhexatin, cypermethrin, cyromazine, deltamethrin, diafentiuron, diazinon, dicofol, dieldrin, dienochlor, diflubenzuron, dimeflutrin, dimethoate, dinotefuran, diofenolan, emamectin, endosulfan, sphenvarelate, phenazolate, phenazolate, phenazolate, phenolate fenpropatrin, fenpyroximate, fenvarelate, fipronil, flonicamid, flubendiamide, flucitrinate, tau-fluvalinate, flufenerim, flufenoxuron, phonophos, halofenozide, hexaflumuron, hexithiazox, hydramethylnon, imiciaphos, imidacloprid, indoxacarb, isophenphos, lufenuron, malation, metaflumizone, methoidophenophenate, methamidophosphate, methamidophosphonate nitenpiram, nitiazine, novaluron, noviflumuron, oxamyl, paration, paration-methyl, permethrin, forate, fosalone, fosmet, phosphamidon, pirimicarb, profenophos, profluthrin, propargite, protrifenbute, pimetrozine, pirafluprol, pyrethrin, pyrethyridine, pyrethrin pyriproxyfen, rotenone, ryanodine, spinetoram, spinosad, spiridiclofen, spiromesifen, spirotetramat, sulprofos, tebufenozide, tebufenpirad, teflubenzuron, teflutrin, tetrachlorvinphos, tiacloprid, tiamethoxytriophonate, thiatrophenolate Bacillus thuringiensissubsp. Aizawai, Bacillus thuringiensis subsp. kurstaki, nucleopoliedrovirus, Bacillus thuringiensis encapsulated delta-endotoxin, bacillovirus, entomopathogenic bacteria, entomopathogenic viruses and entomopathogenic fungi.
Merece observação específica uma composição de acordo com apresente invenção em que pelo menos um agente ou composto biologicamenteativo adicional é selecionado a partir do grupo que consiste de abamectina,acefato, acetamiprid, acetoprol, amidoflumet (S-1955), avermectina,azadiractina, azinfós-metil, bifentrina, bifenazato, bistrifluron, buprofezina,carbofuran, cartap, clorfenapir, clorfluazuron, clorpirifós, clorpirifós-metil,cromafenozida, clotianidina, ciflutrina, beta-ciflutrina, cialotrina, gama-cialotrina,lambda-cialotrina, cipermetrina, ciromazina, deltametrina, diafentiuron,diazinon, dieldrina, diflubenzuron, dimetoato, dinotefuran, diofenolan,emamectina, endosulfan, esfenvarelato, etiprol, fenotiocarb, fenoxicarb,fenpropatrina, fenvarelato, fipronil, flonicamid, flubendiamida, flucitrinato, tau-fluvalinato, flufenerim (UR-50701), flufenoxuron, halofenozida, hexaflumuron,hidrametilnon, imidacloprid, indoxacarb, isofenfós, lufenuron, malation,metaflumizona, metaldeído, metamidofós, metidation, metomil, metoprene,metoxiclor, metoxifenozida, metoflutrina, monocrotofós, nitenpiram, nitiazina,novaluron, noviflumuron (XDE-007), oxamil, paration, paration-metil,permetrina, forato, fosalona, fosmet, fosfamidon, pirimicarb, profenofós,proflutrina, protrifenbute, pimetrozina, piretrina, piridalil, piriproxifen, rotenona,rianodina, S1812 (VaIent)1 espinosad, espiridiclofen, espiromesifen (BSN 2060),sulprofós, tebufenozida, teflubenzuron, teflutrina, terbufós, tetraclorvinfós,tiacloprid, tiametoxam, tiodicarb, tiosultap-sódio, tolfenpirad, tralometrina,triazamato, triclorfon, triflumuron, aldicarb, fenamifós, amitraz, chinometionat,clorobenzilato, cihexatina, dicofol, dienoclor, etoxazol, fenazaquina, oxido defenbutatina, fenpiroximato, hexitiazox, propargita, piridaben, tebufenpirad,Bacillus thuringiensis aizawai, Bacillus thuringiensis kurstaki, delta-endotoxinade Bacillus thuringiensis, bacilovírus, bactérias entomopatogênicas, vírusentomopatogênicos e fungos entomopatogênicos.Of particular note is a composition according to the present invention wherein at least one additional biologically active agent or compound is selected from the group consisting of abamectin, acetate, acetamiprid, acetoprol, amidoflumet (S-1955), avermectin, azadiractin, azinphosphine. methyl, bifenthrin, bifenazate, bistrifluron, buprofezin, carbofuran, cartap, chlorfenapyr, chlorfluazuron, chlorpyrifos, chlorpyrifos-methyl, chromafenozide, clotianidine, cyfluthrin, beta-cyfluthrin, gamma cyrothruthinine, cyrothruthinine, diafentiuron, diazinon, dieldrin, diflubenzuron, dimethoate, dinotefuran, diophenolan, emamectin, endosulfan, sphenvarelate, etiprol, fenothiocarb, fenpropicarin, fenvarelate, fenprelil, fipronil, flonictruvate, flubufenulfate, flubendaminate, flubendaminate, flubendaminate, flubendaminate, , halofenozide, hexaflumuron, hydramethylnon, imidacloprid, indoxacarb, isofenphos, lufenuron, malation, metaflumizone, metalldehyde of, metamidophos, metidation, methomyl, metoprene, methoxychlor, methoxyphenozide, metofluthrin, monocrotophos, nitenpiram, nitiazine, novaluron, noviflumuron (XDE-007), oxamyl, paration, paration-methyl, permethrin, phosphatonate, phosphamone , profenophos, profluthrin, protrifenbute, pimetrozine, pyrethrin, pyridalyl, pyriproxyfen, rotenone, ryanodine, S1812 (VaIent) 1 spinosad, spiridiclofen, spiromesifen (BSN 2060), sulprofos, tebufenozide, teflubenzyron, teflubenzuron, teflubenzuron thiodicarb, thiosultap-sodium, tolfenpyrad, tralometrine, triazamate, trichloron, triflumuron, aldicarb, fenamiphos, amitraz, chinomethionat, chlorobenzylate, cyhexatin, dicofol, dienochlor, ethoxazole, phenazaquine, oxido fenbutyrate, tetrahydrate, tetrahydrate aizawai thuringiensis, Bacillus thuringiensis kurstaki, delta endotoxinade Bacillus thuringiensis, bacillovirus, entomopathogenic bacteria, entomopath virus ogenic and entomopathogenic fungi.
Também merece observação uma composição de acordo com apresente invenção em que pelo menos um agente ou composto biologicamenteativo adicional é selecionado a partir do grupo que consiste de abamectina,acetamiprid, amitraz, avermectina, azadiractina, bifentrina, buprofezina, cartap,clorantraniliprol, clorfenapir, clorpirifós, clotianidina, ciflutrina, beta-ciflutrina,cialotrina, lambda-cialotrina, cipermetrina, ciromazina, deltametrina, dieldrina,dinotefuran, diofenolan, emamectina, endosulfan, esfenvarelato, etiprol,fenotiocarb, fenoxicarb, fenvarelato, fipronil, flonicamid, flubendiamida,flufenoxuron, hexaflumuron, hidrametilnon, imidacloprid, indoxacarb, lufenuron,metaflumizona, metomil, metoprene, metoxifenozida, nitenpiram, nitiazina,novaluron, oxamil, pimetrozina, piretrina, piridaben, piridalil, piriproxifen,rianodina, espinetoram, espinosad, espirodiclofen, espiromesifen, tebufenozida,tiacloprid, tiametoxam, tiodicarb, tiosultap-sódio, tralometrina, triazamato,triflumuron, Bacilius thuringiensis subsp. aizawai, Bacillus thuringiensis subsp.kurstaki, nucleopoliedrovírus e delta-endotoxina encapsulada de Bacillusthuringiensis.Also of note is a composition according to the present invention wherein at least one additional biologically active agent or compound is selected from the group consisting of abamectin, acetamiprid, amitraz, avermectin, azadiractin, bifentrin, buprofezin, cartap, chlorantraniliprol, chlorphenapyr, chlorpyrifos , clotianidine, cyfluthrin, beta-cyfluthrin, cyhalothrin, lambda-cyhalothrin, cypermethrin, cyromazine, deltamethrin, dieldrin, dinotefuran, diophenolan, emamectin, endosulfan, sphenvarelate, etiprol, fenotiendonuron, fluvumphonate, fluvofenamide hydramethylnon, imidacloprid, indoxacarb, lufenuron, metaflumizone, methomyl, metoprene, methoxyphenzide, nitenpiram, nitiazine, novaluron, oxamyl, pimetrozine, pyrethrin, pyridaben, pyridalyl, pyriproxifen, rianodiclen, sphenofenamide, tibenamide , thiodicarb, thiosultap-sodium, tralometrine, triazamate, triflum uron, Bacilius thuringiensis subsp. aizawai, Bacillus thuringiensis subsp.kurstaki, nucleopoliedrovirus and encapsulated Bacillusthuringiensis delta endotoxin.
Merece observação adicional uma composição de acordo com apresente invenção em que o pelo menos um agente ou compostobiologicamente ativo adicional é selecionado a partir do grupo que consiste decipermetrina, cialotrina, ciflutrina e beta-ciflutrina, esfenvarelato, fenvarelato,tralometrina, fenotiocarb, metomil, oxamil, tiodicarb, acetamiprid, clotianidina,imidacloprid, tiametoxam, tiacloprid, indoxacarb, espinosad, abamectina,avermectina, emamectina, endossulfan, etiprol, fipronil, flufenoxuron,triflumuron, diofenolan, piriproxifen, pimetrozina, amitraz, Bacillus thruingiensisaizawai, Bacillus thuringiensis kurstaki, delta endotoxina de Bacillusthuringiensis e fungos entomófagos.Further note is a composition according to the present invention wherein the at least one additional or compostobiologically active agent is selected from the group consisting of decipermethrin, cyhalothrin, cyfluthrin and beta-cyfluthrin, sphenvarelate, fenvarelate, tralomethrin, phenothiocarb, methomyl, oxamyl , thiodicarb, acetamiprid, clotianidine, imidacloprid, tiametoxam, tiacloprid, indoxacarb, spinosad, abamectin, avermectin, emamectin, endosulfan, ethiprol, fipronil, flufenoxuron, triflumuron, diphenylan thipropane, pyrazine thiocyanate Bacillusthuringiensis and entomophagous fungi.
Para realizações em que são utilizados um ou mais desses váriosparceiros de mistura, a razão em peso entre esses vários parceiros de mistura(no total) e o composto da Fórmula 1 é tipicamente de cerca de 1:3000 a cercade 3000:1. Merecem observação razões em peso de cerca de 1:300 a cerca de300:1 (tais como razões de cerca de 1:30 a cerca de 30:1). Os técnicos noassunto podem determinar facilmente por meio de experimentação simples asquantidades biologicamente eficazes de ingredientes ativos necessários para oespectro desejado de atividade biológica. Será evidente que a inclusão dessescomponentes adicionais pode expandir o espectro de pragas invertebradascontroladas para além do espectro controlado pelo composto da Fórmula 1isoladamente.For embodiments where one or more of these various mixing partners are used, the weight ratio between these various mixing partners (in total) and the compound of Formula 1 is typically from about 1: 3000 to about 3000: 1. Note weight ratios of from about 1: 300 to about 300: 1 (such as ratios of about 1:30 to about 30: 1). Those skilled in the art can readily determine by simple experimentation the biologically effective amounts of active ingredients required for the desired spectrum of biological activity. It will be apparent that the inclusion of such additional components may expand the spectrum of controlled invertebrate pests beyond the spectrum controlled by the compound of Formula 1 alone.
Em certos casos, combinações de um composto de acordo com apresente invenção com outros agentes ou compostos (ou seja, ingredientesativos) biologicamente ativos (particularmente no controle de pragasinvertebradas) podem resultar em um efeito maior que o aditivo (ou seja,sinérgico). Sempre é desejável reduzir a quantidade de ingredientes ativosliberados no ambiente ainda que garantindo controle eficaz de pragas. Quandofor encontrada sinergia de ingredientes ativos de controle de pragasinvertebradas em taxas de aplicação que gerem níveis agronomicamentesatisfatórios de controle de pragas invertebradas, essas combinações podemser vantajosas para reduzir o custo de produção de safras e reduzir a cargaambiental.In certain cases, combinations of a compound according to the present invention with other biologically active agents or compounds (i.e. active ingredients) (particularly in the control of invertebrate pests) may result in a greater effect than the additive (i.e. synergistic). It is always desirable to reduce the amount of active ingredients released into the environment while ensuring effective pest control. When synergy of active invertebrate pest control ingredients is found at application rates that generate satisfactory agronomic levels of invertebrate pest control, these combinations may be advantageous in reducing crop production costs and reducing environmental burden.
Merece observação uma combinação de um composto daFórmula 1 com pelo menos um outro ingrediente ativo de controle de pragasinvertebradas. Merece observação específica uma combinação em que o outroingrediente ativo de controle de pragas invertebradas possui um local de açãodiferente do composto da Fórmula 1. Em certos casos, uma combinação compelo menos um outro ingrediente ativo de controle de pragas invertebradas quepossui um espectro de controle similar mas local de ação diferente seráparticularmente vantajosa para administração de resistência. Desta forma, umacomposição de acordo com a presente invenção pode compreenderadicionalmente uma quantidade biologicamente eficaz de pelo menos umingrediente ativo de controle de pragas invertebradas adicional que possui umespectro de controle similar mas local de ação diferente. O contato de umaplanta geneticamente modificada para que expresse um composto de pragainvertebrada (tal como proteína) ou o local da planta com uma quantidadebiologicamente eficaz de um composto de acordo com a presente invençãopode também fornecer um espectro mais amplo de proteção às plantas e servantajoso para a administração de resistência.Note a combination of a Formula 1 compound with at least one other active pest control ingredient. Of particular note is a combination in which the other active invertebrate pest control ingredient has a different site of action than the compound of Formula 1. In certain cases, a combination of at least one other active invertebrate pest control ingredient that has a similar control spectrum but Different site of action will be particularly advantageous for resistance administration. Accordingly, a composition according to the present invention may additionally comprise a biologically effective amount of at least one additional active invertebrate pest control ingredient having a similar control spectrum but different site of action. Contacting a genetically modified plant to express a pragainvertebrate compound (such as protein) or the plant site with a biologically effective amount of a compound according to the present invention may also provide a broader spectrum of plant protection and is beneficial for resistance administration.
A Tabela A relaciona combinações específicas de um compostoda Fórmula 1 com outros agentes de controle de pragas invertebradas queilustram as misturas, composições e métodos de acordo com a presenteinvenção. A primeira coluna da Tabela A relaciona os agentes de controle depragas invertebradas específicos (tais como "abamectina" na primeira linha). Asegunda coluna da Tabela A relaciona o modo de ação (quando conhecido) ouclasse química dos agentes de controle de pragas invertebradas. A terceiracoluna da Tabela A relaciona realização(ões) de faixas de razões em peso parataxas em que o agente de controle de pragas invertebradas pode ser aplicadocom relação a um composto da Fórmula 1, seu N-óxido ou sal (tal como "50:1 a1:50" de abamectina com relação a um composto da Fórmula 1 em peso).Table A lists specific combinations of a Formula 1 compound with other invertebrate pest control agents illustrating the mixtures, compositions and methods according to the present invention. The first column of Table A lists specific invertebrate control agents (such as "abamectin" in the first row). The second column of Table A lists the mode of action (where known) or chemical class of invertebrate pest control agents. The third column of Table A relates to the realization (s) of relative weight ratio ranges where the invertebrate pest control agent may be applied to a compound of Formula 1, its N-oxide or salt (such as "50: 1"). a: 1:50 "abamectin with respect to a compound of Formula 1 by weight).
Desta forma, por exemplo, a primeira linha da Tabela A descreveespecificamente que a combinação de um composto da Fórmula 1 comabamectina pode ser aplicada em razão em peso de 50:1 a 1:50. As linhasrestantes da Tabela A devem ser interpretadas de forma similar. Mereceobservação adicional que a Tabela A relaciona combinações específicas decomposto da Fórmula 1 com outros agentes de controle de pragasinvertebradas ilustrativos das misturas, composições e métodos de acordo coma presente invenção e inclui realizações adicionais de faixas de razão em pesopara taxas de aplicação.Thus, for example, the first row of Table A specifically describes that the combination of a compound of Formula 1 withbamectin may be applied by weight ratio from 50: 1 to 1:50. The remaining lines of Table A should be interpreted similarly. It is further noted that Table A relates specific decomposed combinations of Formula 1 with other illustrative invertebrate pest control agents of the mixtures, compositions and methods according to the present invention and includes additional embodiments of weight ratio ranges for application rates.
Tabela aTable a
<table>table see original document page 115</column></row><table><table>table see original document page 116</column></row><table><table>table see original document page 117</column></row><table><table>table see original document page 118</column></row><table><table>table see original document page 119</column></row><table><table> table see original document page 115 </column> </row> <table> <table> table see original document page 116 </column> </row> <table> <table> table see original document page 117 < / column> </row> <table> <table> table see original document page 118 </column> </row> <table> <table> table see original document page 119 </column> </row> <table>
Uma realização de agentes de controle de pragas invertebradas(tais como inseticidas e acaricidas) para mistura com compostos de acordocom a presente invenção inclui moduladores de canais de sódio tais comobifentrina, cipermetrina, cialotrina, lambda-cialotrina, ciflutrina, beta-ciflutrina,deltametrina, dimeflutrina, esfenvarelato, fenvarelato, indoxacarb, metoflutrina,proflutrina, piretrina e tralometrina; inibidores da colinesterase, tais comoclorpirifós, metomil, oxamil, tiodicarb e triazamato; neonicotinóides, tais comoacetamiprid, clotianidina, dinotefuran, imidacloprid, nitempiram, nitiazina,tiacloprid e tiametoxam; Iactonas macrocíclicas inseticidas, tais comoespinetoram, espinosad, abamectina, avermectina e emamectina;bloqueadores de canais de cloreto regulados por GABA (ácido γ-aminobutírico),tais como endossufan, etiprol e fipronil; inibidores da síntese de chitina, taiscomo buprofezina, ciromazina, flufenoxuron, hexaflumuron, lufenuron,novaluron, noviflumuron e triflumuron; imitadores de hormônios juvenis, taiscomo diofenolan, fenoxicarb, metoprene e piriproxifen; Iigantes receptores deoctopamina, tais como amitraz; agonistas de ecdisona, tais como azadiractina,metoxifenozida e tebufenozida; Iigantes receptores de rianodina, tais comorianodina, diamidas antranílicas tais como clorantraniliprol (vide a PatenteNorte-Americana n° 6.747.047, Publicações PCT WO 2003/015518 e WO2004/067528) e flubendiamida (vide Patente Norte-Americana n° 6.603.044);análogos de nereistoxina tais como cartap; inibidores do transporte de elétronsda mitocôndria tais como clorfenapir, hidrametilnon e piridaben; inibidores dabiossíntese de lipídios, tais como espirodiclofen e espiromesifen; inseticidas deciclodieno tais como dieldrina; ciflumetofen; fenotiocarb; flonicamid;metaflumizona; pirafluprol; piridalil; piriprol; pimetrozina; espirotetramat etiosultap-sódio. Uma realização de agentes biológicos para mistura comcompostos de acordo com a presente invenção inclui nucleopoliedrovírus taiscomo HzNPV e AfN PV; Bacillus thuringiensis e delta-endotoxinasencapsuladas de Bacillus thuringiensis, tais como Cellcap, MPV e MPVII; bemcomo inseticidas virais de ocorrência natural e geneticamente modificados queincluem membros da família dos bacilovirídeos, bem como fungosentomófagos. Merece observação a composição de acordo com a presenteinvenção em que o pelo menos um agente ou composto biologicamente ativoadicional é selecionado a partir dos Agentes de Controle de PragasInvertebradas relacionados na Tabela A acima.An embodiment of invertebrate pest control agents (such as insecticides and acaricides) for admixture with compounds of the present invention includes sodium channel modulators such asobifenthrin, cypermethrin, cyhalothrin, lambda-cyhalothrin, cyfluthrin, beta-cyfluthrin, deltamethrin, dimeflutrin, sphenvarelate, fenvarelate, indoxacarb, metofluthrin, profluthrin, pyrethrin and tralomethrin; cholinesterase inhibitors such as chlorpyrifos, methomyl, oxamyl, thiodicarb and triazamate; neonicotinoids, such as acetamprid, clotianidine, dinotefuran, imidacloprid, nitempiram, nitiazine, thiacloprid and thiametoxam; Insecticidal macrocyclic lactones such as sputum, spinosad, abamectin, avermectin and emamectin; GABA (γ-aminobutyric acid) -regulated chloride channel blockers such as endosufan, etiprol and fipronil; chitin synthesis inhibitors such as buprofezin, cyromazine, flufenoxuron, hexaflumuron, lufenuron, novaluron, noviflumuron and triflumuron; juvenile hormone mimics such as diofenolan, phenoxycarb, metoprene and pyriproxyfen; Deoctopamine receptor binders such as amitraz; ecdisone agonists such as azadiractin, methoxyphenozide and tebufenozide; Ryanodine receptor binders such as comorianodine, anthranilic diamides such as chlorantraniliprol (see U.S. Patent No. 6,747,047, PCT Publications WO 2003/015518 and WO2004 / 067528) and flubendiamide (see U.S. Patent No. 6,603,044) nereistoxin analogs such as cartap; mitochondrial electron transport inhibitors such as chlorfenapyr, hydramethylnon and pyridaben; lipid diosynthesis inhibitors such as spirodiclofen and spiromesifen; decyclodiene insecticides such as dieldrin; ciflumetofen; fenothiocarb; flonicamid; metaflumizone; pirafluprol; pyridalyl; pyriprole; pymetrozine; spirotetramat etiosultap-sodium. An embodiment of compounding biological agents according to the present invention includes nucleopolydoviruses such as HzNPV and AfN PV; Bacillus thuringiensis and delta-endotoxins encapsulated from Bacillus thuringiensis, such as Cellcap, MPV and MPVII; as well as genetically modified and naturally occurring viral insecticides that include members of the bacillovirid family as well as fungi-phages. Of note is the composition according to the present invention wherein the at least one additional biologically active agent or compound is selected from the Invertebrate Pest Control Agents listed in Table A above.
As razões em peso entre um composto, incluindo um compostoda Fórmula 1, seu N-óxido ou sal, e o agente de controle de pragasinvertebradas adicional são tipicamente de 1000:1 a 1:1000, em que umarealização é de 500:1 a 1:500, outra realização é de 250:1 a 1:200 e outrarealização é de 100:1 a 1:50.Encontram-se relacionadas abaixo na Tabela B realizações decomposições específicas que compreendem composto da Fórmula 1 (osnúmeros de compostos designam compostos nas Tabelas índice A a C) eagente de controle de pragas invertebradas adicional.The weight ratios between a compound including a Formula 1 compound, its N-oxide or salt, and the additional invertebrate pest control agent are typically from 1000: 1 to 1: 1000, where an embodiment is from 500: 1 to 1. : 500, another embodiment is from 250: 1 to 1: 200 and the other embodiment is from 100: 1 to 1: 50. Listed below are embodiments of specific decompositions comprising compound of Formula 1 (compound numbers designate compounds in the Index Tables A to C) and additional invertebrate pest control agent.
Tabela BTable B
<table>table see original document page 121</column></row><table><table>table see original document page 122</column></row><table><table>table see original document page 123</column></row><table><table>table see original document page 124</column></row><table><table> table see original document page 121 </column> </row> <table> <table> table see original document page 122 </column> </row> <table> <table> table see original document page 123 < / column> </row> <table> <table> table see original document page 124 </column> </row> <table>
As misturas específicas relacionadas na Tabela B tipicamentecombinam composto da Fórmula 1 com o outro agente de pragas invertebradasnas razões especificadas na Tabela A.Specific mixtures listed in Table B typically combine the compound of Formula 1 with the other invertebrate pest agent for the reasons specified in Table A.
As pragas invertebradas são controladas em aplicaçõesagronômicas e não agronômicas por meio da aplicação de um ou maiscompostos de acordo com a presente invenção, tipicamente na forma decomposição, em uma quantidade biologicamente eficaz, ao ambiente daspragas, que inclui o local de infestação agronômico e/ou não agronômico, àárea a ser protegida ou diretamente sobre as pragas a serem controladas.Invertebrate pests are controlled in agronomic and non-agronomic applications by applying one or more compounds according to the present invention, typically in the form of decomposition, in a biologically effective amount, to the pest environment, including the site of agronomic infestation and / or non-agronomic, the area to be protected or directly over the pests to be controlled.
Desta forma, a presente invenção compreende um método decontrole de pragas invertebradas em aplicações agronômicas e/ou nãoagronômicas, que compreende o contato da praga invertebrada ou seuambiente com uma quantidade biologicamente eficaz de um ou mais doscompostos de acordo com a presente invenção, ou com uma composição quecompreende pelo menos um desses compostos ou uma composição quecompreende pelo menos um desses compostos e uma quantidadebiologicamente eficaz de pelo menos um agente ou composto biologicamenteativo adicional. Exemplos de composições apropriadas que compreendem umcomposto de acordo com a presente invenção e uma quantidadebiologicamente eficaz de pelo menos um agente ou composto biologicamenteativo adicional incluem composições granulares, em que o composto ativoadicional está presente sobre o mesmo grânulo do composto de acordo com apresente invenção ou sobre grânulos separados do composto de acordo com apresente invenção.Accordingly, the present invention comprises a method of controlling invertebrate pests in agronomic and / or nonagronomic applications comprising contacting the invertebrate pest or its environment with a biologically effective amount of one or more of the compounds according to the present invention or a A composition comprising at least one such compound or a composition comprising at least one such compound and a biologically effective amount of at least one additional biologically active agent or compound. Examples of suitable compositions comprising a compound according to the present invention and a biologically effective amount of at least one additional biologically active agent or compound include granular compositions, wherein the additional active compound is present on the same granule as the compound according to the present invention or above. separate granules of the compound according to the present invention.
Para atingir contato com um composto ou composição de acordocom a presente invenção para proteger uma safra de campo contra pragasinvertebradas, o composto ou a composição é aplicada tipicamente à sementeda safra antes do plantio, à folhagem (tal como folhas, hastes, flores, frutos) deplantas de safra ou ao solo ou outro meio de crescimento antes ou depois doplantio da safra.In order to achieve contact with a compound or composition according to the present invention to protect a field crop against invertebrate pests, the compound or composition is typically applied to the crop before planting, to foliage (such as leaves, stems, flowers, fruits). plant or soil plants or other growth media before or after crop planting.
Uma realização de um método de contato é por meio depulverização. Alternativamente, uma composição granular que compreendecomposto de acordo com a presente invenção pode ser aplicada à folhagem daplanta ou ao solo. Os compostos de acordo com a presente invenção podemtambém ser efetivamente fornecidos por meio de absorção da planta porcontato da planta com uma composição que compreende um composto deacordo com a presente invenção aplicado na forma de encharcamento de solocom uma formulação líquida, uma formulação granular ao solo, tratamento deuma caixa de mudas ou mergulhamento de transplantes. Merece observaçãouma composição de acordo com a presente invenção na forma de formulaçãolíquida para encharcamento de solo. Também merece observação um métodode controle de pragas invertebradas que compreende o contato da pragainvertebrada ou seu ambiente com uma quantidade biologicamente eficaz deum composto de acordo com a presente invenção ou com uma composiçãoque compreende uma quantidade biologicamente eficaz de um composto deacordo com a presente invenção. Merece observação adicional é o método emque o ambiente é solo e a composição é aplicada ao solo na forma deformulação de encharcamento de solo. Merece observação adicional quecompostos de acordo com a presente invenção também são eficazes por meiode aplicação localizada ao local de infestação. Outros métodos de contatoincluem a aplicação de um composto ou composição de acordo com a presenteinvenção por meio de pulverizações diretas e residuais, pulverizações aéreas,géis, revestimentos de sementes, microencapsulações, absorção sistêmica,iscas, marcas de orelhas, misturas, nebulizadores, fumigantes, aerossóis, póse muitos outros. Uma realização de método de contato é um grânulo, bastão oupastilha fertilizante com dimensões estáveis que compreende um composto oucomposição de acordo com a presente invenção. Os compostos de acordo coma presente invenção podem também ser impregnados em materiais para afabricação de dispositivos de controle de invertebrados (tais como redes contrainsetos).One embodiment of a contact method is by means of spraying. Alternatively, a granular composition comprising a composition according to the present invention may be applied to plant foliage or soil. The compounds according to the present invention may also be effectively provided by absorbing the plant by contacting the plant with a composition comprising a compound according to the present invention applied in the form of soil soaking with a liquid formulation, a granular soil formulation, treatment of a seedling box or transplant dipping. A composition according to the present invention is in the form of a liquid formulation for soaking soil. Also of note is an invertebrate pest control method comprising contacting the invertebrate pest or its environment with a biologically effective amount of a compound according to the present invention or with a composition comprising a biologically effective amount of a compound according to the present invention. Deserves further observation is the method in which the environment is soil and the composition is applied to the soil in the form of soil drenching. It deserves further observation that compounds according to the present invention are also effective by localized application to the infestation site. Other contact methods include the application of a compound or composition according to the present invention by direct and residual sprays, aerial sprays, gels, seed coatings, microencapsulations, systemic absorption, bait, ear tags, mixtures, nebulizers, fumigants, aerosols, and many others. One contact method embodiment is a stable size fertilizer granule, stick or pad comprising a compound or composition according to the present invention. The compounds according to the present invention may also be impregnated with materials for fabrication of invertebrate control devices (such as counter-insects).
Os compostos de acordo com a presente invenção também sãoúteis em tratamentos de sementes para proteger sementes contra pragasinvertebradas. No contexto do presente relatório descritivo e reivindicações, otratamento de semente indica o contato da semente com uma quantidadebiologicamente eficaz de composto de acordo com a presente invenção, que étipicamente formulado na forma de composição de acordo com a presenteinvenção. Este tratamento de semente protege a semente contra pragasinvertebradas do solo e geralmente pode também proteger raízes e outraspartes da planta em contato com o solo da muda que se desenvolve a partir dasemente em germinação. O tratamento de sementes pode também fornecerproteção da folhagem por meio de translocação do composto de acordo com apresente invenção ou segundo ingrediente ativo na planta em desenvolvimento.Tratamentos de sementes podem ser aplicados a todos os tipos de sementes,incluindo aquelas das quais germinarão plantas geneticamente transformadaspara expressar características especializadas. Exemplos representativosincluem as que expressam proteínas tóxicas para pragas invertebradas, taiscomo toxina de Bacillus thuringiensis ou as que expressam resistência aherbicidas tais como gIifosato acetiltransferase, que fornece resistência aglifosato.The compounds of the present invention are also useful in seed treatments to protect seeds against invertebrate pests. In the context of the present disclosure and claims, seed treatment indicates contact of the seed with a biologically effective amount of compound according to the present invention, which is typically formulated as a composition according to the present invention. This seed treatment protects the seed against soil invertebrate pests and can generally also protect roots and other parts of the plant in contact with the soil from seedlings that develop from the germinating germination. Seed treatment can also provide foliage protection by translocating the compound according to the present invention or second active ingredient into the developing plant. Seed treatments can be applied to all types of seeds, including those from which genetically transformed plants will germinate. express specialized characteristics. Representative examples include those expressing proteins toxic to invertebrate pests, such as Bacillus thuringiensis toxin or those expressing herbicide resistance such as glyphosate acetyltransferase, which provides agglosphosate resistance.
Um método de tratamento de sementes é por meio depulverização ou polvilhamento da semente com um composto de acordo com apresente invenção (ou seja, na forma de composição formulada) antes doplantio das sementes. Composições formuladas para o tratamento desementes geralmente compreendem um agente adesivo ou formador de filme.One method of treating seeds is by spraying or dusting the seed with a compound according to the present invention (i.e., in formulated composition form) prior to seed planting. Compositions formulated for seed treatment generally comprise an adhesive or film-forming agent.
Portanto, uma composição de revestimento de sementes de acordo com apresente invenção compreende tipicamente uma quantidade biologicamenteeficaz de um composto da Fórmula 1, seu N-óxido ou sal e um formador defilme ou agente adesivo. As sementes podem ser revestidas por meio depulverização de um concentrado em suspensão fluida diretamente para umleito de tombamento de sementes e secagem das sementes em seguida.Therefore, a seed coating composition according to the present invention typically comprises a biologically effective amount of a compound of Formula 1, its N-oxide or salt and a film former or adhesive agent. The seeds may be coated by spraying a fluid suspension concentrate directly onto a seed tipping bed and then drying the seeds.
Alternativamente, outros tipos de formulação tais como pós umedecidos,soluções, suspoemulsões, concentrados emlusionáveis e emulsões em águapodem ser pulverizados sobre a semente. Este processo é particularmente útilpara aplicação de revestimentos de filme sobre sementes. Vários processos emáquinas de revestimento são disponíveis para os técnicos no assunto.Processos apropriados incluem os relacionados em P. Kosters et al, SeedTreatment: Progress and Prospects, Monografia BCPC 1994 n° 57, ereferências ali relacionadas.Alternatively, other types of formulation such as wet powders, solutions, suspoemulsions, melt concentrates and water emulsions may be sprayed onto the seed. This process is particularly useful for applying seed film coatings. Various processes and coating machines are available to those skilled in the art. Suitable processes include those listed in P. Kosters et al, SeedTreatment: Progress and Prospects, Monograph BCPC 1994 No. 57, and related references.
A semente tratada compreende tipicamente um composto deacordo com a presente invenção em quantidade de cerca de 0,1 g a 1 kg por100 kg de sementes (ou seja, cerca de 0,0001 a 1% em peso da sementeantes do tratamento). Uma suspensão fluida formulada para tratamento desementes compreende tipicamente cerca de 0,5 a cerca de 70% do ingredienteativo, cerca de 0,5 a cerca de 30% de um adesivo formador de filme, cerca de0,5 a cerca de 20% de um agente dispersante, 0 a cerca de 5% de umespessante, 0 a cerca de 5% de pigmento e/ou tinta, 0 a cerca de 2% de umagente antiespumante, 0 a cerca de 1% de um conservante e 0 a cerca de 75%de um diluente líquido volátil.The treated seed typically comprises a compound according to the present invention in an amount of from about 0.1 g to 1 kg per 100 kg of seeds (i.e. about 0.0001 to 1% by weight of the seeds after treatment). A fluid suspension formulated for seed treatment typically comprises about 0.5 to about 70% of the reactive ingredient, about 0.5 to about 30% of a film-forming adhesive, about 0.5 to about 20% of an active ingredient. dispersing agent, 0 to about 5% of a thickener, 0 to about 5% of pigment and / or paint, 0 to about 2% of a defoaming agent, 0 to about 1% of a preservative and 0 to about 75 % of a volatile liquid diluent.
Os compostos de acordo com a presente invenção podem ser1incorporados a uma composição de isca que é consumida por pragasinvertebradas ou utilizados em um dispositivo tal como uma armadilha, estaçãode isca e similares. Essa composição de isca pode apresentar-se na forma degrânulos que compreendem (a) ingredientes ativos, nomeadamente umaquantidade biologicamente eficaz de um composto da Fórmula 1, seu A/-óxidoou sal, (b) um ou mais materiais alimentícios, opcionalmente (c) um atrativo e,opcionalmente, (d) um ou mais umectantes. Merecem observação grânulos oucomposições de isca que compreendem cerca de 0,001 a 5% de ingredientesativos, cerca de 40 a 99% de material alimentício e/ou atrativo e,opcionalmente, cerca de 0,05 a 10% de umectantes, que são eficazes nocontrole de pragas invertebradas do solo em taxas de aplicação muito baixas,particularmente em doses de ingrediente ativo que são letais por ingestão emvez de por contato direto. Alguns materiais alimentícios podem funcionar comofonte de alimento e como atrativo. Os materiais alimentícios incluemcarboidratos, proteínas e lipídios. Exemplos de materiais alimentícios sãofarinha vegetal, açúcar, amidos, gordura animal, óleo vegetal, extratos delevedura e sólidos de leite. Exemplos de atrativos são odorizantes earomatizantes, tais como extratos de plantas ou de frutas, perfume ou outrocomponente animal ou vegetal, feromônios ou outros agentes conhecidos poratraírem pragas invertebradas alvo. Exemplos de umectantes, ou seja, agentesretentores de umidade, são glicóis e outros polióis, glicerina e sorbitol. Mereceobservação uma composição de isca (e um método de uso dessa composiçãode isca) utilizada para controlar pelo menos uma praga invertebradaselecionada a partir do grupo que consiste de formigas, cupins e baratas. Umdispositivo de controle de pragas invertebradas pode compreender acomposição de isca do presente e um abrigo adaptado para receber acomposição de isca, em que o abrigo possui pelo menos uma aberturadimensionada para permitir que a praga invertebrada passe através daabertura, de forma que a praga invertebrada possa ter acesso à composição deisca a partir de um local fora do abrigo e em que o abrigo é adicionalmenteadaptado para colocação em um local de atividade conhecida ou potencial paraa praga invertebrada.The compounds of the present invention may be incorporated into a bait composition that is consumed by invertebrate pests or used in a device such as a trap, bait station and the like. Such a bait composition may be in the form of granules comprising (a) active ingredients, namely a biologically effective amount of a compound of Formula 1, its A / -oxide or salt, (b) one or more food materials, optionally (c) an attractive and optionally (d) one or more humectants. Note that granules or bait compositions comprising about 0.001 to 5% of active ingredients, about 40 to 99% of food and / or attractive material and optionally about 0.05 to 10% of humectants, which are effective in controlling Invertebrate soil pests at very low application rates, particularly at active ingredient doses that are lethal by ingestion rather than by direct contact. Some food materials may work as food sources and as attractive. Food materials include carbohydrates, proteins and lipids. Examples of food materials are vegetable flour, sugar, starches, animal fat, vegetable oil, yeast extracts and milk solids. Examples of attractants are odorants and flavorants such as plant or fruit extracts, perfume or other animal or plant components, pheromones or other agents known to target target invertebrate pests. Examples of humectants, ie moisture retaining agents, are glycols and other polyols, glycerin and sorbitol. Note a bait composition (and a method of using this bait composition) used to control at least one selected invertebrate pest from the group consisting of ants, termites and cockroaches. An invertebrate pest control device may comprise gift bait assembly and a shelter adapted for receiving bait arrangement, wherein the shelter has at least one dimensioned opening to allow the invertebrate pest to pass through the opening so that the invertebrate pest may have access to composition is from a location outside the shelter and where the shelter is further adapted for placement in a known or potential invertebrate pest site.
Os compostos de acordo com a presente invenção podem seraplicados sem outros adjuvantes, mas mais freqüentemente a aplicação seráde uma formulação que compreende um ou mais ingredientes ativos comveículos, diluentes e tensoativos apropriados e, possivelmente, em combinaçãocom um alimento, dependendo do uso final contemplado. Um método deaplicação envolve a pulverização de uma dispersão em água ou solução emóleo refinado de um composto de acordo com a presente invenção.Combinações com óleos de pulverização, concentrações de óleo depulverização, adesivos espalhantes, adjuvantes, outros solventes e sinérgicostais como butóxido de piperonila freqüentemente aumentam a eficácia docomposto. Para usos não agronômicos, essas pulverizações podem seraplicadas a partir de recipientes de pulverização tais como uma lata, garrafa ououtro recipiente, seja por meio de uma bomba ou de sua liberação de umrecipiente pressurizado, tal como uma lata de pulverização de aerossolpressurizada. Essas composições de pulverização podem assumir váriasformas, tais como pulverizações, névoas, espumas, fumaças ou neblina. Essascomposições de pulverização podem compreender adicionalmente, portanto,propelentes, agentes espumantes etc., conforme venha a ser o caso. Mereceobservação uma composição de pulverização que compreende umaquantidade biologicamente eficaz de um composto ou composição de acordocom a presente invenção e um veículo. Uma realização dessa composição depulverização compreende uma quantidade biologicamente eficaz de umcomposto ou composição de acordo com a presente invenção e um propelente.Os propelentes representativos incluem, mas sem limitar-se a metano, etano,propano, butano, isobutano, buteno, pentano, isopentano, neopentano,penteno, hidrofluorocarbonos, clorofluorocarbonos, dimetil éter e misturas dosacima. Merece observação uma composição de pulverização (e um métodoque utiliza essa composição de pulverização liberada de um recipiente depulverização) utilizada para controlar pelo menos uma praga invertebradaselecionada a partir do grupo que consiste de mosquitos, moscas negras,moscas dos estábulos, moscas dos cervos, moscas dos cavalos, vespas,vespas americanas, vespões, carrapatos, aranhas, formigas, mosquitos esimilares, incluindo individualmente ou em combinações.The compounds according to the present invention may be applied without other adjuvants, but most often the application will be of a formulation comprising one or more active ingredients with appropriate carriers, diluents and surfactants and possibly in combination with a food, depending on the intended end use. One method of application involves spraying a dispersion in water or refined oil solution of a compound according to the present invention. Combinations with spray oils, spray oil concentrations, spreading adhesives, adjuvants, other solvents and synergists such as piperonyl butoxide often increase compound effectiveness. For non-agronomic uses, these sprays may be applied from spray containers such as a can, bottle or other container, either by means of a pump or by releasing a pressurized container such as an aerosolpressurized spray can. Such spray compositions may take various forms, such as sprays, mists, foams, fumes or fog. Such spray compositions may therefore further comprise propellants, foaming agents etc., as the case may be. Note a spray composition comprising a biologically effective amount of a compound or composition according to the present invention and a carrier. One embodiment of such a spray composition comprises a biologically effective amount of a compound or composition according to the present invention and a propellant. Representative propellants include, but are not limited to methane, ethane, propane, butane, isobutane, butene, pentane, isopentane. , neopentane, pentene, hydrofluorocarbons, chlorofluorocarbons, dimethyl ether and mixtures above. A spray composition (and a method using such a spray composition released from a spray container) that is used to control at least one selected invertebrate pest from the group consisting of mosquitoes, black flies, stable flies, deer flies, flies deserves observation. of horses, wasps, hornets, hornets, ticks, spiders, ants, and similar mosquitoes, including individually or in combinations.
Aplicações não agronômicas incluem a proteção de animais,particularmente vertebrados, mais particularmente vertebrados homeotérmicos(tais como mamíferos ou pássaros) e, ainda mais particularmente, mamíferos,contra pragas parasíticas invertebradas por meio da administração de umaquantidade eficaz como parasiticida (ou seja, biologicamente eficaz) de umcomposto de acordo com a presente invenção, tipicamente na forma de umacomposição formulada para uso veterinário, ao animal a ser protegido. Mereceobservação, portanto, um método de proteção de animais que compreende aadministração ao animal de uma quantidade eficaz como parasiticida de umcomposto de acordo com a presente invenção. Conforme indicado no presenterelatório descritivo e nas reivindicações, as expressões "parasiticida" e "comoparasiticida" indicam efeitos observáveis sobre pragas parasitas invertebradaspara fornecer proteção de um animal contra a praga. Os efeitos parasiticidasreferem-se tipicamente à redução da ocorrência ou atividade da pragaparasítica invertebrada alvo. Esses efeitos sobre a praga incluem necrose,morte, crescimento retardado, redução da mobilidade ou redução dacapacidade de permanecer no animal hospedeiro ou sobre ele, redução daalimentação e inibição da reprodução. Estes efeitos sobre pragas parasitasinvertebradas fornecem controle (incluindo prevenção, redução ou eliminação)de infestação parasítica ou infecção do animal. Exemplos de pragas parasíticasinvertebradas controladas por meio da administração de uma quantidade eficazcomo parasiticida de um composto de acordo com a presente invenção aanimais a serem protegidos incluem ectoparasitas (artrópodes, acarinas etc.) eendoparasitas (helmíntios, tais como nematóides, trematóides, céstodes,acantocéfalos etc.). Particularmente, os compostos de acordo com a presenteinvenção são eficazes contra ectoparasitas, incluindo: moscas tais comoHaematobia (Lyperosia) irritans (mosca do chifre), Stomoxys calcitrans (moscados estábulos), Simulium spp (mosca negra), Glossina spp (mosca tse-tsé),Hydrotaea irritans (mosca da cabeça), Musca autumnalis (mosca da face),Musca domestica (mosca doméstica), Moreliia simplex (mosca do suor),Tabanus spp (mosca dos cavalos), Hypoderma bovis, Hypoderma lineatum,Lucilia sericata, Lucilia cuprina (mosca do sopro verde), Cailiphora spp (moscado sopro), Protophormia spp, Oestrus ovis (mosca do berne nasal), Culicoidesspp (mosquito pólvora), Hippobosca equine, Gastrophilus intestinalis,Gastrophilus haemorrhoidalis e Gastrophilus naslis; piolhos, tais como Bovieola(DamaIinia) bovis, Bovieola equi, Haematopinus asini, Felieola subrostratus,Heterodoxus spiniger, Lignonathus setosus e Trichodeetes eanis\ piolhos taiscomo Melophagus ovinus; ácaros, tais como Psoroptes spp, Sareoptes seabei,Chorioptes bovis, Demodex equi, Cheyletiella spp, Notoedres cati, Trombiculaspp e Otodectes cyanotis (ácaros dos ouvidos); percevejos, tais como Ixodesspp, Boophilus spp, Rhipicephalus spp, Amblyomma spp, Dermacentor spp,Hyalomma spp e Haemaphysalis spp; e pulgas tais como Ctenocephalides felis(pulga dos gatos) e Ctenocephalides canis (pulga dos cães).Non-agronomic applications include the protection of animals, particularly vertebrates, more particularly homeothermic vertebrates (such as mammals or birds), and even more particularly mammals, against invertebrate parasitic pests by administering an effective amount as a parasiticide (ie biologically effective). ) of a compound according to the present invention, typically in the form of a compound formulated for veterinary use, to the animal to be protected. A method of animal protection which comprises administering to the animal a parasiticidal effective amount of a compound according to the present invention deserves observation. As indicated in the present descriptive report and the claims, the terms "parasiticide" and "as parasiticide" indicate observable effects on invertebrate parasitic pests to provide protection of an animal against the pest. Parasiticidal effects typically refer to a reduction in the occurrence or activity of target invertebrate pragaparasitic. These effects on the pest include necrosis, death, retarded growth, reduced mobility or reduced ability to stay in or on the host animal, reduced feeding and inhibition of reproduction. These effects on parasitic invertebrate pests provide control (including prevention, reduction or elimination) of parasitic infestation or infection of the animal. Examples of invertebrate parasitic pests controlled by administering an effective parasiticidal amount of a compound according to the present invention to animals to be protected include ectoparasites (arthropods, mites etc.) and endoparasites (helminths such as nematodes, trematodes, cantodes, acanthocephalus etc. .). In particular, the compounds according to the present invention are effective against ectoparasites, including: flies such as Haematobia (Lyperosia) irritans (horn fly), Stomoxys calcitrans (threaded stables), Simulium spp (black fly), Glossina spp (tse-tse fly) ), Hydrotaea irritans (head fly), Musca autumnalis (face fly), Musca domestica (house fly), Moreliia simplex (sweat fly), Tabanus spp (horse fly), Hypoderma bovis, Hypoderma lineatum, Lucilia sericata, Lucilia cuprina (green breath fly), Cailiphora spp (musk breath), Protophormia spp, Oestrus ovis (nasal berne fly), Culicoidesspp (mosquito gunpowder), Hippobosca equine, Gastrophilus intestinalis, Gastrophilus haemorrhoidalis and Gastrophilus naslis; lice such as Bovieola (DamaIinia) bovis, Bovieola equi, Haematopinus asini, Felieola subrostratus, Heterodoxus spiniger, Lignonathus setosus and Trichodeetes eanis such as Melophagus ovinus; mites, such as Psoroptes spp, Sareoptes seabei, Chorioptes bovis, Demodex equi, Cheyletiella spp, Notoedres cati, Trombiculaspp and Otodectes cyanotis (ear mites); bed bugs such as Ixodesspp, Boophilus spp, Rhipicephalus spp, Amblyomma spp, Dermacentor spp, Hyalomma spp and Haemaphysalis spp; and fleas such as Ctenocephalides felis (cat flea) and Ctenocephalides canis (dog flea).
Aplicações não agronômicas no setor veterinário têm lugar pormeios convencionais, tais como por meio de administração enteral na forma de,por exemplo, pastilhas, cápsulas, bebidas, preparações de encharcamento,granulados, pastas, misturas, procedimentos de alimentação, supositórios; pormeio de administração parenteral, tal como por injeção (incluindointramuscular, subcutânea, intravenosa, intraperitoneal), implantes; poradministração nasal; por administração local, tal como na forma de imersão oumergulhamento, pulverização, lavagem, revestimento com pó ou aplicação auma pequena área do animal e por meio de artigos tais como coleiras, marcasna orelha, fitas na cauda, fitas de medição dos membros ou cabrestos quecompreendem compostos ou composições de acordo com a presenteinvenção.Non-agronomic applications in the veterinary sector take place by conventional means, such as by enteral administration in the form of, for example, tablets, capsules, beverages, soaking preparations, granules, pastes, mixtures, feeding procedures, suppositories; by parenteral administration, such as by injection (including intramuscular, subcutaneous, intravenous, intraperitoneal), implants; by nasal administration; by local administration, such as by dipping or dipping, spraying, washing, dusting or applying to a small area of the animal and by means of articles such as collars, ear tags, tail straps, limb measuring tapes or halters which comprise compounds or compositions according to the present invention.
Tipicamente, uma composição parasiticida de acordo com apresente invenção compreende uma mistura de um composto da Fórmula 1,seu A/-óxido ou sal, com um ou mais veículos farmacêutica ou veterinariamenteaceitáveis que compreendem excipientes e auxiliares selecionados comrelação à via de administração pretendida (tal como administração oral, local ouparenteral como injeção) e de acordo com a prática padrão. Além disso, umveículo apropriado é selecionado com base na compatibilidade com um oumais ingredientes ativos na composição, incluindo considerações tais comoestabilidade com relação ao pH e teor de umidade. Merece observação,portanto, uma composição de proteção de animais contra pragas parasitasinvertebradas que compreende uma quantidade eficaz como parasiticida de umcomposto de acordo com a presente invenção e pelo menos um veículo.Typically, a parasiticidal composition according to the present invention comprises a mixture of a compound of Formula 1, its A / oxide or salt, with one or more pharmaceutically or veterinarily acceptable carriers comprising excipients and auxiliaries selected with respect to the intended route of administration (such as as oral, local or parenteral administration as injection) and according to standard practice. In addition, an appropriate vehicle is selected based on compatibility with one or more active ingredients in the composition, including considerations such as pH stability and moisture content. Therefore, an animal parasitic pest protection composition comprising a parasiticidal effective amount of a compound according to the present invention and at least one vehicle deserves observation.
Para administração parenteral, incluindo injeção intravenosa,intramuscular e subcutânea, um composto de acordo com a presente invençãopode ser formulado em suspensão, solução ou emulsão em veículos oleososou aquosos e pode conter adjuntos tais como agentes de suspensão,estabilização e/ou dispersão. Composições farmacêuticas para injeção incluemsoluções aquosas de formas hidrossolúveis de ingredientes ativos (tais comoum sal de um composto ativo), preferencialmente em tampões fisiologicamentecompatíveis que contêm outros excipientes ou auxiliares, conforme conhecidona técnica de formulação farmacêutica.For parenteral administration, including intravenous, intramuscular and subcutaneous injection, a compound according to the present invention may be formulated in suspension, solution or emulsion in oily or aqueous vehicles and may contain adjuncts such as suspending, stabilizing and / or dispersing agents. Pharmaceutical compositions for injection include aqueous solutions of water-soluble forms of active ingredients (such as a salt of an active compound), preferably in physiologically compatible buffers containing other excipients or auxiliaries, as known in the pharmaceutical formulation art.
Para administração oral incluindo soluções (a forma maisfacilmente disponível de absorção), emulsões, suspensões, pastas, géis,cápsulas, pastilhas, misturas, pós, grânulos, blocos de retenção no rume eblocos de alimentação/água/lambedura, um composto de acordo com apresente invenção pode ser formulado com aglutinantes/cargas conhecidos natécnica que sejam apropriados para composições para administração oral, taiscomo açúcares (como lactose, sacarose, manitol, sorbitol), amido (tais comoamido de milho, amido de trigo, amido de arroz, amido de batata), celulose ederivados (tais como metilcelulose, carboximetilcelulose, etil hidroxicelulose),derivados de proteína (tais como zeina e gelatina) e polímeros sintéticos (taiscomo álcool polivinílico, polivinilpirrolidona). Se desejado, lubrificantes (taiscomo estearato de magnésio), agentes desintegrantes (tais comopolivinilpirrolidinona reticulada, agar, ácido algínico) e tinturas ou pigmentospodem ser adicionados. Pastas e géis freqüentemente também contêmadesivos (tais como acácia, ácido algínico, bentonita, celulose, goma xantana,silicato de alumínio e magnésio coloidal) para ajudar a manter a composiçãoem contato com a cavidade oral sem que seja facilmente ejetada.For oral administration including solutions (the most readily available form of absorption), emulsions, suspensions, pastes, gels, capsules, lozenges, mixtures, powders, granules, retention blocks and feed / water / licking blocks, a compound according to The present invention may be formulated with art-known binders / fillers that are suitable for compositions for oral administration, such as sugars (such as lactose, sucrose, mannitol, sorbitol), starch (such as cornstarch, wheat starch, rice starch, potato), derived cellulose (such as methylcellulose, carboxymethylcellulose, ethyl hydroxycellulose), protein derivatives (such as zein and gelatin) and synthetic polymers (such as polyvinyl alcohol, polyvinylpyrrolidone). If desired, lubricants (such as magnesium stearate), disintegrating agents (such as cross-linked polyvinylpyrrolidinone, agar, alginic acid) and dyes or pigments may be added. Pastes and gels often also contain adhesives (such as acacia, alginic acid, bentonite, cellulose, xanthan gum, aluminum silicate and colloidal magnesium) to help keep the composition in contact with the oral cavity without being easily ejected.
Caso as composições parasiticidas encontrem-se na forma deconcentrados alimentares, o veículo é tipicamente selecionado a partir dealimentos de alto desempenho, cereais alimentícios ou concentrados deproteína. Essas composições que contêm concentrado alimentício podemcompreender, além dos ingredientes ativos parasiticidas, aditivos quepromovam a saúde ou crescimento animal, melhorando a qualidade da carnede animais para abate, ou úteis de outra forma para a criação de animais.Estes aditivos podem incluir, por exemplo, vitaminas, antibióticos,quimioterapêuticos, bactericidas, fungicidas, coccidicidas e hormônios.If the parasiticidal compositions are in food-centric form, the carrier is typically selected from high performance foods, food cereals or protein concentrates. Such feed concentrate compositions may comprise, in addition to the parasiticidal active ingredients, additives that promote animal health or growth, improve the quality of animal slaughter or otherwise useful for breeding. These additives may include, for example, vitamins, antibiotics, chemotherapeutic agents, bactericides, fungicides, coccidicides and hormones.
Descobriu-se que os compostos de acordo com a presenteinvenção possuem propriedades farmacocinéticas e farmacodinâmicasfavoráveis, fornecendo disponibilidade sistêmica a partir de administração orale ingestão. Após a ingestão pelo animal a ser protegido, portanto,concentrações eficazes como parasiticidas de compostos de acordo com apresente invenção no fluxo sangüíneo protegem o animal tratado contra pragassugadoras de sangue, tais como pulgas, camundongos e piolhos. Mereceobservação, portanto, uma composição de proteção de animais contra pragasparasitas invertebradas em uma forma para administração oral (ou seja, quecompreendem, além de uma quantidade eficaz como parasiticida de umcomposto de acordo com a presente invenção, um ou mais veículosselecionados a partir de aglutinantes e cargas apropriadas para administraçãooral e veículos de concentrados alimentícios).The compounds according to the present invention have been found to possess unfavorable pharmacokinetic and pharmacodynamic properties, providing systemic availability from administration or ingestion. After ingestion by the animal to be protected, therefore, parasiticidal effective concentrations of compounds of the present invention in blood flow protect the treated animal against blood pests such as fleas, mice and lice. Therefore, an animal protection composition against invertebrate pests in a form for oral administration deserves observation (i.e. comprising, in addition to a parasiticidal effective amount of a compound according to the present invention, one or more vehicles selected from binders and loads suitable for oral administration and food concentrate vehicles).
Formulações para administração local encontram-se tipicamentena forma de pó, creme, suspensão, pulverização, emulsão, espuma, pasta,aerossol, ungüento, pomada ou gel. Mais tipicamente, uma formulação local éuma solução hidrossolúvel, que pode apresentar-se na forma de umconcentrado que é diluído antes do uso. As composições parasiticidasapropriadas para administração local compreendem tipicamente um compostode acordo com a presente invenção e um ou mais veículos apropriados parauso local. Em aplicações de uma composição parasiticida localmente ao ladoexterno de animais tal como linha ou ponto (ou seja, tratamento "de ponto"),espera-se que o ingrediente ativo migre sobre a superfície do ativo para cobrir,no todo ou em sua maior parte, a sua extensão externa. Como resultado, oanimal tratado é particularmente protegido contra pragas invertebradas que sealimentam da epiderme do animal, tais como percevejos, pulgas e piolhos.Formulações para administração localizada compreendem freqüentemente,portanto, pelo menos um solvente orgânico para facilitar o transporte doingrediente ativo sobre a pele e/ou a penetração na epiderme do animal.Solventes comumente utilizados como veículos nessas formulações incluempropileno glicol, parafinas, aromáticos, ésteres tais como miristato deisopropila, glicol éteres e álcoois tais como etanol e n-propanol.Formulations for local administration are typically in the form of powder, cream, suspension, spray, emulsion, foam, paste, aerosol, ointment, ointment or gel. More typically, a local formulation is a water soluble solution, which may be in the form of a concentrate that is diluted prior to use. Parasiticidal compositions suitable for local administration typically comprise a compound of the present invention and one or more vehicles suitable for local use. In applications of a parasiticidal composition locally to the external side of animals such as line or dot (i.e. "dot" treatment), the active ingredient is expected to migrate over the active surface to cover all or most of it. , its external extension. As a result, the treated animal is particularly protected against invertebrate pests that seal the animal's epidermis, such as bed bugs, fleas and lice. Formulations for localized administration therefore often comprise at least one organic solvent to facilitate active transport on the skin and / or penetration into the epidermis of the animal. Commonly used solvents as carriers in such formulations include propylene glycol, paraffins, aromatics, esters such as deisopropyl myristate, glycol ethers and alcohols such as ethanol and n-propanol.
A taxa de aplicação necessária para controle efetivo (ou seja,"quantidade biologicamente eficaz") dependerá de fatores tais como a espéciede invertebrado a ser controlada, o ciclo de vida da praga, estágio de vida, seutamanho, localização, época do ano, animal ou safra hospedeira,comportamento alimentar, comportamento de acasalamento, umidadeambiente, temperatura e similares. Sob circunstâncias normais, taxas deaplicação de cerca de 0,01 a 2 kg de ingrediente ativo por hectare sãosuficientes para controlar pragas em ecossistemas agronômicos, mas até0,0001 kg/hectare podem ser suficientes ou até 8 kg/hectare podem sernecessários. Para aplicações não agronômicas, taxas de uso eficazes variarãode cerca de 1,0 a 50 mg/metro quadrado, mas até 0,1 mg/metro quadradopodem ser suficientes ou até 150 mg/metro quadrado podem ser necessários.Os técnicos no assunto podem determinar facilmente a quantidadebiologicamente eficaz necessária para o nível desejado de controle de pragasinvertebradas.The application rate required for effective control (ie "biologically effective amount") will depend on factors such as the invertebrate species to be controlled, the pest life cycle, life stage, size, location, time of year, animal or host crop, feeding behavior, mating behavior, environmental humidity, temperature and the like. Under normal circumstances, application rates of about 0.01 to 2 kg of active ingredient per hectare are sufficient to control pests in agronomic ecosystems, but up to 0.0001 kg / hectare may be sufficient or up to 8 kg / hectare may be required. For non-agronomic applications, effective use rates will range from about 1.0 to 50 mg / square meter, but up to 0.1 mg / square meter may be sufficient or up to 150 mg / square meter may be required. easily the biologically effective amount required for the desired level of invertebrate pest control.
Geralmente, para uso veterinário, um composto da Fórmula 1, seu N-óxido ou sal é administrado em uma quantidade eficaz como parasiticida a umanimal a ser protegido contra pragas parasitas invertebradas. Uma quantidadeeficaz como parasiticida é a quantidade de ingrediente ativo necessária para atingirum efeito observável de redução da ocorrência ou atividade da praga parasitainvertebrada alvo. Os técnicos no assunto apreciarão que a dose eficaz comoparasiticida pode variar para os diversos compostos e composições de acordo coma presente invenção, o efeito parasiticida e a duração desejada, a espécie de pragainvertebrada alvo, o animal a ser protegido, o modo de aplicação e similares, e aquantidade necessária para atingir um resultado específico pode ser determinadapor meio de simples experimentação.Generally, for veterinary use, a compound of Formula 1, its N-oxide or salt is administered in a parasiticidal effective amount to a animal to be protected against invertebrate parasitic pests. An effective amount as a parasiticide is the amount of active ingredient required to achieve an observable effect of reducing the occurrence or activity of the target invertebrate parasitic pest. Those skilled in the art will appreciate that the effective dose for parasiticide may vary for the various compounds and compositions according to the present invention, the parasiticidal effect and desired duration, the target pest species, the animal to be protected, the mode of application and the like. The amount required to achieve a specific result can be determined by simple experimentation.
Para administração oral a animais homeotérmicos, a dosagemdiária de um composto de acordo com a presente invenção varia tipicamentede cerca de 0,01 mg/kg a cerca de 100 mg/kg, mais tipicamente cerca de 0,5mg/kg a cerca de 100 mg/kg, de peso do corpo do animal. Para administraçãolocal (tal como dérmica), mergulhantes e pulverizadores contêm tipicamentecerca de 0,5 ppm a cerca de 5000 ppm, mais tipicamente cerca de 1 ppm acerca de 3000 ppm, de um composto de acordo com a presente invenção.For oral administration to homeothermic animals, the daily dosage of a compound according to the present invention typically ranges from about 0.01 mg / kg to about 100 mg / kg, more typically about 0.5 mg / kg to about 100 mg. / kg body weight of the animal. For local administration (such as dermal), divers and sprays typically contain from about 0.5 ppm to about 5000 ppm, more typically about 1 ppm to about 3000 ppm, of a compound according to the present invention.
As abreviações a seguir são utilizadas nas Tabelas índice AaDque se seguem: CF3 indica trifluorometila, -CN é ciano e -NO2 é nitro. Aabreviação "Ex." representa "Exemplo" e é seguida por um número que indicaem qual exemplo é preparado o composto. Nas Tabelas índice A, B e C, (R2)mindica a combinação de (R2)n conforme exibido no caso em que Z é CR2conforme especificado para a Fórmula 1.The following abbreviations are used in the following Index Tables AaD: CF3 indicates trifluoromethyl, -CN is cyano and -NO2 is nitro. "Ex." represents "Example" and is followed by a number indicating which example is prepared the compound. In Index Tables A, B, and C, (R2) is the combination of (R2) n as shown in the case where Z is CR2 as specified for Formula 1.
Tabela Índice ATable Index A
<formula>formula see original document page 136</formula><table>table see original document page 137</column></row><table><formula> formula see original document page 136 </formula> <table> table see original document page 137 </column> </row> <table>
m.p.f°0m.p ° 0
Vide Tabela índice C para dados de NMR 1H.See Table C index for 1H NMR data.
Vide exemplo de síntese para dados de NMR 1H.See synthesis example for 1 H NMR data.
Tabela Índice BTable Index B
<formula>formula see original document page 137</formula><formula> formula see original document page 137 </formula>
Vide Tabela índice C para dados de NMR 1H.See Table C index for 1H NMR data.
Tabela Índice C<formula>formula see original document page 138</formula>Table Index C <formula> formula see original document page 138 </formula>
* Vide exemplo de síntese para dados de NMR 1H.Tabela Índice D* See synthesis example for 1H NMR data. Table Index D
<table>table see original document page 138</column></row><table><table>table see original document page 139</column></row><table><table> table see original document page 138 </column> </row> <table> <table> table see original document page 139 </column> </row> <table>
Os dados de NMR 1H são em ppm a partir de1H NMR data are in ppm from
tetrametilsilano. Os acoplamentos são designados por (s) isolado, (d) dupla, (t)trio, (m) múltiplo, (br s) isolado amplo, (br d) isolado duplo, (br t) triplo amplo,(dd) par de duplas e (dt) par de trios.tetramethylsilane. Couplings are referred to as (s) isolated, (d) double, (t) trio, (m) multiple, (br s) wide isolated, (br d) double isolated, (br t) triple wide, (dd) even of doubles and (dt) triplets.
Exemplos Biológicos da InvençãoBiological Examples of the Invention
Os Testes a seguir demonstram a eficácia de controle decompostos de acordo com a presente invenção sobre pragas específicas."Eficácia de controle" representa a inibição do desenvolvimento de pragasinvertebradas (incluindo a mortalidade) que causa alimentaçãosignificativamente reduzida. A proteção de controle de pragas oferecida peloscompostos não se limita, entretanto, a essas espécies. Vide as Tabelas índiceA a D para descrições de compostos.The following Tests demonstrate the efficacy of control decomposed in accordance with the present invention on specific pests. "Control effectiveness" represents the inhibition of the development of invertebrate pests (including mortality) that causes significantly reduced feeding. The pest control protection offered by the compounds is not limited, however, to these species. See tables indexA through D for compound descriptions.
Teste ATest A
Para avaliar o controle de traça das crucíferas (Plutella xylostellá),a unidade de teste consistiu de um pequeno recipiente aberto com uma plantade rabanete com doze a quatorze dias de idade no seu interior. Esta foipreviamente infestada com dez a quinze larvas neonatais sobre um pedaço dealimento para insetos, utilizando um amostrador central para remover umbatoque de uma folha de alimento para insetos endurecido que contém váriaslarvas crescendo sobre ela e transferir o batoque que contém larvas e alimentopara a unidade de teste. As larvas moveram-se para a planta de teste à medidaque o batoque de alimento secou.To evaluate the control of cruciferous moths (Plutella xylostellá), the test unit consisted of a small open container with a twelve to fourteen day old radish plant inside. It was previously infested with ten to fifteen neonatal larvae on an insect-feeding piece, using a central sampler to remove a bump from a hardened multi-larva insect food leaf growing on it and transfer the larvae-containing bung to the test unit. . The larvae moved to the test plant as the food bung dried.
Compostos de teste foram formulados utilizando uma soluçãocontendo 10% de acetona, 90% de água e 300 ppm de tensoativo não iônicoFórmula X-77® Spreader Lo-Foam contendo alquilarilpolioxietileno, ácidosgraxos livres, glicóis e isopropanol (Loveland Industries, Inc., Greeley,Colorado, Estados Unidos). Os compostos formulados foram aplicados em 1 mlde líquido por meio de um bocal atomizador SUJ2 com corpo customizado 1/8JJ (Spraying Systems Co., Wheaton, Illinois, Estados Unidos) posicionado a1,27 cm acima do topo de cada unidade de teste. Todos os compostosexperimentais nestes testes foram pulverizados a 50 ppm, o que foi repetidopor três vezes. Após a pulverização do composto de teste formulado, cadaunidade de teste foi mantida para secar por uma hora e, em seguida, umatampa com tela preta foi colocada sobre o topo. As unidades de teste forammantidas por seis dias em uma câmara de crescimento a 25 0C e umidaderelativa de 70%. O nível de eficácia de controle do composto de teste foideterminado visualmente em seguida com base nos danos por alimentação dafolhagem e na mortalidade das larvas de cada unidade de teste.Test compounds were formulated using a solution containing 10% acetone, 90% water and 300 ppm nonionic surfactant Formula X-77® Spreader Lo-Foam containing alkylaryl polyoxyethylene, free fatty acids, glycols and isopropanol (Loveland Industries, Inc., Greeley, Colorado, United States). The formulated compounds were applied to 1 ml of liquid by means of a 1 / 8JJ custom body SUJ2 atomizer nozzle (Spraying Systems Co., Wheaton, Illinois, United States) positioned at 1.27 cm above the top of each test unit. All experimental compounds in these tests were sprayed at 50 ppm, which was repeated three times. After spraying of the formulated test compound, each test unit was kept to dry for one hour and then a black screen cap was placed over the top. The test units were maintained for six days in a growth chamber at 25 ° C and 70% relative humidity. The control efficacy level of the test compound was then visually determined based on leaf feed damage and larval mortality of each test unit.
Dos compostos da Fórmula 1 testados, os seguintes forneceramníveis muito bons a excelentes de proteção das plantas (20% ou menos dedanos por alimentação ou 80% ou mais de mortalidade): 1, 2, 6, 10, 12, 13, 15,16, 18, 19 e 102.Of the compounds of Formula 1 tested, the following provided very good to excellent levels of plant protection (20% or less dietary damage or 80% or more mortality): 1, 2, 6, 10, 12, 13, 15,16 , 18, 19 and 102.
Teste BTest B
Para avaliação do controle de lagarta dos cereais de outono(Spodoptera frugiperda), a unidade de teste consistiu de um pequeno recipienteaberto com uma planta de milho com quatro a cinco dias de idade no seuinterior. Esta foi previamente infestada (utilizando um amostrador central) comdez a quinze larvas com um dia de idade sobre um pedaço de alimento deinsetos.For evaluation of caterpillar control of autumn cereals (Spodoptera frugiperda), the test unit consisted of a small open container with a four to five day old maize plant inside. It was previously infested (using a central sampler) with ten to fifteen day old larvae on a piece of insect food.
Os compostos de teste foram formulados e pulverizados a 250ppm conforme descrito para o Teste A e reproduzidos por três vezes. Após apulverização, as unidades de teste foram mantidas em uma câmara decrescimento e avaliadas visualmente em seguida conforme descrito para oTeste A.Test compounds were formulated and sprayed at 250ppm as described for Test A and reproduced three times. After spraying, the test units were kept in a decreasing chamber and then visually evaluated as described for Test A.
Dos compostos da Fórmula 1 testados, os seguintes forneceramníveis muito bons a excelentes de proteção das plantas (20% ou menos dedanos por alimentação ou 80% ou mais de mortalidade): 1,2, 16, 18 e 19.Of the compounds of Formula 1 tested, the following provided very good to excellent levels of plant protection (20% or less dietary damage or 80% or more mortality): 1,2, 16, 18 and 19.
Teste CC test
Para avaliação do controle de tripé das flores do oeste(,Frankliniella occidentalis) por meio de contato e/ou meios sistêmicos, aunidade de teste consistiu de um pequeno recipiente aberto com uma planta defeijão Longio com cinco a sete dias de idade no seu interior.For evaluation of the tripod control of western flowers (Frankliniella occidentalis) by contact and / or systemic means, the test unit consisted of a small open container with a five to seven day old Long defect plant inside.
Os compostos de teste foram formulados e pulverizados a 250ppm e repetidos por três vezes conforme descrito para o Teste A. Após apulverização, as unidades de teste foram mantidas para secar por uma hora e,em seguida, 22 a 27 tripés adultos foram adicionados a cada unidade e umatampa com tela preta foi colocada sobre ela em seguida. As unidades de testeforam mantidas por sete dias a 25 °C e umidade relativa de 45 a 55%. Foideterminada uma avaliação de mortalidade para cada unidade de teste.Test compounds were formulated and sprayed at 250ppm and repeated three times as described for Test A. After spraying, the test units were kept to dry for one hour and then 22 to 27 adult tripods were added each unit and a black screen cover was then placed on it. The test units were kept for seven days at 25 ° C and relative humidity 45 to 55%. A mortality assessment was determined for each test unit.
Dos compostos testados, os seguintes forneceram níveis muitobons a excelentes de proteção das plantas (20% ou menos de danos poralimentação ou 80% ou mais de mortalidade): 2, 12, 18 e 19.Of the compounds tested, the following provided very good levels of plant protection (20% or less of food damage or 80% or more of mortality): 2, 12, 18 and 19.
Teste DTest D
Para avaliação do controle de gafanhoto da batata (Empoascafabae Harris) por meio de contato e/ou meios sistêmicos, a unidade de testeconsistiu de um pequeno recipiente aberto com uma planta de feijão Soleil comcinco a seis dias de idade (folhas primárias emergiram) no seu interior.Adicionou-se areia branca ao topo do solo e uma das folhas primárias foiextirpada antes da aplicação. Os compostos de teste foram formulados epulverizados a 250 ppm e o teste foi reproduzido por três vezes conformedescrito para o Teste A. Após a pulverização, as undiades de teste forammantidas para secar por uma hora antes que fossem pós-infestadas com cincogafanhotos da batata (adultos com 18 a 21 dias de idade). Uma tampa pretacom tela foi colocada sobre o cilindro. As unidades de teste foram mantidas porseis dias em uma câmara de crescimento a 19-21 °C e umidade relativa de 50a 70%. A eficácia de controle de cada unidade de teste foi avaliada visualmenteem seguida por meio da mortalidade dos insetos.For evaluation of potato grasshopper (Empoascafabae Harris) control by contact and / or systemic means, the test unit consisted of a small open container with a six-day-old Soleil comcinco bean plant (primary leaves emerged) on its interior.White sand was added to the top of the soil and one of the primary leaves was excised before application. Test compounds were formulated and sprayed at 250 ppm and the test was reproduced three times as described for Test A. After spraying, the test strips were kept to dry for one hour before they were post-infested with potato cycoforms. 18 to 21 days old). A black cover with screen was placed over the cylinder. The test units were kept for six days in a growth chamber at 19-21 ° C and 50 to 70% relative humidity. The control efficacy of each test unit was assessed visually and then by insect mortality.
Dos compostos da Fórmula 1 testados, os seguintes forneceremníveis muito bons a excelentes de eficácia de controle (mortalidade de 70% oumais): 2, 12, 16, 18, 19 e 103.Of the compounds of Formula 1 tested, the following provide very good to excellent control efficacy (70% or greater mortality): 2, 12, 16, 18, 19 and 103.
Teste ETest E
Para avaliação do controle de afídeo do pêssego verde (Myzuspersicae) por meio de contato e/ou meios sistêmicos, a unidade de testeconsistiu de um pequeno recipiente aberto com uma planta de rabanete comdoze a quinze dias de idade no seu interior. Esta foi previamente infestada pormeio da colocação sobre uma folha da planta de teste de trinta a quarentaafídeos sobre um pedaço de folha extirpado de uma planta de cultivo (métodode folha cortada). As larvas moveram-se para a planta de teste à medida que opedaço de folha dissecava-se. Após a infestação prévia, o solo da unidade deteste foi coberto com uma camada de areia.For evaluation of green peach (Myzuspersicae) aphid control by contact and / or systemic means, the test unit consisted of a small open container with a radish plant twelve to fifteen days old inside. This was previously infested by placing on a leaf of the test plant thirty to forty aphids on a piece of extirpated leaf from a crop plant (cut leaf method). The larvae moved to the test plant as the leaf seed dissected. After the previous infestation, the soil of the detesting unit was covered with a layer of sand.
Todos os compostos de teste foram formulados e pulverizados a250 ppm conforme descrito para o Teste A e repetidos por três vezes. Após apulverização do composto de teste formulado, cada unidade de teste foimantida para secar por uma hora e, em seguida, uma tampa preta com tela foicolocada sobre o topo. As unidades de teste foram mantidas por seis dias emuma câmara de crescimento a 19-21 0C e 50 a 70% de umidade relativa. Cadaunidade de teste teve determinada em seguida a mortalidade de insetos.All test compounds were formulated and sprayed at 250 ppm as described for Test A and repeated three times. After spraying of the formulated test compound, each test unit was kept to dry for one hour and then a black cap with screen was placed over the top. The test units were maintained for six days in a growth chamber at 19-21 ° C and 50 to 70% relative humidity. Each test unit then determined the mortality of insects.
Dos compostos da Fórmula 1 testados, os seguintes resultaramem 50% ou mais de mortalidade: 2, 18 e 19.Teste FOf the compounds of Formula 1 tested, the following resulted in 50% or more mortality: 2, 18, and 19. Test F
Para avaliação do controle de afídeo do melão e algodão (Aphysgossypii) por meio de contato e/ou meios sistêmicos, a unidade de testeconsistiu de um pequeno recipiente aberto com uma planta de algodão comseis a sete dias de idade no seu interior. Esta foi previamente infestada comtrinta a quarenta insetos sobre um pedaço de folha de acordo com o método defolha cortada descrito para o Teste Ceo solo da unidade de teste foi cobertocom uma camada de areia. Os compostos de teste foram formulados epulverizados a 250 ppm conforme descrito para o Teste A. As aplicações foramrepetidas por três vezes. Após a pulverização do composto de teste formulado,cada unidade de teste foi mantida para secar por uma hora e, em seguida, foicolocada uma tampa com tela preta sobre ela. As unidades de teste forammantidas por seis dias em uma câmara de crescimento a 19-21 0C e umidaderelativa de 50 a 70%. Cada unidade de teste foi avaliada visualmente emseguida para determinar a mortalidade dos insetos.For evaluation of the control of aphid of melon and cotton (Aphysgossypii) by contact and / or systemic means, the test unit consisted of a small open container with a seven-day-old cotton plant in its interior. It was previously infested with thirty insects on a piece of leaf according to the cut leaf method described for the Test and the soil of the test unit was covered with a layer of sand. Test compounds were formulated sprayed at 250 ppm as described for Test A. Applications were repeated three times. After spraying of the formulated test compound, each test unit was kept to dry for one hour and then a black screen cap was placed over it. Test units were maintained for six days in a growth chamber at 19-21 ° C and a relative humidity of 50 to 70%. Each test unit was then visually evaluated to determine insect mortality.
Dos compostos da Fórmula 1 testados, os seguintes resultaramem 50% ou mais de mortalidade: 16, 18 e 19.Of the compounds of Formula 1 tested, the following resulted in 50% or more mortality: 16, 18 and 19.
Teste GG test
Para avaliação do controle da pulga dos gatos (Ctenocephalidesfelis, Bouche), um camundongo CD-1® (cerca de 30 g, macho, obtido por meiode Charles River Laboratories, Wilmington MA) recebeu dosagem oral de umcomposto de teste a 30 ppm solubilizado em propileno glicol/glicerol formal(60:40). Duas horas após a administração oral do composto de teste, cerca deoito a dezesseis pulgas adultas foram aplicadas a cada camundongo. Aspulgas foram avaliadas em seguida para determinar a mortalidade 48 horasapós a aplicação de pulga ao camundongo.For evaluation of cat flea control (Ctenocephalidesfelis, Bouche), a CD-1® mouse (about 30 g male, obtained from Charles River Laboratories, Wilmington MA) received oral dosing of a 30 ppm test compound solubilized in propylene glycol / glycerol formal (60:40). Two hours after oral administration of the test compound, about eighteen to sixteen adult fleas were applied to each mouse. Fleas were then evaluated to determine mortality 48 hours after flea application to the mouse.
Dos compostos testados, os compostos a seguir causarammortalidade de 50% ou mais: 1, 2, 12, 13, 16, 18, 19 e 102.Of the compounds tested, the following compounds caused mortality of 50% or more: 1, 2, 12, 13, 16, 18, 19 and 102.
Claims (27)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US79347606P | 2006-04-20 | 2006-04-20 | |
| US60/793,476 | 2006-04-20 | ||
| PCT/US2007/009181 WO2007123853A2 (en) | 2006-04-20 | 2007-04-13 | Five-membered heterocyclic invertebrate pest control agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0710380A2 true BRPI0710380A2 (en) | 2011-08-09 |
Family
ID=38625525
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0710380-8A BRPI0710380A2 (en) | 2006-04-20 | 2007-04-13 | compound, composition, pest control composition, invertebrate, spray, bait, trap device, control methods, protection methods, treated seed and protection composition |
Country Status (5)
| Country | Link |
|---|---|
| CN (1) | CN101426769A (en) |
| AU (1) | AU2007240952A1 (en) |
| BR (1) | BRPI0710380A2 (en) |
| MX (1) | MX2008013305A (en) |
| WO (1) | WO2007123853A2 (en) |
Families Citing this family (62)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2183228B1 (en) | 2007-07-26 | 2014-08-20 | Vitae Pharmaceuticals, Inc. | CYCLIC INHIBITORS OF 11ß -HYDROXYSTERIOD DEHYDROGENASE 1 |
| AR069207A1 (en) | 2007-11-07 | 2010-01-06 | Vitae Pharmaceuticals Inc | CYCLIC UREAS AS INHIBITORS OF THE 11 BETA - HIDROXI-ESTEROIDE DESHIDROGENASA 1 |
| CA2708303A1 (en) | 2007-12-11 | 2009-06-18 | Vitae Pharmaceuticals, Inc. | Cyclic urea inhibitors of 11.beta.-hydroxysteroid dehydrogenase 1 |
| TW200934490A (en) | 2008-01-07 | 2009-08-16 | Vitae Pharmaceuticals Inc | Lactam inhibitors of 11 &abgr;-hydroxysteroid dehydrogenase 1 |
| WO2009094169A1 (en) | 2008-01-24 | 2009-07-30 | Vitae Pharmaceuticals, Inc. | Cyclic carbazate and semicarbazide inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
| AU2009211909A1 (en) | 2008-02-07 | 2009-08-13 | Bayer Cropscience Ag | Insecticidal arylpyrrolines |
| US8598160B2 (en) | 2008-02-15 | 2013-12-03 | Vitae Pharmaceuticals, Inc. | Cycloalkyl lactame derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| JP5538356B2 (en) * | 2008-03-18 | 2014-07-02 | ヴァイティー ファーマシューティカルズ,インコーポレイテッド | Inhibitors of 11β-hydroxysteroid dehydrogenase type 1 |
| AR071236A1 (en) | 2008-05-01 | 2010-06-02 | Vitae Pharmaceuticals Inc | CYCLE INHIBITORS OF 11BETA-HYDROXIESTEROID DEHYDROGENASE 1 |
| CL2009001059A1 (en) | 2008-05-01 | 2010-11-12 | Boehringer Ingelheim Int | Compounds derived from substituted 1,3-oxazin-2-one-3.6, inhibitors of the activity of 11-beta-hydroxysteroid dehydrogenase i; pharmaceutical composition that includes them; Useful in the treatment of diseases such as diabetes mellitus, among others. |
| US8846668B2 (en) | 2008-07-25 | 2014-09-30 | Vitae Pharmaceuticals, Inc. | Inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
| WO2010011314A1 (en) | 2008-07-25 | 2010-01-28 | Boehringer Ingelheim International Gmbh | Cyclic inhibitors of 11 beta-hydroxysteroid dehydrogenase 1 |
| CA2744946A1 (en) | 2009-02-04 | 2010-08-12 | Boehringer Ingelheim International Gmbh | Cyclic inhibitors of 11.beta.-hydroxysteroid dehydrogenase 1 |
| JP5747440B2 (en) | 2009-02-06 | 2015-07-15 | 住友化学株式会社 | Hydrazide compound and its use for pest control |
| UA109255C2 (en) | 2009-04-30 | 2015-08-10 | Берінгер Інгельхайм Інтернешнл Гмбх | Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
| WO2010131881A2 (en) * | 2009-05-12 | 2010-11-18 | 성균관대학교 산학협력단 | Bifunctional organic chiral catalyst compound with superior stereoselectivity, method for preparing same, and method for preparing chiral amino acids from azlactone using same |
| US8410141B2 (en) | 2009-05-19 | 2013-04-02 | Bayer Cropscience Ag | Insecticidal arylpyrrolines |
| EP2440537A1 (en) | 2009-06-11 | 2012-04-18 | Vitae Pharmaceuticals, Inc. | Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 based on the 1,3 -oxazinan- 2 -one structure |
| JPWO2011007819A1 (en) | 2009-07-17 | 2012-12-27 | 塩野義製薬株式会社 | Pharmaceuticals containing lactam or benzenesulfonamide compounds |
| WO2011016559A1 (en) * | 2009-08-07 | 2011-02-10 | 武田薬品工業株式会社 | Heterocyclic compound and use thereof |
| CN102017993A (en) * | 2009-09-22 | 2011-04-20 | 南京华洲药业有限公司 | Synergistic insecticidal compound containing pymetrozine and chlorpyrifos-methyl and application thereof |
| JP2011093855A (en) * | 2009-10-30 | 2011-05-12 | Bayer Cropscience Ag | Insecticidal oxazolidinone derivative |
| TWI487486B (en) | 2009-12-01 | 2015-06-11 | Syngenta Participations Ag | Insecticidal compound based on isoxazoline derivatives |
| NZ601638A (en) * | 2010-02-22 | 2014-07-25 | Syngenta Participations Ag | Dihydrofuran derivatives as insecticidal compounds |
| CN102197822A (en) * | 2010-03-23 | 2011-09-28 | 中农立华生物科技股份有限公司 | Flubendiamide and Chlorpyrifos mixed emulsion |
| US8933072B2 (en) | 2010-06-16 | 2015-01-13 | Vitae Pharmaceuticals, Inc. | Substituted 5-,6- and 7-membered heterocycles, medicaments containing such compounds, and their use |
| JP5813106B2 (en) | 2010-06-25 | 2015-11-17 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Azaspirohexanone as an inhibitor of 11-β-HSD1 for the treatment of metabolic disorders |
| AU2011205081A1 (en) | 2010-08-03 | 2012-02-23 | Sumitomo Chemical Company Limited | Pest control composition |
| EP2601835A4 (en) | 2010-08-03 | 2014-01-15 | Sumitomo Chemical Co | COMPOSITION FOR THE CONTROL OF PESTS |
| EP2601837A4 (en) | 2010-08-03 | 2014-01-15 | Sumitomo Chemical Co | COMPOSITION FOR THE CONTROL OF PESTS |
| US20130131118A1 (en) | 2010-08-03 | 2013-05-23 | Sumitomo Chemical Company, Limited | Pest control composition |
| EP2601836A4 (en) | 2010-08-03 | 2014-01-15 | Sumitomo Chemical Co | COMPOSITION FOR THE CONTROL OF PESTS |
| BR112013007056A2 (en) | 2010-10-01 | 2019-09-24 | Basf Se | imine compounds |
| PH12013500808A1 (en) | 2010-11-02 | 2015-10-07 | Boehringer Ingelheim Int | Pharmaceutical combinations for the treatment of metabolic disorders |
| UY33887A (en) | 2011-02-03 | 2012-09-28 | Syngenta Ltd | PEST CONTROL METHODS IN SOYA |
| JP2012232910A (en) | 2011-04-28 | 2012-11-29 | Bayer Cropscience Ag | Pesticidal allyl heterocyclyl derivative |
| CN102217615A (en) * | 2011-05-24 | 2011-10-19 | 青岛海利尔药业有限公司 | Pesticide composition containing Spirotetramat and amide insecticides |
| TW201311677A (en) * | 2011-05-31 | 2013-03-16 | Syngenta Participations Ag | Insecticidal compounds |
| CN103732567A (en) * | 2011-08-22 | 2014-04-16 | 先正达参股股份有限公司 | Dihydrofuran derivatives as insecticidal compounds |
| US20140343049A1 (en) * | 2011-08-22 | 2014-11-20 | Syngenta Participations Ag | Dihydrofuran derivatives as insecticidal compounds |
| WO2013026939A1 (en) | 2011-08-25 | 2013-02-28 | Syngenta Participations Ag | Methods for the control of termites and ants |
| CN102379290B (en) * | 2011-09-13 | 2013-09-11 | 广西田园生化股份有限公司 | Ultralow volume liquid containing chlorantraniliprole |
| CN103238616A (en) * | 2012-02-13 | 2013-08-14 | 陕西美邦农药有限公司 | Insecticide composite containing metaflumizone and flubendiamide |
| CN103300019B (en) * | 2012-03-08 | 2015-06-24 | 中化蓝天集团有限公司 | Pesticidal composition |
| CN103518721A (en) * | 2012-06-12 | 2014-01-22 | 永农生物科学有限公司 | Compound pesticide composition containing spirodiclofen and flubendiamide and preparation thereof |
| CN103518732A (en) * | 2012-06-12 | 2014-01-22 | 永农生物科学有限公司 | Compound pesticide composition containing spirodiclofen and tolfenpyrad and preparation thereof |
| US9867375B2 (en) | 2012-07-31 | 2018-01-16 | Syngenta Participations Ag | Methods of pest control in soybean |
| US20150189883A1 (en) | 2012-08-03 | 2015-07-09 | Syngenta Participations Ag | Methods of controlling insects |
| CN104519739A (en) | 2012-08-03 | 2015-04-15 | 先正达参股股份有限公司 | Methods of pest control in soybean |
| WO2014019957A2 (en) | 2012-08-03 | 2014-02-06 | Syngenta Participations Ag | Methods of pest control in soybean |
| BR112015003630A2 (en) | 2012-08-24 | 2017-07-04 | Syngenta Participations Ag | insect control methods |
| CN104582487B (en) | 2012-08-24 | 2019-05-31 | 先正达参股股份有限公司 | Methods of Controlling Insects |
| ES2736314T3 (en) | 2012-08-24 | 2019-12-27 | Syngenta Participations Ag | Methods to control elaterid worms |
| CN103651497A (en) * | 2012-08-29 | 2014-03-26 | 南京华洲药业有限公司 | Synergistic insecticidal composition containing clothianidin and flubendiamide and application of synergistic insecticidal composition |
| CN103734177B (en) * | 2013-12-30 | 2015-08-05 | 徐茂航 | A kind of Pesticidal combination containing fipronil bisamide |
| CN103704262B (en) * | 2013-12-30 | 2015-10-14 | 顾祥茂 | A kind of Pesticidal combination containing pymetrozine |
| CN103734179B (en) * | 2013-12-30 | 2016-01-13 | 南京南翔科技开发有限公司 | A kind of Fungicidal insecticidal composition containing bupirimate |
| PL3207023T3 (en) * | 2014-10-14 | 2020-01-31 | Syngenta Participations Ag | Process for the preparation of 1-(3,5-dichlorophenyl)-2,2,2-trifluoroethanone and derivatives thereof |
| WO2018192793A1 (en) | 2017-04-20 | 2018-10-25 | Basf Se | Substituted rhodanine derivatives |
| AU2018260098A1 (en) | 2017-04-26 | 2019-10-31 | Basf Se | Substituted succinimide derivatives as pesticides |
| CN107353189A (en) * | 2017-07-06 | 2017-11-17 | 荆门医药工业技术研究院 | Prepare 3,5 dichloro a(Trifluoromethyl)The method of styrene |
| EP3613736A1 (en) | 2018-08-22 | 2020-02-26 | Basf Se | Substituted glutarimide derivatives |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI97382C (en) * | 1988-03-04 | 1996-12-10 | Sankyo Co | Process for the preparation of 1,2,4-triazole derivatives useful as a drug |
| DE10114597A1 (en) * | 2001-03-23 | 2002-10-02 | Bayer Cropscience Gmbh | Arylisoxazoline derivatives, process for their preparation and their use as pesticides |
| DE60215644T2 (en) * | 2001-06-22 | 2007-02-15 | Dow Agrosciences Llc, Indianapolis | 2- (2,6-DISUBSTITUTED PHENYL) -4-ARYL-5-ALKYL-1,3-OXAZOLINE DERIVATIVES FOR USE AS INSECTICIDES AND ACARICIDES |
| DE10154515A1 (en) * | 2001-11-07 | 2003-05-15 | Bayer Cropscience Ag | DELTA · 1 · -pyrrolines |
-
2007
- 2007-04-13 MX MX2008013305A patent/MX2008013305A/en not_active Application Discontinuation
- 2007-04-13 AU AU2007240952A patent/AU2007240952A1/en not_active Abandoned
- 2007-04-13 CN CNA2007800141192A patent/CN101426769A/en active Pending
- 2007-04-13 WO PCT/US2007/009181 patent/WO2007123853A2/en not_active Ceased
- 2007-04-13 BR BRPI0710380-8A patent/BRPI0710380A2/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| WO2007123853A3 (en) | 2008-01-10 |
| MX2008013305A (en) | 2008-10-27 |
| AU2007240952A1 (en) | 2007-11-01 |
| WO2007123853A2 (en) | 2007-11-01 |
| CN101426769A (en) | 2009-05-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0710380A2 (en) | compound, composition, pest control composition, invertebrate, spray, bait, trap device, control methods, protection methods, treated seed and protection composition | |
| ES2445651T3 (en) | Isoxazoline insecticides | |
| KR101411775B1 (en) | 5-aryl isoxazolines for controlling invertebrate pests | |
| RU2433123C2 (en) | Isoxazolines for invertebrate pest control | |
| ES2399572T3 (en) | Naxaphthalene isoxazoline compounds for the control of invertebrate pests | |
| TWI430995B (en) | Naphthalene isoxazoline invertebrate pest control agents | |
| CN102947278B (en) | 4-[5-[the chloro-5-of 3-(trifluoromethyl) phenyl]-4,5-dihydro-5-(trifluoromethyl)-3-isoxazolyl]-N-[2-oxo-2-[(2,2,2-trifluoroethyl) amino] ethyl] crystalline form of-1-naphthoamide | |
| BRPI0710403A2 (en) | compound composition, control composition, spraying, bait, trap device, control methods, protection methods, treated seed, protective composition | |
| BRPI0620668A2 (en) | compound of formula 1, composition comprising compound, invertebrate pest control composition, spray composition, bait composition, trap device, invertebrate pest control methods, cockroach, ants or termites control method and protection method. seeds against invertebrate pests | |
| ES2737404T3 (en) | Bicyclic Pyrazole Pesticides | |
| KR20120047996A (en) | Mesoionic pesticides | |
| KR102750692B1 (en) | Heterocycle-substituted bicyclic azole insecticides | |
| BR112019023474A2 (en) | compound, composition, method to control an invertebrate pest and treated seed | |
| CN101331127B (en) | 5-aryl isoxazolines for controlling invertebrate pests | |
| CN105745201B (en) | 1-aryl-3-alkylpyrazole insecticides | |
| KR102447284B1 (en) | Heterocycle-substituted bicyclic azole pesticides | |
| BR112018007034B1 (en) | COMPOUND, COMPOSITION, METHOD TO CONTROL AN INVERTEBRATE PEST AND COATED SEED | |
| CN101330828A (en) | Isoxazolines for the control of invertebrate pests | |
| KR20230048084A (en) | Triazolone compounds for controlling invertebrate pests | |
| JP2024505491A (en) | Azole compounds for controlling invertebrate pests | |
| KR20230027242A (en) | Chromenone compounds for invertebrate pest control |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE AS 3A, 4A E 5A ANUIDADES. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2161 DE 05/06/2012. |